False
True
[#8:1]-[#6:2]1:[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]>>[#6:2]1(-[#8]\[#6@@]2-[#6@](\[#8])-[#6@@](/[#8])-[#6@](\[#8])-[#6@@](/[#6]-[#7]=[#7;+]=[#7;-])-[#8]-2):[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]
C[C@H](O)CC(=O)c1c(C[C@@H](C)O)cc2cccc(O)c2c1O
CYP71BN1
C=C1/C=C/C(C)=C\c2csc(n2)C2(CC2)NC(=O)C[C@@](CC(=O)O)(SS)CC/C(C)=C/C1
doi:10.1046/j.1432-1327.2001.02038.x
Vmt
C=C/C(C)=C/C[C@H]1C(=C)CC[C@H]2C(C)(C)CCC[C@]12C
CSc1c(O)cc(-c2ccccn2)nc1/C=N/O
CC(C)[C@H]1CC=C2C[C@H](O)C[C@H](C)[C@@]2(C)C1
doi:10.1128/JB.187.6.2084-2092.2005
Substrate bound as thioester to coenzyme A
Cc1cc(O)c(C)c2c1C(=O)Oc1c(C)c(O)c(C(=O)O)c(C)c1O2
55896
Q194P8
Q194P9
N[C@H]1C(=O)N[C@@H]2Cc3ccc(c(Cl)c3)Oc3cc4cc(c3O[C@H]3C[C@@H](O)[C@H](O)[C@@H](CO)O3)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(O)cc(c2)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@@H](C(=O)O)NC3=O
CSCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CN)C(C)C)C(C)C)C(C)C)[C@@H](C)c1ccccc1)C(=O)O
COc1c(O)c(I)c(C)c(C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2OP(=O)(O)O)c1OC
Q194P6
Q194P7
Q194P4
[#6:4]\[#6:3](-[#6:5])=[#6:2]\[#6:1]-[#6:6]-[#6:7](-[#6:8])=[#6:9]-[#6:10]-[#6:11]\[#6:12](-[#6:13])=[#6:14]\[#6:15]-[#6:16]-[#6:17](-[#6:18])=[#6:19]-[#6:20]-[c:21]1[c:31][c:27]([c:26][c:24](-[#8:25])[c:22]1-[#8:23])-[#6:28](-[#8:29])=[O:30]>>[H:13][C@:12]12[#6:14]-[c:15]3[c:25]([c:21]([c:20][c:18](-[#8:19])[c:16]3-[#8:17])-[#6:22](-[#8:23])=[O:24])[C@:26]1([#6:27])[#6:28]-[#6:29][C@:30]1([H:31])[C@:10]2([#6:11])[#6:9]-[#6:8][C@:6]2([H:7])[C:3]([#6:4])([#6:5])[#6:2]-[#6:1]-[#6:34][C@@:32]12[#6:33]
CSCC[C@H](NC(=O)[C@@H]1CSC([C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2CCCN2C(=O)CN)C(C)C)C(C)C)C(C)C)=N1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)O
AlbA
Cc1ccc(C)c(C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2OP(=O)(O)O)c1O
AnkA is a gatekeeping enzyme (cyclodipeptide synthase, producing the cyclo-Arg-Tyr diketopiperazine) and not a tailoring enzyme and therefore out of scope of MITE.
MITE0000108
MITE0000109
The halogenase chlorinates the bht residue of the balhimycin precursor, probably while the precursor is bound to module 2 of the NRPS. The PCP domain is probably required for the reaction. The substrate specificity of the enzyme might be less specific than represented in the SMARTS pattern. In order to make the specificity not too broad structures were rather kept in the pattern than left out.
[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\[#8:24])-[#6@@:21](/[#8:22])-[#6@:19](\[#8:20])-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3].[#6:91]/[#6@:92]1-[#6@:124](\[#8:125])-[#6@:121](-[#7:123])(\[#6:122])-[#6:120]-[#6@@:94](/[#8:95]-[#15:96](-[#8:99]-[#15:100](-[#8:103]-[#6:104]\[#6@@:105]2-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\[#7:108]3:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:3)-[#8:106]-2)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97])-[#8:93]-1>>[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\[#8:24]/[#6@@:94]2-[#6:120]-[#6@@:121](-[#6@@:124](\[#8:125])-[#6@@:92](-[#8:93]-2)/[#6:91])(-[#7:123])\[#6:122])-[#6@@:21](/[#8:22])-[#6@:19](\[#8:20])-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3].[#15:96](-[#8])(-[#8:99]-[#15:100](-[#8:103]-[#6:104]\[#6@@:105]1-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\[#7:108]2:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:2)-[#8:106]-1)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97]
MITE0000100
MITE0000101
MITE0000102
MITE0000103
MITE0000104
MITE0000105
MITE0000106
CSCC[C@H](NC(=O)[C@@H]1CSC([C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](/N=C2\NCC(=O)N3CC[C@H](C)[C@H]3C(=O)N[C@@H](C(C)C)C(=O)N[C@H]2C(C)(C)C)C(C)(C)C)[C@@H](C)c2ccccc2)=N1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)O
CC(C)C[C@@H](N)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H](c3ccc(O)cc3)C(=O)N[C@H](C=O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O)Oc2ccc(cc2Cl)[C@H]1O
MITE0000107
4.1.1.52
[#6:1]-[#6:2]-[#6@H:3]1-[#8:4]-[#6:5](=[O:6])-[#6@@H:7](-[#8:8])-[#6:9]-[#6:10]-2-[#6:11]=[#6:12]-[#6:13]-3-[#6:14]-[#6@H:15](-[#8:16])-[#6@H:17](-[#6:18])-[#6@H:19](-[#8:20])-[#6:21]-3-[#6:22]-2\[#6:23](-[#6:24])=[#6:25]\[#6@H:26]-1-[#6:27]>>[#6:1]-[#6@H:2](-[#8:3])-[#6@H:4]1-[#8:5]-[#6:6](=[O:7])-[#6@@H:8](-[#8:9])-[#6:10]-[#6:11]-2-[#6:12]=[#6:13]-[#6:14]-3-[#6:15]-[#6@H:16](-[#8:17])-[#6@H:18](-[#6:19])-[#6@H:20](-[#8:21])-[#6:22]-3-[#6:23]-2\[#6:24](-[#6:25])=[#6:26]\[#6@H:27]-1-[#6:28]
4-DPMC is the first stable intermediate of the mithramycin biosynthesis. This is converted into PMC by methylation at C-4-O through the MtmMI methyltransferase in Streptomyces argillaceus
CO[C@@H]1C(O)=C(C(C)=O)C(=O)[C@@]2(OC3CC(OC4CC(O)C(O)C(C)O4)C(O)C(C)O3)C(=O)c3c(cc4cc(O)cc(O)c4c3O)CC12
MpaG
Reaction with TDP-glucose and vancomycin intermediate as substrates.
CO[C@H]1C[C@H]2C=C[C@@H]3C[C@H](O)[C@H](C)[C@H](O)[C@H]3[C@@H]2C(C)=C[C@@H](C)[C@@H]([C@H](C)O)OC1=O
N=C(N)NCCC[C@@H]1NC(=O)C(=Cc2ccc(O)c(OCC[C@H](NC(=O)C[C@](O)(CC(=O)O)C(=O)O)C(=O)O)c2)NC1=O
[#6:1]-[#6:2]1:[#6:20]:[#6:17](-[#6:18]-[#8:19]):[#6:6](-[#6:7](-[#6:9]2:[#6:15](-[#8:16]):[#6:14]:[#6:13]:[#6:12]:[#6:10]:2-[#8:11])=[#8:8]):[#6:4](-[#8:5]):[#6:3]:1>>[#6:1]-[#6:2]1-[#6@@:20](/[#8])-[#6:17](-[#6:18]-[#8:19])=[#6:6](-[#6:7](-[#6:9]2:[#6:15](-[#8:16]):[#6:14]:[#6:13]:[#6:12]:[#6:10]:2-[#8:11])=[#8:8])-[#6:4](=[#8:5])-[#6:3]=1
Bottromycin-precursor acting rSAM methyltransferase from Streptomyces sp. BC16019;C-methylation of Pro2 of bottromycin A2.
[#7:1]/[#6@:2](-[#6:97]-[#6:98](-[#6:100])-[#6:99])-[#6:3](=[#8:96])-[#7:4]\[#6@:5]1-[#6:94](=[#8:95])-[#7:93]-[#6@@:88](\[#6:89]-[#6:90](-[#7:92])=[#8:91])-[#6:86](=[#8:87])-[#7:85]-[#6@:44]2-[#6:45](=[#8:84])-[#7:46]/[#6@:47]3-[#6:82](=[#8:83])-[#7:81]-[#6@@:70](-[#6@@:71](/[#8:80])-[#6:72]4:[#6:79]:[#6:77](-[Cl:78]):[#6:75](-[#8:76]-[#6:40]5:[#6:41]:[#6:42]/2:[#6:43]:[#6:16](:[#6:17]:5-[#8:18]\[#6@:19]2-[#8:39]-[#6@:36](/[#6:37]-[#8:38])-[#6@@:34](\[#8:35])-[#6@:32](/[#8:33])-[#6@:20]-2\[#8:21]\[#6@:22]2-[#6:31]-[#6@:28](-[#6:30])(/[#7:29])-[#6@:26](/[#8:27])-[#6@:24](/[#6:25])-[#8:23]-2)-[#8:15]-[#6:12]2:[#6:13]:[#6:14]:[#6:8](:[#6:9]:[#6:10]:2-[Cl:11])-[#6@@:6]-1/[#8:7]):[#6:74]:[#6:73]:4)/[#6:68](=[#8:69])-[#7:67]-[#6@:63](/[#6:64](=[#8:66])-[#8:65])-[#6:56]1:[#6:57]:[#6:58](-[#8:62]):[#6:59]:[#6:60](-[#8:61]):[#6:55]:1-[#6:53]1:[#6:54]:[#6:48]-3:[#6:49]:[#6:50]:[#6:51]:1-[#8:52]>>[#7:1](-[#6])(/[#6@@:2](-[#6:3](-[#7:4]\[#6@@:5]1-[#6@@:6](/[#8:7])-[#6:8]2:[#6:9]:[#6:10](-[Cl:11]):[#6:12](:[#6:13]:[#6:14]:2)-[#8:15]-[#6:16]2:[#6:17](-[#8:18]\[#6@@:19]3-[#6@:20](\[#8:21]\[#6@@:22]4-[#8:23]-[#6@@:24](/[#6:25])-[#6@@:26](/[#8:27])-[#6@:28](-[#7:29])(\[#6:30])-[#6:31]-4)-[#6@@:32](/[#8:33])-[#6@:34](\[#8:35])-[#6@@:36](/[#6:37]-[#8:38])-[#8:39]-3):[#6:40]3:[#6:41]:[#6:42](:[#6:43]:2)-[#6@:44](-[#6:45](-[#7:46]\[#6@@:47]2-[#6:48]4:[#6:49]:[#6:50]:[#6:51](-[#8:52]):[#6:53](:[#6:54]:4)-[#6:55]4:[#6:56](:[#6:57]:[#6:58](:[#6:59]:[#6:60]:4-[#8:61])-[#8:62])-[#6@@:63](\[#6:64](-[#8:65])=[#8:66])-[#7:67]-[#6:68](=[#8:69])-[#6@:70](-[#6@:71](-[#6:72]4:[#6:73]:[#6:74]:[#6:75](-[#8:76]-3):[#6:77](-[Cl:78]):[#6:79]:4)\[#8:80])\[#7:81]-[#6:82]-2=[#8:83])=[#8:84])\[#7:85]-[#6:86](=[#8:87])-[#6@:88](\[#6:89]-[#6:90](=[#8:91])-[#7:92])-[#7:93]-[#6:94]-1=[#8:95])=[#8:96])-[#6:97]-[#6:98](-[#6:100])-[#6:99])-[#6]
C/C1=C\[C@@H](C)[C@@H]([C@H](C)O)OC(=O)[C@@H](O)C[C@H]2C=C[C@@H]3C[C@H](O)[C@H](C)[C@H](O)[C@H]3[C@H]12
[#6:1]1(/[#6@@:9]2-[#8:33]-[#6:31](=[#8:32])-[#6:30]-[#6@:28](/[#8:29])-[#6@@:26](\[#6:27])-[#6:25]-[#6@@:23](\[#6:24])-[#6:22]-[#6@@:20](\[#6:21])-[#6:19]-[#6@:17](/[#6:18])-[#6@@:15](/[#8:16])-[#6:13](-[#6:14])=[#6:12]-[#6:34]=[#6:11]-[#6:10]-2)-[#6@@:5](\[#6:6](=[#8:8])-[#8:7])-[#6:4]-[#6:3]-[#6:2]-1>>[#6:1]1(/[#6@@:9]2-[#8:33]-[#6:31](=[#8:32])-[#6:30]-[#6@:28](/[#8:29])-[#6@@:26](\[#6:27])-[#6:25]-[#6@@:23](\[#6:24])-[#6:22]-[#6@@:20](\[#6:21])-[#6:19]-[#6@:17](/[#6:18])-[#6@@:15](/[#8:16])-[#6:13](-[#6:14]-[#8])=[#6:12]-[#6:34]=[#6:11]-[#6:10]-2)-[#6@@:5](\[#6:6](=[#8:8])-[#8:7])-[#6:4]-[#6:3]-[#6:2]-1
AYN62308.1
putative methyltransferase
Oxidation terminal methyl
ClmM1
[#6:1]-[#8:2]\[#6@:3]1-[#6:68]2-[#6@@:12](-[#6:42](-[#6:44]3:[#6:65](-[#8:66]):[#6:64]4:[#6:47](:[#6:48]:[#6:49](:[#6:60](:[#6:62]:4-[#8:63])-[#6:61])-[#8:50]-[#6:51]4-[#8:59]-[#6:57](-[#6:58])-[#6:55](-[#8:56])-[#6:53](-[#8:54])-[#6:52]-4):[#6:46]:[#6:45]:3-[#6:67]-2)=[#8:43])(\[#8:13]-[#6:14]2-[#8:41]-[#6:39](-[#6:40])-[#6:37](-[#8:38])-[#6:16](-[#8:17]-[#6:18]3-[#8:36]-[#6:34](-[#6:35])-[#6:32](-[#8:33])-[#6:20](-[#8:21]-[#6:22]4-[#8:31]-[#6:29](-[#6:30])-[#6:27](-[#8:28])-[#6:24](-[#8:26])(-[#6:25])-[#6:23]-4)-[#6:19]-3)-[#6:15]-2)-[#6:10](=[#8:11])-[#6:6](-[#6:7](=[#8:9])-[#6:8])=[#6:4]-1-[#8:5]>>[#6:1]-[#8:2]\[#6@:3]1-[#6:68]2-[#6@@:12](-[#6:42](-[#6:44]3:[#6:65](-[#8:66]):[#6:64]4:[#6:47](:[#6:48]:[#6:49](:[#6:60](:[#6:62]:4-[#8:63])-[#6:61])-[#8:50]-[#6:51]4-[#8:59]-[#6:57](-[#6:58])-[#6:55](-[#8:56]-[#6]5-[#6]-[#6](-[#8])-[#6](-[#8])-[#6](-[#6])-[#8]-5)-[#6:53](-[#8:54])-[#6:52]-4):[#6:46]:[#6:45]:3-[#6:67]-2)=[#8:43])(\[#8:13]-[#6:14]2-[#8:41]-[#6:39](-[#6:40])-[#6:37](-[#8:38])-[#6:16](-[#8:17]-[#6:18]3-[#8:36]-[#6:34](-[#6:35])-[#6:32](-[#8:33])-[#6:20](-[#8:21]-[#6:22]4-[#8:31]-[#6:29](-[#6:30])-[#6:27](-[#8:28])-[#6:24](-[#8:26])(-[#6:25])-[#6:23]-4)-[#6:19]-3)-[#6:15]-2)-[#6:10](=[#8:11])-[#6:6](-[#6:7](=[#8:9])-[#6:8])=[#6:4]-1-[#8:5]
ClmM2
COC12C(=O)C(C(N)=O)=C(O)C(O)C1CC1C(=C2O)C(=O)c2c(ccc(C3CC(O)C(O)C(C)O3)c2O)C1(C)O
UPI00206D4B6A
[#6:1]\[#6@:2]1-[#6@:22](/[#8:23])-[#6@@:18](-[#6:20]=[#6:21])(\[#6:19])-[#6:17]-[#6@@:15](\[#8:16])-[#6@:9]2(\[#6:14])-[#6@@:10](-[#6:12]-[#6:13]/[#6@@:3]3-1-[#6:7]-[#6:6]-[#6:5](=[#8:8])\[#6@:4]-3-2)/[#6:11]>>[#6:1]\[#6@:2]1-[#6@:22](/[#8:23])-[#6@@:18](-[#6:20]=[#6:21])(\[#6:19])-[#6:17]-[#6@@:15](\[#8:16]-[#6](=[#8])-[#6])-[#6@:9]2(\[#6:14])-[#6@@:10](-[#6:12]-[#6:13]/[#6@@:3]3-1-[#6:7]-[#6:6]-[#6:5](=[#8:8])\[#6@:4]-3-2)/[#6:11]
doi:10.1021/jacs.1c12778
MITE0000210
MITE0000211
[#6:1]-[#6:2]1-[#6@:15]2-[#6@:10]3(-[#6@@:11](-[#6:13]-[#6:14]\2)/[#6:12])-[#6:4](-[#6:5]-[#6:6](-[#6:9]/3)(-[#6:8])-[#6:7])-[#6:3]=1>>[#6:12]/[#6@:11]1-[#6@@:10]23-[#6@:15](-[#6:2](=[#6:3]-[#6:4]-2-[#6:5]-[#6:6](-[#6:9]/3)(-[#6:7])-[#6:8])-[#6:1]=[#8])\[#6:14]-[#6:13]-1
[#6:1]-[#6:2](-[#6:4]-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]-[#6:17]1:[#6:24]:[#6:22](-[#8:23]):[#6:21]:[#6:19](-[#8:20]):[#6:18]:1)-[#6:3]>>[#6:3]-[#6:2](-[#6:4]-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]-[#6:17]1:[#6:18](-[#8]):[#6:19](-[#8:20]):[#6:21]:[#6:22](-[#8:23]):[#6:24]:1)-[#6:1]
[#8:1]-[#6:2]1:[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]>>[#6:2]1(-[#8]/[#6@@]2-[#8]-[#6@](\[#6]-[#8])-[#6@@](/[#8])-[#6@](\[#8])-[#6]-2):[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]
WPM83319.1
WPM83320.1
WPM83322.1
WPM83325.1
Catalyzes oxidation of pentalen-13-al in the neopentalenolactone pathway
WPM83323.1
B0BLM5
WPM83321.1
[#6:19](-[#6:20]1-[#7:28]-[#6:26](=[#8:27])-[#6:24](-[#6:25]-[#6:10]2:[#6:18]:[nH1:17]:[#6:16]3:[#6:11]:2:[#6:12]:[#6:13]:[#6:14]:[#6:15]:3)-[#7:23]-[#6:21]-1=[#8:22])-[#6:1]1:[#6:2]:[nH1:3]:[#6:4]2:[#6:9]:1:[#6:8]:[#6:7]:[#6:6]:[#6:5]:2>>[#6:19](=[#6:20]1-[#7:28]-[#6:26](=[#8:27])-[#6:24](=[#6:25]-[#6:10]2:[#6:18]:[nH1:17]:[#6:16]3:[#6:11]:2:[#6:12]:[#6:13]:[#6:14]:[#6:15]:3)-[#7:23]-[#6:21]-1=[#8:22])-[#6:1]1:[#6:2]:[nH1:3]:[#6:4]2:[#6:9]:1:[#6:8]:[#6:7]:[#6:6]:[#6:5]:2
B0BLM7
AFV25479.1
AFV25485.1
Carboxyl methyltransferase
AviG2 is responsible for methylation of the hydroxyl group at position 6 of the D-mannose moiety
RslO4
CCCCC[C@@H]1CC2=C(C(=O)OC2=O)[C@H](O)[C@H](CCCC)CC2=C1C(=O)OC2=O
[#6:1]-[#6:2](=[#6:4]-[#6:5]-[#6:6]-[#6:7](=[#6:9]-[#6:10](-[#6@@:12](-[#6@:14](-[#6@@:16]1(-[#6:21]2-[#6@:22](-[#6:24]/[#6@@:25]3-[#6@@:33](/[#6:34])(-[#6:20]=2-[#6:19]-[#6:18]-1)-[#6:32]-[#6:31]-[#6@:29](/[#8:30])-[#6:26]-3(-[#6:28])-[#6:27])/[#8:23])/[#6:17])\[#6:15])\[#8:13])=[#8:11])-[#6:8])-[#6:3]>>[#6]-[#6](-[#8:13]\[#6@:12](-[#6@:14](-[#6@@:16]1(-[#6:21]2-[#6@:22](-[#6:24]/[#6@@:25]3-[#6@@:33](/[#6:34])(-[#6:20]=2-[#6:19]-[#6:18]-1)-[#6:32]-[#6:31]-[#6@:29](/[#8:30])-[#6:26]-3(-[#6:28])-[#6:27])/[#8:23])/[#6:17])\[#6:15])-[#6:10](-[#6:9]=[#6:7](-[#6:6]-[#6:5]-[#6:4]=[#6:2](-[#6:1])-[#6:3])-[#6:8])=[#8:11])=[#8]
PntD
doi:10.1039/c9ob00807a
O=C(O)C(=O)C=CC1=CN[C@H](C(=O)O)C1
doi:10.1007/s10295-015-1694-6
FMN-dependent monooxygenase
P0DUK3
[#6:1]-[#8:2]-[#6:3]1-[#6:77]2-[#6:12](-[#6:42](-[#6:44]3:[#6:74](-[#8:75]):[#6:73]4:[#6:47](:[#6:48]:[#6:49](:[#6:69](:[#6:71]:4-[#8:72])-[#6:70])-[#8:50]-[#6:51]4-[#8:68]-[#6:66](-[#6:67])-[#6:64](-[#8:65])-[#6:53](-[#8:54]-[#6:55]5-[#8:63]-[#6:61](-[#6:62])-[#6:59](-[#8:60])-[#6:57](-[#8:58])-[#6:56]-5)-[#6:52]-4):[#6:46]:[#6:45]:3-[#6:76]-2)=[#8:43])(-[#8:13]-[#6:14]2-[#8:41]-[#6:39](-[#6:40])-[#6:37](-[#8:38])-[#6:16](-[#8:17]-[#6:18]3-[#8:36]-[#6:34](-[#6:35])-[#6:32](-[#8:33])-[#6:20](-[#8:21]-[#6:22]4-[#8:31]-[#6:29](-[#6:30])-[#6:27](-[#8:28])-[#6:24](-[#8:26])(-[#6:25])-[#6:23]-4)-[#6:19]-3)-[#6:15]-2)-[#6:10](=[#8:11])-[#6:6](-[#6:7](=[#8:9])-[#6:8])=[#6:4]-1-[#8:5]>>[#6:1]-[#8:2]-[#6:3]1-[#6:77]2-[#6:12](-[#6:42](-[#6:44]3:[#6:74](-[#8:75]):[#6:73]4:[#6:47](:[#6:48]:[#6:49](:[#6:69](:[#6:71]:4-[#8:72])-[#6:70])-[#8:50]-[#6:51]4-[#8:68]-[#6:66](-[#6:67])-[#6:64](-[#8:65])-[#6:53](-[#8:54]-[#6:55]5-[#8:63]-[#6:61](-[#6:62])-[#6:59](-[#8:60])-[#6:57](-[#8:58])-[#6:56]-5)-[#6:52]-4):[#6:46]:[#6:45]:3-[#6:76]-2)=[#8:43])(-[#8:13]-[#6:14]2-[#8:41]-[#6:39](-[#6:40])-[#6:37](-[#8:38])-[#6:16](-[#8:17]-[#6:18]3-[#8:36]-[#6:34](-[#6:35])-[#6:32](-[#8:33])-[#6:20](-[#8:21]-[#6:22]4-[#8:31]-[#6:29](-[#6:30])-[#6:27](-[#8:28])-[#6:24](-[#8:26])(-[#6:25])-[#6:23]-4)-[#6:19]-3)-[#6:15]-2)-[#6:10](=[#8:11])-[#8]-[#6:6](-[#6:7](=[#8:9])-[#6:8])=[#6:4]-1-[#8:5]
doi:10.1128/AEM.01225-20
CC(=O)O[C@H](C)Cc1cc2cccc(O)c2c(O)c1C(=O)C[C@H](C)O.CC(=O)O[C@H](C)Cc1cc2cccc(O)c2c(O)c1C(=O)C[C@H](C)O
[#6:1]1-[#6:15]-[#6@:13](\[#6:14])-[#6@@:4]2(\[#6:12])-[#6:5]-[#6@@:6](/[#6:9](-[#6:11])~[#6:10])-[#6:7]-[#6:8]=[#6:3]-2-[#6:2]-1>>[#6:1]1-[#6:15]-[#6@:13](\[#6:14])-[#6@@:4]2(\[#6:12])-[#6:5]-[#6@@:6](/[#6:9](~[#6:10])-[#6:11](=[#8])-[#8])-[#6:7]-[#6:8]=[#6:3]-2-[#6:2]-1
doi:10.1002/cbic.201000628
doi:10.1002/anie.201808028
doi:10.1002/cbic.200800823
[#6:1]-[#6:2](-[#6@@:10](/[#8:21])-[#6:11](-[#7:13]-[#6:14]-[#6:15]-[#6:16](-[#7:18]-[#6:19]-[#6:20]-[#16:22]-[#6:23](-[#6:25]1:[#6:34](-[#6:35]):[#6:32](-[I:33]):[#6:30](-[#8:31]):[#6:29]:[#6:26]:1-[#8:27]-[#6:28])=[#8:24])=[#8:17])=[#8:12])(-[#6:4]-[#8:5]-[#15:6](-[#8:9])(-[#8:8])=[#8:7])-[#6:3]>>[#6:3]-[#6:2](-[#6:1])(-[#6:4]-[#8:5]-[#15:6](=[#8:7])(-[#8:8])-[#8:9])-[#6@:10](-[#6:11](=[#8:12])-[#7:13]-[#6:14]-[#6:15]-[#6:16](=[#8:17])-[#7:18]-[#6:19]-[#6:20]-[#16:22]-[#6:23](=[#8:24])-[#6:25]1:[#6:26](-[#8:27]-[#6:28]):[#6:29](-[#8]):[#6:30](-[#8:31]):[#6:32](-[I:33]):[#6:34]:1-[#6:35])\[#8:21]
Cleavage of N-terminal Met from a NH2-Met-Gly-Pro-Xn chain, exposing a N-terminal Gly; bottromycin biosynthesis in Streptomyces sp. BC16019.
doi:10.1002/anie.201205426
AoL4 is a P450 responsible for converting aristolochene to 8-hydroxy aristolochene
doi:10.1002/anie.202102224
[#6:1]-[#6:2](-[#6:19])-[#6:3]-[#6:4]1-[#7:18]-[#6:16](=[#8:17])-[#6:8](-[#6:9]-[#6:10]2:[#6:15]:[#6:14]:[#6:13]:[#6:12]:[#6:11]:2)-[#7:7]-[#6:5]-1=[#8:6]>>[#6:1]-[#6:2](-[#6:19])-[#6:3]=[#6:4]1-[#6:5](=[#8:6])-[#7:7]-[#6:8](=[#6:9]-[#6:10]2:[#6:11]:[#6:12]:[#6:13]:[#6:14]:[#6:15]:2)-[#6:16](=[#8:17])-[#7:18]-1
SAM-dependent C-methyltransferase
[#6:1]-[#6:2](/[#6@@:4](-[#6:107](-[#7:109]\[#6@:110](-[#6:116](-[#7:118]/[#6@:119](-[#6:127](-[#7:129]-[#6:130]-[#6:131](-[#8:133])=[#8:132])=[#8:128])-[#6:120]-[#6:121]-[#6:122]-[#7:123]-[#6:124](-[#7:126])=[#7:125])=[#8:117])-[#6:111]-[#6:112]-[#6:113]-[#6:114]-[#7:115])=[#8:108])-[#7:5]-[#6:6](-[#6:8]-[#7:9]-[#6:10](/[#6@@:12](-[#7:20]-[#6:21](-[#6:23]-[#7:24]-[#6:25](\[#6@@:27](-[#7:35]-[#6:36](\[#6@@:38](-[#7:44]-[#6:45](-[#6:47]-[#7:48]-[#6:49](\[#6@@:51](-[#7:56]-[#6:57](-[#6:59]-[#7:60]-[#6:61](/[#6@:63]1-[#7:67](-[#6:68](\[#6@@:70](-[#7:76]-[#6:77](/[#6@@:79](-[#7:82]-[#6:83](\[#6@@:85](-[#7:91]-[#6:92](/[#6@@:94](-[#7:100]-[#6:101](-[#6@:103](-[#6:105]-[#8:106])/[#7:104])=[#8:102])-[#6:95]-[#6:96]-[#6:97]-[#6:98]-[#7:99])=[#8:93])-[#6:86]-[#6:87]-[#6:88]-[#6:89]-[#7:90])=[#8:84])-[#6:80]-[#8:81])=[#8:78])-[#6:71]-[#6:72]-[#6:73]-[#6:74]-[#7:75])=[#8:69])-[#6:66]-[#6:65]-[#6:64]-1)=[#8:62])=[#8:58])-[#6:52]-[#6:53](-[#8:55])=[#8:54])=[#8:50])=[#8:46])-[#6:39]-[#6:40]-[#6:41]-[#6:42]-[#7:43])=[#8:37])-[#6:28]-[#6:29]1:[#6:34]:[#6:33]:[#6:32]:[#6:31]:[#6:30]:1)=[#8:26])=[#8:22])-[#6:13]-[#6:14]-[#6:15]-[#7:16]-[#6:17](-[#7:19])=[#7:18])=[#8:11])=[#8:7])-[#6:3]>>[#6:3]-[#6:2](/[#6@@:4](-[#6:107](-[#7:109]\[#6@:110](-[#6:116](-[#7:118]/[#6@:119](-[#6:127](-[#7:129]-[#6:130]-[#6:131](-[#8:133])=[#8:132])=[#8:128])-[#6:120]-[#6:121]-[#6:122]-[#7:123]-[#6:124](-[#7:126])=[#7:125])=[#8:117])-[#6:111]-[#6:112]-[#6:113]-[#6:114]-[#7:115])=[#8:108])-[#7:5]-[#6:6](-[#6:8]-[#7:9]-[#6:10](/[#6@@:12](-[#7:20]-[#6:21](-[#6:23]-[#7:24]-[#6:25](\[#6@@:27](-[#7:35]-[#6:36](\[#6@@:38](-[#7:44]-[#6:45](-[#6:47]-[#7:48]-[#6:49](\[#6@:51]1-[#7:56]-[#6:57](-[#6:59]-[#7:60]-[#6:61](/[#6@:63]2-[#7:67](-[#6:68](\[#6@@:70](-[#7:76]-[#6:77](/[#6@@:79](-[#7:82]-[#6:83](\[#6@@:85](-[#7:91]-[#6:92](/[#6@@:94](-[#7:100]-[#6:101](-[#6@@:103](/[#7:104]-[#6:53](=[#8:54])-[#6:52]-1)-[#6:105]-[#8:106])=[#8:102])-[#6:95]-[#6:96]-[#6:97]-[#6:98]-[#7:99])=[#8:93])-[#6:86]-[#6:87]-[#6:88]-[#6:89]-[#7:90])=[#8:84])-[#6:80]-[#8:81])=[#8:78])-[#6:71]-[#6:72]-[#6:73]-[#6:74]-[#7:75])=[#8:69])-[#6:66]-[#6:65]-[#6:64]-2)=[#8:62])=[#8:58])=[#8:50])=[#8:46])-[#6:39]-[#6:40]-[#6:41]-[#6:42]-[#7:43])=[#8:37])-[#6:28]-[#6:29]1:[#6:34]:[#6:33]:[#6:32]:[#6:31]:[#6:30]:1)=[#8:26])=[#8:22])-[#6:13]-[#6:14]-[#6:15]-[#7:16]-[#6:17](-[#7:19])=[#7:18])=[#8:11])=[#8:7])-[#6:1]
doi:10.1021/ja9003365
COc1cc(O)c2c(O)c3c(c(O)c2c1O)C(O)(C(=O)O)OC1(CCc2cc4cc(C)oc(=O)c4c(O)c2O1)C3=O
FAD-dependent monooxygenase 
A4D0H5
CSCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CN)C(C)C)C(C)C)C(C)C)C(=O)O
FrsA
FrsC
[#6:1]-[#6:2](-[#7:4]/[#6@@:5]1-[#6@@:30](\[#8:31])-[#6@:28](/[#8:29])-[#6@@:25](\[#6:26]-[#8:27])-[#8:24]-[#6:6]-1-[#8:7]-[#6:8]-[#6:9](=[#6:12]1-[#6:19]2-[#6:20]-[#6:21]-[#6@:22](/[#6:23])-[#6:18]-2-[#6:17]-[#6:14](-[#6:16])(-[#6:15])-[#6:13]-1)-[#6:10]-[#8:11])=[#8:3]>>[#6:1]-[#6:2](-[#7:4]/[#6@@:5]1-[#6@@:30](\[#8:31])-[#6@:28](/[#8:29])-[#6@@:25](\[#6:26]-[#8:27])-[#8:24]-[#6:6]-1-[#8:7]-[#6:8]-[#6@:9]1(\[#8]\[#6@@:12]2-1-[#6:19]1-[#6:20]-[#6:21]-[#6@:22](/[#6:23])-[#6:18]-1-[#6:17]-[#6:14](-[#6:15])(-[#6:16])-[#6:13]-2)-[#6:10]=[#8:11])=[#8:3]
CAK50791.1
1.14.99.62
CAK50790.1
FrsH
doi:10.1038/s41467-021-25798-8
1.14.99.61
1.14.19.60
CAK50792.1
doi:10.1021/ja907852c 
[#6:1]-[#8:2]-[#6:3]\[#6@@:4]1-[#6@@:40](/[#8:41]/[#6@:42]2-[#6@:93](\[#8:94])-[#6@@:49](/[#8:50]\[#6@@:51]3-[#8:92]-[#6@:90](\[#6:91])-[#6@@:89]4-[#6@@:53](-[#8:55]-[#6:56]5(-[#8:88]/4)-[#8:87]-[#6@:85](\[#6:86])-[#6@@:60](/[#8:61]\[#6@@:62]4-[#8:84]-[#6@:82](\[#6:83])-[#6@@:66](/[#8:67]-[#6:68](-[#6:70]6:[#6:79](-[#8:80]-[#6:81]):[#6:77](-[Cl:78]):[#6:75](-[#8:76]):[#6:73](-[Cl:74]):[#6:71]:6-[#6:72])=[#8:69])-[#6@:64](\[#8:65])-[#6:63]-4)-[#6@@:58](/[#8:59])-[#6:57]-5)(/[#6:54])-[#6:52]-3)-[#6@@:46](/[#8:47]-[#6:48])-[#6@@:44](/[#6:45])-[#8:43]-2)-[#6@:38](\[#8:39])-[#6@:36](\[#8:37])-[#6@:6](\[#8:7]/[#6@:8]2-[#6@:16](\[#8:17]-[#6:18](-[#6:20](-[#6:22])-[#6:21])=[#8:19])-[#6@:15]3-[#6@@:11](-[#8:12]/[#6@:13]4(-[#6:35]5-[#6:31](-[#8:32]-[#6:33]-[#8:34]-5)-[#6@@:26](-[#6:28](=[#8:30])-[#6:29])(/[#8:27])-[#6@@:24](/[#6:25])-[#8:23]-4)-[#8:14]\3)/[#6:10]-[#8:9]-2)-[#8:5]-1>>[#6:1]-[#8:2]-[#6:3]\[#6@@:4]1-[#6@@:40](/[#8:41]/[#6@:42]2-[#6@:93](\[#8:94])-[#6@@:49](/[#8:50]\[#6@@:51]3-[#8:92]-[#6@:90](\[#6:91])-[#6@@:89]4-[#6@@:53](-[#8:55]-[#6:56]5(-[#8:88]/4)-[#8:87]-[#6@:85](\[#6:86])-[#6@@:60](/[#8:61]\[#6@@:62]4-[#8:84]-[#6@:82](\[#6:83])-[#6@@:66](/[#8:67]-[#6:68](-[#6:70]6:[#6:79](-[#8:80]-[#6:81]):[#6:77](-[Cl:78]):[#6:75](-[#8:76]):[#6:73](-[Cl:74]):[#6:71]:6-[#6:72])=[#8:69])-[#6@:64](\[#8:65])-[#6:63]-4)-[#6@@:58](/[#8:59])-[#6:57]-5)(/[#6:54])-[#6:52]-3)-[#6@@:46](/[#8:47]-[#6:48])-[#6@@:44](/[#6:45])-[#8:43]-2)-[#6@:38](\[#8:39])-[#6@:36](\[#8:37]-[#6])-[#6@:6](\[#8:7]/[#6@:8]2-[#6@:16](\[#8:17]-[#6:18](-[#6:20](-[#6:21])-[#6:22])=[#8:19])-[#6@:15]3-[#6@@:11](-[#8:12]/[#6@:13]4(-[#6:35]5-[#6:31](-[#8:32]-[#6:33]-[#8:34]-5)-[#6@@:26](-[#6:28](=[#8:30])-[#6:29])(/[#8:27])-[#6@@:24](/[#6:25])-[#8:23]-4)-[#8:14]\3)/[#6:10]-[#8:9]-2)-[#8:5]-1
[#6:1]-[#6:2](-[#6:4]/[#6@@:5](-[#6:12](-[#7:14]-[#6@:15](-[#6:17](-[#7:19]-[#6:20]-[#6:21](-[#7:23]-[#6@:24](-[#6:26](-[#7:28]\[#6@:29](-[#6:38](-[#7:40]1-[#6@:44](/[#6:45](-[#7:47]/[#6@:48](-[#6:59](-[#7:61]/[#6@:62](-[#6:69](-[#8:71])=[#8:70])-[#6:63]-[#6:64]2:[nH:68]:[#6:67]:[#7:66]:[#6:65]:2)=[#8:60])-[#6:49]-[#6:50]2:[#6:58]3:[#6:53](:[#6:54]:[#6:55]:[#6:56]:[#6:57]:3):[nH:52]:[#6:51]:2)=[#8:46])-[#6:43]-[#6:42]-[#6:41]-1)=[#8:39])-[#6:30]-[#6:31]1:[#6:37]:[#6:36]:[#6:34](-[#8:35]):[#6:33]:[#6:32]:1)=[#8:27])\[#6:25])=[#8:22])=[#8:18])\[#6:16])=[#8:13])-[#7:6]-[#6:7](-[#6@@:9](/[#7:11])-[#6:10])=[#8:8])-[#6:3]>>[#6:3]-[#6:2](-[#6:4]/[#6@@:5](-[#6:12](-[#7:14]-[#6@:15](-[#6:17](-[#7:19]-[#6:20]-[#6:21](-[#7:23]-[#6@:24](-[#6:26](-[#7:28]\[#6@@:29]1-[#6:38](-[#7:40]2-[#6@:44](/[#6:45](-[#7:47]/[#6@:48](-[#6:59](-[#7:61]/[#6@:62](-[#6:69](-[#8:71])=[#8:70])-[#6:63]-[#6:64]3:[nH:68]:[#6:67]:[#7:66]:[#6:65]:3)=[#8:60])-[#6:49]-[#6:50]3:[#6:58]4:[#6:53](:[#6:54]:[#6:55]:[#6:56](-[#6:33]5:[#6:32]:[#6:31](:[#6:37]:[#6:36]:[#6:34]:5-[#8:35])-[#6:30]-1):[#6:57]:4):[nH:52]:[#6:51]:3)=[#8:46])-[#6:43]-[#6:42]-[#6:41]-2)=[#8:39])=[#8:27])\[#6:25])=[#8:22])=[#8:18])\[#6:16])=[#8:13])-[#7:6]-[#6:7](-[#6@@:9](/[#7:11])-[#6:10])=[#8:8])-[#6:1]
CO[C@@H]1C(O)=C(C(C)=O)C(=O)C2(O)C(=O)c3c(cc4cc(O)cc(O)c4c3O)CC12
CC(C(=O)O)[C@H]1CC=C2[C@H](O)CC[C@H](C)[C@@]2(C)C1
kynurenine formamidase
[#6:1]-[#6:2](=[#8:99])-[#7:3]/[#6@@:4]1-[#6@@:97](\[#8:98])-[#6@:95](/[#8:96])-[#6@@:92](\[#6:93]-[#8:94])-[#8:91]-[#6@:5]-1\[#8:6]-[#6:7]1:[#6:57]2:[#6:58]:[#6:59]3:[#6:60]:[#6:8]:1-[#8:9]-[#6:10]1:[#6:90]:[#6:89]:[#6:14](-[#6@@:15](/[#8:88])-[#6@@:16]4-[#7:87]-[#6:85](=[#8:86])-[#6@:39](-[#7:40]-[#6:41](=[#8:84])\[#6@@:42]-3-[#7:43]-[#6:44](=[#8:83])\[#6@@:45]3-[#6:78]5:[#6:79]:[#6:80](-[#8:82]):[#6:81]:[#6:76](:[#6:77]:5)-[#8:75]-[#6:70]5:[#6:71](-[#8:74]):[#6:72]:[#6:73]:[#6:68](:[#6:69]:5)-[#6@@:66](/[#7:67])-[#6:64](=[#8:65])-[#7:63]-[#6@:49](-[#6:50]-[#6:51]5:[#6:62]:[#6:61]:[#6:55](-[#8:56]-2):[#6:53](-[Cl:54]):[#6:52]:5)\[#6:47](=[#8:48])-[#7:46]-3)/[#6:34]2:[#6:35]:[#6:36]:[#6:37](-[#8:38]):[#6:32](:[#6:33]:2)-[#6:25]2:[#6:26](-[#8:31]):[#6:27]:[#6:28](-[#8:30]):[#6:29]:[#6:24]:2-[#6@@:20](/[#6:21](-[#8:23])=[#8:22])-[#7:19]-[#6:17]/4=[#8:18]):[#6:13]:[#6:11]:1-[Cl:12]>>[#6]-[#6](-[#7]\[#6@]1-[#6@](/[#8:88]\[#6@:15]2-[#6@:16]3-[#6:17](-[#7:19]-[#6@@:20](-[#6:24]4:[#6:29]:[#6:28](-[#8:30]):[#6:27]:[#6:26](-[#8:31]):[#6:25]:4-[#6:32]4:[#6:33]:[#6:34](-[#6@:39](-[#6:85](-[#7:87]\3)=[#8:86])\[#7:40]-[#6:41](=[#8:84])-[#6@@:42]3-[#7:43]-[#6:44](/[#6@:45]5-[#7:46]-[#6:47](=[#8:48])-[#6@@:49](-[#6:50]-[#6:51]6:[#6:52]:[#6:53](-[Cl:54]):[#6:55](-[#8:56]-[#6:57]7:[#6:58]:[#6:59]/3:[#6:60]:[#6:8](:[#6:7]:7-[#8:6]/[#6@@:5]3-[#8:91]-[#6@:92](/[#6:93]-[#8:94])-[#6@@:95](\[#8:96])-[#6@:97](/[#8:98])-[#6@:4]-3\[#7:3]-[#6:2](=[#8:99])-[#6:1])-[#8:9]-[#6:10]3:[#6:11](:[#6:13]:[#6:14]-2:[#6:89]:[#6:90]:3)-[Cl:12]):[#6:61]:[#6:62]:6)/[#7:63]-[#6:64](=[#8:65])-[#6@:66](\[#7:67])-[#6:68]2:[#6:69]:[#6:70](:[#6:71](:[#6:72]:[#6:73]:2)-[#8:74])-[#8:75]-[#6:76]2:[#6:77]:[#6:78]-5:[#6:79]:[#6:80](:[#6:81]:2)-[#8:82])=[#8:83]):[#6:35]:[#6:36]:[#6:37]:4-[#8:38])\[#6:21](=[#8:22])-[#8:23])=[#8:18])-[#8]-[#6@](/[#6]-[#8])-[#6@@](\[#8])-[#6@@]-1/[#8])=[#8]
[#7:13]-[#6@@H:11](-[#6:10]-[c:7]1[c:8][n:9][c:5]2[c:4][c:3][c:2][c:1][c:6]12)-[#6:12](-[#8:15])=[O:16]>>[#7:13]-[#6@@H:11](-[#6:10]-[c:7]1[c:8][n:9][c:5]2[c:4][c:3]([Cl:14])[c:2][c:1][c:6]12)-[#6:12](-[#8:15])=[O:16]
CC(C)CC(C(=O)O)n1sc2c(O)cc(-c3ccccn3)nc2c1=O
EryK
CC(C)(CO[PH](O)(O)O)C(O)C(O)NCCC(O)NCCSC(=O)[C@H](N)[C@H](O)C(N)=O
beta-hydroxylation of PCP-bound tyrosine (syn)
doi:10.1105/tpc.113.111013
HrmF
HrmI
HrmJ
BGC0001179
ProsC works in concert with P450 ProsA to yield the pathway intermediate. Order of reactions is not clear from experimental data. Overexpression of either ProsA or ProsC alone does not yield any product.
Cc1c2cccc(O)c2c(O)c2c(O)c3c(O)c(C(N)=O)c(O)cc3cc12
N[C@H]1C(=O)N[C@@H]2Cc3ccc(c(Cl)c3)Oc3cc4cc(c3O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(O)cc(c2)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@@H](C(=O)O)NC3=O
Chemical probe
UZP48215.1
UZP48214.1
UZP48216.1
TMU80020.1
UZP48213.1
TMU76675.1
COc1cc(O)c2c(O)c3c(c(O)c2c1O)OC1(CCc2cc4cc(C)oc(=O)c4c(O)c2O1)C3=O
Reaction with UDP-6-azido-glucose and vancomycin intermediate as substrates.
Reaction with UDP-2-azido-glucose and vancomycin intermediate as substrates.
NC1=N[C@H]2[C@H](COC(=O)NS(=O)(=O)O)N=C(N)N3CCC(O)(O)[C@]23N1
Reaction with TDP-3-amino-glucose and vancomycin intermediate as substrates.
Reaction with UDP-2-amino-glucose and vancomycin intermediate as substrates.
Reaction with UDP-6-amino-glucose and vancomycin intermediate as substrates.
Reaction with TDP-4-amino-glucose and vancomycin intermediate as substrates.
Macrolactam formation
A7KH06
Hydroxylation at C-12
Hydroxylation at C-18
C=C[C@]1(C)C[C@@H](O)[C@]2(C)[C@H](C)CC[C@]3(CCC[C@H]32)[C@@H](C)C1
MITE0000203
MITE0000202
MITE0000201
MITE0000200
MITE0000207
MITE0000206
MITE0000205
MITE0000204
[#6:1](-[Br:10])1:[#6:9]:[#6:8]2:[#6:4](:[#7:5]:[#6:6]:[#6:7]:2):[#6:3]:[#6:2]:1>>[#6:1](-[Br:10])1:[#6:9]:[#6:8]2:[#6:4](:[#7:5]:[#6:6]:[#6:7](-[Br]):2):[#6:3]:[#6:2]:1
MITE0000209
MITE0000208
[#6:1]1:[#6:24]:[#6:23]2:[#6:5](:[#6:6](-[#8:25]):[#6:7]3:[#6:19](-[#8]):[#6:11](-[#6:12](=[#8:18])-[#6:13]-[#6:14]-[#6:15](-[#6:17])-[#6:16]):[#6:10](-[#6:21]):[#6:9]:[#6:8]:3:[#6:22]:2):[#6:3](-[#8:4]):[#6:2]:1>>[#6:1]1:[#6:24]:[#6:23]2:[#6:5](:[#6:6](-[#8:25]):[#6:7]3:[#6:8](:[#6:22]:2)-[#6:9](=[#8:27])-[#6:10](-[#6:21])=[#6:11](-[#6:12](=[#8:18])-[#6:13]-[#6:14]-[#6:15](-[#6:16])-[#6:17])-[#6:19]-3=[#8:26]):[#6:3](-[#8:4]):[#6:2]:1
Reaction of UDP-L-4-epi-vancosamine with 6-deoxy-glycosyl-vancomycin-pseudoaglycone.
Reaction of UDP-L-4-epi-vancosamine with 6-amino-glycosyl-vancomycin-pseudoaglycone.
EAQ93007.1
[#6:1]-[#8:2]-[#6:3]1-[#6:33]2-[#6:34]3(-[#6:11]4-[#6:12]-[#6:13](-[#6:15]5:[#6:25](-[#8:26]):[#6:24]6:[#6:19](:[#6:20]:[#6:21]:[#6:22]:[#6:23]:6):[#6:17](-[#8:18]):[#6:16]:5-[#6:10]-4=[#7:9]-[#6:8](-[#6:27]#[#6:28]-[#6:29]=[#6:30]-[#6:31]#[#6:32]-2)-[#6:7]-3=[#6:5](-[#6:6])-[#6:4]=1)=[#8:14])-[#6:35]=[#8:36]>>[#6:1]-[#8:2]-[#6:3]1-[#6:33]2-[#6:34]3-[#6:11]4:[#6:12]:[#6:13](:[#6:15]5-[#6:25](=[#8:26])-[#6:24]6:[#6:19](:[#6:20]:[#6:21]:[#6:22]:[#6:23]:6)-[#6:17](=[#8:18])-[#6:16]:5:[#6:10]:4-[#7:9]-[#6:8](-[#6:27]#[#6:28]-[#6:29]=[#6:30]-[#6:31]#[#6:32]-2)-[#6:7]-3=[#6:5](-[#6:6])-[#6:4]=1)-[#8:14]
[#16:1](-[#6:15]-[#6:16]-[#7:17]-[#6:18](=[#8:61])-[#6:19]-[#6:20]-[#7:21]-[#6:22](=[#8:60])-[#6@@:23](-[#6:25](-[#6:59])(-[#6:58])-[#6:26]-[#8:27]-[#15:28](=[#8:57])(-[#8:56])-[#8:29]-[#15:30](=[#8:55])(-[#8:54])-[#8:31]-[#6:32]/[#6@@:33]1-[#6@@:48](\[#8:49]-[#15:50](=[#8:53])(-[#8:52])-[#8:51])-[#6@@:46](\[#8:47])-[#6@:35](/[#7:36]2:[#6:45]:[#7:44]:[#6:38]3:[#6:39](:[#7:41]:[#6:42]:[#7:43]:[#6:37]:2:3)-[#7:40])-[#8:34]-1)/[#8:24])-[#6:2](=[#8:14])-[#6:3]1:[#6:11](-[#8:12]-[#6:13]):[#6:10]:[#6:8](-[#8:9]):[#6:6](-[I:7]):[#6:4]:1-[#6:5]>>[#16:1](-[#6:15]-[#6:16]-[#7:17]-[#6:18](=[#8:61])-[#6:19]-[#6:20]-[#7:21]-[#6:22](=[#8:60])-[#6@@:23](-[#6:25](-[#6:58])(-[#6:59])-[#6:26]-[#8:27]-[#15:28](=[#8:57])(-[#8:56])-[#8:29]-[#15:30](=[#8:55])(-[#8:54])-[#8:31]-[#6:32]/[#6@@:33]1-[#6@@:48](\[#8:49]-[#15:50](=[#8:53])(-[#8:51])-[#8:52])-[#6@@:46](\[#8:47])-[#6@:35](/[#7:36]2:[#6:45]:[#7:44]:[#6:38]3:[#6:39](:[#7:41]:[#6:42]:[#7:43]:[#6:37]:2:3)-[#7:40])-[#8:34]-1)/[#8:24])-[#6:2](=[#8:14])-[#6:3]1:[#6:11](-[#8:12]-[#6:13]):[#6:10](-[#8]):[#6:8](-[#8:9]):[#6:6](-[I:7]):[#6:4]:1-[#6:5]
COC(C(=O)C(O)C(C)=O)C1Cc2cc3cc(OC4CC(OC5CC(O)C(O)C(C)O5)C(O)C(C)O4)c(C)c(O)c3c(O)c2C(=O)C1OC1CC(OC2CC(OC3CC(C)(O)C(O)C(C)O3)C(O)C(C)O2)C(O)C(C)O1
[#6:1]-[#6:2]1:[#6:8]:[#6:7]2-[#6:9](-[#6:11]3:[#6:17](-[#6:18](=[#8:19])-[#6:6]:2:[#6:4](-[#8:5]):[#6:3]:1):[#6:15](-[#8:16]):[#6:14]:[#6:13]:[#6:12]:3)=[#8:30]>>[#6:1]-[#6:2]1:[#6:8]:[#6:7]2-[#6:9](-[#6:11]3:[#6:17](-[#6:18](=[#8:19])-[#6:6]:2:[#6:4](-[#8:5]):[#6:3]:1):[#6:15](-[#8:16]):[#6:14]:[#6:13]:[#6:12]:3)-[#8]
Hydroxylation of isopropenyl side chain of aristolochene.
BAC70705.1
BAG12889.1
[#6:1]-[#8:2]/[#6@@:3]1-[#6:26](=[#8:27])-[#8:25]/[#6@:24](-[#6@@:28](\[#8:30])-[#6:29])-[#6@:22](/[#6:23])-[#6:21]=[#6:19](-[#6:20])-[#6@:11]23\[#6@@:12]4-[#6@:13](-[#6@:15](-[#6@@:17](/[#8:18])-[#6@:9](\[#8:10]/2)-[#6@@:8]-4/[#6:7]=[#6:6]-[#6@@:5]-3/[#6:4]-1)/[#6:16])/[#8:14]>>[#6:1]-[#8:2]/[#6@@:3]1-[#6:26](=[#8:27])-[#8:25]/[#6@:24](-[#6@@:28](\[#8:30])-[#6:29])-[#6@:22](/[#6:23])-[#6:21]=[#6:19](-[#6:20])-[#6@:11]23\[#6@@:12]4-[#6@:13](-[#6@:15](-[#6@@:17](/[#8:18]-[#6](-[#6]5:[nH]:[#6]:[#6]:[#6]:5)=[#8])-[#6@:9](\[#8:10]/2)-[#6@@:8]-4/[#6:7]=[#6:6]-[#6@@:5]-3/[#6:4]-1)/[#6:16])/[#8:14]
[#7:1]-[#6:2](-[#6:13](-[#8:15])=[#8:14])-[#6:3]-[#6:4]1:[#6:12]2:[#6:7](:[#6:8]:[#6:9]:[#6:10]:[#6:11]:2):[nH:6]:[#6:5]:1>>[#7:1]-[#6:2](-[#6:13](-[#8:15])=[#8:14])-[#6:3]-[#6:4]1:[#6:12]2:[#6:7](:[#6:8](:[#6:9]:[#6:10]:[#6:11]:2)-[Cl]):[nH:6]:[#6:5]:1
N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O
C[C@@H]1C=C(/C=C/c2ccc(O)cc2)C(=O)O1
Q70AY4
CC(=O)N[C@H]1C(OC/C(CO)=C2\CC(C)(C)CC3C2CC[C@@H]3C)O[C@H](CO)[C@@H](O)[C@@H]1O
Dehydration; elimination of primary alcohol under formation exo-methylene group
Iodination of orsellenic acid derivate, assumed to be bound to coenzyme A co-factor
C-methylation of methylsalicylic acid bound to coenzyme A. Auxiliary enzyme PokM3 needed to load methylsalicylic acid on coenzyme A.
doi:10.1016/j.chembiol.2003.11.009
Bottromycin-precursor acting rSAM methyltransferase from Streptomyces sp BC16019;C-methylation of both Val4 and Val5 of bottromycin A2
CC(C)CC[C@@H](N)C(=O)SCCNC(O)CCNC(O)C(O)C(C)(C)CO[PH](O)(O)O
doi:10.1016/j.chembiol.2005.02.005
doi:10.1016/j.chembiol.2004.12.005
doi:10.1016/j.chembiol.2009.06.007
MITE0000070
MITE0000071
MITE0000072
MITE0000073
MITE0000074
MITE0000075
CC(CCCCCCCCCCCc1c(C)c(O)cc(OC)c1)C
MITE0000077
MITE0000076
doi:10.1111/j.1472-765X.2010.02973.x
doi:10.1021/jacs.7b09898
doi:10.1021/jacs.7b09899
Glycosyltransferase
doi:10.1074/jbc.M117.791269
[#6:44]-[#6@H:18](\[#7:17]=[#6:16]-1/[#7:15]-[#6:14]-[#6:12](=[O:13])-[#7:11]-2-[#6:10]-[#6:9]-[#6@@H:7](-[#6:8])-[#6@H:6]-2-[#6:4](=[O:5])-[#7:3]-[#6@@H:2](-[#6:1])-[#6:48](=[O:49])-[#7:47]-[#6@H:45]-1-[#6:46])-[#6:19](=[O:20])-[#7:21]-[#6@@H:22](-[#6@@H:36](-[#6:37])-[c:38]1[c:39][c:40][c:41][c:42][c:43]1)-[#6:23](=[O:24])-[#7:25]-[#6@H:26](-[#6:27]-[#6:28](-[#8H:30])=[O:29])-[c:31]1[n:32][c:33][c:34][s:35]1>>[#6]-[#8:30]-[#6:28](=[O:29])-[#6:27]-[#6@@H:26](-[#7:25]-[#6:23](=[O:24])-[#6@@H:22](-[#7:21]-[#6:19](=[O:20])-[#6@H:18](-[#6:44])\[#7:17]=[#6:16]-1/[#7:15]-[#6:14]-[#6:12](=[O:13])-[#7:11]-2-[#6:10]-[#6:9]-[#6@@H:7](-[#6:8])-[#6@H:6]-2-[#6:4](=[O:5])-[#7:3]-[#6@@H:2](-[#6:1])-[#6:48](=[O:49])-[#7:47]-[#6@H:45]-1-[#6:46])-[#6@@H:36](-[#6:37])-[c:38]1[c:39][c:40][c:41][c:42][c:43]1)-[c:31]1[n:32][c:33][c:34][s:35]1
Bound via thioester to 4'-phosphopantetheine (acyl carrier protein prosthetic group)
CC(C)=CCCC1(C)OC1CCC(C)=CCCC(C)=Cc1c[nH]c2ccccc12
1.4.3.23
AvaC
AvaB
AKH82808.1
AvaA
MITE0000119
MITE0000118
AvaD
MITE0000116
MITE0000115
Introduces the first biaryl-ether crosslink between hpg4 and bht6 in the vancomycin and balhimycin precursors. Reaction occurs while the backbone precursor is bound to the PCP domain of module 6 or 7. The link to the PCP domain is required for the reaction.
MITE0000113
[#6:1]-[#16:2]-[#6:3]-[#6:4]-[#6@@:5](-[#6:7](-[#7:9]/[#6@:10](-[#6:18](-[#7:20]/[#6@:21](-[#6:28](-[#7:30]-[#6@:31](-[#6:33](-[#7:35]/[#6@:36](-[#6:43](=[#8:45])-[#8:44])-[#6:37]-[#6:38]1:[#7:42]:[#6:41]:[nH:40]:[#6:39]:1)=[#8:34])/[#6:32])=[#8:29])-[#6:22]-[#6:23]1:[#7:27]:[#6:26]:[nH:25]:[#6:24]:1)=[#8:19])-[#6:11]-[#6:12]-[#6:13]-[#7:14]-[#6:15](=[#7:17])-[#7:16])=[#8:8])/[#7:6]>>[#6:1]-[#16:2]-[#6:3]-[#6:4]-[#6@@:5](-[#6:7](-[#7:9]/[#6@:10](-[#6:18](-[#7:20]/[#6@@:21]1-[#6:28](-[#7:30]-[#6@:31](-[#6:33](-[#7:35]/[#6@:36](-[#6:43](=[#8:45])-[#8:44])-[#6:37]-[#6:38]2:[#7:42]:[#6&H0:41](-[#6&H0:26]3:[#7:27]:[#6:23](:[#6:24]:[nH:25]:3)-[#6:22]-1):[nH:40]:[#6:39]:2)=[#8:34])/[#6:32])=[#8:29])=[#8:19])-[#6:11]-[#6:12]-[#6:13]-[#7:14]-[#6:15](=[#7:17])-[#7:16])=[#8:8])/[#7:6]
MITE0000117
MITE0000110
removal of the leucine residue
MITE0000112
Baeyer-Villiger monooxygenase
MITE0000111
MITE0000114
Brominates free-floating L-tryptophan in position 5
[#6:1]-[#6:2]-[#6:3]-[#6:4]-[#6:5]\[#6@:6]1-[#6:18]2-[#6:19](-[#8:21]-[#6:22](=[#8:23])-[#6:17]=2-[#6:16]-[#6@@:11](\[#6:12]-[#6:13]-[#6:14]-[#6:15])-[#6:10]-[#6:9]2-[#6:24](-[#8:26]-[#6:27](=[#8:28])-[#6:8]=2-[#6:7]-1)=[#8:25])=[#8:20]>>[#6:1]-[#6:2]-[#6:3]-[#6:4]-[#6:5]\[#6@:6]1-[#6:18]2-[#6:19](-[#8:21]-[#6:22](=[#8:23])-[#6:17]=2-[#6:16]-[#6@@:11](/[#8])(-[#6:12]-[#6:13]-[#6:14]-[#6:15])-[#6:10]-[#6:9]2-[#6:24](-[#8:26]-[#6:27](=[#8:28])-[#6:8]=2-[#6:7]-1)=[#8:25])=[#8:20]
[#8:1]-[#6:2]1:[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]>>[#6:2]1(-[#8]\[#6@@]2-[#6@](\[#8])-[#6@@](/[#8])-[#6@](\[#7])-[#6@@](/[#6]-[#8])-[#8]-2):[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]
The halogenase chlorinates the second bht residue of the balhimycin precursor, probably while the precursor is bound to module 6 of the NRPS. The PCP domain of module 6 might be required for the reaction. The substrate specificity of the enzyme might be less specific than represented in the SMARTS pattern. In order to make the specificity not too broad structures were rather kept in the pattern than left out.
Acyltransferase can use acyl-CoA of different acyl chain length and glucosamine free as UDP-glucosamine or bound to hpg4 of teicoplanin pseudoaglycone as substrates.
BGC0003093
BGC0000093
BGC0000891
Reductase component of flavoprotein monooxygenase TrlCD, reduces the flavin cofactor needed for enzyme catalysis
BGC0003094
BGC0001299
BGC0002099
C=C1C=C([C@H](O)CCCCCCC)C(=O)O1
A7KGZ9
[#6:6]-[#6:11]-1=[#6:12]-2-[#8:13]-[#6:15](=[O:14])-[c:20]3[c:25](-[#6:17])[c:24][c:23](-[#8:19])[c:22](-[#6:16])[c:21]3-[#8:18]-[#6@@H:10]-2[C@@:9]([#6:5])([#8:27])[#6@H:8](-[#8:26])-[#6:7]-1=[O:4]>>[#6:28]-[#8:27][C@@:9]1([#6:5])[#6@H:8](-[#8:26])-[#6:7](=[O:4])-[#6:11](-[#6:6])=[#6:12]-2-[#8:13]-[#6:15](=[O:14])-[c:20]3[c:25](-[#6:17])[c:24][c:23](-[#8:19])[c:22](-[#6:16])[c:21]3-[#8:18]-[#6@H:10]1-2 
A7KGZ3
O=c1c(-c2ccc(O)c(-c3c(O)ccc4c(=O)c(-c5ccc(O)cc5)coc34)c2)coc2cc(O)ccc12
C=C[C@]1(C)C[C@@H](O)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O
Catalyzes a ring contraction of the nine-membered central ring to yield a octadride ring
Site-directed mutagenesis
Plays a role in internal macrocyclization of lariocidin leading to congeners lariocidin B but mechanism is not yet elucidated.
A0A3S7Q0I4
A0A0P0G6I4
A0A2S1JZI6
A0A2S1JZI9
doi:10.1038/s41589-023-01476-2
doi:10.1186/s12934-020-01368-3
N-terminal cleavage of leader peptide, resulting in immature intermediate core peptide.
CC(=O)Nc1ccccc1C(=O)C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC1=O
CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C=C(\C)CC/C=C(\C)CCC1OC1(C)C
[#6:1]-[#8:2]/[#6@:3]1-[#6:30]2-[#6@@:12](-[#6:14](-[#6:16]3:[#6:27](-[#8:28]):[#6:26]4:[#6:19](:[#6:20]:[#6:21](:[#6:23]:[#6:24]:4-[#8:25])-[#8:22]):[#6:18]:[#6:17]:3-[#6:29]-2)=[#8:15])(/[#8:13])-[#6:10](=[#8:11])-[#6:6](-[#6:7](=[#8:9])-[#6:8])=[#6:4]-1-[#8:5]>>[#6:1]-[#8:2]/[#6@:3]1-[#6:30]2-[#6@@:12](-[#6:14](-[#6:16]3:[#6:27](-[#8:28]):[#6:26]4:[#6:19](:[#6:20]:[#6:21](:[#6:23]:[#6:24]:4-[#8:25])-[#8:22]):[#6:18]:[#6:17]:3-[#6:29]-2)=[#8:15])(/[#8:13]-[#6]2-[#8]-[#6](-[#6])-[#6](-[#8])-[#6](-[#8])-[#6]-2)-[#6:10](=[#8:11])-[#6:6](-[#6:7](=[#8:9])-[#6:8])=[#6:4]-1-[#8:5]
C=C(C(=O)O)[C@H]1CC=C2C[C@H](O)C[C@H](C)[C@@]2(C)C1
doi:10.1038/s41589-020-0624-8
BorJ
BorK
BorH
BorI
O=C(O)C(=O)Cc1c[nH]c2c(Cl)cccc12
MciB
[#6:1]-[#6:2]1-[#6:29]-[#6@@:28]2-[#6@:6](-[#6@:7]3-[#6@@:25](\[#6:26]=[#6:27]\2)-[#6@:23](\[#6:24])-[#6:22]=[#6:21]-[#6:20]=[#6:19]-[#6@:17](/[#6:18])-[#8:16]-[#6:14](=[#8:15])-[#6:13]-[#6:11](=[#8:12])-[#6:10]-[#6:8]\3=[#8:9])/[#6@:4](/[#6:5])-[#6:3]=1>>[#6:1]-[#6:2]1-[#6:29]-[#6@@:28]2-[#6@:6](-[#6@:7]3-[#6@@:25](\[#6:26]=[#6:27]\2)-[#6@:23](\[#6:24])-[#6:22]=[#6:21]-[#6:20]=[#6:19]-[#6@:17](/[#6:18])-[#8:16]-[#6:14](=[#8:15])-[#6:13]-[#6:11](=[#8:12])-[#6:10](-[Cl])(-[Cl])-[#6:8]\3=[#8:9])/[#6@:4](/[#6:5])-[#6:3]=1
[#6:1]-[#6:2]1-[#6:29]-[#6@@:28]2-[#6@:6](-[#6@:7]3-[#6@@:25](\[#6:26]=[#6:27]\2)-[#6@:23](\[#6:24])-[#6:22]=[#6:21]-[#6:20]=[#6:19]-[#6@:17](/[#6:18])-[#8:16]-[#6:14](=[#8:15])-[#6:13]-[#6:11](=[#8:12])-[#6:10]=[#6:8]\3-[#8:9])/[#6@:4](/[#6:5])-[#6:3]=1>>[#6:1]-[#6:2]1-[#6:29]-[#6@@:28]2-[#6@:6](-[#6@:7]3-[#6@@:25](\[#6:26]=[#6:27]\2)-[#6@:23](\[#6:24])-[#6:22]=[#6:21]-[#6:20]=[#6:19]-[#6@:17](/[#6:18])-[#8:16]-[#6:14](=[#8:15])-[#6:13]-[#6:11](=[#8:12])-[#6:10](-[Cl])(-[Cl])-[#6:8]\3=[#8:9])/[#6@:4](/[#6:5])-[#6:3]=1
[#6:1]-[#6:2]1-[#6:29]-[#6@@:28]2-[#6@:6](-[#6@:7]3-[#6@@:25](\[#6:26]=[#6:27]\2)-[#6@:23](\[#6:24])-[#6:22]=[#6:21]-[#6:20]=[#6:19]-[#6@:17](/[#6:18])-[#8:16]-[#6:14](=[#8:15])-[#6:13]-[#6:11](-[#8:12])=[#6:10]-[#6:8]\3=[#8:9])/[#6@:4](/[#6:5])-[#6:3]=1>>[#6:1]-[#6:2]1-[#6:29]-[#6@@:28]2-[#6@:6](-[#6@:7]3-[#6@@:25](\[#6:26]=[#6:27]\2)-[#6@:23](\[#6:24])-[#6:22]=[#6:21]-[#6:20]=[#6:19]-[#6@:17](/[#6:18])-[#8:16]-[#6:14](=[#8:15])-[#6:13]-[#6:11](=[#8:12])-[#6:10](-[Cl])(-[Cl])-[#6:8]\3=[#8:9])/[#6@:4](/[#6:5])-[#6:3]=1
doi:10.1021/ja056749x
AAM70343.1
AAM33672.1
AAM70356.1
[#6:1]-[#6:2]1:[#6:14]:[#6:13]2:[#6:6](:[#6:7](:[#6:9]3-[#6:19](=[#8:20])-[#6:18]=[#6:16](-[#8:17])-[#6:15]-[#6:10]:3:[#6:11]:2-[#8:12])-[#8:8]):[#6:4](-[#8:5]):[#6:3]:1>>[#6:1]-[#6:2]1:[#6:14]:[#6:13]2:[#6:6](:[#6:7](:[#6:9]3-[#6:19](=[#8:20])-[#6:18]-[#6@@:16](/[#8:17])-[#6:15]-[#6:10]:3:[#6:11]:2-[#8:12])-[#8:8]):[#6:4](-[#8:5]):[#6:3]:1
AAM97314.1
CSc1c(O)cc(-c2ccccn2)nc1C(=O)O
Substrate bound via thioester to coenzyme A
[#6:1]/[#6@:2]1(-[#6:26]-[#6@@:21](/[#8:22]-[#6:23](=[#8:25])-[#6:24])-[#6@:19]2(\[#6:20])-[#6@:12](/[#6:13])-[#6:11]-[#6:10]\[#6@:9]3(-[#6:17]-[#6:16]-[#6:15](=[#8:18])\[#6@:14]-3-2)-[#6@@:7](/[#6:8])-[#6@@:5]-1\[#8:6])-[#6:3]=[#6:4]>>[#6:1]/[#6@:2]1(-[#6:26]-[#6@@:21](/[#8:22]-[#6:23](=[#8:25])-[#6:24]-[#8])-[#6@:19]2(\[#6:20])-[#6@:12](/[#6:13])-[#6:11]-[#6:10]\[#6@:9]3(-[#6:17]-[#6:16]-[#6:15](=[#8:18])\[#6@:14]-3-2)-[#6@@:7](/[#6:8])-[#6@@:5]-1\[#8:6])-[#6:3]=[#6:4]
[#6:1]=[#6:2]1-[#8:16]-[#6:14](=[#8:15])-[#6:4](-[#6@@:5](-[#6:7]-[#6:8]-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13])/[#8:6])=[#6:3]-1>>[#6:13]-[#6:12]-[#6:11]-[#6:10]-[#6:9]-[#6:8]-[#6:7]-[#6@:5](-[#6:4]1-[#6:14](=[#8:15])-[#8:16]-[#6:2](-[#6:1])-[#6:3]=1)/[#8:6]
QRM13814.1
QRM13816.1
FAD-dependent halogenase
[#6:1]-[#8:2]\[#6@:3]1-[#6:48]2-[#6@@:12](-[#6:32](-[#6:34]3:[#6:45](-[#8:46]):[#6:44]4:[#6:37](:[#6:38]:[#6:39](:[#6:41]:[#6:42]:4-[#8:43])-[#8:40]):[#6:36]:[#6:35]:3-[#6:47]-2)=[#8:33])(\[#8:13]-[#6:14]2-[#8:31]-[#6:29](-[#6:30])-[#6:27](-[#8:28])-[#6:16](-[#8:17]-[#6:18]3-[#8:26]-[#6:24](-[#6:25])-[#6:22](-[#8:23])-[#6:20](-[#8:21])-[#6:19]-3)-[#6:15]-2)-[#6:10](=[#8:11])-[#6:6](-[#6:7](=[#8:9])-[#6:8])=[#6:4]-1-[#8:5]>>[#6:1]-[#8:2]\[#6@:3]1-[#6:48]2-[#6@@:12](-[#6:32](-[#6:34]3:[#6:45](-[#8:46]):[#6:44]4:[#6:37](:[#6:38]:[#6:39](:[#6:41]:[#6:42]:4-[#8:43])-[#8:40]):[#6:36]:[#6:35]:3-[#6:47]-2)=[#8:33])(\[#8:13]-[#6:14]2-[#8:31]-[#6:29](-[#6:30])-[#6:27](-[#8:28])-[#6:16](-[#8:17]-[#6:18]3-[#8:26]-[#6:24](-[#6:25])-[#6:22](-[#8:23])-[#6:20](-[#8]-[#6]4-[#8]-[#6](-[#6])-[#6](-[#8])-[#6](-[#8])-[#6]-4)-[#6:19]-3)-[#6:15]-2)-[#6:10](=[#8:11])-[#6:6](-[#6:7](=[#8:9])-[#6:8])=[#6:4]-1-[#8:5]
The substrate UDP-glucosamine might not be available as substrate in the cell naturally.
Q8KND6
Q8KND5
A0A2D1CM82
A0A6S6QI82
Generation of the bis-dehydro cyclo(L-Trp-L-Trp)
A0A7S9SW80
Bmp2
Q8KND2
A0A1C6TS88
A0A397HK89
A0A397HQ89
Minor component
[#6:1]-[#8:2]-[#6:3]1-[#6:78]2-[#6:13](-[#6:43](-[#6:45]3:[#6:75](-[#8:76]):[#6:74]4:[#6:48](:[#6:49]:[#6:50](:[#6:70](:[#6:72]:4-[#8:73])-[#6:71])-[#8:51]-[#6:52]4-[#8:69]-[#6:67](-[#6:68])-[#6:65](-[#8:66])-[#6:54](-[#8:55]-[#6:56]5-[#8:64]-[#6:62](-[#6:63])-[#6:60](-[#8:61])-[#6:58](-[#8:59])-[#6:57]-5)-[#6:53]-4):[#6:47]:[#6:46]:3-[#6:77]-2)=[#8:44])(-[#8:14]-[#6:15]2-[#8:42]-[#6:40](-[#6:41])-[#6:38](-[#8:39])-[#6:17](-[#8:18]-[#6:19]3-[#8:37]-[#6:35](-[#6:36])-[#6:33](-[#8:34])-[#6:21](-[#8:22]-[#6:23]4-[#8:32]-[#6:30](-[#6:31])-[#6:28](-[#8:29])-[#6:25](-[#8:27])(-[#6:26])-[#6:24]-4)-[#6:20]-3)-[#6:16]-2)-[#6:11](=[#8:12])-[#8:10]-[#6:6](-[#6:7](=[#8:9])-[#6:8])=[#6:4]-1-[#8:5]>>[#6:1]-[#8:2]-[#6:3](-[#6:78]1-[#6:13](-[#6:11](-[#8:10])=[#8:12])(-[#8:14]-[#6:15]2-[#8:42]-[#6:40](-[#6:41])-[#6:38](-[#8:39])-[#6:17](-[#8:18]-[#6:19]3-[#8:37]-[#6:35](-[#6:36])-[#6:33](-[#8:34])-[#6:21](-[#8:22]-[#6:23]4-[#8:32]-[#6:30](-[#6:31])-[#6:28](-[#8:29])-[#6:25](-[#8:27])(-[#6:26])-[#6:24]-4)-[#6:20]-3)-[#6:16]-2)-[#6:43](=[#8:44])-[#6:45]2:[#6:46](:[#6:47]:[#6:48]3:[#6:74](:[#6:75]:2-[#8:76]):[#6:72](-[#8:73]):[#6:70](-[#6:71]):[#6:50](-[#8:51]-[#6:52]2-[#8:69]-[#6:67](-[#6:68])-[#6:65](-[#8:66])-[#6:54](-[#8:55]-[#6:56]4-[#8:64]-[#6:62](-[#6:63])-[#6:60](-[#8:61])-[#6:58](-[#8:59])-[#6:57]-4)-[#6:53]-2):[#6:49]:3)-[#6:77]-1)-[#6:4](-[#6:6](-[#6:7](=[#8:9])-[#6:8])-[#8])=[#8:5]
K4CI56
[#7:1]/[#6@:2](-[#6:10](-[#8:12])=[#8:11])-[#6:3]-[#6:4]-[#6:5]-[#6:6]-[#7;+:7](-[#8;-:9])=[#8:8]>>[#7:1]\[#6@@:2](-[#6:3]/[#6@@:4]1-[#6:5]-[#6@:6]-1\[#7;+:7](=[#8:8])-[#8;-:9])-[#6:10](=[#8:11])-[#8:12]
CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)O
[#6:1]-[#6:2]-[#6:3]-[#6:4]-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]1:[#6:23](-[#8:24]):[#6:21](-[#8:22]):[#6:20]:[#6:18](-[#8:19]):[#6:17]:1>>[#6:1]-[#6:2]-[#6:3]-[#6:4]-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]1:[#6:23](-[#8:24]):[#6:21](-[#8:22]-[#6]):[#6:20]:[#6:18](-[#8:19]):[#6:17]:1
CC(C)(COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O)[C@@H](O)C(=O)NCCC(=O)NCCSSC(=O)C1=C(O)CC=CC=C1
1.14.13.59
1.14.19.59
1.14.19.58
COC(=CC(=O)N1C(=O)C=CC1C)CCNC(=O)CCC=CC(C)CCC(=CCl)CCCC#CI
AurH
Methyltransferase
2.1.1.304
Q2U1B3
Q2U1B0
26494
THAS
MtmMII
CC(=O)N[C@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@H](CO)[C@@H](O)[C@@H]1O
THAO
THAH
NgnO3
CN[C@H](CC(C)C)C(=O)N[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]1C(=O)N[C@H](c2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@H](C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)O)c2cc(O)cc(O)c2)[C@@H](O)c2ccc(c(Cl)c2)Oc2cc1ccc2O)[C@@H](O)c1ccc(O)c(Cl)c1
Acyltransferase subfamily IIIa, Arabidopsis lyrata ssp lyrata
Short-chain dehydrogenases/reductase (SDR)
CO[C@@]1(C)[C@H](O)C(O)=C(C)C(=O)[C@@H]1Oc1cc(C)cc(O)c1C
doi:10.1039/C7SC00460E
EOY45603.1
LauB1
CC(C)C[C@@H](N)C(=O)N[C@@H](C=O)[C@H](O)c1ccc(O)cc1
[#6:1]-[#8:2]-[#6:3]1:[#6:24](-[#8:25]):[#6:8](-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]-[#6:17]-[#6:18]-[#6:19]-[#6:20]-[#6:21](-[#6:23])-[#6:22]):[#6:7]:[#6:5](-[#8:6]):[#6:4]:1>>[#6:1]-[#8:2]-[#6:3]1:[#6:24](-[#8:25]):[#6:8](-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]-[#6:17]-[#6:18]-[#6:19]-[#6:20]-[#6:21](-[#6:22])-[#6:23]):[#6:7]:[#6:5](-[#8:6]-[#6]-[#6]=[#6](-[#6]-[#6]-[#6]=[#6](-[#6]-[#6]-[#6]=[#6](-[#6])-[#6])-[#6])-[#6]):[#6:4]:1
Oxidosqualene cyclase
Proline adenyltransferase
Catalyzes the flavin-dependent Baeyer-Villiger oxidation in the biosynthesis of pentalenolactone
N=C(N)NCCC[C@@H]1NC(=O)C(=Cc2ccc(O)c(O)c2)NC1=O
doi:10.1016/j.jbiotec.2006.04.009
[#6:3]-[#6@H:2](-[#8:1])-[#6:4]-[#6:5](=[O:6])-[c:7]1[c:8](-[#6:19]-[#6:20](-[#6:21])=[O:22])[c:9][c:10]2[c:11][c:12][c:13][c:14](-[#8:15])[c:16]2[c:17]1-[#8:18]>>[#6:3]-[#6@H:2](-[#8:1])-[#6:4]-[#6:5](=[O:6])-[c:7]1[c:8](-[#6:19]-[#6@@H:20](-[#6:21])-[#8:22])[c:9][c:10]2[c:11][c:12][c:13][c:14](-[#8:15])[c:16]2[c:17]1-[#8:18]
doi:10.1038/s41467-017-01659-1
Reaction from demethyl-vancomycin to dimethyl-vancomycin. Vancomycin is usually only monomethylated.
TnmK2
TnmK1
A0A346D7L2
Reaction from demethyl-vancomycin to vancomycin.
The enzyme accepts the vancomycin and teicoplanin aglycone as substrate. Therefore, the SMARTS was reduced to the maximum common substructure of both glycopeptide precursors. The true substrate specificity might still be broader.
[#8:1]-[#6:2]1:[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]>>[#6:2]1(-[#8]\[#6@@]2-[#6@@](-[#6@@](/[#8])-[#6@@](-[#6@](-[#8]-2)/[#6]-[#8])\[#8])\[#7]=[#7;+]=[#7;-]):[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]
CCCCCCCCCCCCCCCc1cc(O)cc(OC)c1O
BotCD
Short-chain dehydrogenase/reductase
oxidation of lysine to nitronorleucine
doi:10.1007/s12033-021-00314-x
PntI
PntM
Hydroxylation of iodinated orsellenic acid derivate, assumed to be bound to coenzyme A
PntE
Describes a deacylation of a C10 carboxylic acid. Probably only slow side reaction during teicoplanin biosynthesis.
AEW97391.1
AEI58868.1
AEI58876.1
C[C@@H]1C[C@H](C)C[C@H](C)[C@@H](O)CC(=O)O[C@@H](C2CCC[C@@H]2C(=O)O)CC=CC=C(C=O)[C@H](O)[C@@H](C)C1
AetF
AEH41787.1
C[C@@H]1C[C@H](C)C[C@H](C)[C@@H](O)CC(=O)O[C@@H](C2CCC[C@@H]2C(=O)O)CC=CC=C(C#N)[C@H](O)[C@@H](C)C1
AEH41784.1
AetA
AEI58872.1
Mediates the methylation of tyrosine into 3-methyl-L-tyrosine (3-Me-Tyr) in biosynthesis of saframycin A
XMN14539.1
XMN14538.1
XMN14537.1
XMN14533.1
Cytochrome P-450
doi:10.1016/S1074-5521(02)00270-3
N=C(N)NCCC[C@@H]1NC(=O)C(=Cc2ccc(O)c(OCC[C@H](N)C(=O)O)c2)NC1=O
doi:10.1016/s1074-5521(02)00101-1
doi:10.1016/s1074-5521(02)00126-6
doi:10.1016/S1074-5521(02)00126-6
BGC0003121
NC(N)=NCCCC1NC(=O)C(Cc2c[nH]c3ccccc23)NC1=O
BGC0000120
Putative FAD-monooxygenase
Leucyl/Phenylalanil-tRNA-Protein transferase
CC(=C\c1ccc([N+](=O)[O-])cc1)/C=C(\C)CCc1oc(O)c(C)c(=O)c1C
FADH2-dependent halogenase in the biosynthesis of bromoalbofungin variants
P9WEJ7
[NH2:1][CH:2]([CH2:3][c:4]1[cH:5][nH:6][c:7]2[c:8]([Cl:16])[cH:9][cH:10][cH:11][c:12]12)[C:13]([OH:14])=[O:15]>>[O:1]=[C:2]([CH2:3][c:4]1[cH:5][nH:6][c:7]2[c:8]([Cl:16])[cH:9][cH:10][cH:11][c:12]12)[C:13]([OH:14])=[O:15]
32631
COc1cc(O)c(I)c(C)c1C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O
CC(C)=CCC[C@@]1(C)C2CCC3Cc4c([nH]c5ccccc45)[C@]3(C)[C@@]2(C)CC[C@@H]1O
[#6](-[#6]-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6@](\[#8])-[#6](-[#6])(-[#6])-[#6]-[#8]-[#15](=[#8])(-[#8])-[#8]-[#15](=[#8])(-[#8])-[#8]-[#6]\[#6@]1-[#8]-[#6@@](\[#7]2:[#6]:[#7]:[#6]3:[#6](-[#7]):[#7]:[#6]:[#7]:[#6]:2:3)-[#6@](/[#8])-[#6@@]-1/[#8]-[#15](=[#8])(-[#8])-[#8])-[#16]-[#6](=[#8])-[#6]1:[#6](-[#6]):[#6]:[#6](-[#8]):[#6]:[#6]:1-[#8]-[#6]>>[#6](-[#6]-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6@](\[#8])-[#6](-[#6])(-[#6])-[#6]-[#8]-[#15](=[#8])(-[#8])-[#8]-[#15](=[#8])(-[#8])-[#8]-[#6]\[#6@]1-[#8]-[#6@@](\[#7]2:[#6]:[#7]:[#6]3:[#6](-[#7]):[#7]:[#6]:[#7]:[#6]:2:3)-[#6@](/[#8])-[#6@@]-1/[#8]-[#15](=[#8])(-[#8])-[#8])-[#16]-[#6](=[#8])-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#8]):[#6](-[I]):[#6]:1-[#6]
CC(C)CCCCCCCCCCCCCc1cc(O)cc(O)c1
CCC(C)CCCCCCCCCCCCc1cc(O)cc(O)c1
MITE0000058
MITE0000059
MITE0000056
doi:10.1021/bi00006a006
MITE0000057
MITE0000055
MITE0000052
MITE0000053
MITE0000050
MITE0000054
c1cc[nH]c1
MITE0000051
EFH40094.1
EFH40098.1
EFH41844.1
Mca
FAD Halogenase
MITE0000135
MITE0000134
MITE0000137
MITE0000136
MITE0000131
MITE0000130
GnmP
MITE0000132
MITE0000133
CC(C)CCCCCCCCCCCCCc1cc(O)cc(O)c1O
CCC(C)CCCCCCCCCCCCc1cc(O)cc(O)c1O
MITE0000139
MITE0000138
Brc1ccc2[nH]cc(Br)c2c1
C[S+](CCC([NH3+])C(=O)[O-])CC1OC(n2cnc3c(N)ncnc32)C(O)C1O.NC(Cc1ccc(O)cc1)C(=O)O
O=c1c(O)ccccc1O
N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O
doi:10.1128/AEM.02262-09
N[C@H]1C(=O)N[C@@H]2Cc3ccc(c(Cl)c3)Oc3cc4cc(c3O[C@H]3O[C@H](CO)[C@@H](O)C[C@H]3O)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(O)cc(c2)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@@H](C(=O)O)NC3=O
N-sulfonation of saxitoxin
CC(C)C[C@H](O)[C@@H](N)C(=O)SCCNC(O)CCNC(O)C(O)C(C)(C)CO[PH](O)(O)O
doi:10.1128/aem.00806-22
NADPH dependent reduction of exo-methylene in styrolide B to methyl group in styrolide A
Emindole SB formation
CC1=C[C@@H]2/C=C/C[C@H](C)/C=C(/C)[C@@H](O)[C@@H](O)/C=C/C(=O)[C@]23C(=O)N[C@@H](Cc2c[nH]c4ccccc24)C3[C@@H]1C
NC(Cc1c[nH]c2ccccc12)C(=O)O.NC(N)=NCCCC(N)C(=O)O
COc1c(O)c(O)c(I)c(C)c1C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O
O=C1OC(CO)C=C1/C=C/c1ccc(O)cc1
Acylation
CC1=C[C@@H](C)CC=C[C@H]2[C@@H]3O[C@]3(C)[C@@H](C)C3[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@]32C(=O)C=CC(=O)[C@@H]1O
NapH1
Cc1cc(O)c(C(=O)c2c(O)cccc2O)c(C(=O)O)c1
Ring contraction
COC1CC2(O)C(C)=CC=CC(C)CC(C)=CCC3CC(CC4(CCC(C)C(C)O4)O3)OC(=O)C2C=C1C
Cleaves modified bottromycin precursor peptide between thiazole8 and Met9.
ALD83700.1
ALJ49912.1
[#8:1]-[#6:2]1:[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]>>[#6:2]1(-[#8]\[#6@@]2-[#6@@](-[#6@@](/[#8])-[#6@@](-[#6@](-[#8]-2)/[#6])\[#8])\[#8]):[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]
CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O)[C@@H](C)CC)[C@@H](C)O
[#7:1]=[#6:2](-[#7:4]-[#6:5]-[#6:6]-[#6:7]\[#6@:8]1-[#6:42](=[#8:43])-[#7:41]-[#6:12](=[#6:13]-[#6:14]2:[#6:40]:[#6:19](-[#8:20]-[#6:21]-[#6:22]/[#6@@:23](-[#6:37](-[#8:39])=[#8:38])-[#7:24]-[#6:25](-[#6:27]-[#6@@:28](-[#6:34](-[#8:36])=[#8:35])(-[#6:30]-[#6:31](-[#8:33])=[#8:32])\[#8:29])=[#8:26]):[#6:17](-[#8:18]):[#6:16]:[#6:15]:2)-[#6:10](=[#8:11])-[#7:9]-1)-[#7:3]>>[#8:43]=[#6:42]1-[#7:41]-[#6:12](-[#6:10](-[#7:9]-[#6@:8]-1\[#6:7]-[#6:6]-[#6:5]-[#7:4]-[#6:2](=[#7:1])-[#7:3])=[#8:11])=[#6:13]-[#6:14]1:[#6:15]:[#6:16]:[#6:17](-[#8:18]):[#6:19](-[#8:20]-[#6:21]-[#6:22]/[#6@:23](-[#7:24]-[#6:25](=[#8:26])-[#6:27]-[#6@:28](\[#8:29])(-[#6:30]-[#6:31](=[#8:32])-[#7]/[#6@](-[#6](-[#8])=[#8])-[#6]-[#6](-[#8])=[#8])-[#6:34](=[#8:35])-[#8:36])-[#6:37](=[#8:38])-[#8:39]):[#6:40]:1
CCCCCCCCCC(=O)N[C@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@H](CO)[C@@H](O)[C@@H]1O.O
Fe
[#8].[#6:100]-[#6:98](=[O:99])-[#7:2]-[#6@@H:3]-1-[#6@@H:4](-[#8:5])-[#6@H:6](-[#8:7])-[#6@@H:8](-[#6:9]-[#8:10])-[#8:11]-[#6@H:12]-1-[#8:13]-[c:14]1[c:15]2-[#8:16]-[c:17]3[c:18][c:19][c:20](-[#6:21]-[#6@H:22]-4-[#7:23]-[#6:24](=[O:25])-[#6@H:26](-[#7:27])-[c:28]5[c:29][c:30][c:31](-[#8:32])[c:33](-[#8:34]-[c:35]6[c:36][c:37](-[#8:38])[c:39][c:40]([c:41]6)-[#6@H:42](-[#7:43]-[#6:44]-4=[O:45])-[#6:46](=[O:47])-[#7:48]-[#6@@H:49]-4-[c:50]([c:51]2)[c:52][c:53]1-[#8:54]-[c:55]1[c:56][c:57][c:58]([c:59][c:60]1[Cl:61])-[#6@@H:62](-[#8:63])-[#6@@H:64]-1-[#7:65]-[#6:66](=[O:67])-[#6@H:68](-[#7:69]-[#6:70]-4=[O:71])-[c:72]2[c:73][c:74][c:75](-[#8:76])[c:77]([c:78]2)-[c:79]2[c:80](-[#8:81])[c:82][c:83](-[#8:84])[c:85][c:86]2-[#6@H:87](-[#7:88]-[#6:89]-1=[O:90])-[#6:91](-[#8:92])=[O:93])[c:94]5)[c:95][c:96]3[Cl:97]>>[#7:2]-[#6@@H:3]-1-[#6@@H:4](-[#8:5])-[#6@H:6](-[#8:7])-[#6@@H:8](-[#6:9]-[#8:10])-[#8:11]-[#6@H:12]-1-[#8:13]-[c:14]1[c:15]2-[#8:16]-[c:17]3[c:18][c:19][c:20](-[#6:21]-[#6@H:22]-4-[#7:23]-[#6:24](=[O:25])-[#6@H:26](-[#7:27])-[c:28]5[c:29][c:30][c:31](-[#8:32])[c:33](-[#8:34]-[c:35]6[c:36][c:37](-[#8:38])[c:39][c:40]([c:41]6)-[#6@H:42](-[#7:43]-[#6:44]-4=[O:45])-[#6:46](=[O:47])-[#7:48]-[#6@@H:49]-4-[c:50]([c:51]2)[c:52][c:53]1-[#8:54]-[c:55]1[c:56][c:57][c:58]([c:59][c:60]1[Cl:61])-[#6@@H:62](-[#8:63])-[#6@@H:64]-1-[#7:65]-[#6:66](=[O:67])-[#6@H:68](-[#7:69]-[#6:70]-4=[O:71])-[c:72]2[c:73][c:74][c:75](-[#8:76])[c:77]([c:78]2)-[c:79]2[c:80](-[#8:81])[c:82][c:83](-[#8:84])[c:85][c:86]2-[#6@H:87](-[#7:88]-[#6:89]-1=[O:90])-[#6:91](-[#8:92])=[O:93])[c:94]5)[c:95][c:96]3[Cl:97].[#8]-[#6](=[#8])-[#6]
1.3.3.13
CO[C@@H]1C(O)=C(C(C)=O)C(=O)[C@@]2(OC3CC(OC4CC(OC5CC(O)C(O)C(C)O5)C(O)C(C)O4)C(O)C(C)O3)C(=O)c3c(cc4cc(O)cc(O)c4c3O)CC12
[#6:1]1(:[#6:11]:[#6:10]:[#6:9]:[#6:7](-[#6:8]):[#6:3]:1-[#6](-[#8])=[#8])-[#8:2]>>[#6:1]1(:[#6:11]:[#6:10]:[#6:9]:[#6:7](-[#6:8]):[#6:3]:1)-[#8:2]
doi:10.1021/acs.orglett.2c01050
doi:10.1021/acs.orglett.9b01344
Converts deoxyscytalidin to 5-hydroxy-deoxyscytalidin
D6MSX0
Carboxylation
[#6:1]-[#8:2]\[#6@@:3]1-[#6:9]2:[#8:10]:[#6:11]3:[#6:17](:[#6:18](=[#8:19]):[#6:8]:2-[#6@:6](\[#8:7])-[#6:5]-[#6:4]-1):[#6:15](-[#8:16]):[#6:14]1-[#6:20]2:[#6:32](-[#8:33]):[#6:31]4:[#6:23](:[#6:24]:[#6:25](:[#7:27](:[#6:29]:4=[#8:30])-[#6:28])-[#6:26]):[#6:22]:[#6:21]:2-[#6:34]-[#6:35]2-[#8:36]-[#6:37]-[#8:38]-[#6:12]:3:[#6:13]:1-2>>[#6:1]-[#8:2]\[#6@@:3]1-[#6:9]2:[#8:10]:[#6:11]3:[#6:17](:[#6:18](=[#8:19]):[#6:8]:2-[#6@:6](\[#8:7])-[#6:5]-[#6:4]-1):[#6:15](-[#8:16]):[#6:14]1-[#6:20]2:[#6:32](-[#8:33]):[#6:31]4:[#6:23](:[#6:24](:[#6:25](:[#7:27](:[#6:29]:4=[#8:30])-[#6:28])-[#6:26])-Cl):[#6:22]:[#6:21]:2-[#6:34]-[#6:35]2-[#8:36]-[#6:37]-[#8:38]-[#6:12]:3:[#6:13]:1-2
AviG6 for methylation of the hydroxyl group at position 2 of the D-mannose moiety.
BAC70710.1
BAI44340.1
BAL92977.1
Terpene cyclase
RufN
RufO
N[C@@H](C[C@@H]1C[C@H]1[N+](=O)[O-])C(=O)O
BAU86124.1
BAC70706.1
BAE64652.1
Decarboxylation of 6-methylsalicylic in the patulin biosynthetic pathway
C#CCCCC(=CCl)CCC(C)C=CCCC(=O)NCCC(=CC(=O)N1C(=O)C=CC1C)OC
Adds N-acetylglucosamine or N-acylglucosamine to Hpg4 of the teicoplanin aglycone. Substrate specificity is probably more general than depicted in the reaction SMARTS, but there is no precise information on substrate specificity. In order to avoid making the reaction too general, the complete backbone is included in the pattern.
CSCC[C@H](NC(=O)[C@@H]1CSC([C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](/N=C2\NCC(=O)N3CCC[C@H]3C(=O)N[C@@H](C(C)C)C(=O)N[C@H]2C(C)C)C(C)C)=N1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)O
Q194Q1
Q194Q0
non-heme diiron monooxygenase
Cytochrome P450
CCC1OC(=O)[C@H](C)[C@@H](OC2C[C@](C)(OC)[C@H](O)[C@@H](C)O2)[C@@H](C)[C@H](OC2O[C@@H](C)C[C@@H](N(C)C)[C@@H]2O)[C@@](C)(O)C[C@H](C)C(=O)[C@H](C)[C@H](O)[C@@H]1C
AEH41788.1
CC[C@H]1OC(=O)CCC2C=CC3C[C@H](O)[C@H](C)[C@H](O)C3C2/C(C)=C/[C@H]1C
O=c1[nH]cc([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1
B0CN31
[#7:1]-[#6:2]-[#6:3]-[#6:4]-[#6:5]-[#6@@:6](-[#6:8](=[#8:10])-[#8:9])/[#7:7]>>[#6:3]1-[#6:2]-[#7:7]-[#6@:6](/[#6:8](=[#8:10])-[#8:9])-[#6:5]-[#6:4]-1.[#7:1]
doi:10.1021/acschembio.9b01034
doi:10.1021/acschembio.6b01031
UPI0001633292
[CH3:1][O:2][C:3]1[CH:33]2[CH:34]([CH:35]=[O:36])[C:7]([CH:8]([C:27]#[C:28][CH:29]=[CH:30][C:31]#[C:32]2)[NH:9][c:10]2[c:16]3[C:17]([c:19]4[c:24]([C:25](=[O:26])[c:15]3[c:13]([OH:14])[cH:12][cH:11]2)[cH:23][cH:22][cH:21][cH:20]4)=[O:18])=[C:5]([CH3:6])[CH:4]=1>>[CH3:1][O:2][C:3]1[CH:33]2[C:34]3([CH:11]4[CH2:12][C:13]([c:15]5[c:25]([OH:26])[c:24]6[c:19]([cH:20][cH:21][cH:22][cH:23]6)[c:17]([OH:18])[c:16]5[C:10]4=[N:9][CH:8]([C:27]#[C:28][CH:29]=[CH:30][C:31]#[C:32]2)[C:7]3=[C:5]([CH3:6])[CH:4]=1)=[O:14])[CH:35]=[O:36]
Dichlorenation of chlorotonil A precursor. Requires an unmethylated C2.
doi:10.1111/j.1365-2958.2004.04433.x
 Glycosyltransferase adds N-acetylglucosamine to Bht6 of the teicoplanin precursor. Substrate specificity is probably more general than depicted in the reaction SMARTS, but there is no precise information on substrate specificity. In order to avoid making the reaction too general, the complete backbone is included in the pattern.
Carboxylate-Amine Ligase
C[C@@H]1C[C@H](C)C[C@H](C)[C@@H](O)CC(=O)O[C@@H](C2CCC[C@@H]2C(=O)O)CC=CC=C(C=NO)[C@H](O)[C@@H](C)C1
[#8:1]-[#6:2]1:[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]>>[#6:2]1(-[#8]/[#6@]2-[#8]-[#6@](\[#6]-[#8])-[#6@@](/[#8])-[#6@](\[#8])-[#6@]-2/[#8]):[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]
[#8:1]-[#6:2]1:[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]>>[#6:2]1(-[#8]/[#6@]2-[#8]-[#6@](\[#6]-[#8])-[#6@@](/[#8])-[#6@](\[#8])-[#6@]-2/[#7]):[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]
QWP75303.1
QWP75305.1
QWP75304.1
QWP75301.1
[#6:1]=[#6:2]-[#6@:3]1(-[#6:22]-[#6@:20](\[#6:21])-[#6@:14]23-[#6@:19](-[#6@:8](-[#6@@:10](-[#6:12]-[#6:13]/2)\[#6:11])(/[#6:9])-[#6@:6](\[#8:7])-[#6:5]-1)/[#6@:17](/[#8:18])-[#6:16]-[#6:15]-3)\[#6:4]>>[#6:1]=[#6:2]-[#6@:3]1(-[#6@@:22](/[#8])-[#6@:20](\[#6:21])-[#6@:14]23-[#6@:19](-[#6@:8](-[#6@@:10](-[#6:12]-[#6:13]/2)\[#6:11])(/[#6:9])-[#6@:6](\[#8:7])-[#6:5]-1)/[#6@:17](/[#8:18])-[#6:16]-[#6:15]-3)\[#6:4]
[#6:1]/[#6@:2]1(-[#6:22]-[#6@@:20](/[#8:21])-[#6@:18]2(\[#6:19])-[#6@:12](/[#6:13])-[#6:11]-[#6:10]\[#6@:9]3(-[#6:17]-[#6:16]-[#6:15]\[#6@:14]-3-2)-[#6@@:7](/[#6:8])-[#6@@:5]-1\[#8:6])-[#6:3]=[#6:4]>>[#6:1]/[#6@:2]1(-[#6:22]-[#6@@:20](/[#8:21])-[#6@:18]2(\[#6:19])-[#6@:12](/[#6:13])-[#6:11]-[#6:10]\[#6@:9]3(-[#6:17]-[#6:16]-[#6@@:15](\[#8])-[#6@:14]\3-2)-[#6@@:7](/[#6:8])-[#6@@:5]-1\[#8:6])-[#6:3]=[#6:4]
O=C(O)C1=C(O)CC=CC=C1
Decarboxylates the phenolic substrate
CC(C)=CCC/C(C)=C/C[C@]1(O)C(=O)c2cc(O)c(C)c(O)c2C(=O)[C@@]1(Cl)CC=C(C)C
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)Cc2c[nH]c3cccc(c23)-n2cc(c3ccccc32)C[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CO)C(=O)O)NC1=O
Cleaves off CoA from 2-hydroxycyclohepta-1,4,6-triene-1-carboxyl-CoA
[#6:1]-[#8:2]-[#6:3]\[#6@@:4]1-[#6@@:41](/[#8:42]/[#6@:43]2-[#6@:93](\[#8:94])-[#6@@:50](/[#8:51]\[#6@@:52]3-[#8:92]-[#6@:90](\[#6:91])-[#6@@:89]4-[#6@@:54](-[#8:56]-[#6:57]5(-[#8:88]/4)-[#8:87]-[#6@:85](\[#6:86])-[#6@@:61](/[#8:62]\[#6@@:63]4-[#8:84]-[#6@:82](\[#6:83])-[#6@@:67](/[#8:68]-[#6:69](-[#6:71]6:[#6:80](-[#8:81]):[#6:78](-[Cl:79]):[#6:76](-[#8:77]):[#6:74](-[Cl:75]):[#6:72]:6-[#6:73])=[#8:70])-[#6@:65](\[#8:66])-[#6:64]-4)-[#6@@:59](/[#8:60])-[#6:58]-5)(/[#6:55])-[#6:53]-3)-[#6@@:47](/[#8:48]-[#6:49])-[#6@@:45](/[#6:46])-[#8:44]-2)-[#6@:39](\[#8:40])-[#6@:36](\[#8:37]-[#6:38])-[#6@:6](\[#8:7]/[#6@:8]2-[#6@:16](\[#8:17]-[#6:18](-[#6:20](-[#6:22])-[#6:21])=[#8:19])-[#6@:15]3-[#6@@:11](-[#8:12]/[#6@:13]4(-[#6:35]5-[#6:31](-[#8:32]-[#6:33]-[#8:34]-5)-[#6@@:26](-[#6:28](=[#8:30])-[#6:29])(/[#8:27])-[#6@@:24](/[#6:25])-[#8:23]-4)-[#8:14]\3)/[#6:10]-[#8:9]-2)-[#8:5]-1>>[#6:1]-[#8:2]-[#6:3]\[#6@@:4]1-[#6@@:41](/[#8:42]/[#6@:43]2-[#6@:93](\[#8:94])-[#6@@:50](/[#8:51]\[#6@@:52]3-[#8:92]-[#6@:90](\[#6:91])-[#6@@:89]4-[#6@@:54](-[#8:56]-[#6:57]5(-[#8:88]/4)-[#8:87]-[#6@:85](\[#6:86])-[#6@@:61](/[#8:62]\[#6@@:63]4-[#8:84]-[#6@:82](\[#6:83])-[#6@@:67](/[#8:68]-[#6:69](-[#6:71]6:[#6:80](-[#8:81]-[#6]):[#6:78](-[Cl:79]):[#6:76](-[#8:77]):[#6:74](-[Cl:75]):[#6:72]:6-[#6:73])=[#8:70])-[#6@:65](\[#8:66])-[#6:64]-4)-[#6@@:59](/[#8:60])-[#6:58]-5)(/[#6:55])-[#6:53]-3)-[#6@@:47](/[#8:48]-[#6:49])-[#6@@:45](/[#6:46])-[#8:44]-2)-[#6@:39](\[#8:40])-[#6@:36](\[#8:37]-[#6:38])-[#6@:6](\[#8:7]/[#6@:8]2-[#6@:16](\[#8:17]-[#6:18](-[#6:20](-[#6:21])-[#6:22])=[#8:19])-[#6@:15]3-[#6@@:11](-[#8:12]/[#6@:13]4(-[#6:35]5-[#6:31](-[#8:32]-[#6:33]-[#8:34]-5)-[#6@@:26](-[#6:28](=[#8:30])-[#6:29])(/[#8:27])-[#6@@:24](/[#6:25])-[#8:23]-4)-[#8:14]\3)/[#6:10]-[#8:9]-2)-[#8:5]-1
doi:10.1128/jb.181.8.2659-2662.1999
doi:10.1128/JB.181.8.2659-2662.1999
JamD
Biaryl formation between Y1 and H3 of the tripeptide, cytochrome P450, Planomonospora strain ID82291
13009
[#6:1]-[#16:2]-[#6:3]-[#6:4]-[#6@H:5](-[#7:6]-[#6:7](=[O:8])-[#6@H:9](-[#6:10]-[#16:11])-[#7:12]-[#6:13](=[O:14])-[#6@H:15](-[#6:16]-[#6:17](-[#8:19])=[O:18])-[#7:20]-[#6:21](=[O:22])-[#6@H:23](-[#6:24]-[c:25]1[c:26][c:27][c:28][c:29][c:30]1)-[#7:31]-[#6:32](=[O:33])-[#6@@H:34](-[#7:35]-[#6:36](=[O:37])-[#6@@H:38](-[#7:39]-[#6:40](=[O:41])-[#6@@H:42](-[#7:43]-[#6:44](=[O:45])-[#6@@H:46]-1-[#6:47]-[#6:48]-[#6:49]-[#7:50]-1-[#6:51](=[O:52])-[#6H2:53]-[#7H2:54])-[#6:55](-[#6:65])-[#6:66])-[#6:56](-[#6:57])-[#6:58])-[#6:59](-[#6:60])-[#6:61])-[#6:62]=[O:63]>>[#6:1]-[#16:2]-[#6:3]-[#6:4]-[#6@H:5](-[#7:6]-[#6:7](=[O:8])-[#6@H:9](-[#6:10]-[#16:11])-[#7:12]-[#6:13](=[O:14])-[#6@H:15](-[#6:16]-[#6:17](-[#8:19])=[O:18])-[#7:20]-[#6:21](=[O:22])-[#6@@H:23](-[#7:31]-[#6:32](=[O:33])-[#6@@H:34](-[#7:35]-[#6:36](=[O:37])-[#6@@H:38](-[#7:39]-[#6:40](=[O:41])-[#6@@H:42](-[#7:43]-[#6:44](=[O:45])-[#6@@H:46]-1-[#6:47]-[#6:48]-[#6:49]-[#7:50]-1-[#6:51](=[O:52])-[#6H2:53]-[#7H2:54])-[#6:55](-[#6:65])-[#6:66])-[#6:56](-[#6:57])-[#6:58])-[#6:59](-[#6:60])-[#6:61])-[#6@@H:24](-[#6:67])-[c:25]1[c:26][c:27][c:28][c:29][c:30]1)-[#6:62]=[O:63]
[#7:1]=[#6:2](-[#7:4]-[#6:5]-[#6:6]-[#6:7]\[#6@:8]1-[#6:22](=[#8:23])-[#7:21]-[#6:12](=[#6:13]-[#6:14]2:[#6:20]:[#6:19]:[#6:17](-[#8:18]):[#6:16]:[#6:15]:2)-[#6:10](=[#8:11])-[#7:9]-1)-[#7:3]>>[#7:1]=[#6:2](-[#7:4]-[#6:5]-[#6:6]-[#6:7]\[#6@:8]1-[#6:22](=[#8:23])-[#7:21]-[#6:12](=[#6:13]-[#6:14]2:[#6:20]:[#6:19](-[#8]):[#6:17](-[#8:18]):[#6:16]:[#6:15]:2)-[#6:10](=[#8:11])-[#7:9]-1)-[#7:3]
a-Ketoglutaric acid
doi:10.1074/jbc.M803995200
[#6:1]-[#6:2](-[#6:10](-[#8:22])-[#6:11](-[#7:13]-[#6:14]-[#6:15]-[#6:16](-[#7:18]-[#6:19]-[#6:20]-[#16:21]-[#6:23](=[#8:26])-[#6@:24](/[#7:27])-[#6:25]-[#6:28]1:[#6:32]:[#6:33]:[#6:31](-[#8:34]):[#6:29]:[#6:30]:1)-[#8:17])-[#8:12])(-[#6:4]-[#8:5]-[#15:6](-[#8:9])(-[#8:8])-[#8:7])-[#6:3]>>[#6:3]-[#6:2](-[#6:10](-[#8:22])-[#6:11](-[#7:13]-[#6:14]-[#6:15]-[#6:16](-[#7:18]-[#6:19]-[#6:20]-[#16:21]-[#6:23](=[#8:26])-[#6@:24](/[#7:27])-[#6@@:25](/[#8])-[#6:28]1:[#6:30]:[#6:29]:[#6:31](-[#8:34]):[#6:33]:[#6:32]:1)-[#8:17])-[#8:12])(-[#6:4]-[#8:5]-[#15:6](-[#8:9])(-[#8:8])-[#8:7])-[#6:1]
CC(=O)O[C@H](C)Cc1cc2cccc(O)c2c(O)c1C(=O)C[C@H](C)O
Acetylation, O-acetylation of 3,11-diol-mutilin to produce 3,11-diol-14-acetyl-mutilin
Q9X2V9
Q9X2V8
35531
Generation of the bis-dehydro cyclo(L-Phe-L-Leu)
CC1OC(c2ccc3c(c2O)C(=O)C2=C(O)C4(O)C(=O)C(C(N)=O)=C(O)C(O)C4CC2C3(C)O)CC(O)C1O
AWF83810.1
AWF83807.1
AWF83808.1
[#6:1]1:[#6:5]:[#6:4]:[#6:3]:[#7:2]:1>>[Br]-[#6:1]1:[#6:5](-[Br]):[#6:4](-[Br]):[#6:3](-[Br]):[nH:2]:1
AWF83809.1
AWH12915.1
[#6:2]-[#6:3](-[#6:4])-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]-[#6:17]-[c:18]1[c:19][c:20](-[#8:21])[c:22][c:23](-[#8:24])[c:25]1-[#6:26]>>[#6]-[#8:21]-[c:20]1[c:22][c:23](-[#8:24])[c:25](-[#6:26])[c:18](-[#6:17]-[#6:16]-[#6:15]-[#6:14]-[#6:13]-[#6:12]-[#6:11]-[#6:10]-[#6:9]-[#6:8]-[#6:7]-[#6:6]-[#6:5]-[#6:3](-[#6:2])-[#6:4])[c:19]1
[#7:1]-[#6:2](-[#6:3]-[c:4]1[c:5][nH1:6][c:7]2[c:8][c:9][c:10][c:11][c:12]12)-[#6:13](-[#8:14])=[O:15]>>[#7:1]-[#6:2](-[#6:3]-[c:4]1[c:5][nH1:6][c:7]2[c:8][c:9](-[#17,#35:10])[c:11][c:12][c:13]12)-[#6:14](-[#8:15])=[O:16]
ATP-dependent protease (cysteine protease-like)
Cc1cc(O)c2c(O)c3c(c(O)c2c1)C[C@H](O)CC3=O
CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H]1Cc2ccc(O)c(c2)-c2ccc3[nH]cc(c3c2)C[C@@H](C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)O)NC(=O)[C@@H]2CCCN2C1=O
C=C1C=C(C)C[C@H]2C[C@@H](OC(=O)C=C(C)C=CC[C@@H](O)C1)[C@@](C)([C@H](O)C=C(C)C[C@H](O)C(C)(C)[C@H](O)C[C@H](O)[C@@H](C)[C@H](O)C[C@@H](CC(=C)C(=CBr)OC)OC(=O)CCCCCCCCCCCCCCC)O2
MstE
[#6:1]-[#6:2](-[#6:13]=[#6:14](-[#6:16]-[#6:17]-[#6:18]1:[#6:26](-[#6:27]):[#6:24](=[#8:25]):[#6:22](-[#6:23]):[#6:20](-[#8:21]):[#8:19]:1)-[#6:15])=[#6:3]-[#6:4]1:[#6:12]:[#6:11]:[#6:7](-[#7;+:8](-[#8;-:10])=[#8:9]):[#6:6]:[#6:5]:1>>[#6:1]-[#6:2](=[#6:3]-[#6:4]1:[#6:12]:[#6:11]:[#6:7](-[#7;+:8](-[#8;-:10])=[#8:9]):[#6:6]:[#6:5]:1)-[#6:13]=[#6:14]1-[#6:16]-[#6:17](-[#6:18]2:[#6:26](-[#6:27]):[#6:24](=[#8:25]):[#6:22](-[#6:23]):[#6:20](-[#8:21]):[#8:19]:2)-[#8]-[#6:15]-1
[N-]=[N+]=N[C@H]1[C@@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@H](CO)[C@@H](O)[C@@H]1O
[#8:1]-[#6:2]1:[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]>>[#6:2]1(-[#8]\[#6@@]2-[#6@](\[#8])-[#6@@](/[#8])-[#6@](\[#8])-[#6@@](/[#6]-[Cl])-[#8]-2):[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]
[#8:1]-[#6:2]1:[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]>>[#6:2]1(-[#8]\[#6@@]2-[#6@](\[#8])-[#6@@](/[#7])-[#6@](\[#8])-[#6@@](/[#6]-[#8])-[#8]-2):[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]
[#6:1]-[#6:2]1-[#6:36](-[#6:37])-[#8:35]-[#6:5]2(-[#8:34]-[#6:9]3-[#6:10]-[#6:11]=[#6:12](-[#6:14]-[#6:15](-[#6:17]=[#6:18]-[#6:19]=[#6:20](-[#6:22]4(-[#6:30](-[#6:31](-[#8:33]-[#6:7](-[#6:8]-3)-[#6:6]-2)=[#8:32])-[#6:29]=[#6:27](-[#6:28])-[#6:25](-[#8:26])-[#6:24]-4)-[#8:23])-[#6:21])-[#6:16])-[#6:13])-[#6:4]-[#6:3]-1>>[#6:1]-[#6:2]1-[#6:36](-[#6:37])-[#8:35]-[#6:5]2(-[#8:34]-[#6:9]3-[#6:10]-[#6:11]=[#6:12](-[#6:14]-[#6:15](-[#6:17]=[#6:18]-[#6:19]=[#6:20]4-[#6:22]5(-[#8:23])-[#6:24](-[#6:25](-[#6:27](=[#6:29]-[#6:30]-5-[#6:31](-[#8:33]-[#6:7](-[#6:8]-3)-[#6:6]-2)=[#8:32])-[#6:28])-[#8:26])-[#8]-[#6:21]-4)-[#6:16])-[#6:13])-[#6:4]-[#6:3]-1
Catalyzes oxidative rearrangement of final step in pentalenolactone pathway
[#6:1]-[#16:2]-[#6:3]-[#6:4]-[#6@H:5](-[#7H2:6])-[#6:7](=[O:8])-[#7:9]-[#6H2:10]-[#6:11](=[O:12])-[#7:13]-1-[#6:14]-[#6:15]-[#6:16]-[#6@H:17]-1-[#6:18]=[O:19]>>[#7H2:9]-[#6:10]-[#6:11](=[O:12])-[#7:13]-1-[#6:14]-[#6:15]-[#6:16]-[#6@H:17]-1-[#6:18]=[O:19]
CYP71BN1 catalyzes the two-step oxidation of lycosantalene to lycosantalonol 
UPI00205EBDF6
Atom number nine (in the SMARTS reaction) could be methylated, then this reaction leads to the final product
MdpB2
MdpB1
XanH
Cleavage of the LrcA precursor peptide resulting in the intermediate core peptide before macrolactam formation.
[6+4] cycloaddition; NgnD acts likely similar to a bispericyclase
CO[C@@H]1C(O)=C(C(C)=O)C(=O)[C@@]2(OC3CC(OC4CC(OC5CC(C)(O)C(O)C(C)O5)C(O)C(C)O4)C(O)C(C)O3)C(=O)c3c(cc4cc(OC5CC(O)C(OC6CC(O)C(O)C(C)O6)C(C)O5)c(C)c(O)c4c3O)CC12
[#6:1]/[#6@@:2](-[#6@@:4]1-[#6@:27](\[#6:28])-[#6:26]=[#6:24](-[#6:25])/[#6@@:23]2-[#6@:11](-[#6:12]=[#6:13]/[#6@:14]3-[#6@:22]-2\[#6@@:20](/[#8:21])-[#6@@:18](/[#6:19])-[#6@@:16](/[#8:17])-[#6:15]-3)\[#6:10]-[#6@:8](\[#8:9])-[#6:6](=[#8:7])-[#8:5]\1)-[#8:3]>>[#6]-[#8:9]\[#6@@:8]1-[#6:6](=[#8:7])-[#8:5]\[#6@:4](-[#6@@:2](/[#8:3])-[#6:1])-[#6@:27](\[#6:28])-[#6:26]=[#6:24](-[#6:25])/[#6@@:23]2-[#6@:11](-[#6:12]=[#6:13]/[#6@:14]3-[#6@:22]-2\[#6@@:20](/[#8:21])-[#6@@:18](/[#6:19])-[#6@@:16](/[#8:17])-[#6:15]-3)\[#6:10]-1
Cc1cccc(O)c1C(=O)O
Cc1cc(O)c(C(=O)c2c(O)cccc2O)c(CO)c1
CPT2
COC1C(O)=C(C(C)=O)C(=O)C2(OC3CC(OC4CC(OC5CC(C)(O)C(O)C(C)O5)C(O)C(C)O4)C(O)C(C)O3)C(=O)c3c(cc4cc(O)cc(O)c4c3O)CC12
BGC0003089
BGC0001485
BGC0002084
BGC0001487
nonribosomal peptide synthetase
BGC0002181
doi:10.1016/j.chembiol.2004.08.016
BGC0001881
BGC0000581
Brominates free-floating L-tryptophan exclusively in position 5
CC(=O)N[C@@H]1[C@@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O)cc(O)cc3[C@@H](C(=O)O)NC2=O)[C@H](O)[C@@H](CO)O[C@H]1O
[#6:1]-[#6:2](\[#6@:4]1-[#6:22]2-[#6@@:7](-[#6:9]/[#6@:10]3-[#6@@:15](/[#6:16])-[#6:14]-[#6@:12](\[#8:13])-[#6@@:11]\3-[#6@@:17](-[#6:20]-[#6:21]=2)(-[#8:19])/[#6:18])(\[#6:8])-[#6:6]-[#6:5]-1)-[#6:3]>>[#6:3]-[#6:2](\[#6@:4]1-[#6:22]2-[#6@@:7](-[#6:9]/[#6@@:10]3\[#6@@:11](-[#6@@:17](-[#6:20]-[#6:21]=2)(-[#8:19])/[#6:18])-[#6@@:12](\[#8:13])-[#6:14]-[#6@@:15]-3/[#6:16]-[#8])(\[#6:8])-[#6:6]-[#6:5]-1)-[#6:1]
N-21 sulfonation of saxitoxin to produce Gonyautoxin 5
MITE0000049
MITE0000048
CC(C)C[C@@H](N)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H](c3ccc(O)cc3)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c3cc(O)cc(O)c3)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O)Oc2ccc(cc2Cl)[C@H]1O
MITE0000045
MITE0000044
MITE0000047
MITE0000046
MITE0000041
MITE0000040
MITE0000043
MITE0000042
[#6:1]1(=[#8])-[#6:32](-[#8:33]-[#6:34])=[#6:31]-[#6:29](=[#8])-[#6:28]2:[#6:2]-1:[#6:3](-[#8:38]):[#6:4]1:[#6:25](:[#6:26]:2-[#8:27])-[#6:23](=[#8:24])-[#6:21]2(-[#8:22])-[#6:7](-[#8:37])(-[#6:8]3:[#6:18](-[#6:19]-[#6:20]-2):[#6:17]:[#6:16]2:[#6:11](:[#6:12](=[#8:36]):[#8:13]:[#6:14](-[#6:35]):[#6:15]:2):[#6:9]:3-[#8:10])-[#6:5]-1=[#8:6]>>[#6:1]1(-[#8]):[#6:32](-[#8:33]-[#6:34]):[#6:31]:[#6:29](-[#8]):[#6:28]2:[#6:2]:1:[#6:3](-[#8:38]):[#6:4]1:[#6:25](:[#6:26]:2-[#8:27])-[#6:23](=[#8:24])-[#6:21]2(-[#6:20]-[#6:19]-[#6:18]3:[#6:8](:[#6:9](-[#8:10]):[#6:11]4:[#6:16](:[#6:17]:3):[#6:15]:[#6:14](-[#6:35]):[#8:13]:[#6:12]:4=[#8:36])-[#8:22]-2)-[#8]-[#6:7]-1(-[#6:5](=[#8:6])-[#8])-[#8:37]
QNL10608.1
QNL15171.1
QNL15176.1
QNL10607.1
QNL10606.1
Iodination of jamaicamide B to jamaicamide F.
N=C(N)NCCC[C@@H]1NC(=O)[C@H](CC23OC2Nc2ccccc23)NC1=O
N=C(N)NCCC[C@@H]1NC(=O)[C@H](CC(=O)c2ccccc2N)NC1=O
C/C=C(C)/C=C(C)/C(O)=C(/C)C(=O)[S-]
CC(CCCCCCCCCCCc1c(C)c(O)cc(O)c1)C
SgvP
Aminotransferase
CC(C)[C@@H]1NC(=O)[C@@H]2[C@H](C)CCN2C(=O)CN/C(=N\[C@H](C(=O)N[C@H](C(=O)N[C@H](CC(=O)O)c2nccs2)[C@@H](C)c2ccccc2)C(C)(C)C)[C@H](C(C)(C)C)NC1=O
A0A5C4KWK7
BotC
[#6:1]1:[#6:2]:[#6:77]2:[#6:78]:[#6:80](:[#6:81]:1-[#8:82]-[#6:83]1:[#6:84](-[#8:85]):[#6:34]3-[#8:35]-[#6:36]4:[#6:38](:[#6:39]:[#6:40](-[#6:41]-[#6@@:42]5\[#6:44](-[#7:45]-[#6@:46](\[#6:47](-[#7:48]-[#6@@:49](\[#6:50](-[#7:51]-[#6@@:52]6/[#6:57]7:[#6:58]:[#6:59](-[#6:66]8:[#6:67](-[#6@:71](-[#7:72]-[#6:74](/[#6@:75](-[#6@@:76]-2/[#8:3])-[#7:4]-[#6:6]-6=[#8:5])=[#8:73])/[#6:70](=[#8:69])-[#8:68]):[#6:62]:[#6:63](:[#6:64]:[#6:65]:8-[#8:60])-[#8:61]):[#6:54](:[#6:55]:[#6:56]:7)-[#8:53])=[#8:7])-[#6:32](:[#6:33]:3):[#6:31]:1)=[#8:8])-[#6:13]1:[#6:14]:[#6:15](-[#8:16]-[#6:21]2:[#6:22]:[#6:23](-[#6@:25](-[#6:27](-[#7:28]-5)=[#8:26])/[#7:24]):[#6:18]:[#6:19]:[#6:20]:2-[#8:17]):[#6:10]:[#6:11](:[#6:12]:1)-[#8:9])=[#8:43]):[#6:29]:[#6:30]:4)-[Cl:37])-[Cl:79]>>[#6:1]1:[#6:2]:[#6:77]2:[#6:78]:[#6:80](:[#6:81]:1-[#8:82]-[#6:83]1:[#6:84](-[#8:85]-[#6]/[#6@@]3-[#6@](-[#6@](/[#8])-[#6@](-[#6@@](-[#8]-3)/[#8])\[#7]-[#6](-[#6]-[#6]-[#6])=[#8])\[#8]):[#6:34]3-[#8:35]-[#6:36]4:[#6:38](:[#6:39]:[#6:40](-[#6:41]-[#6@@:42]5\[#6:44](-[#7:45]-[#6@:46](\[#6:47](-[#7:48]-[#6@@:49](\[#6:50](-[#7:51]-[#6@@:52]6/[#6:57]7:[#6:58]:[#6:59](-[#6:66]8:[#6:67](-[#6@:71](-[#7:72]-[#6:74](/[#6@:75](-[#6@@:76]-2/[#8:3])-[#7:4]-[#6:6]-6=[#8:5])=[#8:73])/[#6:70](=[#8:69])-[#8:68]):[#6:62]:[#6:63](:[#6:64]:[#6:65]:8-[#8:60])-[#8:61]):[#6:54](:[#6:55]:[#6:56]:7)-[#8:53])=[#8:7])-[#6:32](:[#6:33]:3):[#6:31]:1)=[#8:8])-[#6:13]1:[#6:14]:[#6:15](-[#8:16]-[#6:21]2:[#6:22]:[#6:23](-[#6@:25](-[#6:27](-[#7:28]-5)=[#8:26])/[#7:24]):[#6:18]:[#6:19]:[#6:20]:2-[#8:17]):[#6:10]:[#6:11](:[#6:12]:1)-[#8:9])=[#8:43]):[#6:29]:[#6:30]:4)-[Cl:37])-[Cl:79]
COC[C@H]1O[C@@H](O[C@@H]2OC[C@@H]3O[C@]4(O[C@H]3[C@H]2OC(=O)C(C)C)O[C@H](C)[C@@](O)(C(C)=O)C2OCOC24)[C@@H](OC)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](C)[C@H](O)[C@H](O[C@H]2C[C@@]3(C)OC4(C[C@H](O)[C@H](O[C@H]5C[C@@H](O)[C@H](OC(=O)c6c(C)c(Cl)c(O)c(Cl)c6OC)[C@@H](C)O5)[C@@H](C)O4)O[C@@H]3[C@@H](C)O2)[C@H]1O
BotH
[#7:1]-[#6:2](-[#6:13](-[#8:15])=[#8:14])-[#6:3]-[#6:4]1:[#6:12]2:[#6:7](:[#6:8]:[#6:9]:[#6:10]:[#6:11]:2):[nH:6]:[#6:5]:1.[#7:16]-[#6:17](-[#6:25](=[#8:27])-[#8:26])-[#6:18]-[#6:19]-[#6:20]-[#7:21]=[#6:22](-[#7:24])-[#7:23]>>[#6:2]1(-[#7:1]-[#6:25](=[#8:27])-[#6:17](-[#7:16]-[#6:13]-1=[#8:14])-[#6:18]-[#6:19]-[#6:20]-[#7:21]=[#6:22](-[#7:23])-[#7:24])-[#6:3]-[#6:4]1:[#6:12]2:[#6:7](:[#6:8]:[#6:9]:[#6:10]:[#6:11]:2):[nH:6]:[#6:5]:1
Dichlorination of chlorotonil precursor.
BotP
NADP
Q8KHV6
[#6:1]-[#6:2](-[#6:15]-[#8:16])=[#6:3]1-[#6:14]-[#6@:11](-[#6:13])(\[#6:12])-[#6:10]/[#6@@:9]2-[#6@@:4]-1\[#6:5]-[#6:6]-[#6@@:7]-2/[#6:8]>>[#6:1]-[#6:2](-[#6:15]-[#8:16]-[#6]1-[#8]-[#6@](\[#6]-[#8])-[#6@@](/[#8])-[#6@](\[#8])-[#6@]-1/[#7]-[#6](=[#8])-[#6])=[#6:3]1-[#6:14]-[#6@:11](-[#6:12])(\[#6:13])-[#6:10]/[#6@@:9]2-[#6@@:4]-1\[#6:5]-[#6:6]-[#6@@:7]-2/[#6:8]
doi:10.1128/JB.00826-07
[#6:1]-[#6:2](-[#6:4]-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]1:[#6:23](-[#8:24]):[#6:21](-[#8:22]):[#6:20]:[#6:18](-[#8:19]):[#6:17]:1)-[#6:3]>>[#6]-[#8:22]-[#6:21]1:[#6:23](-[#8:24]):[#6:16](-[#6:15]-[#6:14]-[#6:13]-[#6:12]-[#6:11]-[#6:10]-[#6:9]-[#6:8]-[#6:7]-[#6:6]-[#6:5]-[#6:4]-[#6:2](-[#6:1])-[#6:3]):[#6:17]:[#6:18](-[#8:19]):[#6:20]:1
[#7:1]-[#6:2](-[#6:11](=[#8:13])-[#8:12])-[#6:3]-[#6:4]1:[#6:10]:[#6:9]:[#6:7](-[#8:8]):[#6:6]:[#6:5]:1.[#6:99]-[#16:98](-[#6]-[#6]1-[#6](-[#8])-[#6](-[#8])-[#6](-[#7]2:[#6]3:[#6](:[#6](:[#7]:[#6]:[#7]:3)-[#7]):[#7]:[#6]:2)-[#8]-1)-[#6]-[#6]-[#6](-[#6](=[#8])-[#8])-[#7]>>[#7:1]-[#6:2](-[#6:11](=[#8:13])-[#8:12])-[#6:3]-[#6:4]1:[#6:10]:[#6:9]:[#6:7](-[#8:8]):[#6:6](-[#6]):[#6:5]:1.[#16:98](-[#6]-[#6]1-[#6](-[#8])-[#6](-[#8])-[#6](-[#7]2:[#6]3:[#6](:[#6](:[#7]:[#6]:[#7]:3)-[#7]):[#7]:[#6]:2)-[#8]-1)-[#6]-[#6]-[#6](-[#6](=[#8])-[#8])-[#7]
O=c1c(-c2ccc(O)c(-c3cc(-c4coc5cc(O)ccc5c4=O)ccc3O)c2)coc2cc(O)ccc12
The monooxygenase PhoM is involved in C5 hydroxlation during biosynethesis of phomoxanthone A
[#6:23][C:22]1([#8:1])[#6:21]-[c:20]2[c:19][c:18]3[c:17][c:16](-[#8:2])[c:15][c:14](-[#8:3])[c:13]3[c:12](-[#8:4])[c:11]2-[#6:10](=[O:9])-[#6:8]1-[#6:7](-[#8-:5])=[O:6]>>[#6:23][C:22]1([#8:1])[#6:8]-[#6:10](=[O:9])-[c:11]2[c:12](-[#8:4])[c:13]3[c:14](-[#8:3])[c:15][c:16](-[#8:2])[c:17][c:18]3[c:19][c:20]2-[#6:21]1
Substrate bound to coenzyme A
[#8:1]-[#6:2](-[#6:4](-[#6:6]-[#6:7]1:[#6:16]2:[#6:10](:[#6:11](:[#6:13]:[#6:14]:[#6:15]:2)-[Cl:12]):[nH:9]:[#6:8]:1)=[#8:5])=[#8:3]>>[#8:1]-[#6:2](-[#6:4]1:[#6:6](-[#6:7]2:[#6:16]3:[#6:10](:[#6:11](:[#6:13]:[#6:14]:[#6:15]:3)-[Cl:12]):[nH:9]:[#6:8]:2):[#6](-[#6]2:[#6]3:[#6](:[#6](:[#6]:[#6]:[#6]:3)-[Cl]):[nH]:[#6]:2):[#6](-[#6](=[#8])-[#8]):[nH]:1)=[#8:3]
AcaR
56528
COC1CC2(O)C(CO)=CC=CC(C)CC(C)=CCC3CC(CC4(CCC(C)C(C)O4)O3)OC(=O)C2C=C1C
heme oxygenase-like dinuclear iron enzyme
4.2.1.124
CC(=O)N[C@H]1C(OCC(C)=C2CC(C)(C)C[C@@H]3[C@@H]2CC[C@@H]3C)O[C@H](CO)[C@@H](O)[C@@H]1O
doi:10.1021/acschembio.8b00608
Introduces the second biaryl-ether crosslink between bht2 and hpg4 in the vancomycin and balhimycin precursor
[#6:1]-[#6:2]\[#6:3]1-[#8:18]-[#6:16](=[#8:17])-[#6:15](/[#6:19])-[#6:14](\[#8:20]/[#6:21]2-[#8:26]-[#6:25](\[#6:27])-[#6:24](/[#8:28])-[#6:23](-[#8:30]-[#6:31])(\[#6:29])-[#6:22]-2)-[#6:13](/[#6:32])-[#6:12](\[#8:33]/[#6:34]2-[#8:39]-[#6:38](/[#6:40])-[#6:37]-[#6:36](/[#7:41](-[#6:43])-[#6:42])-[#6:35]-2\[#8:44])-[#6:11](-[#8:46])(\[#6:45])-[#6:10]-[#6:9](\[#6:47])-[#6:7](=[#8:8])-[#6:6](\[#6:48])-[#6:5](\[#8:49])-[#6:4]-1/[#6:50]>>[#6:1]-[#6:2]/[#6:3]1-[#6:4](-[#6:50])(\[#8])-[#6:5](/[#8:49])-[#6:6](\[#6:48])-[#6:7](=[#8:8])-[#6:9](/[#6:47])-[#6:10]-[#6:11](/[#6:45])(-[#8:46])-[#6:12](/[#8:33]\[#6:34]2-[#6:35](/[#8:44])-[#6:36](\[#7:41](-[#6:42])-[#6:43])-[#6:37]-[#6:38](\[#6:40])-[#8:39]-2)-[#6:13](\[#6:32])-[#6:14](\[#8:20]\[#6:21]2-[#6:22]-[#6:23](/[#6:29])(-[#8:30]-[#6:31])-[#6:24](\[#8:28])-[#6:25](/[#6:27])-[#8:26]-2)-[#6:15](/[#6:19])-[#6:16](=[#8:17])-[#8:18]-1
[#6:1]1:[#6:6]:[#6:5](-[#6:8]-[#6@@:9](-[#6:11](-[#8:13])=[#8:12])/[#7:10]):[#6:4]:[#6:3]:[#6:2]:1-[#8:7]>>[#6:1]1:[#6:6]:[#6:5](-[#6:8]-[#6@@:9](-[#6:11](-[#8:13])=[#8:12])/[#7:10]):[#6:4]:[#6:3]:[#6:2]:1-[#8:7]-[#6]
Acts on phenolic lipids to yield alkylresorcinol methyl ethers
Acyltransferase
Introduces a biaryl bond between Y1 and H3, cytochrome P450 from Planomonospora strain ID107089
[#6:78]-[#7:77]-[#6@H:76](-[#6:75]-[#6:74](-[#6:72])-[#6:73])-[#6:71](=[O:70])-[#7:69]-[#6@H:68](-[#6@@H:3](-[#8:2])-[c:7]1[c:8][c:9][c:10](-[#8:101])[c:5]([Cl:4])[c:6]1)-[#6:67](=[O:66])-[#7:65]-[#6@@H:64](-[#6:63]-[#6:62](-[#7:61])=[O:60])-[#6:59](=[O:58])-[#7:57]-[#6@@H:56]-1-[c:15]2[c:16][c:17][c:12](-[#8:11])[c:13](-[#8:18]-[c:21]3[c:20][c:19][c:24]([c:23][c:22]3[Cl:1])-[#6@H:26](-[#8:25])-[#6@H:48](-[#7:49]-[#6:51](=[O:50])-[#6@H:52](-[#7:53]-[#6:55]-1=[O:54])-[c:31]1[c:30][c:29][c:28](-[#8:27])[c:33][c:32]1)-[#6:47](=[O:46])-[#7:45]-[#6@H:44](-[#6:43](=[O:42])-[#16:99]-[#6:98]-[#6:97]-[#7:96]-[#6:94](=[O:95])-[#6:93]-[#6:92]-[#7:91]-[#6:89](=[O:90])-[#6@H:88](-[#8:100])[C:80]([#6:79])([#6:81])[#6:82]-[#8:83][P:84]([#8:86])([#8:87])=[O:85])-[c:41]1[c:34][c:36](-[#8:35])[c:37][c:39](-[#8:38])[c:40]1)[c:14]2>>[#6:78]-[#7:77]-[#6@H:76](-[#6:75]-[#6:74](-[#6:73])-[#6:72])-[#6:71](=[O:70])-[#7:69]-[#6@@H:68]-1-[#6@@H:3](-[#8:2])-[c:7]2[c:8][c:9][c:10](-[#8:101]-[c:17]3[c:16][c:15]-4[c:14][c:13](-[#8:18]-[c:21]5[c:20][c:19][c:24]([c:23][c:22]5[Cl:1])-[#6@H:26](-[#8:25])-[#6@H:48](-[#7:49]-[#6:51](=[O:50])-[#6@H:52](-[#7:53]-[#6:55](=[O:54])-[#6@@H:56]-4-[#7:57]-[#6:59](=[O:58])-[#6@H:64](-[#6:63]-[#6:62](-[#7:61])=[O:60])-[#7:65]-[#6:67]-1=[O:66])-[c:31]1[c:32][c:33][c:28](-[#8:27])[c:29][c:30]1)-[#6:47](=[O:46])-[#7:45]-[#6@H:44](-[#6:43](=[O:42])-[#16:99]-[#6:98]-[#6:97]-[#7:96]-[#6:94](=[O:95])-[#6:93]-[#6:92]-[#7:91]-[#6:89](=[O:90])-[#6@H:88](-[#8:100])[C:80]([#6:81])([#6:79])[#6:82]-[#8:83][P:84]([#8:87])([#8:86])=[O:85])-[c:41]1[c:40][c:39](-[#8:38])[c:37][c:36](-[#8:35])[c:34]1)[c:12]3-[#8:11])[c:5]([Cl:4])[c:6]2
[#6]1:[#6]:[#6]2:[#6](-[#6]-[#6](-[#7])-[#6](-[#8])=[#8]):[#6]:[#7;H]:[#6]:2:[#6](-[Cl]):[#6]:1>>[#6]1:[#6]2:[#6](-[#6]-[#6](-[#7])-[#6](-[#8])=[#8]):[#6]:[#7;H]:[#6]:2:[#6](-[Cl]):[#6](-[Cl]):[#6]:1
Bromination of 3,5-bromoindole, leading to 2,3,5-tribromoindole
80251
[#6:1]-[#16:2]-[#6:3]-[#6:4]/[#6@@:5](-[#6:64]=[#8:65])-[#7:6]-[#6:7](\[#6@@:9](-[#7:12]-[#6:13](/[#6@@:15](-[#7:20]-[#6:21](/[#6@@:23](-[#7:31]-[#6:32](/[#6@:34](-[#6:61](-[#6:63])-[#6:62])-[#7:35]-[#6:36](\[#6@:38](-[#6:58](-[#6:60])-[#6:59])-[#7:39]-[#6:40](/[#6@:42](-[#6:55](-[#6:57])-[#6:56])-[#7:43]-[#6:44](/[#6@:46]1-[#7:50](-[#6:51](-[#6:53]-[#7:54])=[#8:52])-[#6:49]-[#6:48]-[#6:47]-1)=[#8:45])=[#8:41])=[#8:37])=[#8:33])-[#6:24]-[#6:25]1:[#6:30]:[#6:29]:[#6:28]:[#6:27]:[#6:26]:1)=[#8:22])-[#6:16]-[#6:17](-[#8:19])=[#8:18])=[#8:14])-[#6:10]-[#16:11])=[#8:8]>>[#6:1]-[#16:2]-[#6:3]-[#6:4]\[#6@@:5](-[#6:64]=[#8:65])-[#7:6]-[#6:7](=[#8:8])/[#6@:9](-[#6:10]-[#16:11])-[#7:12]-[#6:13](=[#8:14])\[#6@:15](-[#6:16]-[#6:17](=[#8:18])-[#8:19])-[#7:20]-[#6:21](=[#8:22])\[#6@:23](-[#6:24]-[#6:25]1:[#6:30]:[#6:29]:[#6:28]:[#6:27]:[#6:26]:1)-[#7:31]-[#6:32](=[#8:33])/[#6@@:34](-[#7:35]-[#6:36](=[#8:37])/[#6@@:38](-[#7:39]-[#6:40](=[#8:41])\[#6@@:42](-[#7:43]-[#6:44](=[#8:45])/[#6@@:46]1-[#6:47]-[#6:48]-[#6:49]-[#7:50]-1-[#6:51](=[#8:52])-[#6:53]-[#7:54])-[#6:55](-[#6:56])-[#6:57])-[#6:58](-[#6])(-[#6:59])-[#6:60])-[#6:61](-[#6])(-[#6:63])-[#6:62]
80255
80259
C=C1C(=O)OC[C@H]2C(C(=O)O)=CC3CC(C)(C)C[C@@]132
macroamidine macrocyclization of Gly1 and Val4 of bottromycin-precursor
C=C(C)[C@@H]1C[C@@]2(C)C(=C[C@H]1O)CCC[C@@H]2C
[#6@:1]1(\[#6:28])-[#6@@:2](\[#8:29])-[#6:3]-[#6:4]2-[#6:7]=[#6:8]-[#6:9]3-[#6:18]-[#6@:17](\[#8:19]-[#6:20])-[#6:16](=[#8:21])-[#8:15]/[#6@:14](-[#6@:22](/[#8:24])-[#6:23])-[#6@:13](/[#6:25])-[#6:12]=[#6:11](-[#6:26])-[#6:10]-3-[#6:5]-2-[#6@@:6]-1/[#8:27]>>[#6@:1]1(\[#6:28])-[#6@@:2](\[#8:29])-[#6@@:3]2/[#8]/[#6@@&H1:10]34-[#6:11](-[#6:26])=[#6:12]-[#6@@:13](/[#6:25])-[#6@@:14](-[#6@:22](/[#8:24])-[#6:23])/[#8:15]-[#6:16](=[#8:21])-[#6@@:17](\[#8:19]-[#6:20])-[#6:18]-[#6:9]-3-[#6:8]=[#6:7]-[#6:4]-2-[#6:5]-4-[#6@@:6]-1/[#8:27]
[#6:1]-[#6:2](\[#6@:4]1-[#6:21]2-[#6@@:7](-[#6:9]/[#6@@:10]3-[#6@@:15](-[#6@@:16](-[#6:19]-[#6:20]=2)(-[#8:18])/[#6:17])\[#6:14]-[#6:13]-[#6@@:11]-3/[#6:12])(\[#6:8])-[#6:6]-[#6:5]-1)-[#6:3]>>[#6:3]-[#6:2](\[#6@:4]1-[#6:21]2-[#6@@:7](-[#6:9]/[#6@:10]3-[#6@@:11](/[#6:12])-[#6:13]-[#6@:14](\[#8])-[#6@@:15]\3-[#6@@:16](-[#6:19]-[#6:20]=2)(-[#8:18])/[#6:17])(\[#6:8])-[#6:6]-[#6:5]-1)-[#6:1]
[#6:1]/[#6@:2]1-[#6:20](=[#8:21])-[#6:17](-[#6:18]-[#8:19])=[#6:6](-[#6:7](-[#6:9]2:[#6:15](-[#8:16]):[#6:14]:[#6:13]:[#6:12]:[#6:10]:2-[#8:11])=[#8:8])-[#6:4](=[#8:5])-[#6:3]-1>>[#6:1]/[#6@:2]1-[#6@@:20](/[#8:21])-[#6@:17]2(-[#8:11]-[#6:10]3:[#6:9](:[#6:15](:[#6:14]:[#6:13]:[#6:12]:3)-[#8:16])-[#6:7](=[#8:8])-[#6:6]-2=[#6:4](-[#8:5])-[#6:3]-1)/[#6:18]-[#8:19]
[#6:1]-[#6:2]\[#6:3]=[#6:4]\[c:5]1[c:6]-2[o:7][c:8](-[#6:9]-[#6:10](=[O:11])-[#8:12]-[#6:13]/[#6:14](=[#6:15]\[#6:16](\[#6:17]-[#6:18])=[#6:19]\[#6:20]-[#6:21])/[#6:22]=[#6:23]/[#6:24](-[#8:25])-[#6:26]-2-[#8:27])[c:28][c:29]1=[O:30]>>[#6:1]-[#6:2]\[#6:3]=[#6:4](/[#6:5]-[#6:6])\[#6:7]=[#6:8]-1/[#6:9]-[#8:10]-[#6:11](=[O:12])-[#6:13]-[c:14]2[c:15][c:16](=[O:17])[c:18](\[#6:19]=[#6:20]\[#6:21](-[#6:22])-[#8:23])[c:24]([o:25]2)-[#6:26](-[#8:27])-[#6:28](-[#8:29])/[#6:30]=[#6:31]/1
Cc1cc(O)cc(O)c1C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O
Short-chain dehydrogenases/reductase
Reaction does not occure naturally during teicoplanin biosynthesis; acyl-CoA as co-substrate.
COC1=CC(C)=C2C3C#CC=CC#CC1C2(C=O)C1CC(=O)c2c(c(O)c4ccccc4c2O)C1=N3
retired
AAM33673.1
[#6]-[#6](=[#6]-[#6]-[#6]-[#6](=[#6]-[#6]-[#6]-[#6](=[#6]-[#6]-[#6]-[#6]=[#6](-[#6]-[#6]-[#6]=[#6](-[#6]-[#6]-[#6]1-[#6](-[#6])(-[#6])-[#8]-1)-[#6])-[#6])-[#6])-[#6])-[#6]>>[#6]-[#6](=[#6]-[#6]-[#6]-[#6](=[#6]-[#6]-[#6]-[#6](-[#6]1(-[#6]2-[#6]-[#6]-[#6]3-[#6](-[#6])(-[#6]=2-[#6]-[#6]-1)-[#6]-[#6]-[#6](-[#8])-[#6]-3(-[#6])-[#6])-[#6])-[#6])-[#6])-[#6]
AAN01216.1
AAM94799.1
AAN01211.1
AAM70353.1
AAN07907.1
AAN01209.1
AAU95674.1
CN[C@H](CC(C)C)C(=O)N[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)O)[C@@H](O)c1ccc(O)cc1)c1ccc(O)cc1)c1ccc(O)cc1)[C@@H](O)c1ccc(O)cc1
CC(C)[C@@H]1NC(=O)[C@@H]2[C@H](C)CCN2C(=O)CNC(=N[C@H](C(=O)N[C@H](C(=O)N[C@H](CC(=O)O)C2=N[C@H](C(=O)O)CS2)[C@@H](C)c2ccccc2)C(C)(C)C)[C@H](C(C)(C)C)NC1=O
amidase
O=C(O)C(S)Cc1c[nH]c2ccccc12
A0A397HQN2
N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2onc3ccccc23)NC1=O
doi:10.1007/pl00008667
N[C@@H](CCCNO)C(=O)O
doi:10.1093/jimb/kuad021
[#6:91]/[#6@:92]1-[#6@:124](\[#8:125])-[#6@:121](-[#7:123])(\[#6:122])-[#6:120]-[#6@@:94](/[#8:95]-[#15:96](-[#8:99]-[#15:100](-[#8:103]-[#6:104]\[#6@@:105]2-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\[#7:108]3:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:3)-[#8:106]-2)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97])-[#8:93]-1.[#7]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\[#8:24])-[#6@@:21](/[#7:201])-[#6@:19](\[#8:20])-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3]>>[#15:96](-[#8])(-[#8:99]-[#15:100](-[#8:103]-[#6:104]\[#6@@:105]1-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\[#7:108]2:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:2)-[#8:106]-1)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97].[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\[#8:24]/[#6@@:94]2-[#6:120]-[#6@@:121](-[#6@@:124](\[#8:125])-[#6@@:92](-[#8:93]-2)/[#6:91])(-[#7:123])\[#6:122])-[#6@@:21](/[#7:201])-[#6@:19](\[#8:20])-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3]
doi:10.1021/jacs.1c10201
Nuclear transport factor 2 family protein
[#6:91]/[#6@:92]1-[#6@:124](\[#8:125])-[#6@:121](-[#7:123])(\[#6:122])-[#6:120]-[#6@@:94](/[#8:95]-[#15:96](-[#8:99]-[#15:100](-[#8:103]-[#6:104]\[#6@@:105]2-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\[#7:108]3:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:3)-[#8:106]-2)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97])-[#8:93]-1.[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\[#8:24])-[#6@@:21](/[#8:22])-[#6:19]-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3]>>[#15:96](-[#8])(-[#8:99]-[#15:100](-[#8:103]-[#6:104]\[#6@@:105]1-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\[#7:108]2:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:2)-[#8:106]-1)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97].[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\[#8:24]/[#6@@:94]2-[#6:120]-[#6@@:121](-[#6@@:124](\[#8:125])-[#6@@:92](-[#8:93]-2)/[#6:91])(-[#7:123])\[#6:122])-[#6@@:21](/[#8:22])-[#6:19]-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3]
active
1.14.19.9
1.14.19.8
acyl-CoA as co-substrate
a chlorine atom is introduced in the indole ring of tryptophan.
Decarboxylase
1.21.98.2
COC1C(O)=C(C(C)=O)C(=O)C2(OC3CC(OC4CC(OC5CC(C)(O)C(O)C(C)O5)C(O)C(C)O4)C(O)C(C)O3)C(=O)c3c(cc4cc(OC5CC(OC6CC(O)C(O)C(C)O6)C(O)C(C)O5)c(C)c(O)c4c3O)CC12
[NH2:1][CH:2]([CH2:3][c:4]1[cH:5][nH:6][c:7]2[cH:8][c:9]([Cl:16])[cH:10][cH:11][c:12]12)[C:13]([OH:14])=[O:15]>>[O:1]=[C:2]([CH2:3][c:4]1[cH:5][nH:6][c:7]2[cH:8][c:9]([Cl:16])[cH:10][cH:11][c:12]12)[C:13]([OH:14])=[O:15]
doi:10.1038/s41467-024-48030-9
[#6:1]-[#8:2]-[#6:3]1-[#6:58]2-[#6:12](-[#6:42](-[#6:44]3:[#6:55](-[#8:56]):[#6:54]4:[#6:47](:[#6:48]:[#6:49](:[#6:51]:[#6:52]:4-[#8:53])-[#8:50]):[#6:46]:[#6:45]:3-[#6:57]-2)=[#8:43])(-[#8:13]-[#6:14]2-[#8:41]-[#6:39](-[#6:40])-[#6:37](-[#8:38])-[#6:16](-[#8:17]-[#6:18]3-[#8:36]-[#6:34](-[#6:35])-[#6:32](-[#8:33])-[#6:20](-[#8:21]-[#6:22]4-[#8:31]-[#6:29](-[#6:30])-[#6:27](-[#8:28])-[#6:24](-[#8:26])(-[#6:25])-[#6:23]-4)-[#6:19]-3)-[#6:15]-2)-[#6:10](=[#8:11])-[#6:6](-[#6:7](=[#8:9])-[#6:8])=[#6:4]-1-[#8:5]>>[#6:1]-[#8:2]-[#6:3]1-[#6:58]2-[#6:12](-[#6:42](-[#6:44]3:[#6:55](-[#8:56]):[#6:54]4:[#6:47](:[#6:48]:[#6:49](:[#6:51](:[#6:52]:4-[#8:53])-[#6])-[#8:50]):[#6:46]:[#6:45]:3-[#6:57]-2)=[#8:43])(-[#8:13]-[#6:14]2-[#8:41]-[#6:39](-[#6:40])-[#6:37](-[#8:38])-[#6:16](-[#8:17]-[#6:18]3-[#8:36]-[#6:34](-[#6:35])-[#6:32](-[#8:33])-[#6:20](-[#8:21]-[#6:22]4-[#8:31]-[#6:29](-[#6:30])-[#6:27](-[#8:28])-[#6:24](-[#8:26])(-[#6:25])-[#6:23]-4)-[#6:19]-3)-[#6:15]-2)-[#6:10](=[#8:11])-[#6:6](-[#6:7](=[#8:9])-[#6:8])=[#6:4]-1-[#8:5]
[#6:21]\[#6:16](-[#6:17]-[#6:18]-[#6:19](-[#8:20])=[O:22])=[#6:15]/[#6:12]-[c:2]1[c:1](-[#8:11])[c:6]2-[#6:7](=[O:10])-[#8:9]-[#6:8]-[c:5]2[c:4](-[#6:13])[c:3]1-[#8:14]>>[#6:23]-[#8:14]-[c:3]1[c:4](-[#6:13])[c:5]2-[#6:8]-[#8:9]-[#6:7](=[O:10])-[c:6]2[c:1](-[#8:11])[c:2]1-[#6:12]\[#6:15]=[#6:16](/[#6:21])-[#6:17]-[#6:18]-[#6:19](-[#8:20])=[O:22]
[#6:1]=[#6:2](-[#6:5](-[#6:7]\[#6@@:8](-[#8:54]-[#6:55](-[#6:57]-[#6:58]-[#6:59]-[#6:60]-[#6:61]-[#6:62]-[#6:63]-[#6:64]-[#6:65]-[#6:66]-[#6:67]-[#6:68]-[#6:69]-[#6:70]-[#6:71])=[#8:56])-[#6:9]-[#6@:10](-[#6@@:12](-[#6@:14](-[#6:16]-[#6@:17](-[#6:19](-[#6@:22](-[#6:24]-[#6:25](=[#6:27]-[#6@:28](-[#6@@:30]1(-[#6@:52]2-[#6:53]-[#6@:33](-[#6:34]-[#6:35](=[#6:37]-[#6:38](-[#6:40]-[#6@@:41](-[#6:43]-[#6:44]=[#6:45]-[#6:46](=[#6:48]-[#6:49](-[#8:51]\2)=[#8:50])-[#6:47])/[#8:42])=[#6:39])-[#6:36])\[#8:32]-1)/[#6:31])\[#8:29])-[#6:26])\[#8:23])(-[#6:21])-[#6:20])\[#8:18])\[#8:15])\[#6:13])\[#8:11])=[#6:6])-[#8:3]-[#6:4]>>[#6:39]=[#6:38]1-[#6:40]-[#6@:41](/[#8:42])-[#6:43]-[#6:44]=[#6:45]-[#6:46](-[#6:47])=[#6:48]-[#6:49](=[#8:50])-[#8:51]-[#6@:52]2-[#6@:30](-[#8:32]-[#6@:33](-[#6:53]\2)\[#6:34]-[#6:35](-[#6:36])=[#6:37]-1)(-[#6@@:28](-[#6:27]=[#6:25](-[#6:24]-[#6@@:22](-[#6:19](-[#6@@:17](-[#6:16]-[#6@@:14](-[#6@:12](-[#6@@:10](-[#6:9]\[#6@:8](-[#8:54]-[#6:55](-[#6:57]-[#6:58]-[#6:59]-[#6:60]-[#6:61]-[#6:62]-[#6:63]-[#6:64]-[#6:65]-[#6:66]-[#6:67]-[#6:68]-[#6:69]-[#6:70]-[#6:71])=[#8:56])-[#6:7]-[#6:5](-[#6:2](-[#8:3]-[#6:4])=[#6:1]-[Br])=[#6:6])\[#8:11])\[#6:13])\[#8:15])\[#8:18])(-[#6:21])-[#6:20])\[#8:23])-[#6:26])\[#8:29])/[#6:31]
CC(C)=CCC/C(C)=C/CC[C@@H](C)[C@@]1(C)CCC2=C1[C@@H](O)C[C@H]1C(C)(C)[C@@H](O)CC[C@]21C
[#6:1]-[#6:2](=[#6:4]-[#6:5]-[#6:6]-[#6:7](=[#6:9]-[#6:10]-[#6:11]-[#6@:12](-[#6@@:14]1(-[#6:19]2-[#6@:20](-[#6:22]/[#6@@:23]3-[#6@@:31](/[#6:32])(-[#6:18]=2-[#6:17]-[#6:16]-1)-[#6:30]-[#6:29]-[#6@:27](/[#8:28])-[#6:24]-3(-[#6:26])-[#6:25])/[#8:21])/[#6:15])\[#6:13])-[#6:8])-[#6:3]>>[#6:3]-[#6:2](=[#6:4]-[#6:5]-[#6:6]-[#6:7](=[#6:9]-[#6:10](-[#6@@:11](-[#6@:12](-[#6@@:14]1(-[#6:19]2-[#6@:20](-[#6:22]/[#6@@:23]3-[#6@@:31](/[#6:32])(-[#6:18]=2-[#6:17]-[#6:16]-1)-[#6:30]-[#6:29]-[#6@:27](/[#8:28])-[#6:24]-3(-[#6:26])-[#6:25])/[#8:21])/[#6:15])\[#6:13])\[#8])=[#8])-[#6:8])-[#6:1]
Other
Amidohydrolase
Aminohydrolase
Introduces the second biaryl-ether crosslink between bht2 and hpg4 in the vancomycin and balhimycin precursor. The reaction occures while the vancomycin precursor is bound to the PCP of module 6 or 7. The enzyme only accepts the chlorinated precursor.
CC(C)[C@@H]1NC(=O)[C@@H]2[C@@H](C)CCN2C(=O)CN/C(=N\[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C2=N[C@H](C(=O)O)CS2)[C@@H](C)c2ccccc2)C(C)(C)C)[C@H](C(C)(C)C)NC1=O
A0A3G2KSQ1
Tryptophan-6 halogenation
A0A7S9XGQ1
COc1cc(O)cc(CCCCCCCCCCCCCC(C)C)c1O
A0A2S1P8Q4
A0A0M4KXQ6
[#6:33]1(-[#6:9]2:[#6:8](-[#8:35]):[#6:7]3:[#6:6](:[#6:4](-[#8:5]):[#6:3](:[#6:38]:[#6:36]:3-[#8:37])-[#8:2]-[#6:1]):[#6:11](:[#6:10]:2-[#6:98](=[#8:99])-[#8:15]-[#6:16]2-1-[#8:17]-[#6:18]1:[#6:23](-[#8:24]):[#6:22]:[#6:21]:[#6:20]:[#6:19]:1-[#6:31]-[#6:32]-2)-[#8:12])=[#8:34]>>[#6:9]12:[#6:8](-[#8:35]):[#6:7]3:[#6:6](:[#6:11](:[#6:10]:1-[#8:15]-[#6:16]1(-[#8:17]-[#6:18]4:[#6:23](-[#8:24]):[#6:22]:[#6:21]:[#6:20]:[#6:19]:4-[#6:31]-[#6:32]-1)-[#6:33]-2=[#8:34])-[#8:12]):[#6:4](-[#8:5]):[#6:3](:[#6:38]:[#6:36]:3-[#8:37])-[#8:2]-[#6:1]
Detoxification of roseopurpurin C to aculeatusquinone by ring cleavage.
CC(=O)O[C@@H](C(=O)C=C(C)CCC=C(C)C)[C@@H](C)[C@@]1(C)CCC2=C1[C@@H](O)C[C@H]1C(C)(C)[C@@H](O)CC[C@]21C
BGC0002857
BGC0000055
BGC0000455
BGC0000653
BGC0001350
BGC0000851
doi:10.1016/j.chembiol.2018.02.008
BGC0000459
Flavin-dependent 5-halogenase
MITE0000034
MITE0000035
MITE0000037
MITE0000030
MITE0000031
MITE0000032
MITE0000033
Reaction with TDP-4-amino-6-deoxy-glucose and vancomycin intermediate as substrates.
MITE0000038
MITE0000039
CC[C@H]1OC(=O)CC/C=C/C=C/C[C@H](O)[C@H](C)[C@@H](O)/C=C/C(C)=C/[C@H]1C
UPI00205DA260
AbmB
AbmA
Q93KV9
L-lysine cyclodeaminase
CC(C)[C@H]1CC=C2[C@H](O)CC[C@H](C)[C@@]2(C)C1
Ple2
[#6:1]-[#16:2]-[#6:3]-[#6:4]/[#6@@:5](-[#6:64]=[#8:65])-[#7:6]-[#6:7](\[#6@@:9](-[#7:12]-[#6:13](/[#6@@:15](-[#7:20]-[#6:21](/[#6@@:23](-[#7:31]-[#6:32](/[#6@:34](-[#6:61](-[#6:63])-[#6:62])-[#7:35]-[#6:36](\[#6@:38](-[#6:58](-[#6:60])-[#6:59])-[#7:39]-[#6:40](/[#6@:42](-[#6:55](-[#6:57])-[#6:56])-[#7:43]-[#6:44](/[#6@:46]1-[#7:50](-[#6:51](-[#6:53]-[#7:54])=[#8:52])-[#6:49]-[#6:48]-[#6:47]-1)=[#8:45])=[#8:41])=[#8:37])=[#8:33])-[#6:24]-[#6:25]1:[#6:30]:[#6:29]:[#6:28]:[#6:27]:[#6:26]:1)=[#8:22])-[#6:16]-[#6:17](-[#8:19])=[#8:18])=[#8:14])-[#6:10]-[#16:11])=[#8:8]>>[#6:1]-[#16:2]-[#6:3]-[#6:4]/[#6@@:5](-[#6:64]=[#8:65])-[#7:6]-[#6:7](\[#6@@:9](-[#7:12]-[#6:13](/[#6@@:15](-[#7:20]-[#6:21](/[#6@@:23](-[#7:31]-[#6:32](/[#6@:34](-[#6:61](-[#6:63])-[#6:62])-[#7:35]-[#6:36](\[#6@:38](-[#6:58](-[#6:59])-[#6:60])-[#7:39]-[#6:40](/[#6@:42](-[#6:55](-[#6:56])-[#6:57])-[#7:43]-[#6:44](/[#6@:46]1-[#7:50](-[#6:51](-[#6:53]-[#7:54])=[#8:52])-[#6:49]-[#6:48]-[#6@@:47]-1/[#6])=[#8:45])=[#8:41])=[#8:37])=[#8:33])-[#6:24]-[#6:25]1:[#6:30]:[#6:29]:[#6:28]:[#6:27]:[#6:26]:1)=[#8:22])-[#6:16]-[#6:17](=[#8:18])-[#8:19])=[#8:14])-[#6:10]-[#16:11])=[#8:8]
Ple1
Ple6
SxtN
MITE0000153
AHA34035.1
MITE0000152
Deacetylates N-acetylglucosaminyl residue on Hpg4 of the teicoplanin precursor.
MITE0000150
MITE0000157
MITE0000155
MITE0000154
AHL46722.1
MITE0000151
MITE0000159
MITE0000158
[#6:1]-[#8:2]-[#6:3]\[#6@@:4]1-[#6@@:41](/[#8:42]/[#6@:43]2-[#6@:93](\[#8:94])-[#6@@:49](/[#8:50]\[#6@@:51]3-[#8:92]-[#6@:90](\[#6:91])-[#6@@:89]4-[#6@@:53](-[#8:55]-[#6:56]5(-[#8:88]/4)-[#8:87]-[#6@:85](\[#6:86])-[#6@@:60](/[#8:61]\[#6@@:62]4-[#8:84]-[#6@:82](\[#6:83])-[#6@@:66](/[#8:67]-[#6:68](-[#6:70]6:[#6:79](-[#8:80]-[#6:81]):[#6:77](-[Cl:78]):[#6:75](-[#8:76]):[#6:73](-[Cl:74]):[#6:71]:6-[#6:72])=[#8:69])-[#6@:64](\[#8:65])-[#6:63]-4)-[#6@@:58](/[#8:59])-[#6:57]-5)(/[#6:54])-[#6:52]-3)-[#6@@:47](/[#8:48])-[#6@@:45](/[#6:46])-[#8:44]-2)-[#6@:39](\[#8:40])-[#6@:36](\[#8:37]-[#6:38])-[#6@:6](\[#8:7]/[#6@:8]2-[#6@:16](\[#8:17]-[#6:18](-[#6:20](-[#6:22])-[#6:21])=[#8:19])-[#6@:15]3-[#6@@:11](-[#8:12]/[#6@:13]4(-[#6:35]5-[#6:31](-[#8:32]-[#6:33]-[#8:34]-5)-[#6@@:26](-[#6:28](=[#8:30])-[#6:29])(/[#8:27])-[#6@@:24](/[#6:25])-[#8:23]-4)-[#8:14]\3)/[#6:10]-[#8:9]-2)-[#8:5]-1>>[#6:1]-[#8:2]-[#6:3]\[#6@@:4]1-[#6@@:41](/[#8:42]/[#6@:43]2-[#6@:93](\[#8:94])-[#6@@:49](/[#8:50]\[#6@@:51]3-[#8:92]-[#6@:90](\[#6:91])-[#6@@:89]4-[#6@@:53](-[#8:55]-[#6:56]5(-[#8:88]/4)-[#8:87]-[#6@:85](\[#6:86])-[#6@@:60](/[#8:61]\[#6@@:62]4-[#8:84]-[#6@:82](\[#6:83])-[#6@@:66](/[#8:67]-[#6:68](-[#6:70]6:[#6:79](-[#8:80]-[#6:81]):[#6:77](-[Cl:78]):[#6:75](-[#8:76]):[#6:73](-[Cl:74]):[#6:71]:6-[#6:72])=[#8:69])-[#6@:64](\[#8:65])-[#6:63]-4)-[#6@@:58](/[#8:59])-[#6:57]-5)(/[#6:54])-[#6:52]-3)-[#6@@:47](/[#8:48]-[#6])-[#6@@:45](/[#6:46])-[#8:44]-2)-[#6@:39](\[#8:40])-[#6@:36](\[#8:37]-[#6:38])-[#6@:6](\[#8:7]/[#6@:8]2-[#6@:16](\[#8:17]-[#6:18](-[#6:20](-[#6:21])-[#6:22])=[#8:19])-[#6@:15]3-[#6@@:11](-[#8:12]/[#6@:13]4(-[#6:35]5-[#6:31](-[#8:32]-[#6:33]-[#8:34]-5)-[#6@@:26](-[#6:28](=[#8:30])-[#6:29])(/[#8:27])-[#6@@:24](/[#6:25])-[#8:23]-4)-[#8:14]\3)/[#6:10]-[#8:9]-2)-[#8:5]-1
MITE0000156
Heterocyclization
[#6:1]\[#6:2]=[#6:3](/[#6:4])\[#6:5]=[#6:6](/[#6:7])\[#6:8](\[#8:9])=[#6:10](\[#6:11])-[#6:12](-[#16-:13])=[O:14]>>[#6:1]\[#6:2]=[#6:3](/[#6:4])-[#6:5]1-[#8:6][C:7]1([#6:8])[#6:9](\[#8:10])=[#6:11](\[#6:12])-[#6:13](-[#16-:14])=[O:15]
Q82IY8
Cytochrome p450 monooxygenase
Cytochrome P450 monooxygenase
MITE0000020
Q82IY3
PhoD is a reductase responsible for the reduction of a double bond during biosynthesis of phomoxanthone A
Q82IY7
COc1c2c(c(O)c3c(=O)c4cccc(O)c4oc13)-c1c(cc(CC(C)=O)c(C(=O)O)c1O)CC2
doi:10.1021/ja111279h
PokMT1
D6MSU6
[#6:1]-[#16:2]-[#6:3]-[#6:4]-[#6@@:5](-[#6:7](-[#7:9]\[#6@:10](-[#6:18](-[#7:20]\[#6@:21](-[#6:30](-[#7:32]\[#6@:33](-[#6:38](-[#7:40]\[#6@:41](-[#6:48](-[#8:50])=[#8:49])-[#6:42]-[#6:43]1:[#7:47]:[#6:46]:[nH1:45]:[#6:44]:1)=[#8:39])-[#6:34]-[#6:35](-[#6:37])-[#6:36])=[#8:31])-[#6:22]-[#6:23]1:[#6:29]:[#6:28]:[#6:26](-[#8:27]):[#6:25]:[#6:24]:1)=[#8:19])-[#6:11]-[#6:12]-[#6:13]-[#7:14]-[#6:15](-[#7:17])=[#7:16])=[#8:8])\[#7:6]>>[#6:1]-[#16:2]-[#6:3]-[#6:4]-[#6@@:5](-[#6:7](-[#7:9]\[#6@:10](-[#6:18](-[#7:20]\[#6@:21](-[#6:30](-[#7:32]\[#6@:33](-[#6:38](-[#7:40]\[#6@:41](-[#6:48](-[#8:50])=[#8:49])-[#6:42]-[#6:43]1:[#7:47]:[#6:46]:[nH1:45]:[#6:44]:1)=[#8:39])-[#6:34]-[#6:35](-[#6:37])-[#6:36])=[#8:31])-[#6:22]-[#6:23]1:[#6:29]:[#6:28](-[#7;+](-[#8;-])=[#8]):[#6:26](-[#8:27]):[#6:25]:[#6:24]:1)=[#8:19])-[#6:11]-[#6:12]-[#6:13]-[#7:14]-[#6:15](-[#7:17])=[#7:16])=[#8:8])\[#7:6]
NOC(=O)c1cc2c([nH]c3cc(Cl)ccc32)s1
C/C=C(\C)C1OC1(C)C(O)=C(C)C(=O)[S-]
O=C1C(O)=CC(=O)c2c(O)cc(O)cc21
O=C(O)c1[nH]c(C(=O)O)c(-c2c[nH]c3c(Cl)cccc23)c1-c1c[nH]c2c(Cl)cccc12
CC(=O)N[C@H]1C(OC[C@@]2(C=O)O[C@@]23CC(C)(C)CC2C3CC[C@@H]2C)O[C@H](CO)[C@@H](O)[C@@H]1O
MtmGIII
A0A0H5B5M5
Q8KHZ8
A0A290YXM6
A0A7S9SWM2
SsfM4
SsfM2
SsfM1
O-methyltransferase
BAR97454.1
BAR97452.1
[#6:1]1(/[#6@@:9]2-[#8:33]-[#6:31](=[#8:32])-[#6:30]-[#6@:28](/[#8:29])-[#6@@:26](\[#6:27])-[#6:25]-[#6@@:23](\[#6:24])-[#6:22]-[#6@@:20](\[#6:21])-[#6:19]-[#6@:17](/[#6:18])-[#6@@:15](/[#8:16])-[#6:13](-[#6:14]-[#7](-[#8])-[#8])=[#6:12]-[#6:34]=[#6:11]-[#6:10]-2)-[#6@@:5](\[#6:6](=[#8:8])-[#8:7])-[#6:4]-[#6:3]-[#6:2]-1>>[#6:1]1(/[#6@@:9]2-[#8:33]-[#6:31](=[#8:32])-[#6:30]-[#6@:28](/[#8:29])-[#6@@:26](\[#6:27])-[#6:25]-[#6@@:23](\[#6:24])-[#6:22]-[#6@@:20](\[#6:21])-[#6:19]-[#6@:17](/[#6:18])-[#6@@:15](/[#8:16])-[#6:13](-[#6:14]=[#7]-[#8])=[#6:12]-[#6:34]=[#6:11]-[#6:10]-2)-[#6@@:5](\[#6:6](=[#8:8])-[#8:7])-[#6:4]-[#6:3]-[#6:2]-1
CC1=CCC2CC(CC3(CCC(C)C(C)O3)O2)OC(=O)C2C=C(C)C(O)CC2(O)C(C)=CC=CC(C)C1
bottromycin A2-precursor peptide with cleaved N-terminal Met
COC[C@H]1O[C@@H](O[C@@H]2OC[C@@H]3O[C@]4(O[C@H]3[C@H]2OC(=O)C(C)C)O[C@H](C)[C@@](O)(C(C)=O)C2OCOC24)[C@@H](OC)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](C)[C@H](OC)[C@H](O[C@H]2C[C@@]3(C)OC4(C[C@H](O)[C@H](O[C@H]5C[C@@H](O)[C@H](OC(=O)c6c(C)c(Cl)c(O)c(Cl)c6O)[C@@H](C)O5)[C@@H](C)O4)O[C@@H]3[C@@H](C)O2)[C@H]1O
NAD(P)H-dependent oxidoreductase
C=C[C@]1(C)C[C@@H](OC(=O)CO)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O
CC(C)[C@@H]1NC(=O)[C@@H]2[C@H](C)CCN2C(=O)CN/C(=N\[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C2=N[C@H](C(=O)O)CS2)[C@@H](C)c2ccccc2)C(C)(C)C)[C@H](C(C)(C)C)NC1=O
O=C(O)[C@@H](O)Cc1ccccc1
[#6:1]12-[#6:35]-[#6:24](-[#6:25]-[#6:26]3(-[#8:34]-1)-[#6:33]-[#6:32]-[#6:30](-[#6:31])-[#6:28](-[#6:29])-[#8:27]-3)-[#8:23]-[#6:21](=[#8:22])-[#6:20]1-[#6:12](-[#6:14]-[#6:15](-[#6:17](=[#6:19]-1)-[#6:18])-[#8:16])(-[#8:13])-[#6:10](-[#6:11])=[#6:9]-[#6:8]=[#6:7]-[#6:6](-[#6:36])-[#6:5]-[#6:4](-[#6:37])=[#6:3]-[#6:2]-2>>[#6:1]12-[#6:35]-[#6:24](-[#6:25]-[#6:26]3(-[#8:34]-1)-[#6:33]-[#6:32]-[#6:30](-[#6:31])-[#6:28](-[#6:29])-[#8:27]-3)-[#8:23]-[#6:21](=[#8:22])-[#6:20]1-[#6:12](-[#6:14]-[#6:15](-[#6:17](=[#6:19]-1)-[#6:18])-[#8:16]-[#6])(-[#8:13])-[#6:10](-[#6:11])=[#6:9]-[#6:8]=[#6:7]-[#6:6](-[#6:36])-[#6:5]-[#6:4](-[#6:37])=[#6:3]-[#6:2]-2
doi:10.1021/bi1019786
doi:10.1038/s41589-022-01246-6
[#7:3]-[#6:4](-[#6:5](=[#8:6])-[#7:7]-[#6:8](-[#6:9]-[#6:10]1:[#6:11]:[#6:12]:[#6:13](-[#8:14]):[#6:15]:[#6:16]:1)-[#6:17](=[#8:18])-[#7:19]-[#6:20](-[#6:21](-[#8:22])=[#8:23])-[#6:24]-[#6:25]1:[n;H]:[#6:27]:[#7:28]:[#6:29]:1)-[#6:30]-[#6:31]1:[#6:32]:[#6:33]:[#6:34](-[#8:35]):[#6:36]:[#6:37]:1>>[#7:3]-[#6:4]1-[#6:30]-[#6:31]2:[#6:37]:[#6:36](:[#6:34](-[#8:35]):[#6:33]:[#6:32]:2)-[#6:27]2:[#7:28]:[#6:29]:[#6:25](:[n;H]:2)-[#6:24]-[#6:20](-[#6:21](=[#8:23])-[#8:22])-[#7:19]-[#6:17](=[#8:18])-[#6:8](-[#6:9]-[#6:10]2:[#6:16]:[#6:15]:[#6:13](-[#8:14]):[#6:12]:[#6:11]:2)-[#7:7]-[#6:5]-1=[#8:6]
Converts premutilin to 3-hydroxypremutilin
Intermediate product in the xantholipin biosynthetic pathway. 
CO[C@@H]1C(O)=C(C(C)=O)C(=O)[C@@]2(OC3CC(O)C(O)C(C)O3)C(=O)c3c(cc4cc(O)cc(O)c4c3O)CC12
[#6:127]-[#16:126]-[#6:125]-[#6:124]-[#6@H:123](-[#7:128]-[#6:129](=[O:130])-[#6@H:131](-[#6:132]-[#16:133])-[#7:134]-[#6:135](=[O:136])-[#6@H:137](-[#6:138])-[#7:139]-[#6:140](=[O:141])-[#6@H:142](-[#6:143]-[c:144]1[c:145][c:146][c:147][c:148][c:149]1)-[#7:150]-[#6:151](=[O:152])-[#6@@H:153](-[#7:154]-[#6:155](=[O:156])-[#6@@H:157](-[#7:158]-[#6:159](=[O:160])-[#6:161](-[#6:162])-[#7:163]-[#6:164](=[O:165])-[#6@@H:166]-1-[#6:167]-[#6:168]-[#6:169]-[#7:170]-1-[#6:171](=[O:172])-[#6:173]-[#7:174])-[#6:175](-[#6:176])-[#6:177])-[#6:178](-[#6:179])-[#6:180])-[#6:121](=[O:122])-[#7:120]-[#6@@H:119](-[#6@@H:181](-[#6:182])-[#8:183])-[#6:117](=[O:118])-[#7:116]-[#6@@H:114](-[#6:115])-[#6:112](=[O:113])-[#7:111]-[#6@@H:106](-[#6:107]-[#6:108](-[#8:110])=[O:109])-[#6:104](=[O:105])-[#7:103]-[#6@@H:95](-[#6:96]-[c:97]1[c:98][c:99][c:100][c:101][c:102]1)-[#6:93](=[O:94])-[#7:92]-[#6@@H:87](-[#6:88]-[#6:89](-[#6:90])-[#6:91])-[#6:85](=[O:86])-[#7:84]-[#6@@H:82](-[#6:83])-[#6:80](=[O:81])-[#7:79]-[#6@@H:77](-[#6:78])-[#6:75](=[O:76])-[#7:74]-[#6@@H:72](-[#6:73])-[#6:70](=[O:71])-[#7:69]-1-[#6:68]-[#6:67]-[#6:66]-[#6@H:65]-1-[#6:63](=[O:64])-[#7:62]-[#6@@H:57](-[#6:58]-[#6:59](-[#7:60])=[O:61])-[#6:55](=[O:56])-[#7:54]-[#6@@H:49](-[#6:50]-[#6:51](-[#7:52])=[O:53])-[#6:47](=[O:48])-[#7:46]-[#6@@H:44](-[#6:45])-[#6:42](=[O:43])-[#7:41]-[#6@@H:39](-[#6:40])-[#6:37](=[O:38])-[#7:36]-[#6@@H:31](-[#6:32]-[#6:33](-[#6:34])-[#6:35])-[#6:29](=[O:30])-[#7:28]-[#6@@H:25](-[#6:26]-[#8:27])-[#6:23](=[O:24])-[#7:22]-[#6@@H:20](-[#6:21])-[#6:18](=[O:19])-[#7:17]-[#6@@H:15](-[#6:16])-[#6:13](=[O:14])-[#7:12]-[#6@@H:6](-[#6:7]-[#6:8]-[#6:9](-[#8:11])=[O:10])-[#6:4](=[O:5])-[#7:3]-[#6@@H:2](-[#6:1])-[#6:184](=[O:185])-[#7:186]-[#6@@H:187](-[#6:188])-[#6:189](=[O:190])-[#7:191]-[#6@@H:192](-[#6:193])-[#6:194](=[O:195])-[#7:196]-[#6@@H:197](-[#6:198]-[#6:199](-[#6:200])-[#6:201])-[#6:202](=[O:203])-[#7:204]-[#6@@H:205](-[#6:206])-[#6:207](=[O:208])-[#7:209]-[#6@@H:210](-[#6:211]-[#8:212])-[#6:213](=[O:214])-[#7:215]-[#6@@H:216](-[#6:217]-[c:218]1[c:219][n:220][c:221]2[c:222][c:223][c:224][c:225][c:226]12)-[#6:227](=[O:228])-[#7:229]-[#6:230]-[#6:231]=[O:232]>>[#6:127]-[#16:126]-[#6:125]-[#6:124]-[#6@H:123](-[#7:128]-[#6:129](=[O:130])-[#6@@H:131]-1-[#6:132]-[#16:133]-[#6:135](=[#7:134]-1)-[#6@H:137](-[#6:138])-[#7:139]-[#6:140](=[O:141])-[#6@H:142](-[#6:143]-[c:144]1[c:145][c:146][c:147][c:148][c:149]1)-[#7:150]-[#6:151](=[O:152])-[#6@@H:153](-[#7:154]-[#6:155](=[O:156])-[#6@@H:157](-[#7:158]-[#6:159](=[O:160])-[#6:161](-[#6:162])-[#7:163]-[#6:164](=[O:165])-[#6@@H:166]-1-[#6:167]-[#6:168]-[#6:169]-[#7:170]-1-[#6:171](=[O:172])-[#6:173]-[#7:174])-[#6:175](-[#6:176])-[#6:177])-[#6:178](-[#6:179])-[#6:180])-[#6:121](=[O:122])-[#7:120]-[#6@@H:119](-[#6@@H:181](-[#6:182])-[#8:183])-[#6:117](=[O:118])-[#7:116]-[#6@@H:114](-[#6:115])-[#6:112](=[O:113])-[#7:111]-[#6@@H:106](-[#6:107]-[#6:108](-[#8:110])=[O:109])-[#6:104](=[O:105])-[#7:103]-[#6@@H:95](-[#6:96]-[c:97]1[c:98][c:99][c:100][c:101][c:102]1)-[#6:93](=[O:94])-[#7:92]-[#6@@H:87](-[#6:88]-[#6:89](-[#6:90])-[#6:91])-[#6:85](=[O:86])-[#7:84]-[#6@@H:82](-[#6:83])-[#6:80](=[O:81])-[#7:79]-[#6@@H:77](-[#6:78])-[#6:75](=[O:76])-[#7:74]-[#6@@H:72](-[#6:73])-[#6:70](=[O:71])-[#7:69]-1-[#6:68]-[#6:67]-[#6:66]-[#6@H:65]-1-[#6:63](=[O:64])-[#7:62]-[#6@@H:57](-[#6:58]-[#6:59](-[#7:60])=[O:61])-[#6:55](=[O:56])-[#7:54]-[#6@@H:49](-[#6:50]-[#6:51](-[#7:52])=[O:53])-[#6:47](=[O:48])-[#7:46]-[#6@@H:44](-[#6:45])-[#6:42](=[O:43])-[#7:41]-[#6@@H:39](-[#6:40])-[#6:37](=[O:38])-[#7:36]-[#6@@H:31](-[#6:32]-[#6:33](-[#6:34])-[#6:35])-[#6:29](=[O:30])-[#7:28]-[#6@@H:25](-[#6:26]-[#8:27])-[#6:23](=[O:24])-[#7:22]-[#6@@H:20](-[#6:21])-[#6:18](=[O:19])-[#7:17]-[#6@@H:15](-[#6:16])-[#6:13](=[O:14])-[#7:12]-[#6@@H:6](-[#6:7]-[#6:8]-[#6:9](-[#8:11])=[O:10])-[#6:4](=[O:5])-[#7:3]-[#6@@H:2](-[#6:1])-[#6:184](=[O:185])-[#7:186]-[#6@@H:187](-[#6:188])-[#6:189](=[O:190])-[#7:191]-[#6@@H:192](-[#6:193])-[#6:194](=[O:195])-[#7:196]-[#6@@H:197](-[#6:198]-[#6:199](-[#6:200])-[#6:201])-[#6:202](=[O:203])-[#7:204]-[#6@@H:205](-[#6:206])-[#6:207](=[O:208])-[#7:209]-[#6@@H:210](-[#6:211]-[#8:212])-[#6:213](=[O:214])-[#7:215]-[#6@@H:216](-[#6:217]-[c:218]1[c:219][n:220][c:221]2[c:222][c:223][c:224][c:225][c:226]12)-[#6:227](=[O:228])-[#7:229]-[#6:230]-[#6:231]=[O:232]
Q70HZ5
Q70HZ4
Q70HZ6
O87676
doi:10.1016/S1074-5521(01)00040-0
[#6:1]1-[#6:15]-[#6@:13](\[#6:14])-[#6@@:4]2(\[#6:12])-[#6:5]-[#6@@:6](/[#6:9](-[#6:11])=[#6:10])-[#6:7]-[#6:8]=[#6:3]-2-[#6:2]-1>>[#6:1]1-[#6:15]-[#6@:13](\[#6:14])-[#6@@:4]2(\[#6:12])-[#6:5]-[#6@@:6](/[#6:9](=[#6:10])-[#6:11])-[#6@:7](\[#8])-[#6:8]=[#6:3]-2-[#6:2]-1
P9WEK3
COC1=CC(=O)c2c(O)c3c(c(O)c2C1=O)C(=O)C1(O)c2c(cc4cc(C)oc(=O)c4c2O)CCC1(O)C3=O
[#6:1]-[#8:2]-[#6:3]1:[#6:24](-[#8:25]-[#6:26]-[#6:27]\[#6@@:28](-[#6:42](-[#8:44])=[#8:43])-[#7:29]-[#6:30](-[#6:32]-[#6@@:33](-[#6:39](-[#8:41])=[#8:40])(-[#6:35]-[#6:36](-[#8:38])=[#8:37])/[#8:34])=[#8:31]):[#6:23]:[#6:6](-[#6:7]=[#6:8]2-[#6:21](=[#8:22])-[#7:20]-[#6@@:12](/[#6:13]-[#6:14]-[#6:15]-[#7:16]-[#6:17](-[#7:19])=[#7:18])-[#6:10](=[#8:11])-[#7:9]-2):[#6:5]:[#6:4]:1>>[#6:1]-[#8:2]-[#6:3]1:[#6:24](-[#8:25]-[#6:26]-[#6:27]\[#6@@:28](-[#6:42](-[#8:44])=[#8:43])-[#7:29]-[#6:30](-[#6:32]-[#6@@:33](-[#6:39](-[#8:41])=[#8:40])(-[#6:35]-[#6:36](-[#7]\[#6@](-[#6](-[#8])=[#8])-[#6]-[#6](-[#8])=[#8])=[#8:37])\[#8:34])=[#8:31]):[#6:23]:[#6:6](-[#6:7]=[#6:8]2-[#6:21](=[#8:22])-[#7:20]-[#6@@:12](/[#6:13]-[#6:14]-[#6:15]-[#7:16]-[#6:17](-[#7:19])=[#7:18])-[#6:10](=[#8:11])-[#7:9]-2):[#6:5]:[#6:4]:1
CC(=O)OC[C@]12Oc3cccc(O)c3C(=O)C1=C(O)C[C@@H](C)[C@H]2OC(C)=O
dipeptide formation arg-phe
P9WEK5
P9WEK4
CO[C@@]1(C)[C@H](O)C(=O)C(C)=C2OC(=O)c3c(C)cc(O)c(C)c3O[C@@H]21
[#6:1]1-[#6:16]-[#6@:14](\[#6:15])-[#6@@:4]2(\[#6:13])-[#6:5]-[#6@@:6](/[#6:10](-[#6:12])=[#6:11])-[#6@@:7](-[#6:9]=[#6:3]-2-[#6:2]-1)\[#8:8]>>[#6:1]1-[#6:16]-[#6@:14](\[#6:15])-[#6@@:4]2(\[#6:13])-[#6:5]-[#6@@:6](/[#6:10](-[#6:12])=[#6:11])-[#6&H0:7](-[#6:9]=[#6:3]-2-[#6:2]-1)=[#8:8]
doi:10.1021/ja402828w
MtmOIV
[#6:1]-[#6:2](-[#6@@:10](/[#8:22])-[#6:11](-[#7:13]-[#6:14]-[#6:15]-[#6:16](-[#7:18]-[#6:19]-[#6:20]-[#16:21]-[#6:29](=[#8:30])-[#6@@:27](\[#7:28])-[#6:26]-[#6:24](-[#6:25])-[#6:23])=[#8:17])=[#8:12])(-[#6:4]-[#8:5]-[#15:6](-[#8:9])(-[#8:8])=[#8:7])-[#6:3]>>[#6:1]-[#6:2](-[#6@@:10](/[#8:22])-[#6:11](-[#7:13]-[#6:14]-[#6:15]-[#6:16](-[#7:18]-[#6:19]-[#6:20]-[#16:21]-[#6:29](=[#8:30])-[#6@@:27](\[#7:28])-[#6:26](-[#8])-[#6:24](-[#6:25])-[#6:23])=[#8:17])=[#8:12])(-[#6:4]-[#8:5]-[#15:6](-[#8:8])(-[#8:9])=[#8:7])-[#6:3]
[#6:123]-[#16:122]-[#6:121]-[#6:120]-[#6@H:119](-[#7:124]-[#6:125](=[O:126])-[#6@@H:127]-1-[#6:128]-[#16:131]-[#6:130](=[#7:129]-1)-[#6@H:132](-[#6:133])-[#7:134]-[#6:135](=[O:136])-[#6@H:137](-[#6:138]-[c:139]1[c:140][c:141][c:142][c:143][c:144]1)-[#7:145]-[#6:146](=[O:147])-[#6@H:148](-[#6:171])-[#7:149]-[#6:150](=[O:151])-[#6@H:152](-[#6:170])-[#7:153]-[#6:154](=[O:155])-[#6@H:156](-[#6:169])-[#7:157]-[#6:158](=[O:159])-[#6@@H:160]-1-[#6:161]-[#6:162]-[#6:163]-[#7:164]-1-[#6:165](=[O:166])-[#6:167]-[#7H2:168])-[#6:117](=[O:118])-[#7:116]-[#6@@H:115](-[#6@@H:172](-[#6:173])-[#8:174])-[#6:113](=[O:114])-[#7:112]-[#6@@H:110](-[#6:111])-[#6:108](=[O:109])-[#7:107]-[#6@@H:102](-[#6:103]-[#6:104](-[#8:106])=[O:105])-[#6:100](=[O:101])-[#7:99]-[#6@@H:91](-[#6:92]-[c:93]1[c:94][c:95][c:96][c:97][c:98]1)-[#6:89](=[O:90])-[#7:88]-[#6@@H:86](-[#6:87])-[#6:84](=[O:85])-[#7:83]-[#6@@H:81](-[#6:82])-[#6:79](=[O:80])-[#7:78]-[#6@@H:76](-[#6:77])-[#6:74](=[O:75])-[#7:73]-[#6@@H:68](-[#6:69]-[#6:70](-[#8:72])=[O:71])-[#6:66](=[O:67])-[#7:65]-1-[#6:64]-[#6:63]-[#6:62]-[#6@H:61]-1-[#6:59](=[O:60])-[#7:58]-[#6@@H:53](-[#6:54]-[#6:55](-[#7:56])=[O:57])-[#6:51](=[O:52])-[#7:50]-[#6@@H:45](-[#6:46]-[#6:47](-[#7:48])=[O:49])-[#6:43](=[O:44])-[#7:42]-[#6@@H:40](-[#6:41])-[#6:38](=[O:39])-[#7:37]-[#6@@H:35](-[#6:36])-[#6:33](=[O:34])-[#7:32]-[#6@@H:30](-[#6:31])-[#6:28](=[O:29])-[#7:27]-[#6@@H:25](-[#6:26])-[#6:23](=[O:24])-[#7:22]-[#6@@H:20](-[#6:21])-[#6:18](=[O:19])-[#7:17]-[#6@@H:15](-[#6:16])-[#6:13](=[O:14])-[#7:12]-[#6@@H:6](-[#6:7]-[#6:8]-[#6:9](-[#8:11])=[O:10])-[#6:4](=[O:5])-[#7:3]-[#6@@H:2](-[#6:1])-[#6:175](=[O:176])-[#7:177]-[#6@@H:178](-[#6:179])-[#6:180](=[O:181])-[#7:182]-[#6@@H:183](-[#6:184])-[#6:185](=[O:186])-[#7:187]-[#6@@H:188](-[#6:189]-[#6:190](-[#6:191])-[#6:192])-[#6:193](=[O:194])-[#7:195]-[#6@@H:196](-[#6:197])-[#6:198](=[O:199])-[#7:200]-[#6@@H:201](-[#6:202]-[#8:203])-[#6:204](=[O:205])-[#7:206]-[#6@@H:207](-[#6:208]-[c:209]1[c:210][n:211][c:212]2[c:213][c:214][c:215][c:216][c:217]12)-[#6:218](=[O:219])-[#7:220]-[#6:221]-[#6:222]=[O:223]>>[#6:123]-[#16:122]-[#6:121]-[#6:120]-[#6@H:119](-[#7:124]-[#6:125](=[O:126])-[#6@@H:127]-1-[#6:128]-[#16:131]-[#6:130](=[#7:129]-1)-[#6@H:132](-[#6:133])-[#7:134]-[#6:135](=[O:136])-[#6@H:137](-[#6:138]-[c:139]1[c:140][c:141][c:142][c:143][c:144]1)-[#7:145]-[#6:146](=[O:147])-[#6@H:148](-[#6:171])\[#7:149]=[#6:150]-1/[#7:168]-[#6:167]-[#6:165](=[O:166])-[#7:164]-2-[#6:163]-[#6:162]-[#6:161]-[#6@H:160]-2-[#6:158](=[O:159])-[#7:157]-[#6@@H:156](-[#6:169])-[#6:154](=[O:155])-[#7:153]-[#6@H:152]-1-[#6:170])-[#6:117](=[O:118])-[#7:116]-[#6@@H:115](-[#6@@H:172](-[#6:173])-[#8:174])-[#6:113](=[O:114])-[#7:112]-[#6@@H:110](-[#6:111])-[#6:108](=[O:109])-[#7:107]-[#6@@H:102](-[#6:103]-[#6:104](-[#8:106])=[O:105])-[#6:100](=[O:101])-[#7:99]-[#6@@H:91](-[#6:92]-[c:93]1[c:94][c:95][c:96][c:97][c:98]1)-[#6:89](=[O:90])-[#7:88]-[#6@@H:86](-[#6:87])-[#6:84](=[O:85])-[#7:83]-[#6@@H:81](-[#6:82])-[#6:79](=[O:80])-[#7:78]-[#6@@H:76](-[#6:77])-[#6:74](=[O:75])-[#7:73]-[#6@@H:68](-[#6:69]-[#6:70](-[#8:72])=[O:71])-[#6:66](=[O:67])-[#7:65]-1-[#6:64]-[#6:63]-[#6:62]-[#6@H:61]-1-[#6:59](=[O:60])-[#7:58]-[#6@@H:53](-[#6:54]-[#6:55](-[#7:56])=[O:57])-[#6:51](=[O:52])-[#7:50]-[#6@@H:45](-[#6:46]-[#6:47](-[#7:48])=[O:49])-[#6:43](=[O:44])-[#7:42]-[#6@@H:40](-[#6:41])-[#6:38](=[O:39])-[#7:37]-[#6@@H:35](-[#6:36])-[#6:33](=[O:34])-[#7:32]-[#6@@H:30](-[#6:31])-[#6:28](=[O:29])-[#7:27]-[#6@@H:25](-[#6:26])-[#6:23](=[O:24])-[#7:22]-[#6@@H:20](-[#6:21])-[#6:18](=[O:19])-[#7:17]-[#6@@H:15](-[#6:16])-[#6:13](=[O:14])-[#7:12]-[#6@@H:6](-[#6:7]-[#6:8]-[#6:9](-[#8:11])=[O:10])-[#6:4](=[O:5])-[#7:3]-[#6@@H:2](-[#6:1])-[#6:175](=[O:176])-[#7:177]-[#6@@H:178](-[#6:179])-[#6:180](=[O:181])-[#7:182]-[#6@@H:183](-[#6:184])-[#6:185](=[O:186])-[#7:187]-[#6@@H:188](-[#6:189]-[#6:190](-[#6:191])-[#6:192])-[#6:193](=[O:194])-[#7:195]-[#6@@H:196](-[#6:197])-[#6:198](=[O:199])-[#7:200]-[#6@@H:201](-[#6:202]-[#8:203])-[#6:204](=[O:205])-[#7:206]-[#6@@H:207](-[#6:208]-[c:209]1[c:210][n:211][c:212]2[c:213][c:214][c:215][c:216][c:217]12)-[#6:218](=[O:219])-[#7:220]-[#6:221]-[#6:222]=[O:223]
CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)C[C@H]2O[C@H]2C[C@](C)(N)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@@H]1O
Cc1cc(O)c2c(c1)C(O)c1cccc(O)c1C2=O
[#6:1]-[#6:2]1-[#6:38](-[#8:39])-[#6:36](-[#8:37])-[#6:35]-[#6:4](-[#6:5]2:[#6:10](-[#8:11]):[#6:9]3-[#6:12](-[#6:14]4-[#6:31](-[#6:32](-[#8:34])(-[#6:33])-[#6:8]:3:[#6:7]:[#6:6]:2)-[#6:30]-[#6:29]2-[#6:17](-[#6:19](-[#6:21](=[#6:25](-[#6:27]-2-[#8:28])-[#8:26])-[#6:22](=[#8:24])-[#7:23])=[#8:20])(-[#8:18])-[#6:15]=4-[#8:16])=[#8:13])-[#8:3]-1>>[#6]-[#8:18]-[#6:17]12-[#6:19](=[#8:20])-[#6:21](-[#6:22](-[#7:23])=[#8:24])=[#6:25](-[#8:26])-[#6:27](-[#8:28])-[#6:29]-1-[#6:30]-[#6:31]1-[#6:14](-[#6:12](=[#8:13])-[#6:9]3:[#6:8](-[#6:32]-1(-[#6:33])-[#8:34]):[#6:7]:[#6:6]:[#6:5](-[#6:4]1-[#6:35]-[#6:36](-[#8:37])-[#6:38](-[#8:39])-[#6:2](-[#6:1])-[#8:3]-1):[#6:10]:3-[#8:11])=[#6:15]-2-[#8:16]
NC(Cc1c[nH]c2c(Cl)c(Cl)ccc12)C(=O)O
[#6:91]/[#6@:92]1-[#6@:124](\[#8:125])-[#6@:121](-[#7:123])(\[#6:122])-[#6:120]-[#6@@:94](/[#8:95]-[#15:96](-[#8:99]-[#15:100](-[#8:103]-[#6:104]\[#6@@:105]2-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\[#7:108]3:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:3)-[#8:106]-2)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97])-[#8:93]-1.[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\[#8:24])-[#6@@:21](/[#8:22])-[#6@:19](\[#7:201])-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3]>>[#15:96](-[#8])(-[#8:99]-[#15:100](-[#8:103]-[#6:104]\[#6@@:105]1-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\[#7:108]2:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:2)-[#8:106]-1)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97].[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\[#8:24]/[#6@@:94]2-[#6:120]-[#6@@:121](-[#6@@:124](\[#8:125])-[#6@@:92](-[#8:93]-2)/[#6:91])(-[#7:123])\[#6:122])-[#6@@:21](/[#8:22])-[#6@:19](\[#7:201])-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3]
ADE34508.1
doi:10.1039/d2sc01952c
Alternative substrate cyclo(L-Leu-L-Ala)
BotCYP
MITE0000126
MITE0000127
MITE0000124
MITE0000125
MITE0000122
MITE0000123
MITE0000120
MITE0000121
Conversion of pentalenene to carboxylated intermediate.
[#6:1]-[#8:2]-[#6@@:3]1(-[#6@@:25]2-[#6:11](-[#8:12]-[#6](-[#6:15]3:[#6:23](-[#8:24]\2):[#6:21](-[#6:22]):[#6:19](-[#8:20]):[#6:18]:[#6:16]:3-[#6:17])=[#8])=[#6:9](-[#6:10])-[#6:7](=[#8:8])-[#6@:5]-1\[#8:6])\[#6:4]>>[#6:1]-[#8:2]-[#6@@:3]1(-[#6@:25](-[#6:11](=[#8:12])-[#6:9](-[#6:10])=[#6:7](-[#8:8])-[#6@:5]-1\[#8:6])\[#8:24]-[#6:23]1:[#6:15]:[#6:16](:[#6:18]:[#6:19](:[#6:21]:1-[#6:22])-[#8:20])-[#6:17])\[#6:4]
O=c1[nH]c(=Cc2c[nH]c3ccccc23)c(=O)[nH]c1=Cc1c[nH]c2ccccc12
MITE0000128
MITE0000129
[#8:14]-[c:8]1[c:9][c:10](-[#8:12])[c:1]2[c:2](-[#8:11])[c:3][c:4](-[#8:13])[c:5][c:6]2[c:7]1>>[#8:13]-[c:4]1[c:3][c:2](-[#8:11])[c:1]2[c:6]([c:5]1)[c:7](=[O:15])[c:8](-[#8:14])[c:9][c:10]2=[O:12]
Conversion of 3-hydroxypremutilin to 3,11-hydroxypremutilin
Carboxylation of isopropenyl side chain of aristolochene.
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)O
[N-]=[N+]=NC[C@H]1O[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O)cc(O)cc3[C@@H](C(=O)O)NC2=O)[C@H](O)[C@@H](O)[C@@H]1O
Hydrolase.
KtzR is a regiospecific halogenase that catalyzes chlorination at the 6-position of 7-Cl-L-Tryptophan to generate 6,7-diCl-L-Trp.
[#6:1]-[#8:2]-[#6:3]1:[#6:24](-[#8:25]):[#6:8](-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]-[#6:17]-[#6:18]-[#6:19]-[#6:20]-[#6:21](-[#6:23])-[#6:22]):[#6:7]:[#6:5](-[#8:6]):[#6:4]:1>>[#6:1]-[#8:2]-[#6:3]1:[#6:24](-[#8:25]):[#6:8](-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]-[#6:17]-[#6:18]-[#6:19]-[#6:20]-[#6:21](-[#6:22])-[#6:23]):[#6:7]:[#6:5](-[#8:6]-[#6]-[#6]=[#6](-[#6]-[#6]-[#6]=[#6](-[#6])-[#6])-[#6]):[#6:4]:1
ScyL2
CCCCCCC[C@@H](O)C1=CC(C)OC1=O
COc1c(O)c(O)c(I)c(C)c1C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)O
[#6:1]-[#6:2](-[#6:67])-[#6:3]-[#6:4](-[#7:66])-[#6:5](=[#8:65])-[#7:6]-[#6:7](-[#6:55](-[#8:64])-[#6:56]1:[#6:63]:[#6:62]:[#6:60](-[#8:61]):[#6:58](-[Cl:59]):[#6:57]:1)-[#6:8](=[#8:54])-[#7:9]-[#6:10](-[#6:50]-[#6:51](-[#7:53])=[#8:52])-[#6:11](=[#8:49])-[#7:12]-[#6:13](-[#6:21](=[#8:48])-[#7:22]-[#6:23](-[#6:31](=[#8:47])-[#7:32]-[#6:33](-[#6:37](-[#8:46])-[#6:38]1:[#6:45]:[#6:44]:[#6:42](-[#8:43]):[#6:40](-[Cl:41]):[#6:39]:1)-[#6:34](-[#8:36])=[#8:35])-[#6:24]1:[#6:30]:[#6:29]:[#6:27](-[#8:28]):[#6:26]:[#6:25]:1)-[#6:14]1:[#6:20]:[#6:19]:[#6:17](-[#8:18]):[#6:16]:[#6:15]:1>>[#6:1]-[#6:2](-[#6:67])-[#6:3]-[#6:4](-[#7:66])-[#6:5](=[#8:65])-[#7:6]-[#6:7](-[#6:55](-[#8:64])-[#6:56]1:[#6:63]:[#6:62]:[#6:60](-[#8:61]):[#6:58](-[Cl:59]):[#6:57]:1)-[#6:8](=[#8:54])-[#7:9]-[#6:10](-[#6:50]-[#6:51](-[#7:53])=[#8:52])-[#6:11](=[#8:49])-[#7:12]-[#6:13]1-[#6:21](=[#8:48])-[#7:22]-[#6:23](-[#6:24]2:[#6:25]:[#6:26]:[#6:27](-[#8:28]):[#6:29]:[#6:30]:2)-[#6:31](=[#8:47])-[#7:32]-[#6:33](-[#6:34](-[#8:36])=[#8:35])-[#6:37](-[#8:46])-[#6:38]2:[#6:45]:[#6:44]:[#6:42](:[#6:40](-[Cl:41]):[#6:39]:2)-[#8:43]-[#6:16]2:[#6:17](:[#6:19]:[#6:20]:[#6:14]-1:[#6:15]:2)-[#8:18]
SrsB
Oxidoreductase
AAD28496.1
AAD28495.1
AAL33761.1
N[C@H]1C(=O)N[C@@H]2Cc3ccc(c(Cl)c3)Oc3cc4cc(c3O[C@H]3O[C@H](CO)C[C@H](O)[C@H]3O)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(O)cc(c2)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@@H](C(=O)O)NC3=O
[#7:1]-[#6:2](-[#6:3]-[#6:4]1:[#6:5]:[n;H]:[#6:7]2:[#6:8]:[#6:9]:[#6:10]:[#6:11]:[#6:12]:1:2)-[#6:13](=[#8:14])-[#8:15]>>[#7:1]-[#6:2](-[#6:3]-[#6:4]1:[#6:5]:[n;H]:[#6:7]2:[#6:8]:[#6:9]:[#6:10](-[Cl]):[#6:11]:[#6:12]:1:2)-[#6:13](=[#8:14])-[#8:15]
[#7:1]-[#6:2](-[#6:3]-[#6:4]1:[#6:5]:[n;H]:[#6:7]2:[#6:8]:[#6:9]:[#6:10]:[#6:11]:[#6:12]:1:2)-[#6:13](=[#8:14])-[#8:15]>>[#7:1]-[#6:2](-[#6:3]-[#6:4]1:[#6:5]:[n;H]:[#6:7]2:[#6:8]:[#6:9]:[#6:10](-[Br]):[#6:11]:[#6:12]:1:2)-[#6:13](=[#8:14])-[#8:15]
Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O
Isomerase
[#8:14]-[#6:13]-[#6:12]-1-[#8:15]-[#6:16](=[O:17])-[#6:10](\[#6:9]=[#6:8]\[c:7]2[c:4][c:3][c:2](-[#8:1])[c:5][c:6]2)=[#6:11]-1>>[#8:16]-[c:13]1[c:12][c:11][c:10](\[#6:9]=[#6:8]\[#6:4]-2=[#6:3]-[#6:2](=[#6:1])-[#8:6]-[#6:5]2=[O:7])[c:15][c:14]1
doi:10.1039/d2sc06638f
[#6:1]\[#6@:2]1-[#6@@:20](\[#8:21])-[#6@:17]2(/[#6:18]-[#8:19])-[#6:6](-[#6:7](-[#6:9]3:[#6:15](-[#8:16]-2):[#6:14]:[#6:13]:[#6:12]:[#6:10]:3-[#8:11])=[#8:8])=[#6:4](-[#8:5])-[#6:3]-1>>[#6:1]\[#6@:2]1-[#6@@:20](\[#8:21]-[#6](=[#8])-[#6])-[#6@:17]2(/[#6:18]-[#8:19]-[#6](=[#8])-[#6])-[#6:6](-[#6:7](-[#6:9]3:[#6:15](-[#8:16]-2):[#6:14]:[#6:13]:[#6:12]:[#6:10]:3-[#8:11])=[#8:8])=[#6:4](-[#8:5])-[#6:3]-1
[#6:28]-[#6:27](=[O:29])-[#7:26]-[#6@@H:1](-[#6:2]-[#16:3]-[#6:4][C@:5]1([#8:6])[#6@@H:7](-[#8:8])-[#6:9]-[#6@H:10]2[C:11]([#6:12])([#6:13])[#6:14]-[#6:15]-[#6:16][C@:17]2([#6:18])[#6@H:19]1-[#6:20]\[#6:21]=[#6:22](/[#6:23])-[#6:24]=[#6:25])-[#6:30](=[O:31])-[#7:32]-[#6:33]-1-[#6:34](-[#8:35])-[#6:36](-[#8:37])-[#6:38](-[#6:39]-[#8:40])-[#8:41]-[#6:42]-1-[#8:43]-[#6:44]-1-[#6:45](-[#8:46])-[#6:47](-[#8:48])-[#6:49](-[#8:50])-[#6:51](-[#8:52])-[#6:53]-1-[#8:54]>>[#6:28]-[#6:27](=[O:29])-[#7:26]-[#6@@H:1](-[#6:2]-[#16:3]-[#6:4][C@:5]1([#8:6])[#6@@H:7](-[#8:8])-[#6:9]-[#6@H:10]2[C:11]([#6:12])([#6:13])[#6:14]-[#6:15]-[#6:16][C@:17]2([#6:18])[#6@H:19]1-[#6:20]\[#6:21]=[#6:22](/[#6:23])-[#6:24]=[#6:25])-[#6:30](-[#8:31])=[O:32].[#7:33]-[#6:34]-1-[#6:35](-[#8:36])-[#6:37](-[#8:38])-[#6:39](-[#6:40]-[#8:41])-[#8:42]-[#6:43]-1-[#8:44]-[#6:45]-1-[#6:46](-[#8:47])-[#6:48](-[#8:49])-[#6:50](-[#8:51])-[#6:52](-[#8:53])-[#6:54]-1-[#8:55]
CC(C)(COP(=O)(O)OP(=O)(O)OCC1OC(n2cnc3c(N)ncnc32)C(O)C1OP(=O)(O)O)C(O)C(=O)NCCC(=O)NCCSC(=O)C1=C(O)CC=CC=C1
NC(Cc1c[nH]c2cc(Br)ccc12)C(=O)O
CC1=C[C@@H](C)[C@H]2[C@@H]3C(=O)C(Cl)(Cl)C(=O)CC(=O)O[C@@H](C)C=CC=C[C@@H](C)[C@@H]3C=C[C@@H]2C1
Prenylation
CC(C)[C@@H]1NC(=O)[C@@H]2[C@H](C)CCN2C(=O)CN/C(=N\[C@H](C(=O)N[C@H](C(=O)N[C@H](CC(=O)O)C2=N[C@H](C(=O)O)CS2)[C@@H](C)c2ccccc2)C(C)(C)C)[C@H](C(C)(C)C)NC1=O
F1DBB3
CalO1
CalO3
CalO2
[#6:1](-[Br:10])1:[#6:9]:[#6:8]2:[#6:4](:[#7:5]:[#6:6]:[#6:7](-[Br:11]):2):[#6:3]:[#6:2]:1>>[#6:1](-[Br:10])1:[#6:9]:[#6:8]2:[#6:4](:[#7:5]:[#6:6](-[Br:12]):[#6:7](-[Br:11]):2):[#6:3]:[#6:2]:1
CalO6
N[C@@H]1[C@@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O)cc(O)cc3[C@@H](C(=O)O)NC2=O)[C@H](O)[C@@H](CO)O[C@H]1O
CSCCC(N)C(=O)NC(CCCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1cnc[nH]1)C(=O)O
AviG6
alpha-ketoglutarate-dependent dioxygenase
AviG4
31035
CC(C)=CCC/C(C)=C\CC/C(C)=C\CC/C(C)=C\COP(=O)([O-])OP(=O)([O-])[O-]
AviG2
MtmW
AviG5
[#6:1][C:2]([#6:3])([#6:4]-[#8:5][P:6]([#8:7])(=[O:8])[#8:9][P:10]([#8:11])(=[O:12])[#8:13]-[#6:14]-[#6@H:15]-1-[#8:16]-[#6@H:17](-[#6@H:18](-[#8:19])-[#6@@H:20]-1-[#8:21][P:22]([#8:23])([#8:24])=[O:25])-[n:26]1[c:27][n:28][c:29]2[c:30](-[#7:31])[n:32][c:33][n:34][c:35]12)[#6@@H:36](-[#8:37])-[#6:38](=[O:39])-[#7:40]-[#6:41]-[#6:42]-[#6:43](=[O:44])-[#7:45]-[#6:46]-[#6:47]-[#16:48]-[#16:49]-[#6:50](=[O:51])-[#6:52]-1=[#6:53](-[#8:54])-[#6:55]-[#6:56]=[#6:57]-[#6:58]=[#6:59]-1>>[#8:1]-[#6:2](=[O:3])-[#6:4]-1=[#6:5](-[#8:6])-[#6:7]-[#6:8]=[#6:9]-[#6:10]=[#6:11]-1
CC1=C[C@@H](C)[C@H]2[C@@H]3C(=O)C=C(O)CC(=O)O[C@@H](C)C=CC=C[C@@H](C)[C@@H]3C=C[C@@H]2C1
TlmF
MITE0000029
doi:10.1021/ja063898m
CAH8278777.1
UPG58743.1
UPG58736.1
UPG58745.1
MITE0000028
MITE0000022
MITE0000021
UPG58741.1
CC(C)(CO[PH](O)(O)O)C(O)C(O)NCCC(O)NCCSC(=O)[C@H](N)CC(N)=O
MITE0000027
N[C@@H](Cc1c[nH]c2cc(Cl)ccc12)C(=O)O
MITE0000024
NgnO3 catalyzes the formation of the ether bridge moiety at position C8/C13 of the substrate molecules.
MITE0000023
PyrH
Q93KW1
PhoO dimerizes penexanthone B to phomoxanthone A
doi:10.1039/C4OB00474D
Q93KW5
[#6:3]-[#6@H:2](-[#8:1])-[#6:4]-[#6:5](=[O:6])-[c:7]1[c:8](-[#6:19]-[#6@@H:20](-[#6:21])-[#8:22]-[#6:23](-[#6:24])=[O:25])[c:9][c:10]2[c:11][c:12][c:13][c:14](-[#8:15])[c:16]2[c:17]1-[#8:18].[#6:28]-[#6@H:27](-[#8:26])-[#6:29]-[#6:30](=[O:31])-[c:32]1[c:33](-[#6:44]-[#6@@H:45](-[#6:46])-[#8:47]-[#6:48](-[#6:49])=[O:50])[c:34][c:35]2[c:36][c:37][c:38][c:39](-[#8:40])[c:41]2[c:42]1-[#8:43]>>[#6:3]-[#6@H:2](-[#8:1])-[#6:4]-[#6:5](=[O:6])-[c:7]1[c:8](-[#6:44]-[#6@@H:45](-[#6:46])-[#8:47]-[#6:48](-[#6:49])=[O:50])[c:9][c:10]2[c:11][c:12][c:13]([c:14](-[#8:15])[c:16]2[c:17]1-[#8:18])-[c:19]1[c:20][c:21][c:22]2[c:23][c:24](-[#6:25]-[#6@@H:26](-[#6:27])-[#8:28]-[#6:29](-[#6:30])=[O:31])[c:32](-[#6:33](=[O:34])-[#6:35]-[#6@H:36](-[#6:37])-[#8:38])[c:39](-[#8:40])[c:41]2[c:42]1-[#8:43]
Reduction of phenylpyruvate to L-phenyllactate
CO[C@@]1(C)c2ccc(C3CC(O)C(O)C(C)O3)c(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@H](O)[C@@H]3C[C@@H]21
Lassopeptide lactam synthetase
COc1c2c(c(O)c3c(=O)c4ccc(Cl)c(O)c4oc13)-c1c(cc(CC(C)=O)c(C(=O)O)c1O)CC2
BGC0000279
BGC0001378
BGC0000678
BGC0000374
BGC0001079
BGC0001476
BGC0000677
BGC0001077
BGC0000378
BGC0002076
BGC0000973
MITE0000012
MITE0000013
Reaction of UDP-L-4-epi-vancosamine with 4-deoxy-glycosyl-vancomycin-pseudoaglycone.
Reaction of UDP-L-4-epi-vancosamine with 4-amino-glycosyl-vancomycin-pseudoaglycone.
MITE0000011
MITE0000017
MITE0000014
MITE0000015
[#7:1]/[#6@:2](-[#6:97]-[#6:98](-[#6:100])-[#6:99])-[#6:3](=[#8:96])-[#7:4]\[#6@:5]1-[#6:94](=[#8:95])-[#7:93]-[#6@@:88](\[#6:89]-[#6:90](-[#7:92])=[#8:91])-[#6:86](=[#8:87])-[#7:85]-[#6@:44]2-[#6:45](=[#8:84])-[#7:46]/[#6@:47]3-[#6:82](=[#8:83])-[#7:81]-[#6@@:70](-[#6@@:71](/[#8:80])-[#6:72]4:[#6:79]:[#6:77](-[Cl:78]):[#6:75](-[#8:76]-[#6:40]5:[#6:41]:[#6:42]/2:[#6:43]:[#6:16](:[#6:17]:5-[#8:18]\[#6@:19]2-[#8:39]-[#6@:36](/[#6:37]-[#8:38])-[#6@@:34](\[#8:35])-[#6@:32](/[#8:33])-[#6@:20]-2\[#8:21]\[#6@:22]2-[#6:31]-[#6@:28](-[#6:30])(/[#7:29])-[#6@:26](/[#8:27])-[#6@:24](/[#6:25])-[#8:23]-2)-[#8:15]-[#6:12]2:[#6:13]:[#6:14]:[#6:8](:[#6:9]:[#6:10]:2-[Cl:11])-[#6@@:6]-1/[#8:7]):[#6:74]:[#6:73]:4)/[#6:68](=[#8:69])-[#7:67]-[#6@:63](/[#6:64](=[#8:66])-[#8:65])-[#6:56]1:[#6:57]:[#6:58](-[#8:62]):[#6:59]:[#6:60](-[#8:61]):[#6:55]:1-[#6:53]1:[#6:54]:[#6:48]-3:[#6:49]:[#6:50]:[#6:51]:1-[#8:52]>>[#7:1](/[#6@@:2](-[#6:3](-[#7:4]\[#6@@:5]1-[#6@@:6](/[#8:7])-[#6:8]2:[#6:9]:[#6:10](-[Cl:11]):[#6:12](:[#6:13]:[#6:14]:2)-[#8:15]-[#6:16]2:[#6:17](-[#8:18]\[#6@@:19]3-[#6@:20](\[#8:21]\[#6@@:22]4-[#8:23]-[#6@@:24](/[#6:25])-[#6@@:26](/[#8:27])-[#6@:28](-[#7:29])(\[#6:30])-[#6:31]-4)-[#6@@:32](/[#8:33])-[#6@:34](\[#8:35])-[#6@@:36](/[#6:37]-[#8:38])-[#8:39]-3):[#6:40]3:[#6:41]:[#6:42](:[#6:43]:2)-[#6@:44](-[#6:45](-[#7:46]\[#6@@:47]2-[#6:48]4:[#6:49]:[#6:50]:[#6:51](-[#8:52]):[#6:53](:[#6:54]:4)-[#6:55]4:[#6:56](:[#6:57]:[#6:58](:[#6:59]:[#6:60]:4-[#8:61])-[#8:62])-[#6@@:63](\[#6:64](-[#8:65])=[#8:66])-[#7:67]-[#6:68](=[#8:69])-[#6@:70](-[#6@:71](-[#6:72]4:[#6:73]:[#6:74]:[#6:75](-[#8:76]-3):[#6:77](-[Cl:78]):[#6:79]:4)\[#8:80])\[#7:81]-[#6:82]-2=[#8:83])=[#8:84])\[#7:85]-[#6:86](=[#8:87])-[#6@:88](\[#6:89]-[#6:90](=[#8:91])-[#7:92])-[#7:93]-[#6:94]-1=[#8:95])=[#8:96])-[#6:97]-[#6:98](-[#6:100])-[#6:99])-[#6]
Q5JCL5
MITE0000018
MITE0000019
MITE0000016
CC(C)C[C@@H](N)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O)Oc2ccc(cc2Cl)[C@H]1O
CC(=O)O
C[C@@H]1CC[C@H]2C(C(=O)O)=CC3CC(C)(C)C[C@]312
Modifies biarylitide YFH precursor MRYFH
NC1C(OC2C(O)C(O)C(O)C(O)C2O)OC(CO)C(O)C1O
C0JWB0
C0JWB3
Acetylation, O-acetylation of mutilin to produce 14-acetyl-mutilin
AoL1 is an SDR responsible for converting 8-hydroxy aristolochene to 8-oxo-aristolochene
CC1(C[C@@]23[C@@H](COC(C42OC4)=O)C(C(O)=O)=CC3C1)C
THAA2
THAA1
doi:10.1021/jacs.1c04996
Flavin-dependent halogenase
MITE0000179
MITE0000178
CC(C)=CCC/C(C)=C/CC[C@@H](C)[C@@]1(C)CCC2=C1CC[C@H]1C(C)(C)[C@@H](O)CC[C@]21C
MITE0000171
P48635
MITE0000170
MITE0000172
MITE0000175
MITE0000174
MITE0000177
MITE0000176
MeiD
MITE0000173
MeiE
[#6:1]-[#6:2](-[#8:4]-[#6:5]\[#6@@:6]12-[#6@:23](/[#8:24]-[#6:25](=[#8:27])-[#6:26])-[#6@:21](/[#6:22])-[#6:20]-[#6:18](-[#8:19])=[#6:17]-1-[#6:15](=[#8:16])-[#6:14]1:[#6:8](:[#6:9]:[#6:10]:[#6:11]:[#6:12]:1-[#8:13])-[#8:7]-2)=[#8:3]>>[#6:1]-[#6:2](-[#8:4]-[#6:5]\[#6@@:6]12-[#6@:23](/[#8:24]-[#6:25](=[#8:27])-[#6:26])-[#6@:21](/[#6:22])-[#6:20]-[#6:18](-[#8:19])=[#6:17]-1-[#6:15](=[#8:16])-[#6:14]1:[#6:8](:[#6:9](-[#6]3:[#6]:[#6]:[#6](:[#6]4-[#6](-[#6]5=[#6](-[#6]-[#6@](-[#6@@](/[#8]-[#6](=[#8])-[#6])-[#6@]-5(-[#8]-[#6]:3:4)\[#6]-[#8]-[#6](=[#8])-[#6])/[#6])-[#8])=[#8])-[#8]):[#6:10]:[#6:11]:[#6:12]:1-[#8:13])-[#8:7]-2)=[#8:3]
doi:10.1016/j.chembiol.2020.11.009
Reaction with UUDP-6-chloro-glucose and vancomycin intermediate as substrates.
doi:10.1021/ja1050814
[#6:1](-[#16:15]-[#6:16]-[#6:17]-[#7:18]-[#6:19](-[#6:21]-[#6:22]-[#7:23]-[#6:24](-[#6@@:26](-[#6:28](-[#6:31]-[#8:32]-[#15:33](-[#8:36]-[#15:37](-[#8:40]-[#6:41]/[#6@@:42]1-[#6@@:57](\[#8:58]-[#15:59](-[#8:62])(-[#8:61])=[#8:60])-[#6@@:55](\[#8:56])-[#6@:44](/[#7:45]2:[#6:54]3:[#6:48](:[#6:49](:[#7:51]:[#6:52]:[#7:53]:3)-[#7:50]):[#7:47]:[#6:46]:2)-[#8:43]-1)(-[#8:39])=[#8:38])(-[#8:35])=[#8:34])(-[#6:30])-[#6:29])/[#8:27])=[#8:25])=[#8:20])(-[#6:3]1:[#6:12](-[#8:13]-[#6:14]):[#6:10](-[#8:11]):[#6:8](-[#8:9]):[#6:6](-[I:7]):[#6:4]:1-[#6:5])=[#8:2]>>[#16:15](-[#6:16]-[#6:17]-[#7:18]-[#6:19](-[#6:21]-[#6:22]-[#7:23]-[#6:24](-[#6@@:26](-[#6:28](-[#6:31]-[#8:32]-[#15:33](-[#8:36]-[#15:37](-[#8:40]-[#6:41]/[#6@@:42]1-[#6@@:57](\[#8:58]-[#15:59](-[#8:61])(-[#8:62])=[#8:60])-[#6@@:55](\[#8:56])-[#6@:44](/[#7:45]2:[#6:54]3:[#6:48](:[#6:49](:[#7:51]:[#6:52]:[#7:53]:3)-[#7:50]):[#7:47]:[#6:46]:2)-[#8:43]-1)(-[#8:39])=[#8:38])(-[#8:35])=[#8:34])(-[#6:30])-[#6:29])/[#8:27])=[#8:25])=[#8:20])-[#6:1](-[#6:3]1:[#6:12](-[#8:13]-[#6:14]):[#6:10](-[#8:11]-[#6]):[#6:8](-[#8:9]):[#6:6](-[I:7]):[#6:4]:1-[#6:5])=[#8:2]
BhaA
CC(=O)N(O)CCC[C@H](N)C(=O)O
Cc1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O
CC/C=C/c1c2oc(cc1=O)CC(=O)OCC(=C\C(=C\CC)CC)/C=C/C(O)C2O
E9LY85
doi:10.1074/jbc.M611046200
Chlorinates free-floating L-tryptophan in position 5
doi:10.1002/anie.202109384
Cc1cc2cc3cccc(O)c3c(O)c2c(O)c1C(=O)CCC(C)C
doi:10.1002/anie.202113189
Acetylates (-)-16-keto-3beta,7beta,15-thaliantriol to become (+)-3beta,7beta-dihydroxy-16-keto-thalian-15-yl acetate
AME18011.1
AME18009.1
AMH40426.1
AMR44308.1
AMR44310.1
AMR44301.1
AME18010.1
NC(=O)c1c(O)cc2cc3cc4cccc(O)c4c(O)c3c(O)c2c1O
Chlorinates balhimycin precursor at bht2 and bht6.
UPI00039B9B9D
N[C@@H]1[C@@H](O)[C@@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@H](CO)[C@H]1O
BBA20962.1
CC(C)(COP(=O)(O)O)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)[C@@H](N)CCCN=C(N)N
BBA20961.1
[#6:1]-[#6:2]-[#6:3](-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]-[#6:17]1:[#6:24]:[#6:22](-[#8:23]):[#6:21]:[#6:19](-[#8:20]):[#6:18]:1)-[#6:4]>>[#6:1]-[#6:2]-[#6:3](-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]-[#6:17]1:[#6:18](-[#8]):[#6:19](-[#8:20]):[#6:21]:[#6:22](-[#8:23]):[#6:24]:1)-[#6:4]
beta-hydroxylation of PCP-bound leucine
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)C[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@@H]1O
[#6:1]-[#6:2]\[#6:3]=[#6:4]\[c:5]1[c:6]-2[o:7][c:8](-[#6:9]-[#6:10](=[O:11])-[#8:12]-[#6:13]/[#6:14](=[#6:15]\[#6:16](\[#6:17]-[#6:18])=[#6:19]\[#6:20]-[#6:21])/[#6:22]=[#6:23]/[#6:24](-[#8:25])-[#6:26]-2-[#8:27])[c:28][c:29]1=[O:30]>>[#6:31]-[#6:30]\[#6:29]=[#6:28](/[#6:27]-[#6:26])\[#6:25]=[#6:24]-1/[#6:23]-[#8:22]-[#6:21](=[O:20])-[#6:19]-[c:18]2[c:17][c:16](=[O:15])[c:14](\[#6:13]=[#6:12]\[#6:11](-[#6:10])-[#8:9])[c:8]([o:7]2)-[#6:6](-[#8:5])-[#6:4](-[#8:3])/[#6:2]=[#6:1]/1
CSCCC(N)C(=O)NC(CCCNC(=N)N)C(=O)NC1Cc2ccc(O)c(c2)-c2ncc([nH]2)CC(C(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O
[#6](=[#7]-[#8])-[#6]1:[#6](-[#16]-[#6]):[#6](-[#8]):[#6]:[#6](-[#6]2:[#7]:[#6]:[#6]:[#6]:[#6]:2):[#7]:1>>[#6](=[#7]-[#8])-[#6]1:[#6](-[#16]-[#6]):[#6](-[#8]-[#6]):[#6]:[#6](-[#6]2:[#7]:[#6]:[#6]:[#6]:[#6]:2):[#7]:1
CC(=Cc1ccc([N+](=O)[O-])cc1)C=C1COC(c2oc(O)c(C)c(=O)c2C)C1
Epoxidation of chaetoglobosin J at C6-7 to chaetoglobosin A
CC1=C2OC(=O)c3c(C)cc(O)c(C)c3O[C@@H]2[C@@](C)(O)[C@H](O)C1=O
[#6]-[#6](-[#6])(-[#6]-[#8]-[#15](=[#8])(-[#8-])-[#8]-[#15](=[#8])(-[#8-])-[#8]-[#6]-[#6]1-[#6](-[#6](-[#6](-[#8]-1)-[#7]1:[#6]:[#7]:[#6]2:[#6](:[#7]:[#6]:[#7]:[#6]:1:2)-[#7])-[#8])-[#8]-[#15](=[#8])(-[#8-])-[#8-])-[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6]-[#16]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#7H]:1)-[#8]>>[#6]1(:[#6](:[#7H]:[#6](:[#6]:1-[#35])-[#35])-[#35])-[#35]
I1SKW0
CC(C)=CCCC(C)=CCC/C(C)=C/CC/C(C)=C/c1c[nH]c2ccccc12
[#6:1]-[#6:2](-[#6:4]-[#6:5](-[#7:9]1:[#6:24](=[#8:25]):[#6:23]2:[#6:11](:[#6:12](:[#6:14]:[#6:15](:[#7:22]:2)-[#6:16]2:[#7:21]:[#6:20]:[#6:19]:[#6:18]:[#6:17]:2)-[#8:13]):[#16:10]:1)-[#6:6](-[#8:8])=[#8:7])-[#6:3]>>[#6]-[#16:10]-[#6:11]1:[#6:23](-[#6:24](-[#7:9]-[#6:5](-[#6:6](-[#8:8])=[#8:7])-[#6:4]-[#6:2](-[#6:3])-[#6:1])=[#8:25]):[#7:22]:[#6:15](-[#6:16]2:[#7:21]:[#6:20]:[#6:19]:[#6:18]:[#6:17]:2):[#6:14]:[#6:12]:1-[#8:13]
UPI000A29AD50
CC1=C[C@@H](C)CC=C[C@H]2[C@@H]3O[C@]3(C)[C@@H](C)C3[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@]32C(=O)C=CCC1
C[C@@H]1C[C@H](C)C[C@H](C)[C@@H](O)CC(=O)O[C@@H](C2CCC[C@@H]2C(=O)O)CC=CC=C(CN(O)O)[C@H](O)[C@@H](C)C1
Dioxygenase
Defining step of scabrirubin biosynthesis
ScnB
NC(Cc1c[nH]c2ccccc12)C(=O)O
The reaction might be less specific than depicted in the reaction SMARTS. There is no detailed study on the specificity so far. Furthermore, the substrate probably needs to be bound to a PCP domain in order to be recognized.
[#6:3]-[#6:2](-[#6:1])-[#6:4]-[#6@@H:5](-[#7:6])-[#6:7](=[O:8])-[#7:9]-[#6@@H:10](-[#6:11]=[O:12])-[#6@@H:13](-[#8:14])-[c:15]1[c:22][c:20][c:18](-[#8:19])[c:17][c:16]1>>[#6:1]-[#6:2](-[#6:3])-[#6:4]-[#6@@H:5](-[#7:6])-[#6:7](=[O:8])-[#7:9]-[#6@@H:10](-[#6:11]=[O:12])-[#6@@H:13](-[#8:14])-[c:15]1[c:16][c:17][c:18](-[#8:19])[c:20]([Cl:21])[c:22]1
Aldoxime-formation via dehydation of N,N-dihydroxylamine
beta-hydroxylation of PCP-bound asparagine (anti)
P96563
P96565
P96564
QTE75983.1
QTE75998.1
methylation of the hydroxyl group at position 4 of the D-fucose moiety
Methylation of L-tyrosine
27302
A0A2I6PJ08
A0A2I6PJ07
[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\[#8:24])-[#6@@:21](/[#8:22])-[#6@:19](\[#8:20])-[#6@@:17](/[#6:18])-[#8:16]-1)=[#8:3].[#6:91]/[#6@:92]1-[#6@:124](\[#8:125])-[#6@:121](-[#7:123])(\[#6:122])-[#6:120]-[#6@@:94](/[#8:95]-[#15:96](-[#8:99]-[#15:100](-[#8:103]-[#6:104]\[#6@@:105]2-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\[#7:108]3:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:3)-[#8:106]-2)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97])-[#8:93]-1>>[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\[#8:24]/[#6@@:94]2-[#6:120]-[#6@@:121](-[#6@@:124](\[#8:125])-[#6@@:92](-[#8:93]-2)/[#6:91])(-[#7:123])\[#6:122])-[#6@@:21](/[#8:22])-[#6@:19](\[#8:20])-[#6@@:17](/[#6:18])-[#8:16]-1)=[#8:3].[#15:96](-[#8])(-[#8:99]-[#15:100](-[#8:103]-[#6:104]\[#6@@:105]1-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\[#7:108]2:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:2)-[#8:106]-1)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97]
[#6:1]-[#8:2]-[#6:3](-[#6:11]1-[#6:47](-[#6](-[#8])=[#8])(-[#8:48]-[#6:49]2-[#8:76]-[#6:74](-[#6:75])-[#6:72](-[#8:73])-[#6:51](-[#8:52]-[#6:53]3-[#8:71]-[#6:69](-[#6:70])-[#6:67](-[#8:68])-[#6:55](-[#8:56]-[#6:57]4-[#8:66]-[#6:64](-[#6:65])-[#6:62](-[#8:63])-[#6:59](-[#8:61])(-[#6:60])-[#6:58]-4)-[#6:54]-3)-[#6:50]-2)-[#6:45](=[#8:46])-[#6:44]2:[#6:13](:[#6:14]:[#6:15]3:[#6:41](:[#6:42]:2-[#8:43]):[#6:39](-[#8:40]):[#6:37](-[#6:38]):[#6:17](-[#8:18]-[#6:19]2-[#8:36]-[#6:34](-[#6:35])-[#6:32](-[#8:33])-[#6:21](-[#8:22]-[#6:23]4-[#8:31]-[#6:29](-[#6:30])-[#6:27](-[#8:28])-[#6:25](-[#8:26])-[#6:24]-4)-[#6:20]-2):[#6:16]:3)-[#6:12]-1)-[#6:4](-[#6:6](-[#6:8](=[#8:10])-[#6:9])-[#8:7])=[#8:5]>>[#6:1]-[#8:2]-[#6:3](-[#6:11]1-[#6:47](-[#8:48]-[#6:49]2-[#8:76]-[#6:74](-[#6:75])-[#6:72](-[#8:73])-[#6:51](-[#8:52]-[#6:53]3-[#8:71]-[#6:69](-[#6:70])-[#6:67](-[#8:68])-[#6:55](-[#8:56]-[#6:57]4-[#8:66]-[#6:64](-[#6:65])-[#6:62](-[#8:63])-[#6:59](-[#8:61])(-[#6:60])-[#6:58]-4)-[#6:54]-3)-[#6:50]-2)-[#6:45](=[#8:46])-[#6:44]2:[#6:13](:[#6:14]:[#6:15]3:[#6:41](:[#6:42]:2-[#8:43]):[#6:39](-[#8:40]):[#6:37](-[#6:38]):[#6:17](-[#8:18]-[#6:19]2-[#8:36]-[#6:34](-[#6:35])-[#6:32](-[#8:33])-[#6:21](-[#8:22]-[#6:23]4-[#8:31]-[#6:29](-[#6:30])-[#6:27](-[#8:28])-[#6:25](-[#8:26])-[#6:24]-4)-[#6:20]-2):[#6:16]:3)-[#6:12]-1)-[#6:4](-[#6:6](-[#6:8](=[#8:10])-[#6:9])-[#8:7])=[#8:5]
AsaB-like alphaKGDD
[#6:1]-[c:2]1[c:5][c:8](-[#8:4])[c:15]2[c:18](-[#8:14])[c:19]3-[#6:16](=[O:10])-[#6:11]-[#6@@H:7](-[#8:3])-[#6:12]-[c:17]3[c:13](-[#8:20])[c:9]2[c:6]1>>[#6:1]-[c:2]1[c:5][c:8](-[#8:4])[c:15]2-[#6:18](=[O:14])-[c:19]3[c:16](-[#8:10])[c:11][c:7][c:12][c:17]3-[#6:13](=[O:20])-[c:9]2[c:6]1
N-sulfotransferase
Hydroxylation
HynE
HynB
HynC
HynA
doi:10.1128/JB.186.18.6093-6100.2004
Reductase
Reduction
Hydroxylation, Ple1 catalyzed hydroxylation on the  position of the acetyl side chain
[#6:24]-[#6:23](-[#6:25])-[#6:21]-[#6:20]-[#6:19]-[#6:18]-[#6:17]-[#6:16]-[#6:15]-[#6:14]-[#6:13]-[#6:12]-[#6:11]-[#6:10]-[c:9]1[c:8][c:6](-[#8:7])[c:5][c:3](-[#8:4])[c:2]1-[#6:1]>>[#6]-[#8:7]-[c:6]1[c:5][c:3](-[#8:4])[c:2](-[#6:1])[c:9](-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]-[#6:17]-[#6:18]-[#6:19]-[#6:20]-[#6:21]-[#6:23](-[#6:24])-[#6:25])[c:8]1
[#6:1]-[#8:2]-[#6:3]1-[#6:9](-[#6:10])=[#6:8]-[#6:7]2-[#6:11](-[#8:13]-[#6:14]3-[#6:38]-[#6:30]4(-[#8:37]-[#6:35](-[#6:36])-[#6:33](-[#6:34])-[#6:32]-[#6:31]-4)-[#8:29]-[#6:16](-[#6:17]-[#6:18]=[#6:19](-[#6:21]-[#6:22](-[#6:24]=[#6:25]-[#6:26]=[#6:27](-[#6:28])-[#6:5]-2(-[#8:6])-[#6:4]-1)-[#6:23])-[#6:20])-[#6:15]-3)=[#8:12]>>[#6:1]-[#8:2]-[#6:3]1-[#6:4]-[#6:5]2(-[#8:6])-[#6:7](-[#6:11](=[#8:12])-[#8:13]-[#6:14]3-[#6:15]-[#6:16](-[#6:17]-[#6:18]=[#6:19](-[#6:20])-[#6:21]-[#6:22](-[#6:23])-[#6:24]=[#6:25]-[#6:26]=[#6:27]-2-[#6:28]-[#8])-[#8:29]-[#6:30]2(-[#6:31]-[#6:32]-[#6:33](-[#6:34])-[#6:35](-[#6:36])-[#8:37]-2)-[#6:38]-3)-[#6:8]=[#6:9]-1-[#6:10]
ATN39899.1
O=C(O)C1Cc2c[nH]c3cccc(c23)S1
ATW47938.1
[#7:1]=[#6:2](-[#7:4]-[#6:5]-[#6:6]-[#6:7]/[#6@:8]1-[#6:23](=[#8:24])-[#7:22]-[#6:12](=[#6:13]-[#6:14]2:[#6:21]:[#6:19](-[#8:20]):[#6:17](-[#8:18]):[#6:16]:[#6:15]:2)-[#6:10](=[#8:11])-[#7:9]-1)-[#7:3]>>[#7:1]=[#6:2](-[#7:4]-[#6:5]-[#6:6]-[#6:7]\[#6@:8]1-[#6:23](=[#8:24])-[#7:22]-[#6:12](=[#6:13]-[#6:14]2:[#6:21]:[#6:19](-[#8:20]-[#6]-[#6]-[#6@@](-[#6](-[#8])=[#8])\[#7]):[#6:17](-[#8:18]):[#6:16]:[#6:15]:2)-[#6:10](=[#8:11])-[#7:9]-1)-[#7:3]
ATY69565.1
34575
34579
L-DOPA dioxygenase
A0A861B8S3
A0A160P4S3
Flavoprotein dioxygenase
The highest catalytic efficiency of the enzyme is achieved with the glucosaminyl-teicoplanin pseudoaglycone as substrate.
doi:10.1038/s41586-025-08723-7
Cyclases the intermediate in the thalianin pathway in Arabidopsis thaliana ssp. lyrata
ThnJ
CO[C@H]1C[C@H]2C=C[C@H]3[C@H]4O[C@]2(C(C)=C[C@@H](C)[C@@H]([C@H](C)O)OC1=O)[C@@H]3[C@@H](O)[C@@H](C)[C@H]4OC(=O)c1ccc[nH]1
ThnH
Bottromycin A2-precursor peptide with cleaved N-terminal Met, first 10 AAs.
[#8:1]-[#6:2]1:[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]>>[#6:2]1(-[#8]/[#6@@]2-[#6@@](-[#6@@](\[#8])-[#6@@](-[#6@](-[#8]-2)\[#6]-[#7])/[#8])/[#8]):[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]
Alternative substrate cyclo(L-Trp-L-Trp)
Q6ZZJ7
ThnA
rSAM methyltransferase
doi:10.1002/cbic.201700090
doi:10.1002/cbic.201100596
[#7:1]-[#6:2]/[#6@@:3]1-[#6@@:8](\[#8:9])-[#6@@:6](\[#8:7])-[#6@:5](/[#6:10]2:[#6:16](=[#8:17]):[#7:15]:[#6:13](=[#8:14]):[#7:12]:[#6:11]:2)-[#8:4]-1>>[#7]\[#6@](-[#6](-[#7:1]-[#6:2]/[#6@@:3]1-[#6@@:8](\[#8:9])-[#6@@:6](\[#8:7])-[#6@:5](/[#6:10]2:[#6:16](=[#8:17]):[#7:15]:[#6:13](=[#8:14]):[#7:12]:[#6:11]:2)-[#8:4]-1)=[#8])-[#6]-[#6]-[#6](=[#8])-[#7]
Lassopeptide ATP-dependent lactam synthetase (C-protein, asparagine synthetase-like)
C6 chlorination of 7-Cl-L-tryptophan
MYS84939.1
CC1=C[C@@H](C)CC=C[C@H]2[C@@H]3O[C@]3(C)[C@@H](C)C3[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@]32C(=O)C=C[C@H](O)[C@@H]1O
CO[C@H](C(=O)[C@H](O)C(C)=O)[C@@H]1Cc2cc3cc(OC4CC(OC5CC(O)C(O)C(C)O5)C(O)C(C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1OC1CC(OC2CC(OC3CC(C)(O)C(O)C(C)O3)C(O)C(C)O2)C(O)C(C)O1
BGC0002841
BGC0000440
BGC0002643
BGC0001945
66944
BGC0000247
doi:10.1016/j.chembiol.2010.12.018
BGC0003046
BGC0003049
O-methylation of orsellenic acid, assumed to be bound to coenzyme A cofactor
doi:10.1016/j.chembiol.2012.01.014
doi:10.1016/j.chembiol.2012.08.013
O-methylating SAM-dependent carboxyl methyltransferase from Streptomyces sp. BC16019 - Bottromycin precursor D-Asp O-methylation
Glyoxalase
SAM (S-adenosyl-L-methionine)-depenent O-methylation of roseopurpurin intermediate.
Hydrolysis
Biaryl bond formation
BytO
C=C[C@]1(C)C[C@@H](O)[C@]2(C)[C@H](C)CC[C@]3(CCC[C@H]32)[C@@H](C)[C@@H]1O
MITE0000001
MITE0000003
MITE0000002
MITE0000005
MITE0000004
MITE0000007
MITE0000006
MITE0000009
MITE0000008
CSCC[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(C)C
[#6:1]-[#8:2]/[#6@@:3](-[#6@:11]1-[#6@:47](\[#8:48]-[#6:49]2-[#8:76]-[#6:74](-[#6:75])-[#6:72](-[#8:73])-[#6:51](-[#8:52]-[#6:53]3-[#8:71]-[#6:69](-[#6:70])-[#6:67](-[#8:68])-[#6:55](-[#8:56]-[#6:57]4-[#8:66]-[#6:64](-[#6:65])-[#6:62](-[#8:63])-[#6:59](-[#8:61])(-[#6])-[#6:58]-4)-[#6:54]-3)-[#6:50]-2)-[#6:45](=[#8])-[#6:44]2:[#6:13](:[#6:14]:[#6:15]3:[#6:41](:[#6:42]:2-[#8]):[#6:39](-[#8]):[#6:37](-[#6]):[#6:17](-[#8:18]-[#6:19]2-[#8:36]-[#6:34](-[#6:35])-[#6:32](-[#8:33])-[#6:21](-[#8:22]-[#6:23]4-[#8:31]-[#6:29](-[#6:30])-[#6:27](-[#8:28])-[#6:25](-[#8:26])-[#6:24]-4)-[#6:20]-2):[#6:16]:3)-[#6:12]/1)-[#6:4](-[#6@@:6](-[#6:8](=[#8:10])-[#6:9])/[#8:7])=[#8]>>[#6:1]-[#8:2]/[#6@@:9](-[#6@:37]1-[#6@:17](\[#8:18]-[#6:19]2-[#8:36]-[#6:34](-[#6:35])-[#6:32](-[#8:33])-[#6:21](-[#8:22]-[#6:49]3-[#8:76]-[#6:74](-[#6:75])-[#6:72](-[#8:73])-[#6:51](-[#8:52]-[#6:53]4-[#8:71]-[#6:69](-[#6:70])-[#6:67](-[#8:68])-[#6:55](-[#8:56])(-[#6])-[#6:54]-4)-[#6:50]-3)-[#6:20]-2)-[#6:16](=[#8])-[#6:15]2:[#6:41](:[#6:42]:[#6:44]3:[#6:13](:[#6:14]:2-[#8]):[#6:12](-[#8]):[#6:11](-[#6:3]):[#6:47](-[#8:48]-[#6:23]2-[#8:31]-[#6:29](-[#6:30])-[#6:27](-[#8:28])-[#6:25](-[#8:26]-[#6:57]4-[#8:66]-[#6:64](-[#6:65])-[#6:62](-[#8:63])-[#6:59](-[#8:61])-[#6:58]-4)-[#6:24]-2):[#6:45]:3)-[#6:39]/1)-[#6:8](-[#6@@:6](-[#6@:4](-[#8])/[#6])/[#8:7])=[#8:10]
doi:10.1186/1471-2164-15-363
QOE88885.1
Nc1ncnc2c1ncn2C1OC(C[SH+]CCC(N)C(=O)O)C(O)C1O
[#8:1]-[#6:2]1:[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:85]:[#6:84]:[#6:9](-[#6@@:10](/[#8:83])-[#6@@:11]4-[#7:82]-[#6:80](=[#8:81])-[#6@:34](-[#7:35]-[#6:36](=[#8:79])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:78])\[#6@@:40]3-[#6:73]5:[#6:74]:[#6:75](-[#8:77]):[#6:76]:[#6:71](:[#6:72]:5)-[#8:70]-[#6:65]5:[#6:66](-[#8:69]):[#6:67]:[#6:68]:[#6:63](:[#6:64]:5)-[#6@@:61](/[#7:62])-[#6:59](=[#8:60])-[#7:58]-[#6@:44](-[#6:45]-[#6:46]5:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:5)\[#6:42](=[#8:43])-[#7:41]-3)/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]>>[#6]-[#6](-[#7]\[#6@]1-[#6@](/[#8:83]\[#6@:10]2-[#6@:11]3-[#6:12](-[#7:14]-[#6@@:15](-[#6:19]4:[#6:24]:[#6:23](-[#8:25]):[#6:22]:[#6:21](-[#8:26]):[#6:20]:4-[#6:27]4:[#6:28]:[#6:29](-[#6@:34](-[#6:80](-[#7:82]\3)=[#8:81])\[#7:35]-[#6:36](=[#8:79])-[#6@@:37]3-[#7:38]-[#6:39](/[#6@:40]5-[#7:41]-[#6:42](=[#8:43])-[#6@@:44](-[#6:45]-[#6:46]6:[#6:47]:[#6:48](-[Cl:49]):[#6:50](-[#8:51]-[#6:52]7:[#6:53]:[#6:54]/3:[#6:55]:[#6:3](:[#6:2]:7-[#8:1])-[#8:4]-[#6:5]3:[#6:6](:[#6:8]:[#6:9]-2:[#6:84]:[#6:85]:3)-[Cl:7]):[#6:56]:[#6:57]:6)/[#7:58]-[#6:59](=[#8:60])-[#6@:61](\[#7:62])-[#6:63]2:[#6:64]:[#6:65](:[#6:66](:[#6:67]:[#6:68]:2)-[#8:69])-[#8:70]-[#6:71]2:[#6:72]:[#6:73]-5:[#6:74]:[#6:75](:[#6:76]:2)-[#8:77])=[#8:78]):[#6:30]:[#6:31]:[#6:32]:4-[#8:33])\[#6:16](=[#8:17])-[#8:18])=[#8:13])-[#8]-[#6@](/[#6]-[#8])-[#6@@](\[#8])-[#6@@]-1/[#8])=[#8]
CC(CCCCCCCCCCCCc1c(C)c(O)cc(O)c1)C
QOE88884.1
[#6:5]-[c:9]1[c:8][c:7](-[#8:4])[c:11](-[#6:6])[c:12]2-[#8:13]-[#6:15](=[O:14])-[c:20]3[c:25](-[#6:17])[c:24][c:23](-[#8:19])[c:22](-[#6:16])[c:21]3-[#8:18]-[c:10]12>>[#6:6]-[#6:11]-1=[#6:12]-2-[#8:13]-[#6:15](=[O:14])-[c:20]3[c:25](-[#6:17])[c:24][c:23](-[#8:19])[c:22](-[#6:16])[c:21]3-[#8:18]-[#6@@H:10]-2[C@@:9]([#6:5])([#8:27])[#6@H:8](-[#8:26])-[#6:7]-1=[O:4] 
[#6:1](-[#16:48]-[#6:49](-[#6:51]1:[#6:58](-[#8:59]):[#6:57]:[#6:55](-[#8:56]):[#6:54]:[#6:52]:1-[#6:53])=[#8:50])-[#6:2]-[#7:3]-[#6:4](-[#6:6]-[#6:7]-[#7:8]-[#6:9](-[#6@@:11](-[#6:13](-[#6:16]-[#8:17]-[#15:18](-[#8:21]-[#15:22](-[#8:25]-[#6:26]/[#6@@:27]1-[#6@@:42](\[#8:43]-[#15:44](-[#8:47])(-[#8:46])=[#8:45])-[#6@@:40](\[#8:41])-[#6@:29](/[#7:30]2:[#6:39]3:[#6:33](:[#6:34](:[#7:36]:[#6:37]:[#7:38]:3)-[#7:35]):[#7:32]:[#6:31]:2)-[#8:28]-1)(-[#8:24])=[#8:23])(-[#8:20])=[#8:19])(-[#6:15])-[#6:14])/[#8:12])=[#8:10])=[#8:5]>>[#6:1](-[#16:48]-[#6:49](-[#6:51]1:[#6:58](-[#8:59]-[#6]):[#6:57]:[#6:55](-[#8:56]):[#6:54]:[#6:52]:1-[#6:53])=[#8:50])-[#6:2]-[#7:3]-[#6:4](-[#6:6]-[#6:7]-[#7:8]-[#6:9](-[#6@@:11](-[#6:13](-[#6:16]-[#8:17]-[#15:18](-[#8:21]-[#15:22](-[#8:25]-[#6:26]/[#6@@:27]1-[#6@@:42](\[#8:43]-[#15:44](-[#8:46])(-[#8:47])=[#8:45])-[#6@@:40](\[#8:41])-[#6@:29](/[#7:30]2:[#6:39]3:[#6:33](:[#6:34](:[#7:36]:[#6:37]:[#7:38]:3)-[#7:35]):[#7:32]:[#6:31]:2)-[#8:28]-1)(-[#8:24])=[#8:23])(-[#8:20])=[#8:19])(-[#6:15])-[#6:14])/[#8:12])=[#8:10])=[#8:5]
D6MSW0
PspC
CSCC[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
CYP158C1
Conversion of pentalenene to pentalen-13-al
CC(C)[C@@H]1CC[C@@]2(C)C[C@H]3[C@@H](CO)C[C@H](O)[C@@H]3[C@](C)(O)CC=C12
CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O)[C@@H](C)CC)[C@@H](C)O
epimerization of L-Asp7 to D-Asp7 of modified bottromycin precursor peptide
CC1(O)Cc2cc3cc(O)cc(O)c3c(O)c2C(=O)C1C(=O)[O-]
Flavoprotein monooxygenase
N-hydroxylation of delta-amine of ornithin
doi:10.1021/bi036130c
K4MJZ1
K4MJZ5
amide bond formation between arginine, encoded by the A domain of the NRPS-like gene, and leucine provided by their cognate aminoacyl-tRNAs as substrate.
BraB
[#6:1]-[#6:2](=[#6:4]-[#6:5]-[#6:6]-[#6:7](=[#6:9]-[#6:10]-[#6:11]-[#6@:12](-[#6@@:14]1(-[#6:19]2-[#6:20]-[#6:21]/[#6@@:22]3-[#6@@:30](/[#6:31])(-[#6:18]=2-[#6:17]-[#6:16]-1)-[#6:29]-[#6:28]-[#6@:26](/[#8:27])-[#6:23]-3(-[#6:25])-[#6:24])/[#6:15])\[#6:13])-[#6:8])-[#6:3]>>[#6:3]-[#6:2](=[#6:4]-[#6:5]-[#6:6]-[#6:7](=[#6:9]-[#6:10]-[#6:11]-[#6@:12](-[#6@@:14]1(-[#6:19]2-[#6@:20](-[#6:21]/[#6@@:22]3-[#6@@:30](/[#6:31])(-[#6:18]=2-[#6:17]-[#6:16]-1)-[#6:29]-[#6:28]-[#6@:26](/[#8:27])-[#6:23]-3(-[#6:25])-[#6:24])/[#8])/[#6:15])\[#6:13])-[#6:8])-[#6:1]
COc1cc(O)cc(C)c1C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O
[#7:1]-[#6:2](-[#6:13](-[#8:15])=[#8:14])-[#6:3]-[#6:4]1:[#6:12]2:[#6:7](:[#6:8]:[#6:9]:[#6:10]:[#6:11]:2):[#7:6]:[#6:5]:1>>[#7:1]-[#6:2](-[#6:13](-[#8:15])=[#8:14])-[#6:3]-[#6:4]1:[#6:12]2:[#6:7](:[#6:8]:[#6:9]:[#6:10](:[#6:11]:2)-[Br]):[#7:6]:[#6:5]:1
C/C(=C\Cc1c(O)c(C)c2c(c1O)C(=O)OC2)CCC(=O)O
Catalyzes the flavin-dependent Baeyer-Villiger oxidation in the biosynthesis of neopentalenolactone
C=C(C)[C@H]1CC=C2CCC[C@H](C)[C@@]2(C)C1
AXG22420.1
UUL71895.1
AXG22416.1
AXG22415.1
AXG22409.1
Hydroxylation at c-2 
AXG22413.1
TGJ85106.1
F420-dependent oxidoreductase
ProsK
SCL44650.1
KtzQ is a regiospecific halogenase that catalyzes the chlorination of L-Trp at C7 position to yield 7-chlorotryptophan
ProsA
ATP-dependent N-terminal cleavage of leader peptide, resulting in immature intermediate core peptide.
ProsC
N=C(N)NCCC[C@@H]1NC(=O)C(=Cc2ccc(O)c(OCC[C@H](NC(=O)C[C@](O)(CC(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)O)C(=O)O)c2)NC1=O
ProsD
ProsF
ProsB
CAK50794.2
CC(=O)N[C@H]1[C@H](O[C@@H]2c3ccc(c(Cl)c3)Oc3cc4cc(c3O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)Oc3ccc(cc3Cl)C[C@H]3NC(=O)[C@H](N)c5ccc(O)c(c5)Oc5cc(O)cc(c5)[C@H](NC3=O)C(=O)N[C@H]4C(=O)N[C@H]3C(=O)N[C@@H]2C(=O)N[C@H](C(=O)O)c2cc(O)cc(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)c2-c2cc3ccc2O)O[C@H](CO)[C@@H](O)[C@@H]1O
CAK50787.1
CAE53349.1
CAE53365.1
CAM00054.1
CAE45674.1
CAK50788.1
CAE45673.1
CAE45675.1
[#7:1]-[#6:2](=[#7:4]-[#6:5]-[#6:6]-[#6:7]-[#6@@:8](-[#6:10](-[#16:12]-[#6:32]-[#6:31]-[#7:30]-[#6:28](=[#8:29])-[#6:27]-[#6:26]-[#7:25]-[#6:23](=[#8:24])-[#6@:22](/[#8:33])-[#6:14](-[#6:16]-[#8:17]-[#15:18](-[#8:21])(-[#8:20])=[#8:19])(-[#6:15])-[#6:13])=[#8:11])/[#7:9])-[#7:3]>>[#7:1]-[#6:2](=[#7:4]-[#6:5]-[#6:6]-[#6:7]-[#6@:8](/[#7:9]-[#6](=[#8])-[#6@@](\[#7])-[#6]-[#6](-[#6])-[#6])-[#6:10](-[#16:12]-[#6:32]-[#6:31]-[#7:30]-[#6:28](=[#8:29])-[#6:27]-[#6:26]-[#7:25]-[#6:23](=[#8:24])-[#6@:22](/[#8:33])-[#6:14](-[#6:16]-[#8:17]-[#15:18](-[#8:21])(-[#8:20])=[#8:19])(-[#6:13])-[#6:15])=[#8:11])-[#7:3]
CAK50789.1
SAM
[#8:1]-[#6:2]1:[#6:17]2:[#6:6](:[#6:7](:[#6:9]3:[#6:15](:[#8:16]:2):[#6:14](-[#8:18]-[#6:19]):[#6:13]2-[#6:20]-[#6:21]-[#6:22]4:[#6:34](-[#6:12]:2:[#6:10]:3-[#8:11]):[#6:32](-[#8:33]):[#6:31](:[#6:24](-[#6:25]-[#6:26](=[#8:35])-[#6:27]):[#6:23]:4)-[#6:29](=[#8:30])-[#8:28])=[#8:8]):[#6:5]:[#6:4]:[#6:3]:1>>[#8:1]-[#6:2]1:[#6:17]2:[#6:6](:[#6:7](:[#6:9]3:[#6:15](:[#8:16]:2):[#6:14](-[#8:18]-[#6:19]):[#6:13]2-[#6:20]-[#6:21]-[#6:22]4:[#6:34](-[#6:12]:2:[#6:10]:3-[#8:11]):[#6:32](-[#8:33]):[#6:31](:[#6:24](-[#6:25]-[#6:26](=[#8:35])-[#6:27]):[#6:23]:4)-[#6:29](=[#8:30])-[#8:28])=[#8:8]):[#6:5]:[#6:4]:[#6:3]:1-[Cl]
Oxidation of 1,3,6,8-tetrahydroxynaphthalene (THN) to flaviolin.
COC(C(=O)C(O)C(C)=O)C1Cc2cc3cc(OC4CC(OC5CC(O)C(O)C(C)O5)C(O)C(C)O4)c(C)c(O)c3c(O)c2C(=O)C1(OC1CC(OC2CC(OC3CC(C)(O)C(O)C(C)O3)C(O)C(C)O2)C(O)C(C)O1)C(=O)O
[#6:1]/[#6@:2]1-[#6@@:18]23-[#6@:6](-[#6:7](=[#6:11]-[#6:12]-2-[#6:13]-[#6:14](-[#6:17]/3)(-[#6:16])-[#6:15])-[#6:8](-[#8:10])=[#8:9])\[#6:5]-[#6:3]-1=[#8:4]>>[#6:1]/[#6@:2]1-[#6@@:18]23-[#6@:6](-[#6:7](=[#6:11]-[#6:12]-2-[#6:13]-[#6:14](-[#6:17]/3)(-[#6:15])-[#6:16])-[#6:8](-[#8:10])=[#8:9])\[#6:5]-[#8]-[#6:3]-1=[#8:4]
OxyC
OxyB
OxyA
UbiA-like prenyltransferase
BotAH
[#6]\[#6](-[#6])=[#6]\[#6]-[#6]\[#6](-[#6])=[#6]/[#6]-[#6]\[#6](-[#6])=[#6]/[#6]-[#6]\[#6](-[#6])=[#6]/[#6]-[#8]P([#8-])(=O)[#8]P([#8-])([#8-])=O>>[#6]\[#6](-[#6])=[#6]\[#6]-[#6]\[#6](-[#6])=[#6]/[#6]-[#6]C1([#6])[#6]-2-[#6]-[#6]3-[#6](-[#6]-2)C13[#6]
ATP-dependent lactam synthetase
Chlorinates albofungin to chloralbofungin
CC(C)CC1NC(=O)C(C)NC1=O
ELS56114.1
Q6ZZI3
A8CF75
A8CF74
SfmM2
Brominates albofungin to bromalbofungin
N[C@@H](Cc1ccc(O)cc1)C(=O)O
Lassopeptide macrolactam formation after N-terminal cleavage: NH2-G-G-X-X-X-X-X-E-X-X-X-X-X-X-X-X-X-X-X-F-X-COOH.
CCC1OC(=O)[C@H](C)[C@@H](OC2C[C@](C)(O)[C@H](O)[C@@H](C)O2)[C@@H](C)[C@H](OC2O[C@@H](C)C[C@@H](N(C)C)[C@@H]2O)[C@@](C)(O)C[C@H](C)C(=O)[C@H](C)[C@H](O)[C@]1(C)O
U6BGC3
Peptidase
O-methylation of collismycin D, resulting in collismycin A
bottromycin A2 precursor after oxidative decarboxylation, last step of catalytic cascade
doi:10.1099/mic.0.26507-0
COC(=O)C=C(C)C12OC13c1cc(O)c4c(c1NC2C#CC=CC#CC3O)C(=O)c1ccccc1C4=O
doi:10.1021/jacs.8b12231
CC[C@H]1OC(=O)[C@@H](O)CC2C=CC3C[C@H](O)[C@H](C)[C@H](O)C3C2/C(C)=C/[C@H]1C
[#6:1]-[#6:2](-[#6:10](-[#8:22])-[#6:11](-[#7:13]-[#6:14]-[#6:15]-[#6:16](-[#7:18]-[#6:19]-[#6:20]-[#16:21]-[#6:23](=[#8:26])-[#6@:24](/[#7:27])-[#6:25]-[#6:28](=[#8:30])-[#7:29])-[#8:17])-[#8:12])(-[#6:4]-[#8:5]-[#15:6](-[#8:9])(-[#8:8])-[#8:7])-[#6:3]>>[#6:3]-[#6:2](-[#6:10](-[#8:22])-[#6:11](-[#7:13]-[#6:14]-[#6:15]-[#6:16](-[#7:18]-[#6:19]-[#6:20]-[#16:21]-[#6:23](=[#8:26])-[#6@:24](/[#7:27])-[#6@:25](\[#8])-[#6:28](=[#8:30])-[#7:29])-[#8:17])-[#8:12])(-[#6:4]-[#8:5]-[#15:6](-[#8:8])(-[#8:7])-[#8:9])-[#6:1]
[#6:16]-[#6:18](-[#6:17])-[#6:19]-[#6@@H:20](-[#7:21])-[#6:15](=[O:14])-[#7:13]-[#6@@H:12](-[#6:11]=[O:10])-[#6@H:2](-[#8:1])-[c:5]1[c:6][c:7][c:8](-[#8:9])[c:3][c:4]1>>[#6:16]-[#6:18](-[#6:17])-[#6:19]-[#6@@H:20](-[#7:21])-[#6:15](=[O:14])-[#7:13]-[#6@@H:12](-[#6:11]=[O:10])-[#6@H:2](-[#8:1])-[c:5]1[c:4][c:3][c:8](-[#8:9])[c:7](Cl)[c:6]1
doi:10.1371/journal.pone.0119302
Bromination of 5-bromoindole, leading to 3,5-tribromoindole
NC(N)=NCCCC1NC(=O)C(Cc2ccc(O)cc2)NC1=O
C=C/C(C)=C/C[C@@H]1[C@@]2(C)CCCC(C)(C)[C@@H]2C[C@H](O)[C@@]12CO2
CC(C)=CCCC(C)=CCC/C(C)=C/CCC(C)=CCc1cc(C(=O)O)cc(O)c1O
MITE0000149
MITE0000144
MITE0000145
MITE0000146
MITE0000147
SLI_0884
MITE0000141
MITE0000142
MITE0000143
TrlC
MITE0000140
CC1=C[C@@]23C(C=C(C(=O)O)[C@@H]2COC(=O)C32CO2)[C@@H]1C
TrlF
TrlE
TrlD
BotOMT
Substrate specificity is probably more general than depicted in the reaction SMARTS, but there is no precise information on substrate specificity. In order to avoid making the reaction too general, the complete backbone is included in the pattern.
N=C(N)NCCC[C@@H]1NC(=O)/C(=C/c2ccc(O)cc2)NC1=O
[C:1][C:2]#[CH1:3]>>[C:1][C:2]#[CH0:3][Br]
AFV25482.1
AFV25490.1
AFJ20768.1
AFV25488.1
AFV25486.1
AFV25480.1
AFV25484.1
doi:10.1021/ja0735857
AFO93376.1
AFV25483.1
Q8KI25
[#8].[#6:108]-[#6:107]-[#6:106]-[#6:105]-[#6:104]-[#6:103]-[#6:102]-[#6:101]-[#6:100]-[#6:98](=[O:99])-[#7:2]-[#6@@H:3]-1-[#6@@H:4](-[#8:5])-[#6@H:6](-[#8:7])-[#6@@H:8](-[#6:9]-[#8:10])-[#8:11]-[#6@H:12]-1-[#8:13]-[c:14]1[c:15]2-[#8:16]-[c:17]3[c:18][c:19][c:20](-[#6:21]-[#6@H:22]-4-[#7:23]-[#6:24](=[O:25])-[#6@H:26](-[#7:27])-[c:28]5[c:29][c:30][c:31](-[#8:32])[c:33](-[#8:34]-[c:35]6[c:36][c:37](-[#8:38])[c:39][c:40]([c:41]6)-[#6@H:42](-[#7:43]-[#6:44]-4=[O:45])-[#6:46](=[O:47])-[#7:48]-[#6@@H:49]-4-[c:50]([c:51]2)[c:52][c:53]1-[#8:54]-[c:55]1[c:56][c:57][c:58]([c:59][c:60]1[Cl:61])-[#6@@H:62](-[#8:63])-[#6@@H:64]-1-[#7:65]-[#6:66](=[O:67])-[#6@H:68](-[#7:69]-[#6:70]-4=[O:71])-[c:72]2[c:73][c:74][c:75](-[#8:76])[c:77]([c:78]2)-[c:79]2[c:80](-[#8:81])[c:82][c:83](-[#8:84])[c:85][c:86]2-[#6@H:87](-[#7:88]-[#6:89]-1=[O:90])-[#6:91](-[#8:92])=[O:93])[c:94]5)[c:95][c:96]3[Cl:97]>>[#7:2]-[#6@@H:3]-1-[#6@@H:4](-[#8:5])-[#6@H:6](-[#8:7])-[#6@@H:8](-[#6:9]-[#8:10])-[#8:11]-[#6@H:12]-1-[#8:13]-[c:14]1[c:15]2-[#8:16]-[c:17]3[c:18][c:19][c:20](-[#6:21]-[#6@H:22]-4-[#7:23]-[#6:24](=[O:25])-[#6@H:26](-[#7:27])-[c:28]5[c:29][c:30][c:31](-[#8:32])[c:33](-[#8:34]-[c:35]6[c:36][c:37](-[#8:38])[c:39][c:40]([c:41]6)-[#6@H:42](-[#7:43]-[#6:44]-4=[O:45])-[#6:46](=[O:47])-[#7:48]-[#6@@H:49]-4-[c:50]([c:51]2)[c:52][c:53]1-[#8:54]-[c:55]1[c:56][c:57][c:58]([c:59][c:60]1[Cl:61])-[#6@@H:62](-[#8:63])-[#6@@H:64]-1-[#7:65]-[#6:66](=[O:67])-[#6@H:68](-[#7:69]-[#6:70]-4=[O:71])-[c:72]2[c:73][c:74][c:75](-[#8:76])[c:77]([c:78]2)-[c:79]2[c:80](-[#8:81])[c:82][c:83](-[#8:84])[c:85][c:86]2-[#6@H:87](-[#7:88]-[#6:89]-1=[O:90])-[#6:91](-[#8:92])=[O:93])[c:94]5)[c:95][c:96]3[Cl:97].[#8]-[#6](-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-[#6])=[#8]
[#6:27]-[#6:26](=[O:28])-[#6:16]-1=[#6:17](-[#8:20])-[#6@@H:18](-[#8:19])-[#6:11]2-[#6:12]-[c:9]3[c:10][c:1]4[c:2][c:3](-[#8:25])[c:4][c:5](-[#8:24])[c:6]4[c:7](-[#8:23])[c:8]3-[#6:13](=[O:22])[C:14]2([#8:29])[#6:15]-1=[O:21]>>[#6:30]-[#8:19]-[#6@H:18]-1-[#6:11]2-[#6:12]-[c:9]3[c:10][c:1]4[c:2][c:3](-[#8:25])[c:4][c:5](-[#8:24])[c:6]4[c:7](-[#8:23])[c:8]3-[#6:13](=[O:22])[C:14]2([#8:29])[#6:15](=[O:21])-[#6:16](-[#6:26](-[#6:27])=[O:28])=[#6:17]-1-[#8:20]
doi:10.1021/ja0639214
CC(C)=CCCC(C)=CCC[C@@H](C)[C@@]1(C)CCC2=C1[C@@H](O)C[C@H]1C(C)(C)[C@@H](O)CC[C@]21C
Dehydrogenates cyclo(L-Phe-L-Leu) in the scope of the albonoursin biosynthetic pathway
[#6:1]/[#6@:2]1(-[#6:23]-[#6@@:21](/[#8:22])-[#6@:19]2(\[#6:20])-[#6@:12](/[#6:13])-[#6:11]-[#6:10]\[#6@:9]3(-[#6:18]-[#6:17]-[#6@@:15](\[#8:16])-[#6@:14]\3-2)-[#6@@:7](/[#6:8])-[#6@@:5]-1\[#8:6])-[#6:3]=[#6:4]>>[#6:1]/[#6@:2]1(-[#6:23]-[#6@@:21](/[#8:22]-[#6](=[#8])-[#6])-[#6@:19]2(\[#6:20])-[#6@:12](/[#6:13])-[#6:11]-[#6:10]\[#6@:9]3(-[#6:18]-[#6:17]-[#6@@:15](\[#8:16])-[#6@:14]\3-2)-[#6@@:7](/[#6:8])-[#6@@:5]-1\[#8:6])-[#6:3]=[#6:4]
CC(=O)N[C@H]1[C@H](O[C@@H]2c3ccc(c(Cl)c3)Oc3cc4cc(c3O)Oc3ccc(cc3Cl)C[C@H]3NC(=O)[C@H](N)c5ccc(O)c(c5)Oc5cc(O)cc(c5)[C@H](NC3=O)C(=O)N[C@H]4C(=O)N[C@H]3C(=O)N[C@@H]2C(=O)N[C@H](C(=O)O)c2cc(O)cc(O)c2-c2cc3ccc2O)O[C@H](CO)[C@@H](O)[C@@H]1O
RebH
A0A125SL25
C-terminal cleavage of glycin from lassopeptide
Oxygenase
C=C/C(C)=C/C[C@@H]1[C@@]2(C)CCCC(C)(C)[C@@H]2C[C@H](O)[C@@]1(O)CSC[C@H](NC(C)=O)C(=O)NC1C(OC2C(O)C(O)C(O)C(O)C2O)OC(CO)C(O)C1O
RebO
RebC
RebD
Oxidation
Flavin-dependent bromination of terminal alkyne
C=C(C)[C@@H]1C[C@@]2(C)C(=CC1=O)C[C@H](O)C[C@@H]2C
H1ZYT5
RebP
Single epoxidation
[#6:1]-[#6:2]1:[#6:8](-[#6:9](-[#16:11]-[#6:12]-[#6:13]-[#7:14]-[#6:15](-[#6:17]-[#6:18]-[#7:19]-[#6:20](-[#6@@:22](-[#6:24](-[#6:27]-[#8:28]-[#15:29](-[#8:32]-[#15:33](-[#8:36]-[#6:37]/[#6@@:38]2-[#6@@:53](\[#8:54]-[#15:55](-[#8:58])(-[#8:57])=[#8:56])-[#6@@:51](\[#8:52])-[#6@:40](/[#7:41]3:[#6:50]4:[#6:44](:[#6:45](:[#7:47]:[#6:48]:[#7:49]:4)-[#7:46]):[#7:43]:[#6:42]:3)-[#8:39]-2)(-[#8:35])=[#8:34])(-[#8:31])=[#8:30])(-[#6:26])-[#6:25])/[#8:23])=[#8:21])=[#8:16])=[#8:10]):[#6:6](-[#8:7]):[#6:5]:[#6:4]:[#6:3]:1>>[#6]-[#6:5]1:[#6:6](-[#8:7]):[#6:8](-[#6:9](-[#16:11]-[#6:12]-[#6:13]-[#7:14]-[#6:15](-[#6:17]-[#6:18]-[#7:19]-[#6:20](-[#6@@:22](-[#6:24](-[#6:27]-[#8:28]-[#15:29](-[#8:32]-[#15:33](-[#8:36]-[#6:37]/[#6@@:38]2-[#6@@:53](\[#8:54]-[#15:55](-[#8:58])(-[#8:57])=[#8:56])-[#6@@:51](\[#8:52])-[#6@:40](/[#7:41]3:[#6:50]4:[#6:44](:[#6:45](:[#7:47]:[#6:48]:[#7:49]:4)-[#7:46]):[#7:43]:[#6:42]:3)-[#8:39]-2)(-[#8:35])=[#8:34])(-[#8:31])=[#8:30])(-[#6:26])-[#6:25])/[#8:23])=[#8:21])=[#8:16])=[#8:10]):[#6:2](-[#6:1]):[#6:3]:[#6:4]:1
NC(Cc1ccc(O)cc1)C(=O)O.NC(N)=NCCCC(N)C(=O)O
specialized dehydrogenase for phenyllactate biosynthesis
[#6:1]1(/[#6@@:9]2-[#8:33]-[#6:31](=[#8:32])-[#6:30]-[#6@:28](/[#8:29])-[#6@@:26](\[#6:27])-[#6:25]-[#6@@:23](\[#6:24])-[#6:22]-[#6@@:20](\[#6:21])-[#6:19]-[#6@:17](/[#6:18])-[#6@@:15](/[#8:16])-[#6:13](-[#6:14]=[#8])=[#6:12]-[#6:34]=[#6:11]-[#6:10]-2)-[#6@@:5](\[#6:6](=[#8:8])-[#8:7])-[#6:4]-[#6:3]-[#6:2]-1>>[#6:1]1(/[#6@@:9]2-[#8:33]-[#6:31](=[#8:32])-[#6:30]-[#6@:28](/[#8:29])-[#6@@:26](\[#6:27])-[#6:25]-[#6@@:23](\[#6:24])-[#6:22]-[#6@@:20](\[#6:21])-[#6:19]-[#6@:17](/[#6:18])-[#6@@:15](/[#8:16])-[#6:13](-[#6:14]-[#7])=[#6:12]-[#6:34]=[#6:11]-[#6:10]-2)-[#6@@:5](\[#6:6](=[#8:8])-[#8:7])-[#6:4]-[#6:3]-[#6:2]-1
[#6:1]1(/[#6@@:9]2-[#8:33]-[#6:31](=[#8:32])-[#6:30]-[#6@:28](/[#8:29])-[#6@@:26](\[#6:27])-[#6:25]-[#6@@:23](\[#6:24])-[#6:22]-[#6@@:20](\[#6:21])-[#6:19]-[#6@:17](/[#6:18])-[#6@@:15](/[#8:16])-[#6:13](-[#6:14]-[#8])=[#6:12]-[#6:34]=[#6:11]-[#6:10]-2)-[#6@@:5](\[#6:6](=[#8:8])-[#8:7])-[#6:4]-[#6:3]-[#6:2]-1>>[#6:1]1(/[#6@@:9]2-[#8:33]-[#6:31](=[#8:32])-[#6:30]-[#6@:28](/[#8:29])-[#6@@:26](\[#6:27])-[#6:25]-[#6@@:23](\[#6:24])-[#6:22]-[#6@@:20](\[#6:21])-[#6:19]-[#6@:17](/[#6:18])-[#6@@:15](/[#8:16])-[#6:13](-[#6:14]=[#8])=[#6:12]-[#6:34]=[#6:11]-[#6:10]-2)-[#6@@:5](\[#6:6](=[#8:8])-[#8:7])-[#6:4]-[#6:3]-[#6:2]-1
[#6:8]-[c:2]1[c:3][c:4][c:5][c:6](-[#8:9])[c:1]1-[#6:7](=[O:10])-[#16:11]-[#6:57]-[#6:56]-[#7:55]-[#6:53](=[O:54])-[#6:52]-[#6:51]-[#7:50]-[#6:48](=[O:49])-[#6@H:47](-[#8:58])[C:13]([#6:12])([#6:14])[#6:15]-[#8:16][P:17]([#8:19])(=[O:18])[#8:20][P:21]([#8:23])(=[O:22])[#8:24]-[#6:25]-[#6@H:26]-1-[#8:30]-[#6@H:29](-[#6@H:28](-[#8:41])-[#6@@H:27]-1-[#8:42][P:43]([#8:45])([#8:46])=[O:44])-[n:31]1[c:32][n:33][c:34]2[c:35](-[#7:40])[n:36][c:37][n:38][c:39]12>>[#6:60]-[c:5]1[c:4][c:3][c:2](-[#6:8])[c:1](-[#6:7](=[O:10])-[#16:11]-[#6:57]-[#6:56]-[#7:55]-[#6:53](=[O:54])-[#6:52]-[#6:51]-[#7:50]-[#6:48](=[O:49])-[#6@H:47](-[#8:58])[C:13]([#6:12])([#6:14])[#6:15]-[#8:16][P:17]([#8:19])(=[O:18])[#8:20][P:21]([#8:23])(=[O:22])[#8:24]-[#6:25]-[#6@H:26]-2-[#8:30]-[#6@H:29](-[#6@H:28](-[#8:41])-[#6@@H:27]-2-[#8:42][P:43]([#8:45])([#8:46])=[O:44])-[n:31]2[c:32][n:33][c:34]3[c:35](-[#7:40])[n:36][c:37][n:38][c:39]23)[c:6]1-[#8:9]
UPI00204975FE
Cxm5
C=C(CO)[C@H]1CC=C2[C@H](O)CC[C@H](C)[C@@]2(C)C1
doi:10.1039/d0np00097c
CC(C)=CCCC1(C)OC1CC/C(C)=C/CC/C(C)=C/c1c[nH]c2ccccc12
Dehydration
tryptophane halogenase
Deamination
CCCCC[C@@H]1CC2=C(C(=O)OC2=O)[C@H](CCCC)CC2=C1C(=O)OC2=O
CCC(C)[C@@H]1NC(=O)[C@@H]2Cc3ccc(O)c(c3)-n3cc(c4cc(ccc43)[C@@]34C[C@H]5C(=O)N[C@H](C(=O)O)Cc6ccc(cc6)Oc6cccc3c6N[C@@H]4N5C1=O)C[C@H](N)C(=O)N2
Oxidation leads to furan-formation
beta-hydroxylation of PCP-bound leucine (syn)
Converts CoA-bound 6-methylsalicylic acid to 3,6-dimethylsalicylic acid
Biaryl-bond formation in the scabrirubin precursor peptide TWFIWYS before final cleavage
Catalysis of radical C-methylation of Phe6 of bottromycin-precursor after precursor Met cleavage.
CC(=O)N[C@H]1C(OC/C(C)=C2\CC(C)(C)CC3C2CC[C@@H]3C)O[C@H](CO)[C@@H](O)[C@@H]1O
doi:10.1073/pnas.1519695113
CN[C@H](CC(C)C)C(=O)N[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]1C(=O)N[C@H](c2ccc(O)cc2)C(=O)N[C@H](C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)O)[C@@H](O)c2ccc(cc2)Oc2cc1ccc2O)[C@@H](O)c1ccc(O)cc1
A0A0H5B8U5
[#6:1]\[#6@@:2]1(/[#6:3])-[#6:20]-[#6@@:19]23-[#6:11](-[#6:12]-[#8:13]-[#6:14](-[#6@:16]4\2/[#8:18]/[#6@:17]-4)=[#8:15])-[#6:7](-[#6:8](-[#8:10])=[#8:9])=[#6:6]-[#6:5]-3-[#6:4]-1>>[#6:3]-[#6:2]1-[#6@@:4](/[#6:1])-[#6:5]2-[#6:6]=[#6:7](-[#6@@:11]3\[#6:12]-[#8:13]-[#6:14](-[#6@:16]4(\[#6@:19]-2-3-[#6:20]=1)/[#8:18]/[#6@:17]-4)=[#8:15])-[#6:8](-[#8:10])=[#8:9]
[#6:1](-[#6:5]1-[#7:13]-[#6:11](=[#8:12])-[#6:9](-[#6:10])-[#7:8]-[#6:6]-1=[#8:7])-[#6:2](-[#6:4])-[#6:3]>>[#6:1](=[#6:5]1-[#7:13]-[#6:11](=[#8:12])-[#6:9](=[#6:10])-[#7:8]-[#6:6]-1=[#8:7])-[#6:2](-[#6:4])-[#6:3]
C=C[C@]1(C)C[C@@H](O)[C@]2(C)[C@H](C)CC[C@]3(CC[C@@H](O)[C@H]32)[C@@H](C)C1
CC(C)[C@@H]1NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]2CC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC1=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N2
BGC0001910
BGC0000311
BGC0001611
BGC0002514
doi:10.1021/jacs.3c05750
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)Oc2ccc(cc2Cl)[C@@H]1O.Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O[C@@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)O2)c(=O)[nH]c1=O
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)Oc2ccc(cc2Cl)[C@@H]1O.Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O[C@@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)O2)c(=O)[nH]c1=O
Heme
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](N)[C@H](O)[C@H]2O)Oc2ccc(cc2Cl)[C@@H]1O.Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O[C@@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)O2)c(=O)[nH]c1=O
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O)Oc2ccc(cc2Cl)[C@@H]1O.Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O[C@@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)O2)c(=O)[nH]c1=O
C12CC=C(CC(C=CC=C(C)C3(O)CC(O)C(C)=CC3C(=O)OC(CC3(OC(C)C(C)CC3)O1)C2)C)C
terpene cyclase
Persulfide methyltransferase
CC1(C)CCC[C@@]2(C)[C@@H]3CC[C@@]4(C)c5c(C(=O)O)cc(O)c(O)c5C[C@@H]4[C@@]3(C)CC[C@H]12
[#6:1]1(/[#6@@:9]2-[#8:33]-[#6:31](=[#8:32])-[#6:30]-[#6@:28](/[#8:29])-[#6@@:26](\[#6:27])-[#6:25]-[#6@@:23](\[#6:24])-[#6:22]-[#6@@:20](\[#6:21])-[#6:19]-[#6@:17](/[#6:18])-[#6@@:15](/[#8:16])-[#6:13](-[#6:14]-[#7])=[#6:12]-[#6:34]=[#6:11]-[#6:10]-2)-[#6@@:5](\[#6:6](=[#8:8])-[#8:7])-[#6:4]-[#6:3]-[#6:2]-1>>[#6:1]1(/[#6@@:9]2-[#8:33]-[#6:31](=[#8:32])-[#6:30]-[#6@:28](/[#8:29])-[#6@@:26](\[#6:27])-[#6:25]-[#6@@:23](\[#6:24])-[#6:22]-[#6@@:20](\[#6:21])-[#6:19]-[#6@:17](/[#6:18])-[#6@@:15](/[#8:16])-[#6:13](-[#6:14]-[#7](-[#8])-[#8])=[#6:12]-[#6:34]=[#6:11]-[#6:10]-2)-[#6@@:5](\[#6:6](=[#8:8])-[#8:7])-[#6:4]-[#6:3]-[#6:2]-1
doi:10.1021/acs.biochem.7b01219
[#8:1]-[#6:2]1:[#6:8]:[#6:7]2-[#6:9](-[#6:11](=[#6:13]-[#6:14](=[#8:15])-[#6:6]:2:[#6:4](-[#8:5]):[#6:3]:1)-[#8:12])=[#8:10]>>[#8:1]-[#6:2]1:[#6:8]:[#6:7]2-[#6:9](-[#6:11](=[#6:13]-[#6:14](=[#8:15])-[#6:6]:2:[#6:4](-[#8:5]):[#6:3]:1-[#6])-[#8:12])=[#8:10]
chlorinates tryptophan to form 6-Cl-tryptophan (6-Cl-Trp)
CSCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1[C@@H](C)CCN1C(=O)CN)C(C)C)C(C)C)C(C)C)C(=O)O
AIG62133.1
The reaction might be less specific than depicted in the reaction SMARTS. There is no detailed study on the specificity so far. The reaction occurs probably while the precursor peptide backbone is bound to the NRPS as shown for the closely related vancomycin biosynthesis (doi:10.1002/ANIE.200461278).
Second reaction, leading to an alternative flavonoid dimerization.
MITE0000197
MITE0000196
tryptophan 6-halogenase
NC(Cc1c[nH]c2ccc(Br)cc12)C(=O)O
MITE0000193
MITE0000192
doi:10.1039/C2SC21190D
MITE0000195
doi:10.1016/J.CHEMBIOL.2008.05.009
MITE0000190
[#7:1]=[#6:2](-[#7:4]-[#6:5]-[#6:6]-[#6:7]\[#6@:8]1-[#6:30](=[#8:31])-[#7:29]-[#6:12](=[#6:13]-[#6:14]2:[#6:28]:[#6:19](-[#8:20]-[#6:21]-[#6:22]-[#6@@:23](-[#6:25](-[#8:27])=[#8:26])\[#7:24]):[#6:17](-[#8:18]):[#6:16]:[#6:15]:2)-[#6:10](=[#8:11])-[#7:9]-1)-[#7:3]>>[#7:1]=[#6:2](-[#7:4]-[#6:5]-[#6:6]-[#6:7]\[#6@:8]1-[#6:30](=[#8:31])-[#7:29]-[#6:12](=[#6:13]-[#6:14]2:[#6:28]:[#6:19](-[#8:20]-[#6:21]-[#6:22]/[#6@@:23](-[#6:25](-[#8:27])=[#8:26])-[#7:24]-[#6](-[#6]-[#6@@](-[#6](-[#8])=[#8])(-[#6]-[#6](-[#8])=[#8])\[#8])=[#8]):[#6:17](-[#8:18]):[#6:16]:[#6:15]:2)-[#6:10](=[#8:11])-[#7:9]-1)-[#7:3]
C=C1NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(NC(=O)/C(=C/C)NC(=O)C(N)C(C)C)CSCC(C(=O)NC2C(=O)N3CCCC3C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC3CSCC4NC(=O)C(CC(N)=O)NC(=O)C(CSCC5NC(=O)C(Cc6ccccc6)NC(=O)C(CSC=CNC5=O)NC4=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)C4C(O)C(O)CN4C3=O)C(C)O)CSC2C)NC(=O)C(CC(C)C)NC1=O
MITE0000194
MITE0000191
CCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O
MITE0000198
MITE0000199
RHZ63459.1
RHZ63463.1
RHZ63465.1
RHZ63464.1
RHZ63462.1
RHZ63466.1
[#6:1]-[#6:2](/[#6@@:4](-[#6:107](-[#7:109]\[#6@:110](-[#6:116](-[#7:118]/[#6@:119](-[#6:127](-[#7:129]-[#6:130]-[#6:131](-[#8:133])=[#8:132])=[#8:128])-[#6:120]-[#6:121]-[#6:122]-[#7:123]-[#6:124](-[#7:126])=[#7:125])=[#8:117])-[#6:111]-[#6:112]-[#6:113]-[#6:114]-[#7:115])=[#8:108])-[#7:5]-[#6:6](-[#6:8]-[#7:9]-[#6:10](/[#6@@:12](-[#7:20]-[#6:21](-[#6:23]-[#7:24]-[#6:25](\[#6@@:27](-[#7:35]-[#6:36](\[#6@@:38](-[#7:44]-[#6:45](-[#6:47]-[#7:48]-[#6:49](\[#6@:51]1-[#7:56]-[#6:57](-[#6:59]-[#7:60]-[#6:61](/[#6@:63]2-[#7:67](-[#6:68](\[#6@@:70](-[#7:76]-[#6:77](/[#6@@:79](-[#7:82]-[#6:83](\[#6@@:85](-[#7:91]-[#6:92](/[#6@@:94](-[#7:100]-[#6:101](-[#6@@:103](/[#7:104]-[#6:53](=[#8:54])-[#6:52]-1)-[#6:105]-[#8:106])=[#8:102])-[#6:95]-[#6:96]-[#6:97]-[#6:98]-[#7:99])=[#8:93])-[#6:86]-[#6:87]-[#6:88]-[#6:89]-[#7:90])=[#8:84])-[#6:80]-[#8:81])=[#8:78])-[#6:71]-[#6:72]-[#6:73]-[#6:74]-[#7:75])=[#8:69])-[#6:66]-[#6:65]-[#6:64]-2)=[#8:62])=[#8:58])=[#8:50])=[#8:46])-[#6:39]-[#6:40]-[#6:41]-[#6:42]-[#7:43])=[#8:37])-[#6:28]-[#6:29]1:[#6:34]:[#6:33]:[#6:32]:[#6:31]:[#6:30]:1)=[#8:26])=[#8:22])-[#6:13]-[#6:14]-[#6:15]-[#7:16]-[#6:17](-[#7:19])=[#7:18])=[#8:11])=[#8:7])-[#6:3]>>[#6:3]-[#6:2](/[#6@:4]1-[#6:107](-[#7:109]\[#6@:110](-[#6:116](-[#7:118]/[#6@:119](-[#6:127](-[#7:129]-[#6:130]-[#6:131](-[#7:99]-[#6:98]-[#6:97]-[#6:96]-[#6:95]-[#6@@:94]2-[#7:100]-[#6:101](-[#6@@:103](/[#7:104]-[#6:53](=[#8:54])-[#6:52]-[#6@:51](-[#7:56]-[#6:57](-[#6:59]-[#7:60]-[#6:61](/[#6@:63]3-[#7:67](-[#6:68](\[#6@@:70](-[#7:76]-[#6:77](/[#6@@:79](-[#7:82]-[#6:83](\[#6@@:85](-[#7:91]-[#6:92]/2=[#8:93])-[#6:86]-[#6:87]-[#6:88]-[#6:89]-[#7:90])=[#8:84])-[#6:80]-[#8:81])=[#8:78])-[#6:71]-[#6:72]-[#6:73]-[#6:74]-[#7:75])=[#8:69])-[#6:66]-[#6:65]-[#6:64]-3)=[#8:62])=[#8:58])\[#6:49](=[#8:50])-[#7:48]-[#6:47]-[#6:45](=[#8:46])-[#7:44]-[#6@@:38](-[#6:39]-[#6:40]-[#6:41]-[#6:42]-[#7:43])\[#6:36](=[#8:37])-[#7:35]-[#6@@:27](-[#6:28]-[#6:29]2:[#6:34]:[#6:33]:[#6:32]:[#6:31]:[#6:30]:2)\[#6:25](=[#8:26])-[#7:24]-[#6:23]-[#6:21](=[#8:22])-[#7:20]-[#6@@:12](-[#6:13]-[#6:14]-[#6:15]-[#7:16]-[#6:17](-[#7:19])=[#7:18])/[#6:10](=[#8:11])-[#7:9]-[#6:8]-[#6:6](=[#8:7])-[#7:5]-1)-[#6:105]-[#8:106])=[#8:102])=[#8:132])=[#8:128])-[#6:120]-[#6:121]-[#6:122]-[#7:123]-[#6:124](-[#7:126])=[#7:125])=[#8:117])-[#6:111]-[#6:112]-[#6:113]-[#6:114]-[#7:115])=[#8:108])-[#6:1]
31699
Ngnp1
PhoD is a dehydratase responsible for the formation of the intermediate chrysophanol during biosynthesis of phomoxanthone A
Decarboxylase responsible for the conversion of atrochrysone carboxylic acid to atrochrysone.
CC(C)C[C@@H](N)C(=O)N[C@@H](C=O)[C@@H](O)c1ccc(O)cc1
Note: structural revision of phormidolide A -- 10.1039/d0cc03055d
[#6]\[#6](-[#6])=[#6]\[#6]-[#8]P([#8-])(=O)[#8]P([#8-])([#8-])=O.[#6]-[#6](=[#6])-[#6]-[#6]-[#8]P([#8-])(=O)[#8]P([#8-])([#8-])=O.[#6]-[#6](=[#6])-[#6]-[#6]-[#8]P([#8-])(=O)[#8]P([#8-])([#8-])=O.[#6]-[#6](=[#6])-[#6]-[#6]-[#8]P([#8-])(=O)[#8]P([#8-])([#8-])=O>>[#8]P([#8-])(=O)[#8]P([#8-])([#8-])=O.[#8]P([#8-])(=O)[#8]P([#8-])([#8-])=O.[#8]P([#8-])(=O)[#8]P([#8-])([#8-])=O.[#6]\[#6](-[#6])=[#6]\[#6]-[#6]\[#6](-[#6])=[#6]/[#6]-[#6]\[#6](-[#6])=[#6]/[#6]-[#6]\[#6](-[#6])=[#6]/[#6]-[#8]P([#8-])(=O)[#8]P([#8-])([#8-])=O
O-methylation of iodinated orsellenic acid derivate, assumed to be bound to 4'-phosphopantetheine co-factor
The reaction probably occurs on the PCP bound precursor.
COc1ccc(C[C@H](N)C(=O)O)cc1
COc1cc(-c2ccccn2)nc(C=NO)c1SC
 Formation of para-quinone substructure in the rishirilide biosynthesis pathway
K4MHV5
Cc1cccc(O)c1C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O
CmxA
K4MHV9
COC1C(C)=CC2C(=O)OC3CC(CC=C(C)CC(C)C=CC=C(CO)C2(O)C1O)OC1(CCC(C)C(C)O1)C3
UPI000A29E8C9
Dehydratase
PatG
doi:10.1002/anie.201914154
Chlorinates bht 2 and bht 6 of vancomycin. The bond to the PCP domain of module 2 of the vancomycin NRPS might be important for the reaction. There is no study on the substrate specificity for the second chlorination reaction in vancomycin biosynthesis on bht 6 so far.
O=C(O)c1cc2c([nH]c3cc(Cl)ccc32)s1
Epimerization
CCCCCCCCCCCCCCCc1cc(O)cc(O)c1O
QPI18725.1
QPI18730.1
QPI18723.1
CAA76550.1
CAE53364.1
CAE02604.1
[#6:1]\[#6:2]-1=[#6:3]/[#6:4]-[#6:5](=[#6:6])\[#6:7]=[#6:8]\[#6:9](\[#6:10])=[#6:11]/[c:12]2[c:13][s:14][c:15]([n:16]2)[C:17]2([#6:18]-[#6:19]2)[#7:20]-[#6:21](=[O:22])-[#6:23][C@:24]([#6:25]-[#6:26](-[#8:27])=[O:28])([#6:29]-[#6:30]1)[#16:31]-[#16:32]>>[#6:1]-[#16:2]-[#16:3][C@@:4]1([#6:5]-[#6:6](-[#8:7])=[O:8])[#6:9]-[#6:10]\[#6:11](-[#6:12])=[#6:13]\[#6:14]-[#6:15](=[#6:16])\[#6:17]=[#6:18]\[#6:19](\[#6:20])=[#6:21]/[c:22]2[c:23][s:24][c:25]([n:26]2)[C:27]2([#6:28]-[#6:29]2)[#7:30]-[#6:31](=[O:32])-[#6:33]1
doi:10.1039/d0sc04309e
C=C1C=C(/C=C/c2ccc(O)cc2)C(=O)O1
doi:10.3762/bjoc.18.113
[#6:1]-[#6:2]-[#6:3]-[#6:4]-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]1:[#6:23]:[#6:21](-[#8:22]):[#6:20]:[#6:18](-[#8:19]):[#6:17]:1>>[#6:1]-[#6:2]-[#6:3]-[#6:4]-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]1:[#6:17](-[#8]):[#6:18](-[#8:19]):[#6:20]:[#6:21](-[#8:22]):[#6:23]:1
Q6E7K6
Oxidation of 8-hydroxy group to 8-oxo, resulting in 8-oxo-aristolochene
Generic deacylation of a long chain fatty acid.
CC[C@@H](C)[C@@H](NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)O
GtfD
GtfE
PhmJ forms the vinyl bromination in phormidolide A
GtfB
GtfA
CCC(CCCCCCCCCCCCc1c(C)c(O)cc(OC)c1)C
CC(CCCCCCCCCCCCCc1c(C)c(O)cc(OC)c1)C
Stereoselective epoxidation of the olefin at C6-7 in the chaetoglobosin A biosynthesis
CC(=O)N[C@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@H](CO)[C@@H](O)[C@@H]1O.O
N=C(N)NCCC[C@@H]1NC(=O)/C(=C/c2ccc(O)c(OCC[C@H](NC(=O)C[C@](O)(CC(=O)O)C(=O)O)C(=O)O)c2)NC1=O
80263
N[C@H]1[C@@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@H](CO)[C@@H](O)[C@@H]1O
N-acetylglucosamine transferase
CC(C)C[C@@H](N)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@@H]1O
Precursor cleavage of the McjA precursor peptide, resulting in the intermediate core peptide before macrolactam formation.
O-methylation of collismycin D
Acetyltransferase
NCCCC[C@H](N)C(=O)O
34639
[#6:24]-[#6:22](-[#6:23])-[#6:20]-[#6:19]-[#6:18]-[#6:17]-[#6:16]-[#6:15]-[#6:14]-[#6:13]-[#6:12]-[#6:11]-[#6:10]-[c:9]1[c:8][c:6](-[#8:7])[c:5][c:3](-[#8:4])[c:2]1-[#6:1]>>[#6]-[#8:7]-[c:6]1[c:5][c:3](-[#8:4])[c:2](-[#6:1])[c:9](-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]-[#6:17]-[#6:18]-[#6:19]-[#6:20]-[#6:22](-[#6:24])-[#6:23])[c:8]1
34635
CC(=O)OC[C@]12Oc3c(-c4ccc(O)c5c4O[C@@]4(COC(C)=O)C(=C(O)C[C@@H](C)[C@H]4OC(C)=O)C5=O)ccc(O)c3C(=O)C1=C(O)C[C@@H](C)[C@H]2OC(C)=O
F8K0I8
[#8:1]=[#6:2](-[#6:4]1:[#6:21](-[#6:22]2:[#6:31]3:[#6:25](:[#6:26](:[#6:28]:[#6:29]:[#6:30]:3)-[Cl:27]):[#7:24]:[#6:23]:2):[#6:10](-[#6:11]2:[#6:20]3:[#6:14](:[#6:15](:[#6:17]:[#6:18]:[#6:19]:3)-[Cl:16]):[#7:13]:[#6:12]:2):[#6:6](-[#6:7](-[#8:9])=[#8:8]):[#7:5]:1)-[#8:3]>>[#8:8]=[#6:7](-[#6:6]1:[#6:10]2:[#6:11]3:[#6:12](:[#6:23]4:[#6:22](:[#6:21]:2:[#6:4](-[#6:2](-[#8:3])=[#8:1]):[#7:5]:1):[#6:31]1:[#6:25](:[#6:26](:[#6:28]:[#6:29]:[#6:30]:1)-[Cl:27]):[#7:24]:4):[#7:13]:[#6:14]1:[#6:20]:3:[#6:19]:[#6:18]:[#6:17]:[#6:15]:1-[Cl:16])-[#8:9]
MITE0000168
MITE0000169
MITE0000162
MITE0000163
MITE0000160
Combines hydroxylation, decarboxylation and oxidation to generate tropolone from dihydrotropone-2-carboxylate
MITE0000166
bottromycin A2 precursor peptide after follower peptide cleavage
MITE0000164
MITE0000165
MITE0000167
Q8KSX7
MITE0000161
Q8KSX5
doi:10.1038/srep25202
[#6:1]-[#8:2]-[#6:3]1-[#6:15]2-[#6:16]3-[#6:17]4:[#6:23](-[#7:24]-[#6:8](-[#6:9]#[#6:10]-[#6:11]=[#6:12]-[#6:13]#[#6:14]-2)-[#6:7]-3=[#6:5](-[#6:6])-[#6:4]=1):[#6:22]1-[#6:25](-[#6:27]2:[#6:32](-[#6:33](=[#8:34])-[#6:21]:1:[#6:19](-[#8:20]):[#6:18]:4):[#6:31]:[#6:30]:[#6:29]:[#6:28]:2)=[#8:26]>>[#8:34]=[#6:33]1-[#6:32]2:[#6:31]:[#6:30]:[#6:29]:[#6:28]:[#6:27]:2-[#6:25](-[#6:22]2:[#6:21]-1:[#6:19](:[#6:18]:[#6:17]1-[#6:16]34-[#8]-[#6:7]-3(-[#6:5](=[#6:4]-[#6:3](=[#8])-[#8:2]-[#6:1])-[#6:6])-[#6:8](-[#6:9]#[#6:10]-[#6:11]=[#6:12]-[#6:13]#[#6:14]-[#6:15]-4-[#8])-[#7:24]-[#6:23]:1:2)-[#8:20])=[#8:26]
decarboxylase, hydrolase
reduction of 4,5-didehydroacaterin to acaterin
Methylation
A0A125SA13
A0A125SA15
A0A224AU14
[#6:1]\[#6@:2]1-[#6@@:19]23-[#6@:7](-[#6:8](=[#6:12]-[#6:13]-2-[#6:14]-[#6:15](-[#6:18]\3)(-[#6:17])-[#6:16])-[#6:9](-[#8:11])=[#8:10])/[#6:6]-[#8:5]-[#6:3]-1=[#8:4]>>[#6:1]=[#6&H0:2]1-[#6@@:19]23-[#6@:7](-[#6:8](=[#6:12]-[#6:13]-2-[#6:14]-[#6:15](-[#6:18]\3)(-[#6:17])-[#6:16])-[#6:9](-[#8:11])=[#8:10])/[#6:6]-[#8:5]-[#6:3]-1=[#8:4]
A0A125SA14
BAI44339.1
[#8:1]-[#6:2]/[#6@@:3]1-[#6@@:8](\[#8:9])-[#6@@:6](\[#8:7])-[#6@:5](/[n:10]2:[#6:16](=[#8:17]):[nH:15]:[#6:13](=[#8:14]):[#6:12]:[#6:11]:2)-[#8:4]-1>>[#8:1]-[#6:2]/[#6@@:3]1-[#6@@:8](\[#8:9])-[#6@@:6](\[#8:7])-[#6@:5](/[#6:12]2:[#6:13](=[#8:14]):[nH:15]:[#6:16](=[#8:17]):[nH:10]:[#6:11]:2)-[#8:4]-1
BAE64655.1
Bromination of vinyl group
Hydroxylates the intermediate in the thalianin pathway in Arabidopsis thaliana ssp. lyrata
[#8:1]-[#6:2]1:[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]>>[#6:2]1(-[#8]/[#6@@]2-[#6@](/[#8])-[#6@@](\[#8])-[#6@](/[#8])-[#6]-[#8]-2):[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]
C9K1X7
C9K1X6
CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCC(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](C(C)C)C(=O)N2CCC[C@H]2C(=O)N1)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O)[C@@H](C)CC)[C@@H](C)O
Modifies biarylitide YYH precursor MRYYH
NgnN4 is responsible for attaching the pyrrole moiety at hydroxyl group at the 9-position of substrate.
Flavin reductase providing FADH2 supply for chlorination
TPS21
doi:10.1016/j.bmc.2006.05.039
CCC(C)CCCCCCCCCCCCc1cc(O)cc(OC)c1O
CC(C)[C@@H]1CC[C@@]2(C)C[C@H]3[C@@H](C)CC[C@@H]3[C@](C)(O)CC=C12
O=P([O-])([O-])OP(=O)([O-])O
Inference from genomic data and chemical structure
[#7:1]=[#6:2](-[#7:4]-[#6:5]-[#6:6]-[#6:7]\[#6@:8]1-[#6:42](=[#8:43])-[#7:41]-[#6:12](=[#6:13]-[#6:14]2:[#6:40]:[#6:19](-[#8:20]-[#6:21]-[#6:22]/[#6@@:23](-[#6:37](-[#8:39])=[#8:38])-[#7:24]-[#6:25](-[#6:27]-[#6@@:28](-[#6:34](-[#8:36])=[#8:35])(-[#6:30]-[#6:31](-[#8:33])=[#8:32])\[#8:29])=[#8:26]):[#6:17](-[#8:18]):[#6:16]:[#6:15]:2)-[#6:10](=[#8:11])-[#7:9]-1)-[#7:3]>>[#7:1]=[#6:2](-[#7:4]-[#6:5]-[#6:6]-[#6:7]\[#6@:8]1-[#6:42](=[#8:43])-[#7:41]-[#6:12](=[#6:13]-[#6:14]2:[#6:40]:[#6:19](-[#8:20]-[#6:21]-[#6:22]/[#6@@:23](-[#6:37](-[#8:39])=[#8:38])-[#7:24]-[#6:25](-[#6:27]-[#6@@:28](-[#6:34](-[#8:36])=[#8:35])(-[#6:30]-[#6:31](-[#8:33])=[#8:32])\[#8:29])=[#8:26]):[#6:17](-[#8:18]-[#6]):[#6:16]:[#6:15]:2)-[#6:10](=[#8:11])-[#7:9]-1)-[#7:3]
Reaction with UDP-xylose and vancomycin intermediate as substrates.
[#6:1]-[#6:2]-[#6:3]-[#6:4]-[#6:5]\[#6@:6]1-[#6:18]2-[#6:19](-[#8:21]-[#6:22](=[#8:23])-[#6:17]=2-[#6:16]-[#6@@:11](\[#6:12]-[#6:13]-[#6:14]-[#6:15])-[#6:10]-[#6:9]2-[#6:24](-[#8:26]-[#6:27](=[#8:28])-[#6:8]=2-[#6:7]-1)=[#8:25])=[#8:20]>>[#6:1]-[#6:2]-[#6:3]-[#6:4]-[#6:5]\[#6@:6]1-[#6:18]2-[#6:19](-[#8:21]-[#6:22](=[#8:23])-[#6:17]=2-[#6:16]-[#6@@:11](\[#6:12]-[#6:13]-[#6:14]-[#6:15])-[#6@@:10](\[#8])-[#6:9]2-[#6:24](-[#8:26]-[#6:27](=[#8:28])-[#6:8]=2-[#6:7]-1)=[#8:25])=[#8:20]
Converts 11-hydroxypremutilin to 3,11-hydroxypremutilin
O=c1c(O)cccc(O)c1O
doi:10.1016/j.chempr.2025.102438
Zn
The enzyme accepts the vancomycin and teicoplanin pseudoaglycone as substrate. The substrate tolerance may be even broader than the largest common substructure between vancomycin and teicoplanin.
Brc1ccc2[nH]ccc2c1
O-methylation of orsellenic acid, assumed to be bound to 4'-phosphopantetheine cofactor
[#6:1]-[#8:2]\[#6@:3]1-[#6:39]2-[#6@@:12](-[#6:23](-[#6:25]3:[#6:36](-[#8:37]):[#6:35]4:[#6:28](:[#6:29]:[#6:30](:[#6:32]:[#6:33]:4-[#8:34])-[#8:31]):[#6:27]:[#6:26]:3-[#6:38]-2)=[#8:24])(\[#8:13]-[#6:14]2-[#8:22]-[#6:20](-[#6:21])-[#6:18](-[#8:19])-[#6:16](-[#8:17])-[#6:15]-2)-[#6:10](=[#8:11])-[#6:6](-[#6:7](=[#8:9])-[#6:8])=[#6:4]-1-[#8:5]>>[#6:1]-[#8:2]\[#6@:3]1-[#6:39]2-[#6@@:12](-[#6:23](-[#6:25]3:[#6:36](-[#8:37]):[#6:35]4:[#6:28](:[#6:29]:[#6:30](:[#6:32]:[#6:33]:4-[#8:34])-[#8:31]):[#6:27]:[#6:26]:3-[#6:38]-2)=[#8:24])(\[#8:13]-[#6:14]2-[#8:22]-[#6:20](-[#6:21])-[#6:18](-[#8:19])-[#6:16](-[#8:17]-[#6]3-[#8]-[#6](-[#6])-[#6](-[#8])-[#6](-[#8])-[#6]-3)-[#6:15]-2)-[#6:10](=[#8:11])-[#6:6](-[#6:7](=[#8:9])-[#6:8])=[#6:4]-1-[#8:5]
OrfA
[#6:17]-[c:25]1[c:24][c:23](-[#8:19])[c:22](-[#6:16])[c:21](-[#8:18])[c:20]1-[#6:15](=[O:14])-[#8:13]-[c:12]1[c:10][c:9](-[#6:5])[c:8](-[#6:3](-[#8:1])=[O:2])[c:7](-[#8:4])[c:11]1-[#6:6]>>[#6:17]-[c:25]1[c:24][c:23](-[#8:19])[c:22](-[#6:16])[c:21]2-[#8:18]-[c:10]3[c:9](-[#6:5])[c:8](-[#6:3](-[#8:1])=[O:2])[c:7](-[#8:4])[c:11](-[#6:6])[c:12]3-[#8:13]-[#6:15](=[O:14])-[c:20]12
BGC0000469
BGC0001168
BGC0000269
Q8KIC8
BGC0002069
BGC0001664
BGC0001763
[#6:1]1(:[#6:36]:[#7:35]:[#6:30]2:[#6:31]:[#6:32]:[#6:33]:[#6:34]:[#6:29]:1:2)-[#6:2]\[#6@:3]1-[#6@:13]2-[#6@@:7]3(-[#6:27](=[#8:28])-[#6:26]=[#6:25]-[#6:24]-[#6:23]-[#6:21](-[#6:22])=[#6:20]-[#6@@:18](/[#6:19])-[#6:17]-[#6:16]=[#6:15]/[#6@:8]-3-[#6:9]=[#6:10](-[#6:14])-[#6@:11]/2/[#6:12])/[#6:5](=[#8:6])-[#7:4]-1>>[#6:1]1(:[#6:36]:[#7:35]:[#6:30]2:[#6:31]:[#6:32]:[#6:33]:[#6:34]:[#6:29]:1:2)-[#6:2]\[#6@:3]1-[#6@:13]2-[#6@@:7]3(-[#6:27](=[#8:28])-[#6:26]=[#6:25]-[#6:24]-[#6:23]-[#6:21](-[#6:22])=[#6:20]-[#6@@:18](/[#6:19])-[#6:17]-[#6:16]=[#6:15]/[#6@:8]-3-[#6@@:9]3\[#8]-[#6@:10]-3(/[#6:14])-[#6@:11]/2/[#6:12])/[#6:5](=[#8:6])-[#7:4]-1
R9R6P6
BGC0002260
Peptidase, clostripain-family
BGC0001061
BGC0002964
Flavin-dependent iodination of terminal alkyne
O=c1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1
C/C=C(/CCCCCCC/C=C\C=C\C=C/Cc1cc(O)cc(O)c1)C(=O)O
[#6:1]-[#6:2]1:[#6:8]:[#6:7]2-[#6:9](-[#6:11]3:[#6:18](-[#6:19](=[#8:20])-[#6:6]:2:[#6:4](-[#8:5]):[#6:3]:1):[#6:16](-[#8:17]):[#6:15]:[#6:13](-[#8:14]):[#6:12]:3)=[#8:10]>>[#6:1]-[#6:2]1:[#6:8]:[#6:7]2-[c:9](=[c:11]3-[c:18](=[c:19](-[#8:20])-[#6:6]:2:[#6:4](-[#8:5]):[#6:3]:1)-[#6:16](=[#8:17])-[#6:15]=[#6:13](-[#8:14])-[#6:12]-3)-[#8:10]
Converts 1-deoxy-11-oxopentalenic acid to neopentalenolactone D
[#6:1]12-[#6@:10](/[#6:29])(-[#6:21]-[#6:22]-[#6:23]=[#6:24](-[#6:26])-[#6:25])-[#6@@:9](/[#8:27])-[#6:8]-[#6:7]-[#6@:6]-1(/[#6:28])-[#6@@:5]1(\[#6:30])-[#6:11]3:[#7:14]:[#6:15]4:[#6:20]:[#6:19]:[#6:18]:[#6:17]:[#6:16]:4:[#6:12]:3-[#6:13]-[#6:4]-1-[#6:3]-[#6:2]-2>>[#6:1]12-[#6@:10](/[#6:29])(\[#6:21]-[#6:22]-[#6:23]=[#6:24](-[#6:25])-[#6:26](=[#8])-[#8])-[#6@@:9](/[#8:27])-[#6:8]-[#6:7]-[#6@:6]-1(/[#6:28])-[#6@@:5]1(\[#6:30])-[#6:11]3:[#7:14]:[#6:15]4:[#6:20]:[#6:19]:[#6:18]:[#6:17]:[#6:16]:4:[#6:12]:3-[#6:13]-[#6:4]-1-[#6:3]-[#6:2]-2
Chlorinates free-floating L-tryptophan exclusively in position 5
O-acetylation as final step of the thalianin pathway in Arabidopsis thaliana ssp. lyrata
CC1=CC(=O)C(C(=O)c2c(O)cccc2O)=C(CO)[C@@H]1O
CSCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(C)C)C(=O)O
CCCC(=O)N[C@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@H](CO)[C@@H](O)[C@@H]1O
[#6:1]-[#6:2](=[#6:4]-[#6:5]-[#6:6]-[#6:7](=[#6:9]-[#6:10]-[#6@:11]1(-[#6@@:26](-[#6:28]-[#6:29]=[#6:30](-[#6:32])-[#6:31])(\[Cl:27])-[#6:24](=[#8:25])-[#6:23]2:[#6:15](:[#6:16]:[#6:17](:[#6:19](:[#6:21]:2-[#8:22])-[#6:20])-[#8:18])-[#6:13]-1=[#8:14])/[#8:12])-[#6:8])-[#6:3]>>[#6:1]-[#6:2](=[#6:4]-[#6:5]-[#6:6]-[#6:7](=[#6:9]-[#6:10]\[#6@:11]12-[#6:13](=[#8:14])-[#6:15]3:[#6:16]:[#6:17](:[#6:19](:[#6:21](-[#8:22]):[#6:23]:3-[#6:24](=[#8:25])-[#6@@:26]-1(\[Cl:27])-[#6:28]-[#6@@:29](/[Cl])-[#6:30](-[#6:32])(-[#6:31])-[#8:12]-2)-[#6:20])-[#8:18])-[#6:8])-[#6:3]
CO[C@H]1CC2C=CC3C[C@H](O)[C@H](C)[C@@H](O)C3C2C(C)=C[C@@H](C)[C@@H]([C@@H](C)O)OC1=O
FADH2-dependent halogenase in the biosynthesis of chloroalbofungin
Oxidation of 2,8-dihydroxy aristolochene to 2-hydroxy,8-oxo-aristolochene
CC(C)CC1NC(=O)C(Cc2ccccc2)NC1=O
BotRMT2
BotRMT3
BotRMT1
[#8:1]=[#6:2]1:[#6:19]2:[#6:13](:[#6:14]:[#6:15](:[#6:17]:[#6:18]:2)-[#8:16]):[#8:12]:[#6:11]:[#6:3]:1-[#6:4]1:[#6:10]:[#6:9]:[#6:7](-[#8:8]):[#6:6]:[#6:5]:1>>[#8:1]=[#6:2]1:[#6:3](-[#6:4]2:[#6:10]:[#6:9]:[#6:7](-[#8:8]):[#6:6](-[#6]3:[#6]:[#6](:[#6]:[#6]:[#6]:3-[#8])-[#6]3:[#6](:[#6]4:[#6]:[#6]:[#6](-[#8]):[#6]:[#6]:4:[#8]:[#6]:3)=[#8]):[#6:5]:2):[#6:11]:[#8:12]:[#6:13]2:[#6:14]:[#6:15](-[#8:16]):[#6:17]:[#6:18]:[#6:19]:1:2
NgnD
CC(=O)/N=C(\N)NCCC[C@@H]1NC(=O)[C@H](Cc2onc3ccccc23)NC1=O
Converts 5-hydroxy-deoxyscytalidin to deoxyzopfiellin
NgnM
[#6:1](-[#6:2]-[#6:3]-[#6:4](=[#6:13]-[#6:12]1:[#6:16]2:[#6:17]:[#6:18]:[#6:19]:[#6:20]:[#6:15]:2:[#7:14]:[#6:11]:1)-[#6:5])=[#6:6](-[#6:28])-[#6:7]-[#6:8]-[#6:9]1-[#8:29]-[#6:10]-1(-[#6:27])-[#6:21]-[#6:22]-[#6:23]=[#6:24](-[#6:26])-[#6:25]>>[#6:1]12-[#6@:10](/[#6:27])(-[#6:21]-[#6:22]-[#6:23]=[#6:24](-[#6:25])-[#6:26])-[#6@@:9](/[#8:29])-[#6:8]-[#6:7]-[#6@:6]-1(/[#6:28])-[#6@@:5]1(\[#6])-[#6:11]3:[#7:14]:[#6:15]4:[#6:20]:[#6:19]:[#6:18]:[#6:17]:[#6:16]:4:[#6:12]:3-[#6:13]-[#6:4]-1-[#6:3]-[#6:2]-2
CC1(C)CC2C=C(C(=O)O)[C@@H]3COC(=O)C4(CO4)[C@]23C1
doi:10.1038/s41467-017-00419-5
AAK83184.1
AAK83186.1
AAK83180.1
TdaE
AAS98776.1
[#7:1]=[#6:2](-[#7:4]-[#6:5]-[#6:6]-[#6:7]\[#6@:8]1-[#6:25](=[#8:26])-[#7:24]-[#6@@:12](\[#6:13]-[#6:14]2(-[#6:23]3:[#6:18](:[#6:19]:[#6:20]:[#6:21]:[#6:22]:3)-[#7:17]=[#6:16]-2)-[#8:15])-[#6:10](=[#8:11])-[#7:9]-1)-[#7:3]>>[#7:1]=[#6:2](-[#7:4]-[#6:5]-[#6:6]-[#6:7]\[#6@:8]1-[#6:25](=[#8:26])-[#7:24]-[#6@@:12](\[#6:13]-[#6&H0:14](-[#6:23]2:[#6:18](:[#6:19]:[#6:20]:[#6:21]:[#6:22]:2)-[#7:17]-[#6:16](=[#8])-[#6])=[#8:15])-[#6:10](=[#8:11])-[#7:9]-1)-[#7:3]
C[C@@H]1CC=CC(=O)NCC=CC=C[C@@H](O)C[C@@H](O)Cc2nc(co2)C(=O)N[C@H](CS)CC(=O)O1
bottromycin A2-precursor peptide after heterocyclization of Cys8
[#6:1]=[#6:2]1-[#6@@:19]23-[#6@:7](-[#6:8](=[#6:12]-[#6:13]-2-[#6:14]-[#6:15](-[#6:18]\3)(-[#6:17])-[#6:16])-[#6:9](-[#8:11])=[#8:10])/[#6:6]-[#8:5]-[#6:3]-1=[#8:4]>>[#6:16]-[#6:15]1(-[#6:18]\[#6@@:19]23-[#6@@:7](/[#6:6]-[#8:5]-[#6:3](-[#6:2]4-2-[#8]-[#6:1]-4)=[#8:4])-[#6:8](-[#6:9](-[#8:11])=[#8:10])=[#6:12]-[#6:13]-3-[#6:14]-1)-[#6:17]
GrhO5
K4MHW2
GrhO6
NC(=O)CC[C@H](N)C(=O)NC[C@H]1O[C@@H](c2c[nH]c(=O)[nH]c2=O)[C@H](O)[C@@H]1O
COc1ccc(C=C2NC(=O)[C@H](CCCNC(=N)N)NC2=O)cc1OCC[C@H](NC(=O)C[C@](O)(CC(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)O)C(=O)O
[#8:1]-[#6:2]1:[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]>>[#6:2]1(-[#8]/[#6@@]2-[#6@@](-[#6@@](\[#8])-[#6@@](-[#6@](-[#8]-2)\[#6]-[#8])/[#8])/[F]):[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]
PeuJ
[#6:1]-[#6:2]1-[#6@:15]2-[#6@:10]3(-[#6@@:11](-[#6:13]-[#6:14]/2)\[#6:12])-[#6:4](-[#6:5]-[#6:6](-[#6:9]\3)(-[#6:8])-[#6:7])-[#6:3]=1>>[#6:12]\[#6@:11]1-[#6@@:10]23-[#6@:15](-[#6:2](=[#6:3]-[#6:4]-2-[#6:5]-[#6:6](-[#6:9]\3)(-[#6:7])-[#6:8])-[#6:1](-[#8])=[#8])/[#6:14]-[#6:13]-1
CPT2 is a gatekeeping enzyme producing the nerylneryl terpene scaffold and not a tailoring enzyme and therefore out of scope of MITE.
[#8:1]-[c:2]1[c:3][c:4][c:5]([c:6][c:7]1)-[c:8]1[c:9][o:10][c:11]2[c:12][c:13](-[#8:14])[c:15][c:16][c:17]2[c:18]1=[O:19]>>[#8:1]-[c:2]1[c:3][c:4][c:5]([c:6][c:7]1)-[c:8]1[c:9][o:10][c:11]2[c:17]([c:15](-[#8:16])[c:14][c:13][c:12]2[c:18]1=[O:19])-[c]1[c][c]([c][c][c]1-[#8])-[c]1[c][o][c]2[c][c](-[#8])[c][c][c]2[c]1=[O]
doi:10.1021/jacs.0c10361
A0A891LWT6
A0A0F7N5T9
N[C@H]1C(=O)N[C@@H]2Cc3ccc(c(Cl)c3)Oc3cc4cc(c3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3F)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(O)cc(c2)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@@H](C(=O)O)NC3=O
MtmGIV
[#8:1]-[#6:2](=[O:3])-[c:4]1[n:28][c:27](-[#6:29](-[#8:30])=[O:31])[c:26]2[c:5]1[c:6]1[c:15]3[c:14][c:13][c:12][c:10]([Cl:11])[c:9]3[n:8][c:7]1[c:16]1[n:20][c:19]3[c:21]([Cl:22])[c:23][c:24][c:25][c:18]3[c:17]21>>[Cl:1][c:2]1[c:3][c:4][c:5][c:6]2[c:7]1[n:8][c:9]1[c:19]3[n:20][c:21]4[c:22]([Cl:23])[c:24][c:25][c:26][c:27]4[c:18]3[c:12]3-[#6:13](=[O:14])-[#7:15]-[#6:16](=[O:17])-[c:11]3[c:10]21
CC(C)=CCCC(C)=CC(=O)[C@H](O)[C@@H](C)[C@@]1(C)CCC2=C1[C@@H](O)C[C@H]1C(C)(C)[C@@H](O)CC[C@]21C
N[C@H]1C(=O)N[C@@H]2Cc3ccc(c(Cl)c3)Oc3cc4cc(c3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(O)cc(c2)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@@H](C(=O)O)NC3=O
MtmGII
[#7:1]/[#6@:2](-[#6:8](-[#8:10])=[#8:9])-[#6:3]-[#6:4]-[#6:5]-[#7:6]-[#8:7]>>[#6]-[#6](-[#7:6](-[#6:5]-[#6:4]-[#6:3]-[#6@@:2](-[#6:8](-[#8:10])=[#8:9])/[#7:1])-[#8:7])=[#8]
F8STX6
F8STX7
F8STX8
NgnM methylates the hydroxyl group at the 2-position of the macrolactone intermediate
I0HIZ2
I0HIZ1
I0HIZ0
[#6:1]-[#6@:32](\[#7:33]-[#6:35](/[#6@:36](-[#6:37])-[#7:38]-[#6:40](-[#6@@:41]/[#7:42]-[#6:44](-[#6:45]-[#7:46]-[#6:48](/[#6@:167]-[#7:166]-[#6:165](=[#8:164])-[#6:163]-[#7:162]-[#6:161](=[#8:160])/[#6@@:159]-[#7:158]-[#6:157](=[#8:156])\[#6@:155](-[#6:154])-[#7:153]-[#6:152](=[#8:151])\[#6@:150](-[#6:149])-[#7:148]-[#6:147](=[#8:146])/[#6@:145](-[#6:144]-[#6:143]-[#6:142](=[#8:141])-[#8:140])-[#7:139]-[#6:138](=[#8:137])\[#6@@:136]-[#7:135]-[#6:134](=[#8:133])\[#6@@:132](-[#7:131]-[#6:130](=[#8:129])\[#6@:128](-[#6:127])-[#7:126]-[#6:125](=[#8:124])-[#6:123]-[#7:122]-[#6:121](=[#8:120])-[#6@:119](\[#6:118])-[#7:117]-[#6:116](=[#8:115])-[#6:114]-[#7:113]-[#6:112](=[#8:111])-[#6:110]-[#7:109]-[#6](=[#8])/[#6@](-[#6]-[#6]-[#6]-[#6]-[#7])-[#7]-[#6](=[#8])\[#6@@](-[#7]-[#6](=[#8])/[#6@](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])\[#6@](-[#6]-[#6]-[#6](-[#7])=[#8])-[#7]-[#6](=[#8])/[#6@](-[#6]-[#8])-[#7]-[#6](=[#8])-[#6@](\[#6])-[#7]-[#6](=[#8])/[#6@](-[#6]-[#8])-[#7]-[#6](=[#8])-[#6@@](/[#7])-[#6]-[#6]-[#6]-[#6]-[#7])-[#6@@](/[#6])-[#8])-[#6:49])=[#8:47])=[#8:43])=[#8:39])=[#8:34])-[#6:31](=[#8:30])-[#7:29]/[#6@@:28](-[#6:27])-[#6:26](=[#8:25])-[#7:24]\[#6@@:23](-[#6:22]-[#6:21])-[#6:20](=[#8:19])-[#7:18]\[#6@@:17](-[#6:16]-[#6:15]1:[#6:14]:[#6:13]:[#6:12](-[#8:11]):[#6:10]:[#6:9]:1)-[#6:8](=[#8:7])-[#7:6]-[#6:5]-[#6:4](=[#8:3])-[#8:2]>>[#6:1]-[#6@:32](\[#7:33]-[#6:35](/[#6@:36](-[#6:37])-[#7:38]-[#6:40](-[#6@@:41]/[#7:42]-[#6:44](-[#6:45]-[#7:46]-[#6:48](/[#6@:167]-[#7:166]-[#6:165](=[#8:164])-[#6:163]-[#7:162]-[#6:161](=[#8:160])/[#6@@:159]-[#7:158]-[#6:157](=[#8:156])\[#6@:155](-[#6:154])-[#7:153]-[#6:152](=[#8:151])\[#6@:150](-[#6:149])-[#7:148]-[#6:147](=[#8:146])/[#6@:145](-[#6:144]-[#6:143]-[#6:142](=[#8:141])-[#8:140])-[#7:139]-[#6:138](=[#8:137])\[#6@@:136]-[#7:135]-[#6:134](=[#8:133])\[#6@@:132](-[#7:131]-[#6:130](=[#8:129])\[#6@:128](-[#6:127])-[#7:126]-[#6:125](=[#8:124])-[#6:123]-[#7:122]-[#6:121](=[#8:120])-[#6@:119](\[#6:118])-[#7:117]-[#6:116](=[#8:115])-[#6:114]-[#7:113]-[#6:112](=[#8:111])-[#6:110]-[#7:109])-[#6:49])=[#8:47])=[#8:43])=[#8:39])=[#8:34])-[#6:31](=[#8:30])-[#7:29]/[#6@@:28](-[#6:27])-[#6:26](=[#8:25])-[#7:24]\[#6@@:23](-[#6:22]-[#6:21])-[#6:20](=[#8:19])-[#7:18]\[#6@@:17](-[#6:16]-[#6:15]1:[#6:9]:[#6:10]:[#6:12](-[#8:11]):[#6:13]:[#6:14]:1)-[#6:8](=[#8:7])-[#7:6]-[#6:5]-[#6:4](=[#8:3])-[#8:2]
ABY66020.1
ABY66018.1
ABI22137.1
ABS50465.1
ABV56597.1
A0A891LYB2
ABS50452.1
ABS50458.1
ABV56598.1
[#6:17]-[c:25]1[c:24][c:23](-[#8:19])[c:22](-[#6:16])[c:21]2-[#8:18]-[c:10]3[c:9](-[#6:5])[c:8](-[#6:3](-[#8:1])=[O:2])[c:7](-[#8:4])[c:11](-[#6:6])[c:12]3-[#8:13]-[#6:15](=[O:14])-[c:20]12>>[#6:5]-[c:9]1[c:8][c:7](-[#8:4])[c:11](-[#6:6])[c:12]2-[#8:13]-[#6:15](=[O:14])-[c:20]3[c:25](-[#6:17])[c:24][c:23](-[#8:19])[c:22](-[#6:16])[c:21]3-[#8:18]-[c:10]12
CC(C)[C@@H]1CC[C@@]2(C)C[C@@H]3[C@H]([C@@H](O)C[C@@H]3C)[C@](C)(O)CC=C12
N=C(N)NCCC[C@@H]1NC(=O)/C(=C/c2ccc(O)c(OCC[C@H](N)C(=O)O)c2)NC1=O
Methylates the N-terminus of the vancomycin backbone. Substrate specificity not known in detail. SMARTS has been designed to be not too unspecific by accident. True substrate specificity might be broader than assumed here.
C12CC(CC3(O1)CCC(C)C(C)O3)OC(=O)C1C(CC(C(=C1)C)OC)(O)C(C)=CC=CC(C)CC(C)=CC2
C-12 hydroxylation of erythromycin D to form erythromycin C
GNAT family N-acetyltransferase
C-12 hydroxylation of erythromycin B to form erythromycin A
Di-hydroxylation of 12-C-bound primary amine of pre-borrelidin
N=C(N)NCCC[C@@H]1NC(=O)[C@H](CC2(O)C=Nc3ccccc32)NC1=O
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@@H]1O
BCI98770.1
BCI98769.1
BCI98773.1
CSCC[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1Cc2c[nH]c(n2)-c2nc(c[nH]2)C[C@@H](C(=O)O)NC(=O)[C@H](C)NC1=O
BCI98774.1
Hydroxylates Thalianol to (+)-3beta,7beta-thalianol
79847
P450-catalyzed oxidative decarboxylation of terminal thiazoline of bottromycin precursor.
dipeptide formation arg-leu
C-methyltransferase
[#6:1]-[#6:2](-[#6:3])-[#6@@H:4]1-[#7:5]-[#6:6](=[O:7])-[#6@H:8](-[#6:9])-[#7:10]-[#6:11](=[O:12])-[#6@H:13](-[#6:14])-[#7:15]-[#6:16](=[O:17])-[#6:18]-[#7:19]\[#6:20]-1=[#7:21]/[#6@@H:22](-[#6:23])-[#6:24](=[O:25])-[#7:26]-[#6@@H:27](-[#6:28])-[#6:29](=[O:30])-[#7:31]-[#6@@H:32](-[#6:33])-[#6:34]-1=[#7:35]-[#6@@H:36](-[#6:37]-[#16:38]-1)-[#6:39](=[O:40])-[#7:41]-[#6@@H:42](-[#6:43])-[#6:44](=[O:45])-[#7:46]-[#6@@H:47](-[#6:48])-[#6:49](=[O:50])-[#7:51]-[#6@@H:52](-[#6:53])-[#6:54](=[O:55])-[#7:56]-[#6@@H:57](-[#6:58])-[#6:59]=[O:60]>>[#6:1]-[#6:2](-[#6:3])-[#6@@H:4]1-[#7:5]-[#6:6](=[O:7])-[#6@H:8](-[#6:9])-[#7:10]-[#6:11](=[O:12])-[#6@H:13](-[#6:14])-[#7:15]-[#6:16](=[O:17])-[#6:18]-[#7:19]\[#6:20]-1=[#7:21]/[#6@@H:22](-[#6:23])-[#6:24](=[O:25])-[#7:26]-[#6@@H:27](-[#6:28])-[#6:29](=[O:30])-[#7:31]-[#6@@H:32](-[#6:33])-[#6:34]-1=[#7:35]-[#6@@H:36](-[#6:37]-[#16:38]-1)-[#6:39](-[#8:40])=[O:41]
doi:10.1021/ja201088k
CtoA
A0A7U9H9E4
[#6:1]-[#6:2]1-[#6:38](-[#8:39])-[#6:36](-[#8:37])-[#6:35]-[#6:4](-[#6:5]2:[#6:10](-[#8:11]):[#6:9]3-[#6:12](-[#6:14]4-[#6@@:31](-[#6@:32](-[#8:34])(/[#6:33])-[#6:8]:3:[#6:7]:[#6:6]:2)/[#6:30]/[#6@@:29]2-[#6@:17](-[#6:19](-[#6:21](=[#6:25](-[#6@@:27]-2/[#8:28])-[#8:26])-[#6:22](=[#8:24])-[#7:23])=[#8:20])(\[#8:18])-[#6:15]=4-[#8:16])=[#8:13])-[#8:3]-1>>[#6]-[#8:34]-[#6@@:32]1(-[#6@@:31]2-[#6:14](=[#6:15](-[#6@:17]3(-[#6@@:29](/[#6:30]/2)-[#6@@:27](/[#8:28])-[#6:25](-[#8:26])=[#6:21](-[#6:22](=[#8:24])-[#7:23])-[#6:19]-3=[#8:20])\[#8:18])-[#8:16])-[#6:12](=[#8:13])-[#6:9]2:[#6:8]-1:[#6:7]:[#6:6]:[#6:5](:[#6:10]:2-[#8:11])-[#6:4]1-[#8:3]-[#6:2](-[#6:1])-[#6:38](-[#8:39])-[#6:36](-[#8:37])-[#6:35]-1)/[#6:33]
NRPS independent siderophore synthetase
C7 chlorination of L-tryptophan
S-methyltransferase
FAD-dependent enzyme RebC catalyse the oxidation of two carboxylic acids to form a maleimide ring. RebC cofactor is FAD.
Meilingmycin intermediate product
doi:10.1038/s41467-020-20418-3
N=C(N)NCCC[C@@H]1NC(=O)/C(=C/c2ccc(O)c(O)c2)NC1=O
COc1ccc(/C=C2\NC(=O)[C@H](CCCNC(=N)N)NC2=O)cc1OCC[C@H](NC(=O)C[C@](O)(CC(=O)O)C(=O)O)C(=O)O
Converts 1-deoxy-11-oxopentalenic acid to pentalenolactone D
Generic deacetylation.
[#7:1]-[#6:2]-[#6:3]-[#6:4]-[#6@@:5](-[#6:7](-[#8:9])=[#8:8])/[#7:6]>>[#7:6]/[#6@:5](-[#6:7](-[#8:9])=[#8:8])-[#6:4]-[#6:3]-[#6:2]-[#7:1]-[#8]
thiazole heterocyclisation of Cys8 of bottromycin-precursor
CC1=CC2CC(C)(C)C[C@@]23[C@H](C)CC[C@@H]13
UDP-N-butyryl-glucosamine as substrate.
UPI00068C79B2
A0A142I749
Flavin-dependent tryptophan-5-halogenase catalyzed halogenation reaction of deschloro-microbisporicin A2
AnkE
Cytochrome P450 Monooxygenase
AnkD
AnkF
AgqB
AgqC
AgqD
[#6:1]-[#6:2]-[#6@H:3]1-[#8:4]-[#6:5](=[O:6])-[#6:7]-[#6:8]\[#6:9]=[#6:10]\[#6:11]=[#6:12]\[#6:13]-[#6@H:14](-[#8:15])-[#6@H:16](-[#6:17])-[#6@@H:18](-[#8:19])\[#6:20]=[#6:21]\[#6:22](\[#6:23])=[#6:24]\[#6@H:25]-1-[#6:26]>>[#6:1]-[#6:2]-[#6@H:3]1-[#8:4]-[#6:5](=[O:6])-[#6:7]-[#6:8]-[#6:9]-2-[#6:10]=[#6:11]-[#6:12]-3-[#6:13]-[#6@H:14](-[#8:15])-[#6@H:16](-[#6:17])-[#6@H:18](-[#8:19])-[#6:20]-3-[#6:21]-2\[#6:22](-[#6:23])=[#6:24]\[#6@H:25]-1-[#6:26]
Cc1cc(O)c(C)c2c1Oc1c(C)c(O)cc(C)c1C(=O)O2
LrcC
AnkC
AnkA
LrcF
O=c1c(-c2ccc(O)cc2)coc2cc(O)ccc12
AFV25487.2
The enzyme seems to be highly specific for the backbone of teicoplanin, as it does not recognize the closely related vancomycin aglycone.
[#6:1]-[#6:2](-[#8:4]\[#6@:5](-[#6@:17](-[#6@@:19]1(-[#6:24]2-[#6@:25](-[#6:27]/[#6@@:28]3-[#6@@:36](/[#6:37])(-[#6:23]=2-[#6:22]-[#6:21]-1)-[#6:35]-[#6:34]-[#6@:32](/[#8:33])-[#6:29]-3(-[#6:31])-[#6:30])/[#8:26])/[#6:20])\[#6:18])-[#6:6](-[#6:8]=[#6:9](-[#6:11]-[#6:12]-[#6:13]=[#6:14](-[#6:16])-[#6:15])-[#6:10])=[#8:7])=[#8:3]>>[#6]-[#6](-[#8:33]/[#6@@:32]1-[#6:29](-[#6:31])(-[#6:30])-[#6@:28]2-[#6@:36](-[#6:23]3-[#6:22]-[#6:21]-[#6@@:19](-[#6@@:17](-[#6@:5](-[#6:6](-[#6:8]=[#6:9](-[#6:11]-[#6:12]-[#6:13]=[#6:14](-[#6:15])-[#6:16])-[#6:10])=[#8:7])\[#8:4]-[#6:2](=[#8:3])-[#6:1])\[#6:18])(/[#6:20])-[#6:24]=3-[#6@:25](-[#6:27]/2)/[#8:26])(/[#6:37])-[#6:35]-[#6:34]-1)=[#8]
H1ZYV7
Cc1cc(O)c2c(O)c3c(c(O)c2c1)CC(O)=CC3=O
H1ZYV4
NC(Cc1c[nH]c2cc(Cl)ccc12)C(=O)O
In vitro assay
Nitrile-formation via dehydation aldoxime
COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2
CSCCC(N)C(=O)NC(CCCNC(=N)N)C(=O)NC1Cc2ccc(O)c(c2)-c2ncc([nH]2)CC(C(=O)O)NC(=O)C(Cc2ccccc2)NC1=O
AUM60065.1
AUM60051.1
AUM60064.1
UPG58737.1
UPG58732.1
UPG58744.1
UPG58733.1
Brc1[nH]c(Br)c(Br)c1Br
UPG58739.1
UPG58742.1
UPG58740.1
[#7:1]-[#6:2](-[#6:13](-[#8:15])=[#8:14])-[#6:3]-[#6:4]1:[#6:12]2:[#6:7](:[#6:8]:[#6:9]:[#6:10](:[#6:11]:2)-[Br:16]):[#7:6]:[#6:5]:1>>[#7:1]-[#6:2](-[#6:13](-[#8:15])=[#8:14])-[#6:3]-[#6:4]1:[#6:12]2:[#6:7](:[#6:8](-[Br]):[#6:9]:[#6:10](:[#6:11]:2)-[Br:16]):[#7:6]:[#6:5]:1
Dichlorochromopyrrolate synthase
CO[C@H]1CC[C@@H](O)c2c1oc1c3c4c(c(O)c1c2=O)-c1c(cc2cc(C)n(C)c(=O)c2c1O)CC4OCO3
COC[C@H]1O[C@@H](O[C@@H]2OC[C@@H]3O[C@]4(O[C@H]3[C@H]2OC(=O)C(C)C)O[C@H](C)[C@@](O)(C(C)=O)C2OCOC24)[C@@H](O)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](C)[C@H](OC)[C@H](O[C@H]2C[C@@]3(C)OC4(C[C@H](O)[C@H](O[C@H]5C[C@@H](O)[C@H](OC(=O)c6c(C)c(Cl)c(O)c(Cl)c6OC)[C@@H](C)O5)[C@@H](C)O4)O[C@@H]3[C@@H](C)O2)[C@H]1O
A0A4Z0Z6W8
doi:10.1111/j.1365-2958.2004.04090.x
Acetylates intermediate to final product thalianin
[#8:1]-[c:2]1[c:3][c:4][c:5][c:6][c:7](-[#8:8])[c:9]1=[O:10]>>[#8:7]-[c:6]1[c:5][c:4][c:3][c:2](-[#8:1])[c:10](=[O:11])[c:8]1-[#8:9]
[#6:55]-[#6:54](-[#7:56]-[#6:57](=[O:58])-[#6&H2:59]-[#7:60]-[#6:61](=[O:62])-[#6&H2:63]-[#7&H2:64])-[#6:52](=[O:53])-[#7:51]-[#6:50]-[#6:48](=[O:49])-[#7:47]-[#6@@H:40](-[#6:41])-[#6:38](=[O:39])-[#7:37]-[#6@@H:36](-[#6:65])-[#6:34](=[O:35])-[#7:33]-[#6:32]-[#6:30](=[O:31])-[#7:29]-[#6@@H:23](-[#6:24]-[#6:25]-[#6:26](-[#8:28])=[O:27])-[#6:21](=[O:22])-[#7:20]-[#6@@H:18](-[#6:19])-[#6:16](=[O:17])-[#7:15]-[#6@@H:13](-[#6:14])-[#6:11](=[O:12])-[#7:10]-[#6:9]-[#6:7](=[O:8])-[#7:6]-[#6:5]-[#6:3](=[O:4])-[#7:2]-[#6:1]-[#6:66](=[O:67])-[#7:68]-[#6:69]-[#6:70](=[O:71])-[#7:72]-[#6:73]-[#6:74](=[O:75])-[#7:76]-[#6@@H:77](-[#6:111])-[#6:78](=[O:79])-[#7:80]-[#6@@H:81](-[#6:110])-[#6:82](=[O:83])-[#7:84]-[#6@@H:85](-[#6:86])-[#6:87](=[O:88])-[#7:89]-[#6@@H:90](-[#6:91])-[#6:92](=[O:93])-[#7:94]-[#6@@H:95](-[#6:96]-[c:97]1[c:98][c:99][c:100][c:101][c:102]1)-[#6:103](=[O:104])-[#7:105]-[#6:106]-[#6:107](-[#8:109])=[O:108]>>[#6:111]-[#6@H:77](-[#7:76]-[#6:74](=[O:75])-[#6:73]-[#7:72]-[#6:70](=[O:71])-[#6:69]-[#7:68]-[#6:66](=[O:67])-[#6:1]-[#7:2]-[#6:3](=[O:4])-[#6:5]-[#7:6]-[#6:7](=[O:8])-[#6:9]-[#7:10]-[#6:11](=[O:12])-[#6@H:13](-[#6:14])-[#7:15]-[#6:16](=[O:17])-[#6@H:18](-[#6:19])-[#7:20]-[#6:21](=[O:22])-[#6@@H:23]-1-[#6:24]-[#6:25]-[#6:26](=[O:27])-[#7&H1:64]-[#6&H2:63]-[#6:61](=[O:62])-[#7:60]-[#6&H2:59]-[#6:57](=[O:58])-[#7:56]-[#6:54](-[#6:55])-[#6:52](=[O:53])-[#7:51]-[#6:50]-[#6:48](=[O:49])-[#7:47]-[#6@@H:40](-[#6:41])-[#6:38](=[O:39])-[#7:37]-[#6@@H:36](-[#6:65])-[#6:34](=[O:35])-[#7:33]-[#6:32]-[#6:30](=[O:31])-[#7:29]-1)-[#6:78](=[O:79])-[#7:80]-[#6@@H:81](-[#6:110])-[#6:82](=[O:83])-[#7:84]-[#6@@H:85](-[#6:86])-[#6:87](=[O:88])-[#7:89]-[#6@@H:90](-[#6:91])-[#6:92](=[O:93])-[#7:94]-[#6@@H:95](-[#6:96]-[c:97]1[c:98][c:99][c:100][c:101][c:102]1)-[#6:103](=[O:104])-[#7:105]-[#6:106]-[#6:107](-[#8:109])=[O:108]
A0A8A5D4W2
SAM-dependent methyltransferase
COC(=CC(=O)N1C(=O)C=CC1C)CCNC(=O)CCC=CC(C)CCC(=CCl)CCCC#CBr
CCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@H]1O
Installs biaryl crosslink between his-his
Installs biaryl crosslink between trp-trp
Substrate bound to 4'-phosphopantetheine
[#6:1]-[#8:2]-[#6:3]1-[#6:9](-[#6:10])=[#6:8]-[#6:7]2-[#6:11](-[#8:13]-[#6:14]3-[#6:39]-[#6:31]4(-[#8:38]-[#6:36](-[#6:37])-[#6:34](-[#6:35])-[#6:33]-[#6:32]-4)-[#8:30]-[#6:16](-[#6:17]-[#6:18]=[#6:19](-[#6:21]-[#6:22](-[#6:24]=[#6:25]-[#6:26]=[#6:27](-[#6:28]-[#8:29])-[#6:5]-2(-[#8:6])-[#6:4]-1)-[#6:23])-[#6:20])-[#6:15]-3)=[#8:12]>>[#6:1]-[#8:2]-[#6:3]1-[#6:9](-[#6:10])=[#6:8]-[#6:7]2-[#6:11](-[#8:13]-[#6:14]3-[#6:39]-[#6:31]4(-[#8:38]-[#6:36](-[#6:37])-[#6:34](-[#6:35])-[#6:33]-[#6:32]-4)-[#8:30]-[#6:16](-[#6:17]-[#6:18]=[#6:19](-[#6:21]-[#6:22](-[#6:24]=[#6:25]-[#6:26]=[#6:27](-[#6:28]-[#8:29])-[#6:5]-2(-[#8:6])-[#6:4]-1-[#8])-[#6:23])-[#6:20])-[#6:15]-3)=[#8:12]
doi:10.1021/acschembio.5b00523
Thiazole heterocyclisation-catalyzing YacO protein
FAD-dependent monooxygenase
[#6:1]-[#6:2]-[#6:3]-[#6:4]-[#6:5]\[#6@:6]1-[#6:24]2-[#6:25](-[#8:27]-[#6:28](=[#8:29])-[#6:23]=2-[#6:22]-[#6@@:17](\[#6:18]-[#6:19]-[#6:20]-[#6:21])-[#6@@](\[#8])-[#6:9]2-[#6:10](-[#8:12]-[#6:13](=[#8:14])-[#6:8]=2-[#6:7]-1)=[#8:11])=[#8:26]>>[#6:1]-[#6:2]-[#6:3]-[#6:4]-[#6:5]\[#6@:6]1-[#6:24]2-[#6:25](-[#8:27]-[#6:28](=[#8:29])-[#6:23]=2-[#6:22]-[#6@@:17](\[#6:18]-[#6:19]-[#6:20]-[#6:21])-[#6:9]2-[#6:10](-[#8:12]-[#6:13](=[#8:14])-[#6:8]=2-[#6:7]-1)=[#8:11])=[#8:26]
3.5.1.9
Catalyzes hydroxylation from tropolone to 7-hydroxytropolone
cyclization and deamination of lysine to pipecolic acid
BGC0000104
Heterologous expression
Bound via thioester to coenzyme A
BGC0001706
BGC0002300
[#7:1]-[#6:2](=[#7:4]-[#6:5]-[#6:6]-[#6:7]-[#6@@:8](-[#6:10](-[#16:12]-[#6:32]-[#6:31]-[#7:30]-[#6:28](=[#8:29])-[#6:27]-[#6:26]-[#7:25]-[#6:23](=[#8:24])-[#6@:22](/[#8:33])-[#6:14](-[#6:16]-[#8:17]-[#15:18](-[#8:21])(-[#8:20])=[#8:19])(-[#6:15])-[#6:13])=[#8:11])/[#7:9])-[#7:3]>>[#7:1]-[#6:2](=[#7:4]-[#6:5]-[#6:6]-[#6:7]-[#6@:8](/[#7:9]-[#6](=[#8])-[#6@](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)\[#7])-[#6:10](-[#16:12]-[#6:32]-[#6:31]-[#7:30]-[#6:28](=[#8:29])-[#6:27]-[#6:26]-[#7:25]-[#6:23](=[#8:24])-[#6@:22](/[#8:33])-[#6:14](-[#6:16]-[#8:17]-[#15:18](-[#8:21])(-[#8:20])=[#8:19])(-[#6:13])-[#6:15])=[#8:11])-[#7:3]
BGC0001001
CC(=CCC[C@@]1(C)C2CCC3Cc4c([nH]c5ccccc45)[C@]3(C)[C@@]2(C)CC[C@@H]1O)C(=O)O
BGC0001008
BGC0003008
[#6:5]-[#6:4](-[#6:6])-[#6:3]-[#6@@H:2](-[#7:1])-[#6:7](=[O:8])-[#7:9]-[#6@@H:10]-1-[#6@H:63](-[#8:64])-[c:60]2[c:61][c:62][c:57](-[#8:56]-[c:49]3[c:50][c:51]-4[c:52][c:53](-[#8:48]-[c:45]5[c:44][c:43][c:42]([c:47][c:46]5)-[#6@@H:40](-[#8:41])-[#6@H:30](-[#7:29]-[#6:27](=[O:28])-[#6@H:26](-[#7:25]-[#6:23](=[O:24])-[#6@@H:22]-4-[#7:21]-[#6:19](=[O:20])-[#6@H:14](-[#6:15]-[#6:16](-[#7:17])=[O:18])-[#7:13]-[#6:11]-1=[O:12])-[c:35]1[c:36][c:37][c:38](-[#8:39])[c:33][c:34]1)-[#6:31]=[O:32])[c:54]3-[#8:55])[c:58]([Cl:65])[c:59]2>>[#6:6]-[#6:4](-[#6:5])-[#6:3]-[#6@@H:2](-[#7:1])-[#6:7](=[O:8])-[#7:9]-[#6@@H:10]-1-[#6@H:63](-[#8:64])-[c:60]2[c:61][c:62][c:57](-[#8:56]-[c:49]3[c:50][c:51]-4[c:52][c:53](-[#8:48]-[c:45]5[c:44][c:43][c:42]([c:47][c:46]5Cl)-[#6@@H:40](-[#8:41])-[#6@H:30](-[#7:29]-[#6:27](=[O:28])-[#6@H:26](-[#7:25]-[#6:23](=[O:24])-[#6@@H:22]-4-[#7:21]-[#6:19](=[O:20])-[#6@H:14](-[#6:15]-[#6:16](-[#7:17])=[O:18])-[#7:13]-[#6:11]-1=[O:12])-[c:35]1[c:36][c:37][c:38](-[#8:39])[c:33][c:34]1)-[#6:31]=[O:32])[c:54]3-[#8:55])[c:58]([Cl:65])[c:59]2
C=C(C)CCOP(=O)([O-])OP(=O)([O-])[O-].C=C(C)CCOP(=O)([O-])OP(=O)([O-])[O-].C=C(C)CCOP(=O)([O-])OP(=O)([O-])[O-].CC(C)=CCOP(=O)([O-])OP(=O)([O-])[O-]
Chlorination of deschloro-microbisporicin A2, leading to mature product.
doi:10.1021/ja508477e
SsfM4 catalyzes C6-methylation
doi:10.1002/1521-3773(20011217)40:24%3C4688::aid-anie4688%3E3.0.co;2-m
Generation of the bis-dehydro cyclo(L-Leu-L-Ala)
CSCC[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)c([N+](=O)[O-])c1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
CC(C)(CO[PH](O)(O)O)C(O)C(O)NCCC(O)NCCSC(=O)[C@H](N)[C@@H](O)c1ccc(O)cc1
Epoxidation of prochaetoglobosin I (chaetoglobosin V) at C6-7 to prochaetoglobosin IV
O-methyltransferase and is responsible for methylation of the phenolic hydroxyl group in the dichloroisoeverninic acid moiety 
[#6:4]-[#6:3]-1=[#6:5]-[#6:6](=[O:7])-[#6:8](-[#6:9](=[O:10])-[c:11]2[c:12](-[#8:13])[c:14][c:15][c:16][c:17]2-[#8:18])=[#6:19](-[#6:20]-[#8:21])-[#6@@H:1]-1-[#8:2]>>[#6:1]-[#6@@H:2]-1-[#6:3]-[#6:4](=[O:5])-[#6:6](-[#6:7](=[O:8])-[c:9]2[c:10](-[#8:11])[c:12][c:13][c:14][c:15]2-[#8:16])=[#6:17](-[#6:18]-[#8:19])-[#6:20]-1=[O:21]
K4MJT7
doi:10.1021/acschembio.7b00456
[#6:3]-[#6@H:2](-[#8:1])-[#6:4]-[#6:5](=[O:6])-[c:7]1[c:8](-[#6:19]-[#6@@H:20](-[#6:21])-[#8:22])[c:9][c:10]2[c:11][c:12][c:13][c:14](-[#8:15])[c:16]2[c:17]1-[#8:18]>>[#6:3]-[#6@H:2](-[#8:1])-[#6:4]-[#6:5](=[O:6])-[c:7]1[c:8](-[#6:19]-[#6@@H:20](-[#6:21])-[#8:22]-[#6:23](-[#6:24])=[O:25])[c:9][c:10]2[c:11][c:12][c:13][c:14](-[#8:15])[c:16]2[c:17]1-[#8:18]
Iterative cofactorless dioxygenase
C[C@@H]1CC(=O)C(C(=O)c2c(O)cccc2O)=C(CO)C1=O
[#6:1]-[c:2]1[c:5][c:8](-[#8:4])[c:15]2-[#6:18](=[O:14])-[c:19]3[c:16](-[#8:10])[c:11][c:7][c:12][c:17]3-[#6:13](-[#8:20])-[c:9]2[c:6]1>>[#6:1]-[c:2]1[c:5][c:8](-[#8:4])[c:15](-[#6:18](=[O:14])-[c:19]2[c:16](-[#8:10])[c:11][c:7][c:12][c:17]2-[#8:22])[c:9]([c:6]1)-[#6:13](-[#8:20])=[O:21]
Cyclization of nerylneryl diphosphate to lycosantalene in the first step of the biosynthetic pathway of lycosantalonol 
CC/C=C(/C=C1/C=C/C(O)C(O)c2oc(cc(=O)c2/C=C/C(C)O)CC(=O)OC1)CC
Reaction with UDP-2-fluoro-glucose and vancomycin intermediate as substrates.
COC1=CC(C)=C2C(Nc3ccc(O)c4c3C(=O)c3ccccc3C4=O)C#CC=CC#CC1C2C=O
COc1c(O)c(I)c(C)c(C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)O)c1OC
doi:10.1002/cbic.201500670
COc1ccc(C=C2NC(=O)[C@H](CCCNC(=N)N)NC2=O)cc1OCC[C@H](NC(=O)C[C@](O)(CC(=O)O)C(=O)O)C(=O)O
N[C@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@H](CO)[C@@H](O)[C@@H]1O
doi:10.1002/ANIE.200461278
F8S6W1
F8S6W0
K4MHF8
11328
CCCCCCCCCC(=O)O
MtmMI
UPI0020472753
[#7]-[#6:2]-[#6:3]-[#6:4]-[#6:5]-[#6@@:6](-[#6:8](-[#8:10])=[#8:9])/[#7:7]>>[#7:7]/[#6@:6](-[#6:8](-[#8:10])=[#8:9])-[#6:5]-[#6:4]-[#6:3]-[#6:2]-[#7;+](-[#8;-])=[#8]
AFJ20767.1
Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O
doi:10.1016/S1074-5521(04)00002-X
Conversion of 6-methylsalicylic acid to m-cresol
CC(C)CC(N)C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC1C(=O)NC(c2ccc(O)cc2)C(=O)NC(C(=O)O)C(O)c2ccc(c(Cl)c2)Oc2cc1ccc2O)C(O)c1ccc(O)c(Cl)c1
Lassopeptide macrolactam formation after N-terminal cleavage
Dioxygenation
FeS
doi:10.1038/nchembio.1564
[#7:1]-[#6:2](=[#7:3])-[#7:4]-[#6:5]-[#6:6]-[#6:7]-[#6@@H:8]-1-[#7:9]-[#6:10](=[O:11])-[#6@H:12](-[#6:13]-[c:14]2[o:22][n:21][c:20]3[c:19][c:18][c:17][c:16][c:15]23)-[#7:23]-[#6:24]-1=[O:25]>>[#6:1]-[#6:2](=[O:3])\[#7:4]=[#6:5](/[#7:6])-[#7:7]-[#6:8]-[#6:9]-[#6:10]-[#6@@H:11]-1-[#7:12]-[#6:13](=[O:14])-[#6@H:15](-[#6:16]-[c:17]2[o:25][n:24][c:23]3[c:22][c:21][c:20][c:19][c:18]23)-[#7:26]-[#6:27]-1=[O:28]
doi:10.1016/s1074-5521(04)00002-x
Bromination of jamaicamide B to jamaicamide A.
COc1cc(OCC=C(C)CCC=C(C)CCC=C(C)C)cc(CCCCCCCCCCCCC(C)C)c1O
Reaction with TDP-4-deoxy-glucose and vancomycin intermediate as substrates.
Reaction with TDP-3-deoxy-glucose and vancomycin intermediate as substrates.
Reaction with TDP-2-deoxy-glucose and vancomycin intermediate as substrates.
Reaction with TDP-6-deoxy-glucose and vancomycin intermediate as substrates.
doi:10.1039/D0CC07421G
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](C)[C@@H](O)[C@H](O)[C@H]2O)Oc2ccc(cc2Cl)[C@@H]1O.Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O[C@@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)O2)c(=O)[nH]c1=O
C=C[C@]1(C)C[C@@H](OC(C)=O)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O
A0A4P8WAD3
Nerylneryl diphosphate synthase
A0A224AVD6
CCCCCCCCCCCCCCCc1cc(O)cc(O)c1
doi:10.1039/d4sc01715c
TdaE relies on its substrate as electron donor (rather than NAD(P)H) for O2 activation and covalent flavin-oxygen adduct formation. Then, TdaE incorporates both O2-derived oxygen atoms into the substrate most likely via transient FlN5OO and FlN5O species, thereby breaking the CoA thioester bond and epoxidizing the tropone ring. 
NodM
NodB
CC(=O)Cc1cc2cccc(O)c2c(O)c1C(=O)C[C@H](C)O
COc1cc(O)c2c(O)c3c(c(O)c2c1O)C(=O)OC1(CCc2cc4cc(C)oc(=O)c4c(O)c2O1)C3=O
I1ZAY9
I1ZAY8
C[C@@H]1C(=O)OC[C@H]2C(C(=O)O)=CC3CC(C)(C)C[C@]312
CC(CCCCCCCCCCCCc1c(C)c(O)cc(OC)c1)C
CC(=O)N[C@H]1C(OCC(CO)=C2CC(C)(C)CC3C2CC[C@@H]3C)O[C@H](CO)[C@@H](O)[C@@H]1O
doi:10.1039/D4SC01715C
Carboxylation of intermediate in pentalenolactone biosynthetic pathway
Q6YL50
NodW
MibS
O=C[C@H]1O[C@@H](c2c[nH]c(=O)[nH]c2=O)[C@H](O)[C@@H]1O
CC1=C[C@@H]2/C=C/C[C@H](C)/C=C(/C)CC/C=C/C(=O)[C@]23C(=O)N[C@@H](Cc2c[nH]c4ccccc24)C3[C@@H]1C
[#8:14]-[#6:15](=[O:16])-[c:13]1[c:12][c:11]2[c:10]([n:9][c:8]3[c:7][c:6]([Cl:5])[c:4][c:3][c:2]23)[s:1]1>>[#7:17]-[#8:16]-[#6:15](=[O:14])-[c:13]1[c:12][c:11]2[c:10]([n:9][c:8]3[c:7][c:6]([Cl:5])[c:4][c:3][c:2]23)[s:1]1
[#8:1]=[#6:2](-[#6:4](-[#6:6]-[#6:7]1:[#6:15]2:[#6:10](:[#6:11]:[#6:12]:[#6:13]:[#6:14]:2):[nH:9]:[#6:8]:1)-[#16:5])-[#8:3]>>[#8:1]=[#6:2](-[#6:4]1-[#16:5]-[#6&H0:14]2:[#6:15]3:[#6:10](:[#6:11]:[#6:12]:[#6:13]:2):[nH:9]:[#6:8]:[#6:7]:3-[#6:6]-1)-[#8:3]
ProsA works in concert with SDR ProsC to yield the pathway intermediate. Order of reactions is not clear from experimental data. Overexpression of either ProsA or ProsC alone does not yield any product.
[#6:1]-[#6:2](-[#6:4]-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]-[#6:17]1:[#6:24](-[#8:25]):[#6:22](-[#8:23]):[#6:21]:[#6:19](-[#8:20]):[#6:18]:1)-[#6:3]>>[#6]-[#8:23]-[#6:22]1:[#6:24](-[#8:25]):[#6:17](-[#6:16]-[#6:15]-[#6:14]-[#6:13]-[#6:12]-[#6:11]-[#6:10]-[#6:9]-[#6:8]-[#6:7]-[#6:6]-[#6:5]-[#6:4]-[#6:2](-[#6:1])-[#6:3]):[#6:18]:[#6:19](-[#8:20]):[#6:21]:1
MibH
doi:10.1039/d3sc04172g
MITE0000180
MITE0000181
MITE0000182
MITE0000183
MITE0000184
MITE0000185
doi:10.1101/2024.07.12.603347
MITE0000187
MITE0000188
MITE0000189
MITE0000186
Sulfonation
doi:10.1073/pnas.0500755102
N[C@H]1[C@H](O)[C@@H](O)[C@@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H]1CO
doi:10.1073/pnas.0904113106
COc1cc(O)cc(C)c1C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)O
Installation of pyrrole-moiety at the hydroxyl group at the 9-position of substrate
D7MUV7
AGK82807.1
AGI62217.1
AGK82800.1
AGN74891.1
AGK82801.1
amidotransferase
CC(C)CC(N)C(=O)NC1C(=O)NC(CC(N)=O)C(=O)NC2C(=O)NC(c3ccc(O)cc3)C(=O)NC(C(=O)O)C(O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O)Oc2ccc(cc2Cl)C1O
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@@H]1O
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@@H]1O
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](N)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@@H]1O
P9WER2
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O[C@H]2C[C@](C)(N)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@@H]1O
P9WER1
Catalyzes the O-methylation of demethylmycophenolic acid into mycophenolic acid
doi:10.1128/AAC.43.7.1565
Cofactorless oxygenase
[#6:1]-[#6:2]-[#6@@:3](-[#6@@:5](/[#6:46](-[#7:48]/[#6@:49](-[#6:60](=[#8:62])-[#8:61])-[#6:50]-[#6:51]1:[#6:59]2:[#6:54](:[#6:55]:[#6:56]:[#6:57]:[#6:58]:2):[nH:53]:[#6:52]:1)=[#8:47])-[#7:6]-[#6:7](\[#6@@:9](-[#7:17]-[#6:18](\[#6@@:20](-[#7:31]-[#6:32](-[#6@@:34](-[#7:36]-[#6:37](-[#6@:39](-[#6:41]-[#6:42]-[#6:43](=[#8:45])-[#7:44])\[#7:40])=[#8:38])\[#6:35])=[#8:33])-[#6:21]-[#6:22]1:[#6:30]2:[#6:25](:[#6:26]:[#6:27]:[#6:28]:[#6:29]:2):[nH:24]:[#6:23]:1)=[#8:19])-[#6:10]-[#6:11]-[#6:12]-[#7:13]-[#6:14](=[#7:16])-[#7:15])=[#8:8])/[#6:4]>>[#6:1]-[#6:2]-[#6@@:3](-[#6@:5]1/[#6:46](-[#7:48]/[#6@:49](-[#6:60](=[#8:62])-[#8:61])-[#6:50]-[#6:51]2:[#6:59]3:[#6:54](:[#6:55]:[#6:56]:[#6:57]:[#6:58]:3):[n&H0:53](-[#6&H0:26]3:[#6:27]:[#6:28]:[#6:29]:[#6:30]4:[#6:25]:3:[nH:24]:[#6:23]:[#6:22]:4-[#6:21]-[#6@:20](-[#7:31]-[#6:32](-[#6@@:34](-[#7:36]-[#6:37](-[#6@:39](-[#6:41]-[#6:42]-[#6:43](=[#8:45])-[#7:44])\[#7:40])=[#8:38])\[#6:35])=[#8:33])\[#6:18](=[#8:19])-[#7:17]-[#6@@:9](-[#6:10]-[#6:11]-[#6:12]-[#7:13]-[#6:14](=[#7:16])-[#7:15])\[#6:7](=[#8:8])-[#7:6]-1):[#6:52]:2)=[#8:47])/[#6:4]
Flavin-dependent monooxygenase
Describes the deacetylation.
Q70KH6
Substrate specificity not known in detail. SMARTS has been designed to be not too unspecific by accident. True substrate specificity might be broader than assumed here.
catalyzes three-step oxidations at the C-4 methyl group to carboxylic acid to yield soppiline C
CC(C)C=c1[nH]c(=O)c(=Cc2ccccc2)[nH]c1=O
[#6:23]-[#7:24]-[#6@H:25](-[#6:26]-[#6:27](-[#6:28])-[#6:29])-[#6:30](=[O:31])-[#7:32]-[#6@H:33](-[#6@@H:84](-[#8:85])-[c:81]1[c:80][c:79][c:78](-[#8:87])[c:83][c:82]1)-[#6:34](=[O:35])-[#7:36]-[#6@@H:37](-[#6:38]-[#6:39](-[#7:40])=[O:41])-[#6:42](=[O:43])-[#7:44]-[#6@@H:45](-[#6:46](=[O:47])-[#7:48]-[#6@@H:49](-[#6:50](=[O:51])-[#7:52]-[#6@@H:53](-[#6@@H:63](-[#8:64])-[c:65]1[c:66][c:67][c:68](-[#8:86])[c:69][c:70]1)-[#6:54](=[O:55])-[#16:21]-[#6:20]-[#6:19]-[#7:18]-[#6:16](=[O:17])-[#6:15]-[#6:14]-[#7:13]-[#6:11](=[O:12])-[#6@H:10](-[#8:22])[C:2]([#6:1])([#6:3])[#6:4]-[#8:5][P:6]([#8:8])([#8:9])=[O:7])-[c:58]1[c:57][c:56][c:61](-[#8:62])[c:60][c:59]1)-[c:73]1[c:72][c:71][c:76](-[#8:77])[c:75][c:74]1>>[#6:23]-[#7:24]-[#6@H:25](-[#6:26]-[#6:27](-[#6:29])-[#6:28])-[#6:30](=[O:31])-[#7:32]-[#6@H:33](-[#6@@H:84](-[#8:85])-[c:81]1[c:82][c:83][c:78](-[#8:87])[c:79][c:80]1)-[#6:34](=[O:35])-[#7:36]-[#6@@H:37](-[#6:38]-[#6:39](-[#7:40])=[O:41])-[#6:42](=[O:43])-[#7:44]-[#6@@H:45]-1-[c:73]2[c:72][c:71][c:76](-[#8:77])[c:75](-[#8:86]-[c:68]3[c:69][c:70][c:65]([c:66][c:67]3)-[#6@H:63](-[#8:64])-[#6@H:53](-[#7:52]-[#6:50](=[O:51])-[#6@H:49](-[#7:48]-[#6:46]-1=[O:47])-[c:58]1[c:59][c:60][c:61](-[#8:62])[c:56][c:57]1)-[#6:54](=[O:55])-[#16:21]-[#6:20]-[#6:19]-[#7:18]-[#6:16](=[O:17])-[#6:15]-[#6:14]-[#7:13]-[#6:11](=[O:12])-[#6@H:10](-[#8:22])[C:2]([#6:3])([#6:1])[#6:4]-[#8:5][P:6]([#8:9])([#8:8])=[O:7])[c:74]2
Hydroxylation at c-2
CC(=O)N[C@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@H](CO)[C@@H](O)[C@@H]1O
C=C/C(C)=C/C[C@@H]1[C@@]2(C)CCCC(C)(C)[C@@H]2C[C@H](O)[C@@]1(O)CSC[C@H](NC(C)=O)C(=O)O
PhoP
K4MHG1
doi:10.1002/anie.201910241
Hydroxylation at c-18
F8S6V7
PhoD
PhoG
[6+4] cycloaddition
PhoC
PhoL
PhoM
PhoN
PhoO
PhoH
PhoJ
PhoK
CCC1OC(=O)[C@H](C)[C@@H](OC2C[C@](C)(O)[C@H](O)[C@@H](C)O2)[C@@H](C)[C@H](OC2O[C@@H](C)C[C@@H](N(C)C)[C@@H]2O)[C@@](C)(O)C[C@H](C)C(=O)[C@H](C)[C@H](O)[C@@H]1C
[#7:1]-[#6:2](-[#6:11](-[#8:13])=[#8:12])-[#6:3]-[#6:4]1:[#6:10]:[#6:9]:[#6:7](-[#8:8]):[#6:6]:[#6:5]:1.[#7:14]-[#6:15](=[#7:17]-[#6:18]-[#6:19]-[#6:20]-[#6:21](-[#6:23](-[#8:25])=[#8:24])-[#7:22])-[#7:16]>>[#6:2]1(-[#7:1]-[#6:23](=[#8:24])-[#6:21](-[#7:22]-[#6:11]-1=[#8:12])-[#6:20]-[#6:19]-[#6:18]-[#7:17]=[#6:15](-[#7:14])-[#7:16])-[#6:3]-[#6:4]1:[#6:10]:[#6:9]:[#6:7](-[#8:8]):[#6:6]:[#6:5]:1
Short-chain dehydrogenase/reductase (SDR)
[#6:1]/[#6@:2]1(-[#6:21]-[#6@@:19](/[#8:20])-[#6@:17]2(\[#6:18])-[#6@:11](/[#6:12])-[#6:10]-[#6:9]\[#6@:8]3(-[#6:16]-[#6:15]-[#6:14]\[#6@:13]-3-2)-[#6@@:6](/[#6:7])-[#6:5]-1)-[#6:3]=[#6:4]>>[#6:1]/[#6@:2]1(-[#6:21]-[#6@@:19](/[#8:20])-[#6@:17]2(\[#6:18])-[#6@:11](/[#6:12])-[#6:10]-[#6:9]\[#6@:8]3(-[#6:16]-[#6:15]-[#6@@:14](\[#8])-[#6@:13]\3-2)-[#6@@:6](/[#6:7])-[#6:5]-1)-[#6:3]=[#6:4]
cyclopropanation (nitronorleucine - nitrocyclopropylalanine)
[#6:1]-[#6:2](/[#6@:4]1-[#6:55](=[#8:56])-[#7:54]-[#6@@:53](/[#6:57](-[#6:60])(-[#6:59])-[#6:58])-[#6:18](=[#7:19]\[#6@@:20](-[#6:49](-[#6:52])(-[#6:51])-[#6:50])-[#6:21](-[#7:23]\[#6@:24](-[#6:33](-[#7:35]/[#6@:36](-[#6:41]2-[#16:45]-[#6:44]-[#6@@:43](/[#6:46](=[#8:48])-[#8:47])-[#7:42]=2)-[#6:37]-[#6:38](=[#8:40])-[#8:39])=[#8:34])-[#6@:25](-[#6:27]2:[#6:32]:[#6:31]:[#6:30]:[#6:29]:[#6:28]:2)\[#6:26])=[#8:22])-[#7:17]-[#6:16]-[#6:14](=[#8:15])-[#7:13]2-[#6@@:8](-[#6@@:9](-[#6:11]-[#6:12]-2)/[#6:10])/[#6:6](=[#8:7])-[#7:5]-1)-[#6:3]>>[#6:3]-[#6:2](/[#6@:4]1-[#6:55](=[#8:56])-[#7:54]-[#6@@:53](/[#6:57](-[#6:60])(-[#6:59])-[#6:58])-[#6:18](=[#7:19]\[#6@@:20](-[#6:49](-[#6:51])(-[#6:50])-[#6:52])-[#6:21](-[#7:23]\[#6@:24](-[#6:33](-[#7:35]\[#6@@:36](-[#6:41]2-[#16:45]-[#6:44]-[#6@@:43](/[#6:46](=[#8:48])-[#8:47])-[#7:42]=2)-[#6:37]-[#6:38](=[#8:40])-[#8:39])=[#8:34])-[#6@:25](-[#6:27]2:[#6:28]:[#6:29]:[#6:30]:[#6:31]:[#6:32]:2)\[#6:26])=[#8:22])-[#7:17]-[#6:16]-[#6:14](=[#8:15])-[#7:13]2-[#6@@:8](-[#6@@:9](-[#6:11]-[#6:12]-2)/[#6:10])/[#6:6](=[#8:7])-[#7:5]-1)-[#6:1]
FAD
23112
CO[C@H](C(=O)[C@H](O)[C@@H](C)O)[C@@H]1Cc2cc3cc(OC4CC(OC5CC(O)C(O)C(C)O5)C(O)C(C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1OC1CC(OC2CC(OC3CC(C)(O)C(O)C(C)O3)C(O)C(C)O2)C(O)C(C)O1
alkylhydroxyhydroquinone methyltransferase
CO[C@H]1CC2C=CC3C4[C@H](O)[C@@H](C)[C@@H](O)[C@@H]3OC24C(C)=C[C@@H](C)[C@@H]([C@@H](C)O)OC1=O
C=C(C)[C@@H]1C[C@@]2(C)C(=C[C@H]1O)C[C@H](O)C[C@@H]2C
O=C1NC(=O)c2c1c1c3cccc(Cl)c3[nH]c1c1[nH]c3c(Cl)cccc3c21
Hydroxylates (+)-3beta,7beta-thalianol to become (-)-16-keto-3beta,7beta,15-thaliantriol
COC[C@H]1O[C@@H](O[C@@H]2OC[C@@H]3O[C@]4(O[C@H]3[C@H]2OC(=O)C(C)C)O[C@H](C)[C@@](O)(C(C)=O)C2OCOC24)[C@@H](OC)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](C)[C@H](OC)[C@H](O[C@H]2C[C@@]3(C)OC4(C[C@H](O)[C@H](O[C@H]5C[C@@H](O)[C@H](OC(=O)c6c(C)c(Cl)c(O)c(Cl)c6OC)[C@@H](C)O5)[C@@H](C)O4)O[C@@H]3[C@@H](C)O2)[C@H]1O
L-Arg, L-Trp
Cc1c(O)cc2c(c1O)C(=O)C=C(O)C2=O
CC(C)C[C@@H](N)C(=O)N[C@@H](C=O)[C@H](O)c1ccc(O)c(Cl)c1
80211
Substrate bound via thioester to 4'-phosphopantetheine cofactor (acyl carrier protein prosthetic group).
Q8GED9
[#8:16]-[c:13]1[c:12][c:11][c:10](\[#6:9]=[#6:8]\[#6:4]-2=[#6:3]-[#6:2](=[#6:1])-[#8:6]-[#6:5]2=[O:7])[c:15][c:14]1>>[#6:1]-[#6@H:2]-1-[#8:6]-[#6:5](=[O:7])-[#6:4](\[#6:8]=[#6:9]\[c:10]2[c:11][c:12][c:13](-[#8:16])[c:14][c:15]2)=[#6:3]-1
Epimerase
CC(CO)[C@H]1CC=C2C[C@H](O)C[C@H](C)[C@@]2(C)C1
NC[C@H]1O[C@@H](c2c[nH]c(=O)[nH]c2=O)[C@H](O)[C@@H]1O
reduction of exocxclic double bond in dehydroacaterin to acaterin
CC(C)=CCCC(C)=CCCC(C)C1(C)CCC2=C1CCC1C2(C)CCC(O)C1(C)C
Epoxidation of 3-geranylgeranylindole substrate in nodulisporic acid pathway.
C[C@@H]1CC(O)=C2C(=O)c3c(O)cccc3O[C@]2(CO)[C@@H]1O
[#6:1]=[#6:2]-[#6@:3]1(-[#6:21]-[#6@:19](\[#6:20])-[#6@:14]23-[#6@:18](-[#6@:8](-[#6@@:10](-[#6:12]-[#6:13]/2)\[#6:11])(/[#6:9])-[#6@:6](\[#8:7])-[#6:5]-1)/[#6:17]-[#6:16]-[#6:15]-3)\[#6:4]>>[#6:1]=[#6:2]-[#6@:3]1(-[#6@@:21](/[#8])-[#6@:19](\[#6:20])-[#6@:14]23-[#6@:18](-[#6@:8](-[#6@@:10](-[#6:12]-[#6:13]/2)\[#6:11])(/[#6:9])-[#6@:6](\[#8:7])-[#6:5]-1)/[#6:17]-[#6:16]-[#6:15]-3)\[#6:4]
C=C(C)[C@@H]1C[C@@]2(C)C(=CC1=O)CCC[C@@H]2C
[#6:1]-[#6:2]\[#6:3]1-[#8:18]-[#6:16](=[#8:17])-[#6:15](/[#6:19])-[#6:14](\[#8:20]/[#6:21]2-[#8:26]-[#6:25](\[#6:27])-[#6:24](/[#8:28])-[#6:23](-[#8:30])(\[#6:29])-[#6:22]-2)-[#6:13](/[#6:31])-[#6:12](\[#8:32]/[#6:33]2-[#8:38]-[#6:37](/[#6:39])-[#6:36]-[#6:35](/[#7:40](-[#6:42])-[#6:41])-[#6:34]-2\[#8:43])-[#6:11](-[#8:45])(\[#6:44])-[#6:10]-[#6:9](\[#6:46])-[#6:7](=[#8:8])-[#6:6](\[#6:47])-[#6:5](\[#8:48])-[#6:4]-1/[#6:49]>>[#6:1]-[#6:2]/[#6:3]1-[#6:4](-[#6:49])(\[#8])-[#6:5](/[#8:48])-[#6:6](\[#6:47])-[#6:7](=[#8:8])-[#6:9](/[#6:46])-[#6:10]-[#6:11](/[#6:44])(-[#8:45])-[#6:12](/[#8:32]\[#6:33]2-[#6:34](/[#8:43])-[#6:35](\[#7:40](-[#6:42])-[#6:41])-[#6:36]-[#6:37](\[#6:39])-[#8:38]-2)-[#6:13](\[#6:31])-[#6:14](\[#8:20]\[#6:21]2-[#6:22]-[#6:23](/[#6:29])(-[#8:30])-[#6:24](\[#8:28])-[#6:25](/[#6:27])-[#8:26]-2)-[#6:15](/[#6:19])-[#6:16](=[#8:17])-[#8:18]-1
doi:10.1021/jacs.7b10909
Introduces the second crosslink (biaryl ether) between hpg5 and dhpg7 of the balhimycin precursor.
CCC(CCCCCCCCCCCCc1c(C)c(O)cc(O)c1)C
CC(CCCCCCCCCCCCCc1c(C)c(O)cc(O)c1)C
Cytochrome P450me
JuiM
JuiL
NADPH-dependent oxidoreductase
K4MJU2
[#6]-[#6](-[#6](-[#6](-[#7]-[#6]-[#6]-[#6](-[#7]-[#6]-[#6]-[#16]-[#6:49](-[#6:51]1-[#6:58]=[#6:57]-[#6:56]=[#6:55]-[#6:54]-[#6:52]=1-[#8:53])=[#8:50])=[#8])=[#8])-[#8])(-[#6]-[#8]-[#15](-[#8]-[#15](-[#8]-[#6]-[#6]1-[#6](-[#8]-[#15](-[#8])(-[#8])=[#8])-[#6](-[#8])-[#6](-[#7]2:[#6]3:[#6](:[#6](:[#7]:[#6]:[#7]:3)-[#7]):[#7]:[#6]:2)-[#8]-1)(-[#8])=[#8])(-[#8])=[#8])-[#6]>>[#8]-[#6:49](/[#6@@:51]12-[#8]\[#6@@:58]-1-[#6:57]=[#6:56]-[#6:55]=[#6:54]-[#6:52]-2=[#8:53])=[#8:50]
O=C(O)[C@@]12O[C@@H]1C=CC=CC2=O
M9QSI0
C=C[C@]1(C)C[C@@H](O)[C@]2(C)[C@H](C)CC[C@]3(CC[C@@H](O)[C@H]32)[C@@H](C)[C@@H]1O
Anthrone oxygenase
[#6:1]-[#8:2]-[#6:3]1:[#6:12](-[#6:13](-[#8:15]/[#6@@:16]2-[#6@@:93](\[#6:94])-[#8:92]-[#6@@:20](\[#8:21]/[#6@@:22]3-[#6@@:90](\[#6:91])-[#8:89]-[#6:26]4(-[#8:88]-[#6@@:86]5(\[#6:87])-[#6@@:28](-[#6@:29](-[#8:31]-[#6@:32](-[#6:85]-5)/[#8:33]\[#6@:34]5-[#6@@:82](\[#8:83]-[#6:84])-[#6@@:80](\[#6:81])-[#8:79]-[#6@@:37](\[#8:38]/[#6@@:39]6-[#6@@:76](\[#6:77]-[#8:78])-[#8:75]-[#6@@:45](\[#8:46]\[#6@:47]7-[#6@:55](/[#8:56]-[#6:57](-[#6:59](-[#6:61])-[#6:60])=[#8:58])-[#6@:54]8-[#6@@:50](-[#8:51]\[#6@:52]9(-[#6:74]%10-[#6:70](-[#8:71]-[#6:72]-[#8:73]-%10)-[#6@@:65](-[#6:67](=[#8:69])-[#6:68])(\[#8:66])-[#6@@:63](\[#6:64])-[#8:62]-9)-[#8:53]/8)\[#6:49]-[#8:48]-7)-[#6@@:42](\[#8:43]-[#6:44])-[#6@:40]-6\[#8:41])-[#6@@:35]-5/[#8:36])/[#6:30])\[#8:27]-4)-[#6:25]-[#6@@:23]-3/[#8:24])-[#6:19]-[#6@:17]-2\[#8:18])=[#8:14]):[#6:10](-[#6:11]):[#6:8](-[Cl:9]):[#6:6](-[#8:7]):[#6:4]:1-[Cl:5]>>[#6]-[#8:78]-[#6:77]/[#6@@:76]1-[#6@@:39](\[#8:38]\[#6@:37]2-[#6@:35](/[#8:36])-[#6@@:34](\[#8:33]/[#6@@:32]3-[#8:31]-[#6@:29](/[#6:30])-[#6@@:28]4-[#6@@:86](-[#8:88]-[#6:26]5(-[#8:27]\4)-[#8:89]-[#6@:90](/[#6:91])-[#6@@:22](\[#8:21]/[#6@@:20]4-[#8:92]-[#6@:93](/[#6:94])-[#6@@:16](\[#8:15]-[#6:13](-[#6:12]6:[#6:3](-[#8:2]-[#6:1]):[#6:4](-[Cl:5]):[#6:6](-[#8:7]):[#6:8](-[Cl:9]):[#6:10]:6-[#6:11])=[#8:14])-[#6@:17](/[#8:18])-[#6:19]-4)-[#6@@:23](\[#8:24])-[#6:25]-5)(\[#6:87])-[#6:85]-3)-[#6@@:82](\[#8:83]-[#6:84])-[#6@@:80](\[#6:81])-[#8:79]-2)-[#6@:40](/[#8:41])-[#6@:42](/[#8:43]-[#6:44])-[#6@:45](/[#8:46]\[#6@:47]2-[#6@:55](/[#8:56]-[#6:57](-[#6:59](-[#6:61])-[#6:60])=[#8:58])-[#6@:54]3-[#6@@:50](-[#8:51]\[#6@:52]4(-[#6:74]5-[#6:70](-[#8:71]-[#6:72]-[#8:73]-5)-[#6@@:65](-[#6:67](=[#8:69])-[#6:68])(\[#8:66])-[#6@@:63](\[#6:64])-[#8:62]-4)-[#8:53]/3)\[#6:49]-[#8:48]-2)-[#8:75]-1
Albonoursin synthase/cyclic dipeptide oxidase
PhoL is responsible for reduction of monodictyphenone towards the biosynthesis of phomoxanthone A
N[C@@H](CCCC[N+](=O)[O-])C(=O)O
CC(C)(COP(=O)([O-])OP(=O)([O-])OCC1OC(n2cnc3c(N)ncnc32)C(O)C1OP(=O)([O-])[O-])C(O)C(=O)NCCC(=O)NCCSC(=O)c1ccc[nH]1
CSCCC(N)C(=O)NC(CCCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1cnc[nH]1)C(=O)O
CC(C)(COP(=O)(O)O)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)c1ccccc1
UDP-N-acetylglucosamine as substrate.
CCCCC[C@@H]1CC2=C(C(=O)OC2=O)C[C@@](CCCC)(O)CC2=C1C(=O)OC2=O
Installs a biaryl ether bond on the balhiycin precursor. The reaction might be less specific than depicted in the reaction SMARTS. There is no detailed study on the specificity so far. The reaction occurs probably while the precursor peptide backbone is bound to the NRPS as shown for the closely related vancomycin biosynthesis (10.1002/ANIE.200461278).
doi:10.1007/s00253-023-12385-8
[#7:1]=[#6:2](-[#7:4]-[#6:5]-[#6:6]-[#6:7]\[#6@:8]1-[#6:24](=[#8:25])-[#7:23]-[#6@@:12](\[#6:13]-[#6:14]2:[#6:22]3:[#6:17](:[#6:18]:[#6:19]:[#6:20]:[#6:21]:3):[nH:16]:[#6:15]:2)-[#6:10](=[#8:11])-[#7:9]-1)-[#7:3]>>[#7:1]=[#6:2](-[#7:4]-[#6:5]-[#6:6]-[#6:7]\[#6@:8]1-[#6:24](=[#8:25])-[#7:23]-[#6@@:12](\[#6:13]-[#6:14]23-[#8]-[#6:15]-2-[NH:16]-[#6:17]2:[#6:22]-3:[#6:21]:[#6:20]:[#6:19]:[#6:18]:2)-[#6:10](=[#8:11])-[#7:9]-1)-[#7:3]
StoR
StoC
doi:10.1073/pnas.2310522120
Cyclization
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](C)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@@H]1O
C[C@H]1O[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O)cc(O)cc3[C@@H](C(=O)O)NC2=O)[C@H](O)[C@@H](O)[C@@H]1N
Halogenation
C[C@H]1O[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O)cc(O)cc3[C@@H](C(=O)O)NC2=O)[C@H](O)[C@@H](O)[C@@H]1O
KtzR
KtzQ
MITE0000089
MITE0000088
MITE0000081
MITE0000080
MITE0000083
MITE0000082
MITE0000085
radical SAM methyltransferase 
MITE0000084
MITE0000086
MITE0000087
CC(C)=CCC/C(C)=C\CCC1(C)C2CC3C(C2)C31C
doi:10.1002/cbic.201200016
Monooxygenation
doi:10.1002/anie.201205414
doi:10.1002/anie.201611617
doi:10.1002/cbic.201402119
P450-catalyzed oxidative decarboxylation of terminal thiazoline of bottromycin precursor in Streptomyces sp. BC16019
C/C1=C\[C@@H](C)[C@@H]([C@H](C)O)OC(=O)[C@@H](O)CC2C=CC3C[C@H](O)[C@H](C)[C@H](O)C3C12
Reaction of UDP-L-4-epi-vancosamine with glycosyl-vancomycin-pseudoaglycone.
P450 installing crosslink
ATP-grasp protein
[#6:19]-[c:18]1[c:15][c:12](-[#8:16])[c:5]2-[#6:2](=[O:6])-[c:1]3[c:4](-[#8:10])[c:9][c:13](-[#8:17])[c:8][c:3]3-[#6:7]-[c:11]2[c:14]1>>[#6:19]-[c:18]1[c:15][c:12](-[#8:16])[c:5]2-[#6:2](=[O:6])-[c:1]3[c:4](-[#8:10])[c:9][c:13](-[#8:17])[c:8][c:3]3-[#6:7](=[O:20])-[c:11]2[c:14]1
A0A2S1JZG9
Bottromycin A2-precursor peptide, first 10 AAs; cleaveage of first AA.
A0A7R6QUG3
A0A2S1JZG6
1.14.11.36
SgrB
1.14.15.32
CC(C)CC(N)C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)C(O)c1ccc(O)c(Cl)c1)c1ccc(O)cc1)c1ccc(O)cc1)C(O)c1ccc(O)c(Cl)c1
O-methylation of alkylresorcinols to yield alkylresorcinol methyl ethers
ketoreductase
[#6:1](-[#16:32]-[#6:31]-[#6:30]-[#7:29]-[#6:27](=[#8:28])-[#6:26]-[#6:25]-[#7:24]-[#6:22](=[#8:23])-[#6@:21](/[#8:33])-[#6:13](-[#6:15]-[#8:16]-[#15:17](-[#8:20])(-[#8:19])=[#8:18])(-[#6:14])-[#6:12])(-[#6:3]1:[#6:10](-[#8:11]):[#6:9]:[#6:7](-[#8:8]):[#6:6]:[#6:4]:1-[#6:5])=[#8:2]>>[#6:1](-[#16:32]-[#6:31]-[#6:30]-[#7:29]-[#6:27](=[#8:28])-[#6:26]-[#6:25]-[#7:24]-[#6:22](=[#8:23])-[#6@:21](/[#8:33])-[#6:13](-[#6:15]-[#8:16]-[#15:17](-[#8:20])(-[#8:19])=[#8:18])(-[#6:14])-[#6:12])(-[#6:3]1:[#6:10](-[#8:11]-[#6]):[#6:9]:[#6:7](-[#8:8]):[#6:6]:[#6:4]:1-[#6:5])=[#8:2]
[#8:1]-[#6:2]/[#6@@:3]1-[#6@@:8](\[#8:9])-[#6@@:6](\[#8:7])-[#6@:5](/[#6:10]2:[#6:16](=[#8:17]):[#7:15]:[#6:13](=[#8:14]):[#7:12]:[#6:11]:2)-[#8:4]-1>>[#8:9]\[#6@:8]1-[#6@@:6](\[#8:7])-[#6@:5](/[#6:10]2:[#6:16](=[#8:17]):[#7:15]:[#6:13](=[#8:14]):[#7:12]:[#6:11]:2)-[#8:4]-[#6@@:3]-1/[#6:2]=[#8:1]
Catalyzes hydroxylation from 7-hydroxytropolone to 3,7-dihydroxytropolone
N
UPI0020464A74
UPI0020648AC1
P0CU31
66696
NgnN4 is responsible for attaching a pyrrole-moiety.
doi:10.1021/ja0743801
Reaction of UDP-L-4-epi-vancosamine with 3-deoxy-glycosyl-vancomycin-pseudoaglycone.
Reaction of UDP-L-4-epi-vancosamine with 3-amino-glycosyl-vancomycin-pseudoaglycone.
27393
CSc1c(O)cc(-c2ccccn2)nc1C(=O)NC(CC(C)C)C(=O)O
[#6:27]-[#16:16]-[c:11]1[c:10](-[#8:25])[c:9][c:8]([n:7][c:12]1-[#6:13](=[O:14])-[#7:15]-[#6:17](-[#6:18]-[#6:19](-[#6:20])-[#6:21])-[#6:22](-[#8:23])=[O:24])-[c:5]1[c:6][c:1][c:2][c:3][n:4]1>>[#6:27]-[#16:16]-[c:11]1[c:10](-[#8:25])[c:9][c:8]([n:7][c:12]1-[#6:13](-[#8:30])=[O:14])-[c:5]1[c:6][c:1][c:2][c:3][n:4]1
CC(C)CCCCCCCCCCCCc1cc(O)cc(O)c1
PtlE
PtlD
A0A142I758
CC1OC(c2ccc3c(c2O)C(=O)C2=C(O)[C@]4(O)C(=O)C(C(N)=O)=C(O)[C@H](O)[C@@H]4C[C@@H]2[C@@]3(C)O)CC(O)C1O
PtlI
W-W biaryl crosslink formation
[#6:1]\[#6:2]=[#6:3](/[#6:26])-[#6:4]-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]\[#6:11]=[#6:12]/[#6:13]=[#6:14]/[#6:15]=[#6:16]\[#6:17]-[c:18]1[c:19][c:20](-[#8:21])[c:22][c:23](-[#8:24])[c:25]1>>[#6:1]\[#6:2]=[#6:3](\[#6:4]-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]\[#6:11]=[#6:12]/[#6:13]=[#6:14]/[#6:15]=[#6:16]\[#6:17]-[c:18]1[c:19][c:20](-[#8:21])[c:22][c:23](-[#8:24])[c:25]1)-[#6:26](-[#8:27])=[O:28]
A0A142I756
A0A397HK51
CC[C@H]1OC(=O)[C@@H](O)CC2C=CC3C[C@H](O)[C@H](C)[C@H](O)C3C2C(C)=C[C@H]1C
A0A397HK53
A0A2H4T153
E3VWI8
E3VWI7
E3VWI3
C-methylation of methylsalicylic acid bound to coenzyme A. Auxiliary enzyme MdpB2 needed to load methylsalicylic acid on coenzyme A.
AnkG
Cyclizes 2,3-oxidosqualene to thalianol
[#6:1]-[#8:2]\[#6@@:3]1-[#6:9]2:[#8:10]:[#6:11]3:[#6:17](:[#6:18](=[#8:19]):[#6:8]:2-[#6@:6](\[#8:7])-[#6:5]-[#6:4]-1):[#6:15](-[#8:16]):[#6:14]1-[#6:20]2:[#6:32](-[#8:33]):[#6:31]4:[#6:23](:[#6:24]:[#6:25](:[#7:27](:[#6:29]:4=[#8:30])-[#6:28])-[#6:26]):[#6:22]:[#6:21]:2-[#6:34]-[#6:35]2-[#8:36]-[#6:37]-[#8:38]-[#6:12]:3:[#6:13]:1-2>>[#6:1]-[#8:2]\[#6@@:3]1-[#6:9]2:[#8:10]:[#6:11]3:[#6:17](:[#6:18](=[#8:19]):[#6:8]:2-[#6@:6](\[#8:7])-[#6:5]-[#6:4]-1):[#6:15](-[#8:16]):[#6:14]1-[#6:20]2:[#6:32](-[#8:33]):[#6:31]4:[#6:23](:[#6:24](:[#6:25](:[#7:27](:[#6:29]:4=[#8:30])-[#6:28])-[#6:26])-Br):[#6:22]:[#6:21]:2-[#6:34]-[#6:35]2-[#8:36]-[#6:37]-[#8:38]-[#6:12]:3:[#6:13]:1-2
CoA ligase
COc1cc(O)cc(CCCCCCCCCCCCC(C)C)c1O
CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
ScaB aka EmbB
[#8:1]-[#6:4](=[O:2])-[#6:11]-1=[#6:7](-[#8:3])-[#6:6]-[#6:5]=[#6:8]-[#6:9]=[#6:10]-1>>[#8:3]-[#6:7]-1=[#6:6]-[#6:5]=[#6:8]-[#6:9]=[#6:10]-[#6:11]-1=O
O=C1NC(Cc2c[nH]c3ccccc23)C(=O)NC1Cc1c[nH]c2ccccc12
[C:1][C:2]#[CH1:3]>>[C:1][C:2]#[CH0:3][I]
NC(=O)OC[C@@H]1N=C(N)N2CCC(O)(O)[C@@]23NC(N)=N[C@@H]13
extradiol cleavage of L-DOPA, rearrangement to alkylproline derivative
Dimerization of penexanthone B to phomoxanthone A via biaryl bond formation
Conversion of premutilin to 11-hydroxypremutilin
C[C@@H]1CC[C@H]2C(C=O)=CC3CC(C)(C)C[C@]312
doi:10.1021/ja910191u
Nodulisporic Acid F formation.
CC(C)=CCCC(C)=CC[C@@]12OC(C)(C)[C@H](Cl)C[C@]1(Cl)C(=O)c1c(cc(O)c(C)c1O)C2=O
E2IHC5
E2IHC6
BGC0002223
BGC0001322
BGC0000821
BGC0000422
AXM43051.1
BGC0002126
BGC0000026
BGC0002224
BGC0002125
AXG22404.1
BGC0002024
BGC0000421
BGC0000024
56824
CC1=C[C@@H](C)[C@H]2[C@@H]3C(=O)CC(=O)CC(=O)O[C@@H](C)C=CC=C[C@@H](C)[C@@H]3C=C[C@@H]2C1
CC1=C[C@@H](C)[C@H]2[C@@H]3C(O)=CC(=O)CC(=O)O[C@@H](C)C=CC=C[C@@H](C)[C@@H]3C=C[C@@H]2C1
NgnP1
BGC0000529
56820
NgnP2
NC[C@H]1O[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O)cc(O)cc3[C@@H](C(=O)O)NC2=O)[C@H](O)[C@@H](O)[C@@H]1O
Transfers vancosamine onto glucose on hpg4 of vancomycin pseudoaglycone.
N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O
[#8:1]-[c:2]1[c:3][c:4][c:5][c:6][c:7][c:8]1=[O:9]>>[#8:1]-[c:2]1[c:3][c:4][c:5][c:6][c:7](-[#8:8])[c:9]1=[O:10]
Carboxylation of C-13 in isopropenyl side chain
Q8KHS0
[#6:1]-[#6:2]-[#6@@H:3](-[#6:4])-[#6@@H:5](-[#7:6]-[#6:7](=[O:8])-[#6@@H:9](-[#6:10]-[c:11]1[c:12][c:13][c:14](-[#8:15])[c:16][c:17]1)-[#7:18]-[#6:19](=[O:20])-[#6@H:21](-[#7:22])-[#6:23]-[c:24]1[c:25][n:26][c:27]2[c:28][c:29][c:30][c:31][c:32]12)-[#6:33](=[O:34])-[#7:35]-[#6@H:36](-[#6:37]-[c:38]1[c:39][n:40][c:41]2[c:42][c:43][c:44][c:45][c:46]12)-[#6:47](=[O:48])-[#7:49]-[#6@H:50](-[#6:51]-[c:52]1[c:53][c:54][c:55](-[#8:56])[c:57][c:58]1)-[#6:59](-[#8:60])=[O:61]>>[#6:1]-[#6:2]-[#6:3](-[#6:4])-[#6@@H:5]-1-[#7:6]-[#6:7](=[O:8])-[#6@@H:9]-2-[#6:10]-[c:11]3[c:12][c:13][c:14](-[#8:15])[c:16]([c:17]3)-[n:18]3[c:19][c:20](-[#6:21]-[#6@H:22](-[#7:23])-[#6:24](=[O:25])-[#7:26]-2)[c:27]2[c:28][c:29]([c:30][c:31][c:32]32)[C@:33]23[#6:34]-[#6@@H:35]-4-[#7:36](-[#6@H:37]2-[#7:38]-[c:39]2[c:40]3[c:41][c:42][c:43][c:44]2-[#8:45]-[c:46]2[c:47][c:48][c:49](-[#6:50]-[#6@H:51](-[#7:52]-[#6:53]-4=[O:54])-[#6:55](-[#8:56])=[O:57])[c:58][c:59]2)-[#6:60]-1=[O:61]
[#8:1]-[#6:2](=[#8:3])-[#6:4](-[#7:5]-[#6:6](=[#8:7])-[#6:8](-[#7:9]-[#6:10](=[#8:11])-[#6:12](-[#7:13])-[#6:17]-[#6:18]1:[#6:19]:[#6:20]:[#6:21](-[#8:22]):[#6:23]:[#6:24]:1)-[#6:25]-[#6:26]1:[#6:27]:[#6:28]:[#6:29]:[#6:30]:[#6:31]:1)-[#6:32]-[#6:33]1:[n;H]:[#6:35]:[#7:36]:[#6:37]:1>>[#8:1]-[#6:2](=[#8:3])-[#6:4]1-[#7:5]-[#6:6](=[#8:7])-[#6:8](-[#6:25]-[#6:26]2:[#6:31]:[#6:30]:[#6:29]:[#6:28]:[#6:27]:2)-[#7:9]-[#6:10](=[#8:11])-[#6:12](-[#7:13])-[#6:17]-[#6:18]2:[#6:19]:[#6:20](:[#6:21](-[#8:22]):[#6:23]:[#6:24]:2)-[#6:35]2:[n;H]:[#6:33](:[#6:37]:[#7:36]:2)-[#6:32]-1
[#6]-[#6](-[#6])(-[#6]-[#8]-[#15](=[#8])(-[#8])-[#8])-[#6@](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6]-[#16]-[#6](=[#8])-[#6]1:[#6](-[#6]):[#6]:[#6](-[#8]):[#6]:[#6]:1-[#8]-[#6])\[#8]>>[#6]-[#6](-[#6])(-[#6]-[#8]-[#15](=[#8])(-[#8])-[#8])-[#6@](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6]-[#16]-[#6](=[#8])-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#8]):[#6](-[I]):[#6]:1-[#6])\[#8]
CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O)Cc2c[nH]c3c(cccc23)-n2cc(c3ccccc32)C[C@@H](C(=O)O)NC1=O
Hydroxylation of iodinated orsellenic acid derivate, assumed to be bound to 4'-phosphopantetheine
Should actually be L-chlorotryptophan.
pyridoxal-phosphate dependent enzyme
radical SAM methyltransferase
Flavin-dependent L-tryptophan oxidase
BAL92978.1
BAL92979.1
Flavin-dependent halogenase with phenolic substrate
CSCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CN)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O
2.3
CCC1OC(=O)[C@H](C)[C@@H](OC2C[C@](C)(OC)[C@H](O)[C@@H](C)O2)[C@@H](C)[C@H](OC2O[C@@H](C)C[C@@H](N(C)C)[C@@H]2O)[C@@](C)(O)C[C@H](C)C(=O)[C@H](C)[C@H](O)[C@]1(C)O
bottromycin A2-precursor peptide after methylation, hetero- and macrocyclization. Higher activity of enzyme measured in presence of Cobalt(II).
o-methyltransferase
SacF
C=c1[nH]c(=O)c(=CC(C)C)[nH]c1=O
C/C(CO)=C1/CC(C)(C)C[C@@H]2[C@@H]1CC[C@@H]2C
Macroamidine linkage-catalyzing YacO protein from Streptomyces sp. BC16019
QCS37511.1
[#6:10]\[#6:9](-[#6:11]=[#6:12])=[#6:8]/[#6:7]-[#6@H:6]1-[#6:4](=[#6:5])-[#6:3]-[#6:2]-[#6@H:1]2[C:18]([#6:19])([#6:20])[#6:17]-[#6:16]-[#6:15][C@:13]12[#6:14]>>[#6:12]\[#6:11](-[#6:13]=[#6:14])=[#6:10]/[#6:9]-[#6@H:8]1[C@:5]2([#6:6]-[#8:7]2)[#6@@H:3](-[#8:4])-[#6:2]-[#6@H:1]2[C:20]([#6:21])([#6:22])[#6:19]-[#6:18]-[#6:17][C@:15]12[#6:16]
CC1=CCC2CC(CC3(CCC(C)C(C)O3)O2)OC(=O)C2C=C(C)C(O)C3OCC(=CC=CC(C)C1)C23O
COc1cc(O)c(I)c(C)c1C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)O
doi:10.1039/D4SC03469D
Tcp24 a.k.a Orf2* a.k.a. tAtf
Responsible for the conversion of emodin anthrone to emodin by oxidation during biosynthesis of phomoxanthone A
A0A2R4FXX7
Installs biaryl crosslinks
A0A2R4FXX8
A0A6S6QLX9
[#6]1:[#6]:[#6]:[#6]2:[#6](:[#6]:1):[#6](:[#6]:[#7H]:2)-[#6]-[#6](-[#6](=[#8])-[#8])-[#7]>>[#6]1:[#6]:[#6]2:[#6](:[#6](:[#6]:1)-[#17]):[#7H]:[#6]:[#6]:2-[#6]-[#6](-[#6](=[#8])-[#8])-[#7]
ACN64833.1
ACN64830.1
C/C=C(\C)CCCCCCC/C=C\C=C\C=C/Cc1cc(O)cc(O)c1
doi:10.1021/ja071038f
A0A3S7PZF0
A0A3S7PZF2
A0A3S7PZF3
TNB95040.1
A0A397HPF2
O=C(O)c1[nH]c(C(=O)O)c2c1c1c3cccc(Cl)c3[nH]c1c1[nH]c3c(Cl)cccc3c12
COC(=O)C[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](/N=C1\NCC(=O)N2CC[C@@H](C)[C@H]2C(=O)N[C@@H](C(C)C)C(=O)N[C@H]1C(C)(C)C)C(C)(C)C)[C@@H](C)c1ccccc1)c1nccs1
doi:10.1074/jbc.275.5.3065
ADC45587.1
ADK32563.1
Cyclization of nerylneryl diphosphate to form lycosantalene
ADK32564.1
ADO85579.1
ADO85571.1
Ring cleavage in the scope of detoxification.
BGC0000230
BGC0000031
BGC0000932
BGC0000033
BGC0003032
BGC0001335
BGC0003035
BGC0001237
23228
[#6:1]-[#6:2]-[#6:3](-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]-[#6:17]1:[#6:24](-[#8:25]):[#6:22](-[#8:23]):[#6:21]:[#6:19](-[#8:20]):[#6:18]:1)-[#6:4]>>[#6:1]-[#6:2]-[#6:3](-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]-[#6:17]1:[#6:24](-[#8:25]):[#6:22](-[#8:23]-[#6]):[#6:21]:[#6:19](-[#8:20]):[#6:18]:1)-[#6:4]
Vanadium-Dependent Chloroperoxidase
CC1(O)CC(=O)c2c(cc3cc(O)cc(O)c3c2O)C1
W8QLE0
Capable of iodinating and brominating arenes and olefins
1.14.13.154
O=c1cccccc1O
CC(C)C[C@@H](N)C(=O)N[C@@H](C=O)[C@@H](O)c1ccc(O)c(Cl)c1
NADH:flavin oxidoreductase
AAN01210.1
AAN01208.1
Two-step sequential oxidation of lycosantalene to lycosantalonol.
Bromination of 5-bromotryptophan, leading to 5,7-bromotryptophan
doi:10.1016/j.ijfoodmicro.2013.11.020
CCCCCCCCCC(=O)N[C@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@H](CO)[C@@H](O)[C@@H]1O
doi:10.1038/s41467-021-21432-9
[#6:1]-[#6:2](-[#6:21])(-[#6:15]-[#8:16]-[#15:17](=[#8:20])(-[#8:19])-[#8:18])-[#6@:3](-[#6:5](=[#8:14])-[#7:6]-[#6:7]-[#6:8]-[#6:9](=[#8:13])-[#7:10]-[#6:11]-[#6:12]-[#16:22]-[#6:23](-[#6:25]1:[#6:34](-[#8:35]-[#6:36]):[#6:32](-[#8:33]):[#6:30](-[#8:31]):[#6:28](-[I:29]):[#6:26]:1-[#6:27])=[#8:24])\[#8:4]>>[#6:21]-[#6:2](-[#6:1])(-[#6:15]-[#8:16]-[#15:17](=[#8:20])(-[#8:18])-[#8:19])-[#6@:3](-[#6:5](=[#8:14])-[#7:6]-[#6:7]-[#6:8]-[#6:9](=[#8:13])-[#7:10]-[#6:11]-[#6:12]-[#16:22]-[#6:23](-[#6:25]1:[#6:34](-[#8:35]-[#6:36]):[#6:32](-[#8:33]-[#6]):[#6:30](-[#8:31]):[#6:28](-[I:29]):[#6:26]:1-[#6:27])=[#8:24])\[#8:4]
UPI00205CF1EC
cRY tRNA-dependent cyclodipeptide synthase
cRW tRNA-dependent cyclodipeptide synthase
cytochrome P450
doi:10.1002/cbic.201500467
Amination
doi:10.1002/cbic.201900667
doi:10.1002/cbic.201400062
CO[C@@H]1C(O)=C(C(C)=O)C(=O)[C@@]2(O)C(=O)c3c(cc4cc(O)cc(O)c4c3O)CC12
braC
CC(=O)O[C@H](C)Cc1cc2ccc(-c3ccc4cc(C[C@@H](C)OC(C)=O)c(C(=O)C[C@H](C)O)c(O)c4c3O)c(O)c2c(O)c1C(=O)C[C@H](C)O
doi:10.1002/cbic.202100569
PhmJ
Brasilane D formation
Brasilane E formation
doi:10.1074/jbc.M710461200
Brasilane A formation
Yields roseopurpurin C and its C-4 epimer roesopurpurin D as the last step of the biosynthetic cascade.
[#8:1]=[#6:2](-[#8:4]-[#6:5]\[#6@:6]1-[#6@:10]2-[#6@:17]3(\[#6:16](-[#8:20])(-[#8:19])-[#6:15]-[#6:14]-[#7:21]-3-[#6:8](-[#7:9])=[#7:7]-1)/[#7:13]-[#6:12](-[#7:18])=[#7:11]/2)-[#7:3]>>[#8:1]=[#6:2](-[#8:4]-[#6:5]\[#6@:6]1-[#6@:10]2-[#6@:17]3(\[#6:16](-[#8:19])(-[#8:20])-[#6:15]-[#6:14]-[#7:21]-3-[#6:8](-[#7:9])=[#7:7]-1)/[#7:13]-[#6:12](-[#7:18])=[#7:11]/2)-[#7:3]-[#16](-[#8])(=[#8])=[#8]
LrcB2
LrcB1
RslO4 catalyzes the monooxygenation of an intermediate in the rishirilide biosynthesis pathway
[#6:1]-[#6:2](-[#6:67])-[#6:3]-[#6:4](-[#7:66])-[#6:5](=[#8:65])-[#7:6]-[#6:7](-[#6:55](-[#8:64])-[#6:56]1:[#6:63]:[#6:62]:[#6:60](-[#8:61]):[#6:58](-[Cl:59]):[#6:57]:1)-[#6:8](=[#8:54])-[#7:9]-[#6:10](-[#6:50]-[#6:51](-[#7:53])=[#8:52])-[#6:11](=[#8:49])-[#7:12]-[#6:13]1-[#6:42](=[#8:43])-[#7:41]-[#6:33](-[#6:34]2:[#6:40]:[#6:39]:[#6:37](-[#8:38]):[#6:36]:[#6:35]:2)-[#6:31](=[#8:32])-[#7:30]-[#6:26](-[#6:27](-[#8:29])=[#8:28])-[#6:24](-[#8:25])-[#6:21]2:[#6:22]:[#6:23]:[#6:18](:[#6:19](-[Cl:44]):[#6:20]:2)-[#8:17]-[#6:16]2:[#6:45](:[#6:47]:[#6:48]:[#6:14]-1:[#6:15]:2)-[#8:46]>>[#6:1]-[#6:2](-[#6:67])-[#6:3]-[#6:4](-[#7:66])-[#6:5](=[#8:65])-[#7:6]-[#6:7]1-[#6:55](-[#8:64])-[#6:56]2:[#6:63]:[#6:62]:[#6:60](-[#8:61]-[#6:47]3:[#6:48]:[#6:14]4:[#6:15]:[#6:16](:[#6:45]:3-[#8:46])-[#8:17]-[#6:18]3:[#6:23]:[#6:22]:[#6:21](-[#6:24](-[#6:26](-[#7:30]-[#6:31](-[#6:33](-[#7:41]-[#6:42](=[#8:43])-[#6:13]-4-[#7:12]-[#6:11](=[#8:49])-[#6:10](-[#6:50]-[#6:51](-[#7:53])=[#8:52])-[#7:9]-[#6:8]-1=[#8:54])-[#6:34]1:[#6:40]:[#6:39]:[#6:37](-[#8:38]):[#6:36]:[#6:35]:1)=[#8:32])-[#6:27](-[#8:29])=[#8:28])-[#8:25]):[#6:20]:[#6:19]:3-[Cl:44]):[#6:58](-[Cl:59]):[#6:57]:2
C=C1/C=C/C(C)=C\c2csc(n2)C2(CC2)NC(=O)C[C@@](CC(=O)O)(SSC)CC/C(C)=C/C1
PhoP is a short-chain dehydrogenases/reductase responsible for a reductive cyclisation step in the biosynthesis of phomoxanthone A
R9USI6
D7MKC1
D7MKC0
Cc1cc(O)c2c(c1)Cc1cc(O)cc(O)c1C2=O
[#7:1]=[#6:2](-[#7:4]-[#6:5]-[#6:6]-[#6:7]\[#6@:8]1-[#6:24](=[#8:25])-[#7:23]-[#6@@:12](\[#6:13]-[#6:14](-[#6:16]2:[#6:21](-[#7:22]):[#6:20]:[#6:19]:[#6:18]:[#6:17]:2)=[#8:15])-[#6:10](=[#8:11])-[#7:9]-1)-[#7:3]>>[#7:1]=[#6:2](-[#7:4]-[#6:5]-[#6:6]-[#6:7]\[#6@:8]1-[#6:24](=[#8:25])-[#7:23]-[#6@@:12](\[#6:13]-[#6:14]2:[#6:16]3:[#6:21](:[#7:22]:[#8:15]:2):[#6:20]:[#6:19]:[#6:18]:[#6:17]:3)-[#6:10](=[#8:11])-[#7:9]-1)-[#7:3]
Hydroxylation of 12-C of pre-borrelidin
CC(C)=CCCC(C)(O)C(=O)CCC1(C)C2CC3C(C2)C31C
[#6:91]/[#6@:92]1-[#6@:124](\[#8:125])-[#6@:121](-[#7:123])(\[#6:122])-[#6:120]-[#6@@:94](/[#8:95]-[#15:96](-[#8:99]-[#15:100](-[#8:103]-[#6:104]\[#6@@:105]2-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\[#7:108]3:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:3)-[#8:106]-2)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97])-[#8:93]-1.[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\[#8:24])-[#6:21]-[#6@:19](\[#8:20])-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3]>>[#15:96](-[#8])(-[#8:99]-[#15:100](-[#8:103]-[#6:104]\[#6@@:105]1-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\[#7:108]2:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:2)-[#8:106]-1)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97].[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\[#8:24]/[#6@@:94]2-[#6:120]-[#6@@:121](-[#6@@:124](\[#8:125])-[#6@@:92](-[#8:93]-2)/[#6:91])(-[#7:123])\[#6:122])-[#6:21]-[#6@:19](\[#8:20])-[#6@@:17](/[#6:18]-[#8:200])-[#8:16]-1)=[#8:3]
Cc1cc(O)c(C)c(O)c1C(=O)Oc1cc(C)c(C(=O)O)c(O)c1C
Oxidation of 12-C hydroxyl group of pre-borrelidin to a carbonyl
CldC
PAPS
NCCC[C@H](N)C(=O)O
Depside bond formation by oxidative ether formation.
Converts pentalenolactone F to pentalenolactone via oxidative rearrangement.
COC1=CC(C)=C2C3C#CC=CC#CC1C2c1cc(O)c2c(c1N3)C(=O)c1ccccc1C2=O
[#6:100]-[#6:98](=[O:99])-[#7:2]-[#6@@H:3]-1-[#6@@H:4](-[#8:5])-[#6@H:6](-[#8:7])-[#6@@H:8](-[#6:9]-[#8:10])-[#8:11]-[#6@H:12]-1-[#8:13]-[c:14]1[c:15]2-[#8:16]-[c:17]3[c:18][c:19][c:20](-[#6:21]-[#6@H:22]-4-[#7:23]-[#6:24](=[O:25])-[#6@H:26](-[#7:27])-[c:28]5[c:29][c:30][c:31](-[#8:32])[c:33](-[#8:34]-[c:35]6[c:36][c:37](-[#8:38])[c:39][c:40]([c:41]6)-[#6@H:42](-[#7:43]-[#6:44]-4=[O:45])-[#6:46](=[O:47])-[#7:48]-[#6@@H:49]-4-[c:50]([c:51]2)[c:52][c:53]1-[#8:54]-[c:55]1[c:56][c:57][c:58]([c:59][c:60]1[Cl:61])-[#6@@H:62](-[#8:63])-[#6@@H:64]-1-[#7:65]-[#6:66](=[O:67])-[#6@H:68](-[#7:69]-[#6:70]-4=[O:71])-[c:72]2[c:73][c:74][c:75](-[#8:76])[c:77]([c:78]2)-[c:79]2[c:80](-[#8:81])[c:82][c:83](-[#8:84])[c:85][c:86]2-[#6@H:87](-[#7:88]-[#6:89]-1=[O:90])-[#6:91](-[#8:92])=[O:93])[c:94]5)[c:95][c:96]3[Cl:97]>>[#7:2]-[#6@@H:3]-1-[#6@@H:4](-[#8:5])-[#6@H:6](-[#8:7])-[#6@@H:8](-[#6:9]-[#8:10])-[#8:11]-[#6@H:12]-1-[#8:13]-[c:14]1[c:15]2-[#8:16]-[c:17]3[c:18][c:19][c:20](-[#6:21]-[#6@H:22]-4-[#7:23]-[#6:24](=[O:25])-[#6@H:26](-[#7:27])-[c:28]5[c:29][c:30][c:31](-[#8:32])[c:33](-[#8:34]-[c:35]6[c:36][c:37](-[#8:38])[c:39][c:40]([c:41]6)-[#6@H:42](-[#7:43]-[#6:44]-4=[O:45])-[#6:46](=[O:47])-[#7:48]-[#6@@H:49]-4-[c:50]([c:51]2)[c:52][c:53]1-[#8:54]-[c:55]1[c:56][c:57][c:58]([c:59][c:60]1[Cl:61])-[#6@@H:62](-[#8:63])-[#6@@H:64]-1-[#7:65]-[#6:66](=[O:67])-[#6@H:68](-[#7:69]-[#6:70]-4=[O:71])-[c:72]2[c:73][c:74][c:75](-[#8:76])[c:77]([c:78]2)-[c:79]2[c:80](-[#8:81])[c:82][c:83](-[#8:84])[c:85][c:86]2-[#6@H:87](-[#7:88]-[#6:89]-1=[O:90])-[#6:91](-[#8:92])=[O:93])[c:94]5)[c:95][c:96]3[Cl:97]
CC(C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)NCC(=O)N1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
doi:10.1021/acschembio.3c00106
product found in vitro only
CC(C)C[C@H](N)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)O
[#6:1]1-[#6:15]-[#6@:13](\[#6:14])-[#6@@:4]2(\[#6:12])-[#6:5]-[#6@@:6](/[#6:9](-[#6:11])~[#6:10])-[#6:7]-[#6:8]=[#6:3]-2-[#6:2]-1>>[#6:1]1-[#6:15]-[#6@:13](\[#6:14])-[#6@@:4]2(\[#6:12])-[#6:5]-[#6@@:6](/[#6:9](~[#6:10])-[#6:11]-[#8])-[#6:7]-[#6:8]=[#6:3]-2-[#6:2]-1
O=C(O)[C@@H]1CCCCN1
CSCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CN)C(C)C)C(C)(C)C)C(C)(C)C)C(=O)O
Replaces 12-C carbonyl with primary amine on the pre-borrelidin intermediate
CC(C)=CCC/C(C)=C/C(=O)[C@H](O)[C@@H](C)[C@@]1(C)CCC2=C1[C@@H](O)C[C@H]1C(C)(C)[C@@H](O)CC[C@]21C
VhaA
[#6:1]-[#6:2]\[#6@@:3]1-[#6@:25](\[#6:26])-[#6:24]=[#6:22](-[#6:23])-[#6:21]2-[#6:9](-[#6:10]=[#6:11]-[#6:12]3-[#6:20]-2-[#6@@:18](/[#8:19])-[#6@@:16](/[#6:17])-[#6@@:14](/[#8:15])-[#6:13]-3)-[#6:8]-[#6:7]-[#6:5](=[#8:6])-[#8:4]-1>>[#6:1]-[#6:2]\[#6@@:3]1-[#6@:25](\[#6:26])-[#6:24]=[#6:22](-[#6:23])-[#6:21]2-[#6:9](-[#6:10]=[#6:11]-[#6:12]3-[#6:20]-2-[#6@@:18](/[#8:19])-[#6@@:16](/[#6:17])-[#6@@:14](/[#8:15])-[#6:13]-3)-[#6:8]-[#6@:7](\[#8])-[#6:5](=[#8:6])-[#8:4]-1
[#6:1]-[#6:2]-[#6:3](-[#6:4])-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]-[c:19]1[c:20][c:21](-[#8:22])[c:23][c:24](-[#8:25])[c:26]1-[#6:27]>>[#6:1]-[#6:2]-[#6:3](-[#6:4])-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]-[c:19]1[c:20][c:21](-[#8:22]-[#6])[c:23][c:24](-[#8:25])[c:26]1-[#6:27]
doi:10.1002/anie.202311533
doi:10.1002/cbic.201700434
UPI002070062C
COc1cc(OCC=C(C)CCC=C(C)C)cc(CCCCCCCCCCCCC(C)C)c1O
CO[C@H]1CC[C@@H](O)c2c1oc1c3c4c(c(O)c1c2=O)-c1c(cc2c(Cl)c(C)n(C)c(=O)c2c1O)CC4OCO3
CO[C@H]1CC[C@@H](O)c2c1oc1c3c4c(c(O)c1c2=O)-c1c(cc2c(Br)c(C)n(C)c(=O)c2c1O)CC4OCO3
Glycosylation
CCCCC[C@@H]1CC2=C(C[C@H](CCCC)CC3=C1C(=O)OC3=O)C(=O)OC2=O
Monooxygenase
MITE0000067
MITE0000066
MITE0000065
MITE0000064
MITE0000063
MITE0000062
MITE0000061
MITE0000060
CC1=C(C(=O)CCC(C)C)C(=O)c2c(cc3cccc(O)c3c2O)C1=O
CC(C)C[C@H](C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@@H]1O)N(C)C
[#8:1]-[#6:2]1:[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]>>[#6:2]1(-[#8]\[#6@@]2-[#6@@](-[#6@@](/[#8])-[#6@@](-[#6@](-[#8]-2)/[#6])\[#7])\[#8]):[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]
MITE0000069
NC(Cc1c[nH]c2c(Br)cc(Br)cc12)C(=O)O
MITE0000068
TnmJ
Lasso macrocyclisation of microcin J25 after precursor cleavage, leading to mature product.
[#6:1]=[#6:2]1-[#6:150](=[#8:151])-[#7:149]-[#6:144](-[#6:145]-[#6:146](-[#6:148])-[#6:147])-[#6:142](=[#8:143])-[#7:141]-[#6:38](-[#6:39](-[#7:41]-[#6:42]2-[#6:139](-[#6:140])-[#16:138]-[#6:137]-[#6:57](-[#6:58](-[#7:60]-[#6:61](-[#6:134](-[#8:136])-[#6:135])-[#6:62](-[#7:64]-[#6:65]3-[#6:132](=[#8:133])-[#7:131]4-[#6:126](-[#6:127](-[#6:129](-[#8:152])-[#6:130]-4)-[#8:128])-[#6:124](=[#8:125])-[#7:123]-[#6:122]-[#6:120](=[#8:121])-[#7:119]-[#6:118]-[#6:116](=[#8:117])-[#7:115]-[#6:114]-[#6:112](=[#8:113])-[#7:111]-[#6:81]4-[#6:82]-[#16:83]-[#6:84]-[#6:85]5-[#6:106](=[#8:107])-[#7:105]-[#6:104]=[#6:103]-[#16:102]-[#6:101]-[#6:100](-[#7:108]-[#6:109](=[#8:110])-[#6:69](-[#7:70]-[#6:71](-[#6:73](-[#7:78]-[#6:79]-4=[#8:80])-[#6:74]-[#6:75](=[#8:77])-[#7:76])=[#8:72])-[#6:68]-[#16:67]-[#6:66]-3)-[#6:98](=[#8:99])-[#7:97]-[#6:89](-[#6:90]-[#6:91]3:[#6:96]:[#6:95]:[#6:94]:[#6:93]:[#6:92]:3)-[#6:87](=[#8:88])-[#7:86]-5)=[#8:63])=[#8:59])-[#7:56]-[#6:54](=[#8:55])-[#6:53]-[#7:52]-[#6:50](=[#8:51])-[#6:49]3-[#7:45](-[#6:46]-[#6:47]-[#6:48]-3)-[#6:43]-2=[#8:44])=[#8:40])-[#6:37]-[#16:36]-[#6:35]-[#6:20](-[#7:21]-[#6:22](-[#6:24](-[#7:27]-[#6:28](-[#6:30](-[#6:32](-[#6:34])-[#6:33])-[#7:31])=[#8:29])=[#6:25]-[#6:26])=[#8:23])-[#6:18](=[#8:19])-[#7:17]-[#6:6](-[#6:7]-[#6:8]2:[#6:16]3:[#6:11](:[#6:12]:[#6:13]:[#6:14]:[#6:15]:3):[#7:10]:[#6:9]:2)-[#6:4](=[#8:5])-[#7:3]-1>>[#6:1]=[#6:2]1-[#6:150](=[#8:151])-[#7:149]-[#6:144](-[#6:145]-[#6:146](-[#6:148])-[#6:147])-[#6:142](=[#8:143])-[#7:141]-[#6:38](-[#6:39](-[#7:41]-[#6:42]2-[#6:139](-[#6:140])-[#16:138]-[#6:137]-[#6:57](-[#6:58](-[#7:60]-[#6:61](-[#6:134](-[#8:136])-[#6:135])-[#6:62](-[#7:64]-[#6:65]3-[#6:132](=[#8:133])-[#7:131]4-[#6:126](-[#6:127](-[#6:129](-[#8:152])-[#6:130]-4)-[#8:128])-[#6:124](=[#8:125])-[#7:123]-[#6:122]-[#6:120](=[#8:121])-[#7:119]-[#6:118]-[#6:116](=[#8:117])-[#7:115]-[#6:114]-[#6:112](=[#8:113])-[#7:111]-[#6:81]4-[#6:82]-[#16:83]-[#6:84]-[#6:85]5-[#6:106](=[#8:107])-[#7:105]-[#6:104]=[#6:103]-[#16:102]-[#6:101]-[#6:100](-[#7:108]-[#6:109](=[#8:110])-[#6:69](-[#7:70]-[#6:71](-[#6:73](-[#7:78]-[#6:79]-4=[#8:80])-[#6:74]-[#6:75](=[#8:77])-[#7:76])=[#8:72])-[#6:68]-[#16:67]-[#6:66]-3)-[#6:98](=[#8:99])-[#7:97]-[#6:89](-[#6:90]-[#6:91]3:[#6:96]:[#6:95]:[#6:94]:[#6:93]:[#6:92]:3)-[#6:87](=[#8:88])-[#7:86]-5)=[#8:63])=[#8:59])-[#7:56]-[#6:54](=[#8:55])-[#6:53]-[#7:52]-[#6:50](=[#8:51])-[#6:49]3-[#7:45](-[#6:46]-[#6:47]-[#6:48]-3)-[#6:43]-2=[#8:44])=[#8:40])-[#6:37]-[#16:36]-[#6:35]-[#6:20](-[#7:21]-[#6:22](-[#6:24](-[#7:27]-[#6:28](-[#6:30](-[#6:32](-[#6:33])-[#6:34])-[#7:31])=[#8:29])=[#6:25]-[#6:26])=[#8:23])-[#6:18](=[#8:19])-[#7:17]-[#6:6](-[#6:7]-[#6:8]2:[#6:16]3:[#6:11](:[#6:12]:[#6:13]:[#6:14](-[Cl]):[#6:15]:3):[#7:10]:[#6:9]:2)-[#6:4](=[#8:5])-[#7:3]-1
Acetylates the intermediate in the thalianin pathway in Arabidopsis thaliana ssp. lyrata
CCC55912.1
CCC55916.1
CCC55909.1
McjC
McjB
doi:10.1038/s41467-020-19153-6
MITE0000010
doi:10.26434/chemrxiv-2024-jt6g5
[#6:91]/[#6@:92]1-[#6@:124](\[#8:125])-[#6@:121](-[#7:123])(\[#6:122])-[#6:120]-[#6@@:94](/[#8:95]-[#15:96](-[#8:99]-[#15:100](-[#8:103]-[#6:104]\[#6@@:105]2-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\[#7:108]3:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:3)-[#8:106]-2)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97])-[#8:93]-1.[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\[#8:24])-[#6@@:21](/[#8:22])-[#6@:19](\[#8:20])-[#6@@:17](/[#6:18]-[#7:200])-[#8:16]-1)=[#8:3]>>[#15:96](-[#8])(-[#8:99]-[#15:100](-[#8:103]-[#6:104]\[#6@@:105]1-[#6@@:118](/[#8:119])-[#6:117]-[#6@:107](\[#7:108]2:[#6:115](=[#8:116]):[#7:114]:[#6:112](=[#8:113]):[#6:110](-[#6:111]):[#6:109]:2)-[#8:106]-1)(=[#8:102])-[#8:101])(=[#8:98])-[#8:97].[#7:1]-[#6:2](-[#6:4]/[#6@@:5]1-[#7:90]-[#6:88](=[#8:89])-[#6@:77](/[#7:78]-[#6:79](=[#8:87])\[#6@@:80](-[#6:83]-[#6:84](-[#6:86])-[#6:85])-[#7:81]-[#6:82])-[#6@@:75](\[#8:76])-[#6:71]2:[#6:72]:[#6:73](-[Cl:74]):[#6:68](:[#6:69]:[#6:70]:2)-[#8:67]-[#6:12]2:[#6:13](:[#6:25]3-[#8:27]-[#6:28]4:[#6:65](-[Cl:66]):[#6:64]:[#6:31](-[#6@@:32](-[#6@:34]5\[#6:62](=[#8:63])-[#7:61]-[#6@:57](\[#6:58](=[#8:60])-[#8:59])-[#6:56]6:[#6:49](:[#6:50](:[#6:52]:[#6:53](:[#6:55]:6)-[#8:54])-[#8:51])-[#6:47]6:[#6:48]:[#6:42](:[#6:43]:[#6:44]:[#6:45]:6-[#8:46])-[#6@@:38](-[#7:39]-[#6:40](=[#8:41])-[#6@@:9](-[#6:10](:[#6:26]:3):[#6:11]:2)/[#7:8]-[#6:6]-1=[#8:7])\[#6:36](=[#8:37])-[#7:35]-5)/[#8:33]):[#6:30]:[#6:29]:4)-[#8:14]/[#6@:15]1-[#6@:23](\[#8:24]/[#6@@:94]2-[#6:120]-[#6@@:121](-[#6@@:124](\[#8:125])-[#6@@:92](-[#8:93]-2)/[#6:91])(-[#7:123])\[#6:122])-[#6@@:21](/[#8:22])-[#6@:19](\[#8:20])-[#6@@:17](/[#6:18]-[#7:200])-[#8:16]-1)=[#8:3]
D6C4C6
AoL1
NgnN4
Brc1ccc2[nH]c(Br)c(Br)c2c1
AoL4
Epoxide formation and oxidation
CO[C@@H]1C(O)=C(C(C)=O)C(=O)[C@@]2(OC3CC(OC4CC(OC5CC(C)(O)C(O)C(C)O5)C(O)C(C)O4)C(O)C(C)O3)C(=O)c3c(cc4cc(OC5CC(O)C(O)C(C)O5)c(C)c(O)c4c3O)CC12
55904
Oxygenase component of flavoprotein monooxygenase TrlCD
CotB3
CotB4
PhoJ is a dioxygenase involved in a ring-opening strategy to form monodictyphenone as in intermediate in phomoxanthone A biosynthesis
A0A3S7PZH4
A0A3S7PZH2
34304
Bromination of L-tryptophan, leading to 5-bromotryptophan
[#6:1]-[#6:2](-[#6:10](-[#8:22])-[#6:11](-[#7:13]-[#6:14]-[#6:15]-[#6:16](-[#7:18]-[#6:19]-[#6:20]-[#16:21]-[#6:23](=[#8:26])-[#6@:24](/[#7:27])-[#6:25]-[#6:28]-[#6:29](-[#6:31])-[#6:30])-[#8:17])-[#8:12])(-[#6:4]-[#8:5]-[#15:6](-[#8:9])(-[#8:8])-[#8:7])-[#6:3]>>[#6:3]-[#6:2](-[#6:10](-[#8:22])-[#6:11](-[#7:13]-[#6:14]-[#6:15]-[#6:16](-[#7:18]-[#6:19]-[#6:20]-[#16:21]-[#6:23](=[#8:26])-[#6@:24](/[#7:27])-[#6@@:25](/[#8])-[#6:28]-[#6:29](-[#6:31])-[#6:30])-[#8:17])-[#8:12])(-[#6:4]-[#8:5]-[#15:6](-[#8:9])(-[#8:8])-[#8:7])-[#6:1]
N[C@H]1C(=O)N[C@@H]2Cc3ccc(c(Cl)c3)Oc3cc4cc(c3O[C@H]3O[C@H](CCl)[C@@H](O)[C@H](O)[C@H]3O)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(O)cc(c2)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@@H](C(=O)O)NC3=O
L8PIQ8
[#8:1]-[#6:2]1:[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]>>[#6:2]1(-[#8]\[#6@@]2-[#6@](\[#8])-[#6@@](/[#8])-[#6]-[#6@@](/[#6]-[#8])-[#8]-2):[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]
doi:10.1021/acs.orglett.0c02469
CC(=O)O[C@H]1CC[C@]2(C)C3=C([C@@H](O)C[C@H]2C1(C)C)[C@@](C)([C@H](C)[C@@H](OC(C)=O)C(=O)C=C(C)CCC=C(C)C)CC3
41428
CC(C)C[C@@H](N)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H](c3ccc(O)cc3)C(=O)N[C@H](C=O)[C@H](O)c3ccc(cc3)Oc3cc2cc(c3O)Oc2ccc(cc2Cl)[C@H]1O
Halogenase
C=C(C)[C@H]1CC=C2C[C@H](O)C[C@H](C)[C@@]2(C)C1
[#7:26]-[#6:24](=[O:25])-[c:16]1[c:17](-[#8:23])[c:18][c:11]2[c:12][c:9]3[c:10][c:1]4[c:2][c:3][c:4][c:5](-[#8:19])[c:6]4[c:7](-[#8:20])[c:8]3[c:13](-[#8:21])[c:14]2[c:15]1-[#8:22]>>[#6:30]-[c:10]1[c:1]2[c:2][c:3][c:4][c:5](-[#8:19])[c:6]2[c:7](-[#8:20])[c:8]2[c:13](-[#8:21])[c:14]3[c:15](-[#8:22])[c:16](-[#6:24](-[#7:26])=[O:25])[c:17](-[#8:23])[c:18][c:11]3[c:12][c:9]12
CC1=C[C@@H]2/C=C/C[C@H](C)/C=C(/C)[C@@H](O)C(=O)/C=C/C(=O)[C@]23C(=O)N[C@@H](Cc2c[nH]c4ccccc24)C3[C@@H]1C
[#6:1]-[#6:2](=[#6:4]-[#6:5]-[#6:6]-[#6:7](=[#6:9]-[#6:10]-[#6:11]-[#6:12]1(-[#6:19]2(-[#6:20])-[#6:16]3-[#6:17]-2-[#6:18]-[#6:14]-1-[#6:15]-3)-[#6:13])-[#6:8])-[#6:3]>>[#6:1]-[#6:2](=[#6:4]-[#6:5]-[#6:6]-[#6:7](-[#6:9](-[#6:10]-[#6:11]-[#6:12]1(-[#6:19]2(-[#6:20])-[#6:17]3-[#6:16]-2-[#6:15]-[#6:14]-1-[#6:18]-3)-[#6:13])=[#8])(-[#8])-[#6:8])-[#6:3]
C[C@@H]1C[C@H](C)C[C@H](C)[C@@H](O)CC(=O)O[C@@H](C2CCC[C@@H]2C(=O)O)CC=CC=C(CN)[C@H](O)[C@@H](C)C1
C[C@@H]1C[C@H](C)C[C@H](C)[C@@H](O)CC(=O)O[C@@H](C2CCC[C@@H]2C(=O)O)CC=CC=C(CO)[C@H](O)[C@@H](C)C1
doi:10.1039/D0CC03950K
CC(C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
Catalyzes the dibromination of 5-bromoindole on the 3rd then on the 2nd position (doesn't act on tryptophan)
A0A861B9Z9
doi:10.1021/bi060419n
CC(C)(CO[PH](O)(O)O)C(O)C(O)NCCC(O)NCCSC(=O)[C@H](N)Cc1ccc(O)cc1
PokM3
A0A2I6PIZ2
A0A075TXZ1
ADO85575.1
ADE34484.1
ADE34498.1
ADE22292.1
ADY00134.1
Q8KNE5
ADO85576.1
A0A7G8Z073
CC(=O)O[C@@H](C(=O)/C=C(\C)CCC=C(C)C)[C@@H](C)[C@@]1(C)CCC2=C1[C@@H](O)C[C@H]1C(C)(C)[C@@H](O)CC[C@]21C
A0A7G8Z072
A0A7G8Z071
A0A6S6QP77
doi:10.1021/ja055750t
Knock-out studies
NC(Cc1c[nH]c2ccc(Cl)cc12)C(=O)O
O-methyltyrosine formation
N[C@H]1C(=O)N[C@@H]2Cc3ccc(c(Cl)c3)Oc3cc4cc(c3O)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(O)cc(c2)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@@H](C(=O)O)NC3=O
kinetically less favored reaction, reaction on monoglycosylated product is favored.
Cc1cccc(O)c1
[#6:1]-[#6:2](-[#6:4]-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]1:[#6:23]:[#6:21](-[#8:22]):[#6:20]:[#6:18](-[#8:19]):[#6:17]:1)-[#6:3]>>[#6:3]-[#6:2](-[#6:4]-[#6:5]-[#6:6]-[#6:7]-[#6:8]-[#6:9]-[#6:10]-[#6:11]-[#6:12]-[#6:13]-[#6:14]-[#6:15]-[#6:16]1:[#6:17](-[#8]):[#6:18](-[#8:19]):[#6:20]:[#6:21](-[#8:22]):[#6:23]:1)-[#6:1]
[#6:77]-[#6:78](-[#6:79])-[#6:76]-[#6@@H:75](-[#7:74])-[#6:73](=[O:72])-[#7:71]-[#6@@H:70]-1-[#6@H:69](-[#8:68])-[c:67]2[c:66][c:65][c:64](-[#8:63]-[c:45]3[c:46][c:47]-4[c:1][c:42](-[#8:41]-[c:40]5[c:39][c:38][c:37]([c:36][c:35]5[Cl:34])-[#6@@H:33](-[#8:32])-[#6@H:31](-[#7:30]-[#6:29](=[O:28])-[#6@H:27](-[#7:26]-[#6:25](=[O:24])-[#6@@H:48]-4-[#7:49]-[#6:51](=[O:50])-[#6@H:56](-[#6:55]-[#6:54](-[#7:53])=[O:52])-[#7:57]-[#6:59]-1=[O:58])-[c:23]1[c:17][c:18][c:20](-[#8:19])[c:21][c:22]1)-[#6:16](=[O:15])-[#7:14]-[#6@H:13](-[#6:12](-[#8:11])=[O:10])-[c:9]1[c:2][c:4](-[#8:3])[c:5][c:7](-[#8:6])[c:8]1)[c:44]3-[#8:43])[c:62]([Cl:61])[c:60]2>>[#6:79]-[#6:78](-[#6:77])-[#6:76]-[#6@@H:75](-[#7:74])-[#6:73](=[O:72])-[#7:71]-[#6@@H:70]-1-[#6@H:69](-[#8:68])-[c:67]2[c:66][c:65][c:64](-[#8:63]-[c:45]3[c:46][c:47]-4[c:1][c:42](-[#8:41]-[c:40]5[c:39][c:38][c:37]([c:36][c:35]5[Cl:34])-[#6@@H:33](-[#8:32])-[#6@@H:31]-5-[#7:30]-[#6:29](=[O:28])-[#6@H:27](-[#7:26]-[#6:25](=[O:24])-[#6@@H:48]-4-[#7:49]-[#6:51](=[O:50])-[#6@H:56](-[#6:55]-[#6:54](-[#7:53])=[O:52])-[#7:57]-[#6:59]-1=[O:58])-[c:23]1[c:17][c:18][c:20](-[#8:19])[c:21]([c:22]1)-[c:2]1[c:4](-[#8:3])[c:5][c:7](-[#8:6])[c:8][c:9]1-[#6@H:13](-[#7:14]-[#6:16]-5=[O:15])-[#6:12](-[#8:11])=[O:10])[c:44]3-[#8:43])[c:62]([Cl:61])[c:60]2
ClmAH
Dehydrogenation
AvaA is a gatekeeping enzyme (cyclodipeptide synthase, producing the cyclo-Arg-Trp diketopiperazine) and not a tailoring enzyme and therefore out of scope of MITE.
direct nitration of tyrosine in MRYLH pentapeptide
C[C@@H]1C(=O)C[C@H]2C(C(=O)O)=CC3CC(C)(C)C[C@]312
doi:10.1021/ja806467a
O=C(O)C(=O)Cc1c[nH]c2cc(Cl)ccc12
MITE0000098
MITE0000099
doi:10.1002/prot.22131
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H](c3ccc(O)cc3)C(=O)N[C@H](C(=O)N[C@H](C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)O)c3cc(O)cc(O)c3)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O)Oc2ccc(cc2Cl)[C@@H]1O
MITE0000092
MITE0000093
MITE0000090
MITE0000091
MITE0000096
MITE0000097
MITE0000094
CC1=CC=CC[C@H](C2CCC[C@@H]2C(=O)O)OC(=O)C[C@H](O)[C@@H](C)C[C@@H](C)C[C@@H](C)C[C@H](C)[C@H]1O
MITE0000095
C=C1NC(=O)C(Cc2c[nH]c3ccc(Cl)cc23)NC(=O)C(NC(=O)C(=CC)NC(=O)C(N)C(C)C)CSCC(C(=O)NC2C(=O)N3CCCC3C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC3CSCC4NC(=O)C(CC(N)=O)NC(=O)C(CSCC5NC(=O)C(Cc6ccccc6)NC(=O)C(CSC=CNC5=O)NC4=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)C4C(O)C(O)CN4C3=O)C(C)O)CSC2C)NC(=O)C(CC(C)C)NC1=O
CC(C)CCCCCCCCCCCCc1cc(O)cc(O)c1O
AEI58869.1
AEI58870.1
Cc1cc(CC(N)C(=O)O)ccc1O
Decarboxylation
AEI58873.1
[#6:47]-[#6@H:18](\[#7:17]=[#6:16]-1/[#7:15]-[#6:14]-[#6:12](=[O:13])-[#7:11]-2-[#6:10]-[#6:9]-[#6@@H:7](-[#6:8])-[#6@H:6]-2-[#6:4](=[O:5])-[#7:3]-[#6@@H:2](-[#6:1])-[#6:50](=[O:51])-[#7:49]-[#6@H:48]-1-[#6:52])-[#6:19](=[O:20])-[#7:21]-[#6@@H:22](-[#6@@H:23](-[#6:24])-[c:25]1[c:26][c:27][c:28][c:29][c:30]1)-[#6:31](=[O:32])-[#7:33]-[#6@H:34](-[#6:35]-[#6:36](-[#8:37])=[O:38])-[#6:39]-1=[#7:40]-[#6@@H:41](-[#6:42]-[#16:43]-1)-[#6:44](-[#8H:45])=[O:46]>>[#6:47]-[#6@H:18](\[#7:17]=[#6:16]-1/[#7:15]-[#6:14]-[#6:12](=[O:13])-[#7:11]-2-[#6:10]-[#6:9]-[#6@@H:7](-[#6:8])-[#6@H:6]-2-[#6:4](=[O:5])-[#7:3]-[#6@@H:2](-[#6:1])-[#6:50](=[O:51])-[#7:49]-[#6@H:48]-1-[#6:52])-[#6:19](=[O:20])-[#7:21]-[#6@@H:22](-[#6@@H:23](-[#6:24])-[c:25]1[c:26][c:27][c:28][c:29][c:30]1)-[#6:31](=[O:32])-[#7:33]-[#6@H:34](-[#6:35]-[#6:36](-[#8:37])=[O:38])-[c:39]1[n:40][c:41][c:42][s:43]1
O-methylation of iodinated orsellenic acid derivate, assumed to be bound to coenzyme A cofactor
AEI58871.1
doi:10.1016/j.apsb.2017.07.005
CheE
doi:10.1021/jacs.2c08957
[#7:1]\[#6@@:2]1-[#6@@:95](/[#8:96])-[#6@:93](\[#8:94])-[#6@@:90](/[#6:91]-[#8:92])-[#8:89]-[#6@:3]-1/[#8:4]>>[#6]-[#6]-[#6]-[#6](=[#8])-[#7:1]\[#6@@:2]1-[#6@@:95](/[#8:96])-[#6@:93](\[#8:94])-[#6@@:90](/[#6:91]-[#8:92])-[#8:89]-[#6@:3]-1/[#8:4]
[#8:1]\[#6@:2]1-[#6@@:6](\[#8:7])-[#6@:5](/[#6:8]2:[#6:14](=[#8:15]):[nH:13]:[#6:11](=[#8:12]):[nH:10]:[#6:9]:2)-[#8:4]-[#6@@:3]-1/[#6:16]=[#8]>>[#7]-[#6:16]/[#6@@:3]1-[#6@@:2](\[#8:1])-[#6@@:6](\[#8:7])-[#6@:5](/[#6:8]2:[#6:14](=[#8:15]):[nH:13]:[#6:11](=[#8:12]):[nH:10]:[#6:9]:2)-[#8:4]-1
K4MV58
PumK
PumJ
PumI
PumG
doi:10.1128/jb.02079-12
Non-Heme Iron-Dependent Dehydrogenase/Oxygenase
Substrate bound as thioester to 4'-phosphopantetheine (acyl carrier protein prosthetic group)
Ple5 a.k.a. PLE5_RHOPP
Transfers glucose onto hpg4 in the vancomycin and teicoplanin aglycone.
[#7:1]\[#6@:2](-[#6:11](-[#8:13])=[#8:12])-[#6:3]-[#6:4]1:[#6:10]:[#6:9](-[#8:14]):[#6:7](-[#8:8]):[#6:6]:[#6:5]:1>>[#6:3]1-[#6@@:2](/[#6:11](=[#8:12])-[#8:13])-[#7:1]-[#6:10]=[#6:4]-1-[#6:5]=[#6:6]-[#6:7](=[#8])-[#6:9](=[#8:8])-[#8:14]
2.5.1.28
glycosyltransferase
Oc1cc(O)c2c(O)cc(O)cc2c1
NapB2
K7WQ45
C[C@@H]1CC=C2SC[C@H](CC(=O)O1)NC(=O)c1coc(n1)C[C@H](O)C[C@H](O)C=CC=CCNC2=O
NapB5
doi:10.1002/cbic.200600308
doi:10.1002/cbic.200400309
C=C(CO)[C@H]1CC=C2C[C@H](O)C[C@H](C)[C@@]2(C)C1
doi:10.1002/cbic.201600406
doi:10.1002/cbic.201402600
amide bond formation between arginine, encoded by the A domain of the NRPS-like gene, and phenylalanine provided by their cognate aminoacyl-tRNAs as substrate.
C=C[C@]1(C)C[C@@H](OC(C)=O)[C@]2(C)[C@H](C)CC[C@]3(CC[C@@H](O)[C@H]32)[C@@H](C)[C@@H]1O
[#8:1]-[#6:2]1:[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]>>[#6:2]1(-[#8]\[#6@@]2-[#6@](\[#8])-[#6]-[#6@](\[#8])-[#6@@](/[#6]-[#8])-[#8]-2):[#6:52]2:[#6:53]:[#6:54]3:[#6:55]:[#6:3]:1-[#8:4]-[#6:5]1:[#6:70]:[#6:69]:[#6:9](-[#6@@:10](/[#8:68])-[#6@@:11]4-[#7:67]-[#6:65](=[#8:66])-[#6@:34](-[#7:35]-[#6:36](=[#8:64])\[#6@@:37]-3-[#7:38]-[#6:39](=[#8:63])\[#6@@:40]-[#7:41]-[#6:42](\[#6@:44](-[#7:58]-[#6:59](-[#6:61]/[#7:62])=[#8:60])-[#6:45]-[#6:46]3:[#6:57]:[#6:56]:[#6:50](-[#8:51]-2):[#6:48](-[Cl:49]):[#6:47]:3)=[#8:43])/[#6:29]2:[#6:30]:[#6:31]:[#6:32](-[#8:33]):[#6:27](:[#6:28]:2)-[#6:20]2:[#6:21](-[#8:26]):[#6:22]:[#6:23](-[#8:25]):[#6:24]:[#6:19]:2-[#6@@:15](/[#6:16](-[#8:18])=[#8:17])-[#7:14]-[#6:12]/4=[#8:13]):[#6:8]:[#6:6]:1-[Cl:7]
Hydroxylation of C-13 in isopropenyl side chain
doi:10.1016/j.jbc.2023.104573
Epoxidation of cytoglobosin D at C6-7 to 20-dihydro-chaetoglobosin A
Cc1cc(O)cc(O)c1C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)O
COC1C(O)=C(C(C)=O)OC(=O)C2(OC3CC(OC4CC(OC5CC(C)(O)C(O)C(C)O5)C(O)C(C)O4)C(O)C(C)O3)C(=O)c3c(cc4cc(OC5CC(OC6CC(O)C(O)C(C)O6)C(O)C(C)O5)c(C)c(O)c4c3O)CC12
Hydroxylation of nine-membered central ring in preparation of ring contraction
O=C(O)C(=O)Cc1ccccc1
ZopL9 a.k.a. ZopK
CC(=O)C1=C(O)[C@@H](O)C2Cc3cc4cc(O)cc(O)c4c(O)c3C(=O)C2(O)C1=O
XhR1
Lassopeptide cysteine protease. Required for macrolactam-synthethase function (folds and cleaves precursor peptide)
COc1c(Cl)c(O)c(Cl)c(C)c1C(=O)O[C@H]1[C@H](O)C[C@H](O[C@H]2[C@@H](O)CC3(O[C@@H]4[C@@H](C)O[C@@H](O[C@@H]5[C@@H](O)[C@H](O[C@H]6[C@H](O)[C@H](OC)[C@H](O[C@@H]7OC[C@@H]8O[C@]9(O[C@H]8[C@H]7OC(=O)C(C)C)O[C@H](C)[C@@](O)(C(C)=O)C7OCOC79)O[C@@H]6CO)O[C@H](C)[C@@H]5OC)C[C@@]4(C)O3)O[C@@H]2C)O[C@@H]1C
Peptidase Subunit
Peptidase subunit
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)C[C@H]2O)Oc2ccc(cc2Cl)[C@@H]1O.Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O[C@@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)O2)c(=O)[nH]c1=O
E3VWJ1
Lassopeptide macrolactam formation of intermediately-cleaved LrcA
CO[C@H]1C[C@H]2C=C[C@H]3[C@H]4O[C@]2(C(C)=C[C@@H](C)[C@@H]([C@H](C)O)OC1=O)[C@@H]3[C@@H](O)[C@@H](C)[C@H]4O
[#6:1]-[c:2]1[c:5][c:8](-[#8:4])[c:15](-[#6:18](=[O:14])-[c:19]2[c:16](-[#8:10])[c:11][c:7][c:12][c:17]2-[#8:22])[c:9]([c:6]1)-[#6:13](-[#8:20])=[O:21]>>[#6:1]-[c:2]1[c:5][c:8](-[#8:4])[c:15](-[#6:18](=[O:14])-[c:19]2[c:16](-[#8:10])[c:11][c:7][c:12][c:17]2-[#8:22])[c:9](-[#6:13]-[#8:20])[c:6]1
[#6]-[#6](-[#7:4]-[#6:5]1:[#6:10](-[#6:11](-[#6:13]\[#6@:14]2-[#6:27](=[#8:28])-[#7:26]-[#6@@:18](\[#6:19]-[#6:20]-[#6:21]-[#7:22]-[#6:23](-[#7:25])=[#7:24])-[#6:16](=[#8:17])-[#7:15]-2)=[#8:12]):[#6:9]:[#6:8]:[#6:7]:[#6:6]:1)=[#8]>>[#7:24]=[#6:23](-[#7:22]-[#6:21]-[#6:20]-[#6:19]\[#6@:18]1-[#6:16](=[#8:17])-[#7:15]-[#6@@:14](\[#6:13]-[#6:11](-[#6:10]2:[#6:5](-[#7:4]):[#6:6]:[#6:7]:[#6:8]:[#6:9]:2)=[#8:12])-[#6:27](=[#8:28])-[#7:26]-1)-[#7:25]
[#6:1]-[#16:2]-[#6:3]-[#6:4]-[#6@@:5](-[#6:7](-[#7:9]/[#6@:10](-[#6:18](-[#7:20]\[#6@:21](-[#6:27](-[#7:29]/[#6@@:30](-[#6:286](-[#6:288])-[#6:287])-[#6:31](-[#7:33]\[#6@:34](-[#6:40](-[#7:42]/[#6@@:43](-[#6:283](-[#6:285])-[#6:284])-[#6:44](-[#7:46]-[#6@:47](-[#6:49](-[#7:51]1-[#6@:55](/[#6:56](-[#7:58]\[#6@:59](-[#6:64](-[#7:66]/[#6@:67](-[#6:73](-[#7:75]\[#6@:76](-[#6:79](-[#7:81]\[#6@:82](-[#6:91](-[#7:93]-[#6:94]-[#6:95](-[#7:97]-[#6@:98](-[#6:100](-[#7:102]\[#6@:103](-[#6:111](-[#7:113]/[#6@:114](-[#6:119](-[#7:121]\[#6@@:122](-[#6@:280](-[#8:282])\[#6:281])-[#6:123](-[#7:125]/[#6@@:126](-[#6:277](-[#6:279])-[#6:278])-[#6:127](-[#7:129]\[#6@@:130](-[#6@:274](-[#8:276])\[#6:275])-[#6:131](-[#7:133]/[#6@:134](-[#6:139](-[#7:141]\[#6@:142](-[#6:145](-[#7:147]/[#6@:148](-[#6:154](-[#7:156]\[#6@:157](-[#6:163](-[#7:165]/[#6@:166](-[#6:169](-[#7:171]\[#6@:172](-[#6:178](-[#7:180]2-[#6@:184](\[#6:185](-[#7:187]-[#6:188]-[#6:189](-[#7:191]\[#6@:192](-[#6:197](-[#7:199]-[#6:200]-[#6:201](-[#7:203]\[#6@:204](-[#6:210](-[#7:212]/[#6@:213](-[#6:221](-[#7:223]-[#6:224]-[#6:225](-[#7:227]/[#6@:228](-[#6:236](-[#7:238]-[#6:239]-[#6:240](-[#7:242]/[#6@@:243](-[#6:271](-[#6:273])-[#6:272])-[#6:244](-[#7:246]\[#6@:247](-[#6:253](-[#7:255]/[#6@:256](-[#6:264](-[#7:266]-[#6:267]-[#6:268](-[#8:270])=[#8:269])=[#8:265])-[#6:257]-[#6:258]-[#6:259]-[#7:260]-[#6:261](-[#7:263])=[#7:262])=[#8:254])-[#6:248]-[#6:249]-[#6:250]-[#6:251]-[#7:252])=[#8:245])=[#8:241])=[#8:237])-[#6:229]-[#6:230]-[#6:231]-[#7:232]-[#6:233](-[#7:235])=[#7:234])=[#8:226])=[#8:222])-[#6:214]-[#6:215]3:[#6:220]:[#6:219]:[#6:218]:[#6:217]:[#6:216]:3)=[#8:211])-[#6:205]-[#6:206]-[#6:207]-[#6:208]-[#7:209])=[#8:202])=[#8:198])-[#6:193]-[#6:194](-[#8:196])=[#8:195])=[#8:190])=[#8:186])-[#6:183]-[#6:182]-[#6:181]-2)=[#8:179])-[#6:173]-[#6:174]-[#6:175]-[#6:176]-[#7:177])=[#8:170])-[#6:167]-[#8:168])=[#8:164])-[#6:158]-[#6:159]-[#6:160]-[#6:161]-[#7:162])=[#8:155])-[#6:149]-[#6:150]-[#6:151]-[#6:152]-[#7:153])=[#8:146])-[#6:143]-[#8:144])=[#8:140])-[#6:135]-[#6:136](-[#6:138])-[#6:137])=[#8:132])=[#8:128])=[#8:124])=[#8:120])-[#6:115]-[#6:116](-[#6:118])-[#6:117])=[#8:112])-[#6:104]-[#6:105]2:[#6:110]:[#6:109]:[#6:108]:[#6:107]:[#6:106]:2)=[#8:101])/[#6:99])=[#8:96])=[#8:92])-[#6:83]-[#6:84]2:[#6:90]:[#6:89]:[#6:87](-[#8:88]):[#6:86]:[#6:85]:2)=[#8:80])-[#6:77]-[#8:78])=[#8:74])-[#6:68]-[#6:69]-[#6:70]-[#6:71]-[#7:72])=[#8:65])-[#6:60]-[#6:61](-[#6:63])-[#6:62])=[#8:57])-[#6:54]-[#6:53]-[#6:52]-1)=[#8:50])\[#6:48])=[#8:45])=[#8:41])-[#6:35]-[#6:36]-[#6:37](=[#8:39])-[#7:38])=[#8:32])=[#8:28])-[#6:22]-[#6:23]-[#6:24]-[#6:25]-[#7:26])=[#8:19])-[#6:11]-[#6:12]-[#6:13]-[#7:14]-[#6:15](-[#7:17])=[#7:16])=[#8:8])/[#7:6]>>[#7:141]\[#6@:142](-[#6:145](-[#7:147]/[#6@:148](-[#6:154](-[#7:156]\[#6@:157](-[#6:163](-[#7:165]/[#6@:166](-[#6:169](-[#7:171]\[#6@:172](-[#6:178](-[#7:180]1-[#6@:184](\[#6:185](-[#7:187]-[#6:188]-[#6:189](-[#7:191]\[#6@:192](-[#6:197](-[#7:199]-[#6:200]-[#6:201](-[#7:203]\[#6@:204](-[#6:210](-[#7:212]/[#6@:213](-[#6:221](-[#7:223]-[#6:224]-[#6:225](-[#7:227]/[#6@:228](-[#6:236](-[#7:238]-[#6:239]-[#6:240](-[#7:242]/[#6@@:243](-[#6:271](-[#6:273])-[#6:272])-[#6:244](-[#7:246]\[#6@:247](-[#6:253](-[#7:255]/[#6@:256](-[#6:264](-[#7:266]-[#6:267]-[#6:268](-[#8:270])=[#8:269])=[#8:265])-[#6:257]-[#6:258]-[#6:259]-[#7:260]-[#6:261](-[#7:263])=[#7:262])=[#8:254])-[#6:248]-[#6:249]-[#6:250]-[#6:251]-[#7:252])=[#8:245])=[#8:241])=[#8:237])-[#6:229]-[#6:230]-[#6:231]-[#7:232]-[#6:233](-[#7:235])=[#7:234])=[#8:226])=[#8:222])-[#6:214]-[#6:215]2:[#6:216]:[#6:217]:[#6:218]:[#6:219]:[#6:220]:2)=[#8:211])-[#6:205]-[#6:206]-[#6:207]-[#6:208]-[#7:209])=[#8:202])=[#8:198])-[#6:193]-[#6:194](-[#8:196])=[#8:195])=[#8:190])=[#8:186])-[#6:183]-[#6:182]-[#6:181]-1)=[#8:179])-[#6:173]-[#6:174]-[#6:175]-[#6:176]-[#7:177])=[#8:170])-[#6:167]-[#8:168])=[#8:164])-[#6:158]-[#6:159]-[#6:160]-[#6:161]-[#7:162])=[#8:155])-[#6:149]-[#6:150]-[#6:151]-[#6:152]-[#7:153])=[#8:146])-[#6:143]-[#8:144]
Pseudouridine synthase
[#6:1](-[#6:2]-[#6:3]-[#6:4](=[#6:13]-[#6:12]1:[#6:16]2:[#6:17]:[#6:18]:[#6:19]:[#6:20]:[#6:15]:2:[#7:14]:[#6:11]:1)-[#6:5])=[#6:6](-[#6:28])-[#6:7]-[#6:8]-[#6:9]=[#6:10](-[#6:27])-[#6:21]-[#6:22]-[#6:23]=[#6:24](-[#6:26])-[#6:25]>>[#6:1](-[#6:2]-[#6:3]-[#6:4](=[#6:13]-[#6:12]1:[#6:16]2:[#6:17]:[#6:18]:[#6:19]:[#6:20]:[#6:15]:2:[#7:14]:[#6:11]:1)-[#6:5])=[#6:6](-[#6:28])-[#6:7]-[#6:8]-[#6:9]1-[#8]-[#6:10]-1(-[#6:27])-[#6:21]-[#6:22]-[#6:23]=[#6:24](-[#6:26])-[#6:25]
A0A6S6QPY4
A0A2R4FXY7
A0A2R4FXY6
CC(C)C(O)[C@H](N)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)O
alkylresorcinol monooxygenase
NC(Cc1c[nH]c2c(Cl)cccc12)C(=O)O
C=C(C)[C@H]1CC=C2[C@H](O)CC[C@H](C)[C@@]2(C)C1
[#6:1]1(/[#6@@:9]2-[#8:33]-[#6:31](=[#8:32])-[#6:30]-[#6@:28](/[#8:29])-[#6@@:26](\[#6:27])-[#6:25]-[#6@@:23](\[#6:24])-[#6:22]-[#6@@:20](\[#6:21])-[#6:19]-[#6@:17](/[#6:18])-[#6@@:15](/[#8:16])-[#6:13](-[#6:14]=[#7]-[#8])=[#6:12]-[#6:34]=[#6:11]-[#6:10]-2)-[#6@@:5](\[#6:6](=[#8:8])-[#8:7])-[#6:4]-[#6:3]-[#6:2]-1>>[#6:1]1(/[#6@@:9]2-[#8:33]-[#6:31](=[#8:32])-[#6:30]-[#6@:28](/[#8:29])-[#6@@:26](\[#6:27])-[#6:25]-[#6@@:23](\[#6:24])-[#6:22]-[#6@@:20](\[#6:21])-[#6:19]-[#6@:17](/[#6:18])-[#6@@:15](/[#8:16])-[#6:13](-[#6:14]#[#7])=[#6:12]-[#6:34]=[#6:11]-[#6:10]-2)-[#6@@:5](\[#6:6](=[#8:8])-[#8:7])-[#6:4]-[#6:3]-[#6:2]-1
CSCC[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
COC1C(O)=C(C(C)=O)C(=O)C2(OC3CC(OC4CC(OC5CC(C)(O)C(O)C(C)O5)C(O)C(C)O4)C(O)C(C)O3)C(=O)c3c(cc4cc(O)c(C)c(O)c4c3O)CC12
[#6:1]1:[#6:5]:[#6:6]:[#6:4]:[#6:2]:[#6:3]:1-[#6:7]-[#6:8](=[#8])-[#6:9](=[#8:11])-[#8:10]>>[#6:1]1:[#6:5]:[#6:6]:[#6:4]:[#6:2]:[#6:3]:1-[#6:7]-[#6@:8](/[#8])-[#6:9](=[#8:11])-[#8:10]
Iodination of orsellenic acid derivate, assumed to be bound to 4'-phosphopantetheine cofactor
[#6:1]/[#6@@:2]1-[#6:6]2-[#6:7]-[#6:8](-[#6:11]-[#6:12](=[#6:13](-[#6:30])-[#6:14]-[#8:15]-[#6:16]3-[#8:21]-[#6@:20](\[#6:22]-[#8:23])-[#6@@:19](/[#8:24])-[#6@:18](\[#8:25])-[#6@:17]-3/[#7:26]-[#6:27](=[#8:29])-[#6:28])-[#6:5]-2-[#6:4]-[#6:3]-1)(-[#6:10])-[#6:9]>>[#6:1]/[#6@@:2]1-[#6:6]2-[#6:7]-[#6:8](-[#6:11]-[#6:12](=[#6:13](-[#6:30]-[#8])-[#6:14]-[#8:15]-[#6:16]3-[#8:21]-[#6@:20](\[#6:22]-[#8:23])-[#6@@:19](/[#8:24])-[#6@:18](\[#8:25])-[#6@:17]-3/[#7:26]-[#6:27](=[#8:29])-[#6:28])-[#6:5]-2-[#6:4]-[#6:3]-1)(-[#6:9])-[#6:10]
Flavin mononucleotide
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)C[C@H](O)[C@H]2O)Oc2ccc(cc2Cl)[C@@H]1O.Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O[C@@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)O2)c(=O)[nH]c1=O
doi:10.1101/2023.11.03.565440
[#6:1]1:[#6:2]:[#6:77]2:[#6:78]:[#6:80](:[#6:81]:1-[#8:82]-[#6:83]1:[#6:84](-[#8:85]):[#6:34]3-[#8:35]-[#6:36]4:[#6:38](:[#6:39]:[#6:40](-[#6:41]-[#6@@:42]5\[#6:44](-[#7:45]-[#6@:46](\[#6:47](-[#7:48]-[#6@@:49](\[#6:50](-[#7:51]-[#6@@:52]6/[#6:57]7:[#6:58]:[#6:59](-[#6:66]8:[#6:67](-[#6@:71](-[#7:72]-[#6:74](/[#6@:75](-[#6@@:76]-2/[#8:3])-[#7:4]-[#6:6]-6=[#8:5])=[#8:73])/[#6:70](=[#8:69])-[#8:68]):[#6:62]:[#6:63](:[#6:64]:[#6:65]:8-[#8:60])-[#8:61]):[#6:54](:[#6:55]:[#6:56]:7)-[#8:53])=[#8:7])-[#6:32](:[#6:33]:3):[#6:31]:1)=[#8:8])-[#6:13]1:[#6:14]:[#6:15](-[#8:16]-[#6:21]2:[#6:22]:[#6:23](-[#6@:25](-[#6:27](-[#7:28]-5)=[#8:26])/[#7:24]):[#6:18]:[#6:19]:[#6:20]:2-[#8:17]):[#6:10]:[#6:11](:[#6:12]:1)-[#8:9])=[#8:43]):[#6:29]:[#6:30]:4)-[Cl:37])-[Cl:79]>>[#6:1]1:[#6:2]:[#6:77]2:[#6:78]:[#6:80](:[#6:81]:1-[#8:82]-[#6:83]1:[#6:84](-[#8:85]\[#6@@]3-[#6@](-[#6@](\[#8])-[#8]-[#6@@](-[#6@]-3/[#8])\[#6]-[#8])/[#7]-[#6](-[#6])=[#8]):[#6:34]3-[#8:35]-[#6:36]4:[#6:38](:[#6:39]:[#6:40](-[#6:41]-[#6@@:42]5\[#6:44](-[#7:45]-[#6@:46](\[#6:47](-[#7:48]-[#6@@:49](\[#6:50](-[#7:51]-[#6@@:52]6/[#6:57]7:[#6:58]:[#6:59](-[#6:66]8:[#6:67](-[#6@:71](-[#7:72]-[#6:74](/[#6@:75](-[#6@@:76]-2/[#8:3])-[#7:4]-[#6:6]-6=[#8:5])=[#8:73])/[#6:70](=[#8:69])-[#8:68]):[#6:62]:[#6:63](:[#6:64]:[#6:65]:8-[#8:60])-[#8:61]):[#6:54](:[#6:55]:[#6:56]:7)-[#8:53])=[#8:7])-[#6:32](:[#6:33]:3):[#6:31]:1)=[#8:8])-[#6:13]1:[#6:14]:[#6:15](-[#8:16]-[#6:21]2:[#6:22]:[#6:23](-[#6@:25](-[#6:27](-[#7:28]-5)=[#8:26])/[#7:24]):[#6:18]:[#6:19]:[#6:20]:2-[#8:17]):[#6:10]:[#6:11](:[#6:12]:1)-[#8:9])=[#8:43]):[#6:29]:[#6:30]:4)-[Cl:37])-[Cl:79]
doi:10.1021/bi010050w
[#6:1]\[#6@:2]1-[#8:34]-[#6:32](=[#8:33])-[#6:31]-[#6@@:28](\[#6:29]-[#16:30])-[#7:27]-[#6:25](=[#8:26])-[#6:22]2:[#6:23]:[#8:24]:[#6:20](:[#7:21]:2)-[#6:19]-[#6@:17](/[#8:18])-[#6:16]-[#6@:14](/[#8:15])-[#6:13]=[#6:12]-[#6:11]=[#6:10]-[#6:9]-[#7:8]-[#6:6](=[#8:7])-[#6:5]=[#6:4]-[#6:3]-1>>[#6:1]\[#6@:2]1-[#8:34]-[#6:32](=[#8:33])-[#6:31]-[#6@:28]2\[#6:29]-[#16:30]-[#6&H0:5](-[#6:6](-[#7:8]-[#6:9]-[#6:10]=[#6:11]-[#6:12]=[#6:13]-[#6@:14](-[#6:16]-[#6@:17](-[#6:19]-[#6:20]3:[#8:24]:[#6:23]:[#6:22](-[#6:25](-[#7:27]-2)=[#8:26]):[#7:21]:3)/[#8:18])/[#8:15])=[#8:7])=[#6:4]-[#6:3]-1
doi:10.1093/gbe/evt082
1.14.13.171
1.14.13.170
doi:10.1128/AEM.03015-10
Catalyzes D-ring-forming Michael addition
AVT42378.1
AVT42380.1
AVT42376.1
AVL27080.1
AVT42379.1
N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
Cleavage of C-terminal glycin cyclicized lariocidin A lassopeptide, resulting in lariocidin C
[#6:1]-[#6:2]-[#6@@:3](-[#6@@:5](/[#6:39](-[#7:41]\[#6@:42](-[#6:53](-[#7:55]\[#6@:56](-[#6:65](-[#7:67]/[#6@:68](-[#6:71](-[#8:73])=[#8:72])-[#6:69]-[#8:70])=[#8:66])-[#6:57]-[#6:58]1:[#6:64]:[#6:63]:[#6:61](-[#8:62]):[#6:60]:[#6:59]:1)=[#8:54])-[#6:43]-[#6:44]1:[#6:52]2:[#6:47](:[#6:48]:[#6:49]:[#6:50]:[#6:51]:2):[#7:46]:[#6:45]:1)=[#8:40])-[#7:6]-[#6:7](\[#6@@:9](-[#7:17]-[#6:18](\[#6@@:20](-[#7:31]-[#6:32](-[#6@:34](-[#6@:36](-[#8:38])\[#6:37])/[#7:35])=[#8:33])-[#6:21]-[#6:22]1:[#6:30]2:[#6:25](:[#6:26]:[#6:27]:[#6:28]:[#6:29]:2):[#7:24]:[#6:23]:1)=[#8:19])-[#6:10]-[#6:11]1:[#6:16]:[#6:15]:[#6:14]:[#6:13]:[#6:12]:1)=[#8:8])/[#6:4]>>[#6:1]-[#6:2]-[#6@@:3](-[#6@:5]1/[#6:39](-[#7:41]\[#6@:42](-[#6:53](-[#7:55]\[#6@:56](-[#6:65](-[#7:67]/[#6@:68](-[#6:71](-[#8:73])=[#8:72])-[#6:69]-[#8:70])=[#8:66])-[#6:57]-[#6:58]2:[#6:59]:[#6:60]:[#6:61](-[#8:62]):[#6:63]:[#6:64]:2)=[#8:54])-[#6:43]-[#6:44]2:[#6:52]3:[#6:47](:[#6:48]:[#6:49]:[#6:50]:[#6:51]:3):[#7&H0:46](-[#6:29]3:[#6:30]4:[#6:25](:[#6:26]:[#6:27]:[#6:28]:3):[#7:24]:[#6:23]:[#6:22]:4-[#6:21]-[#6@:20](-[#7:31]-[#6:32](-[#6@:34](-[#6@:36](-[#8:38])\[#6:37])/[#7:35])=[#8:33])\[#6:18](=[#8:19])-[#7:17]-[#6@@:9](-[#6:10]-[#6:11]3:[#6:12]:[#6:13]:[#6:14]:[#6:15]:[#6:16]:3)\[#6:7](=[#8:8])-[#7:6]-1):[#6:45]:2)=[#8:40])/[#6:4]
nitroc oxide synthase oxygenase
[#6:1]1:[#6:2]:[#6:77]2:[#6:78]:[#6:80](:[#6:81]:1-[#8:82]-[#6:83]1:[#6:84](-[#8:85]):[#6:34]3-[#8:35]-[#6:36]4:[#6:38](:[#6:39]:[#6:40](-[#6:41]-[#6@@:42]5\[#6:44](-[#7:45]-[#6@:46](\[#6:47](-[#7:48]-[#6@@:49](\[#6:50](-[#7:51]-[#6@@:52]6/[#6:57]7:[#6:58]:[#6:59](-[#6:66]8:[#6:67](-[#6@:71](-[#7:72]-[#6:74](/[#6@:75](-[#6@@:76]-2/[#8:3])-[#7:4]-[#6:6]-6=[#8:5])=[#8:73])/[#6:70](=[#8:69])-[#8:68]):[#6:62]:[#6:63](:[#6:64]:[#6:65]:8-[#8:60])-[#8:61]):[#6:54](:[#6:55]:[#6:56]:7)-[#8:53])=[#8:7])-[#6:32](:[#6:33]:3):[#6:31]:1)=[#8:8])-[#6:13]1:[#6:14]:[#6:15](-[#8:16]-[#6:21]2:[#6:22]:[#6:23](-[#6@:25](-[#6:27](-[#7:28]-5)=[#8:26])/[#7:24]):[#6:18]:[#6:19]:[#6:20]:2-[#8:17]):[#6:10]:[#6:11](:[#6:12]:1)-[#8:9])=[#8:43]):[#6:29]:[#6:30]:4)-[Cl:37])-[Cl:79]>>[#6:1]1:[#6:2]:[#6:77]2:[#6:78]:[#6:80](:[#6:81]:1-[#8:82]-[#6:83]1:[#6:84](-[#8:85]\[#6@@]3-[#6@](-[#6@](\[#8])-[#8]-[#6@@](-[#6@]-3/[#8])\[#6]-[#8])/[#7]):[#6:34]3-[#8:35]-[#6:36]4:[#6:38](:[#6:39]:[#6:40](-[#6:41]-[#6@@:42]5\[#6:44](-[#7:45]-[#6@:46](\[#6:47](-[#7:48]-[#6@@:49](\[#6:50](-[#7:51]-[#6@@:52]6/[#6:57]7:[#6:58]:[#6:59](-[#6:66]8:[#6:67](-[#6@:71](-[#7:72]-[#6:74](/[#6@:75](-[#6@@:76]-2/[#8:3])-[#7:4]-[#6:6]-6=[#8:5])=[#8:73])/[#6:70](=[#8:69])-[#8:68]):[#6:62]:[#6:63](:[#6:64]:[#6:65]:8-[#8:60])-[#8:61]):[#6:54](:[#6:55]:[#6:56]:7)-[#8:53])=[#8:7])-[#6:32](:[#6:33]:3):[#6:31]:1)=[#8:8])-[#6:13]1:[#6:14]:[#6:15](-[#8:16]-[#6:21]2:[#6:22]:[#6:23](-[#6@:25](-[#6:27](-[#7:28]-5)=[#8:26])/[#7:24]):[#6:18]:[#6:19]:[#6:20]:2-[#8:17]):[#6:10]:[#6:11](:[#6:12]:1)-[#8:9])=[#8:43]):[#6:29]:[#6:30]:4)-[Cl:37])-[Cl:79]
C=C1/C=C(\C)C[C@H]2C[C@@H](OC(=O)/C=C(C)/C=C/C[C@@H](O)C1)[C@@](C)([C@H](O)/C=C(\C)C[C@H](O)C(C)(C)[C@H](O)C[C@H](O)[C@@H](C)[C@H](O)C[C@@H](CC(=C)C(=C)OC)OC(=O)CCCCCCCCCCCCCCC)O2
Dehydrogenase, improves conversion rate of BorI
L-Ornithine N(5)-oxygenase
Acetylation
PyiA
